DATABASE;NAME;GO ACCESSION;SIZE;ES;NES;NOM p-val;FDR q-val
GO BP;COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE;GO:0006613;92;0.71573025;3.2465608;0;0
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM;GO:0072599;105;0.6588838;2.9851322;0;0
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY;GO:0000184;110;0.59762233;2.7641044;0;0
GO BP;MITOCHONDRIAL TRANSLATIONAL TERMINATION;GO:0070126;85;0.6109978;2.691212;0;0
GO BP;TRANSLATIONAL TERMINATION;GO:0006415;99;0.58944416;2.661685;0;0
GO BP;MITOCHONDRIAL TRANSLATION;GO:0032543;130;0.54118466;2.5721054;0;0
GO BP;TRANSLATIONAL INITIATION;GO:0006413;167;0.52176017;2.5628197;0;0
GO BP;PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM;GO:0070972;124;0.54611933;2.5463364;0;0
GO BP;TRANSLATIONAL ELONGATION;GO:0006414;122;0.5386861;2.498355;0;6.03E-05
GO BP;PROTEIN TARGETING TO MEMBRANE;GO:0006612;162;0.5000758;2.4268973;0;5.43E-05
GO BP;MITOCHONDRIAL GENE EXPRESSION;GO:0140053;157;0.50181234;2.4118555;0;4.93E-05
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS;GO:0000956;186;0.46930838;2.363152;0;4.52E-05
GO BP;CYTOPLASMIC TRANSLATION;GO:0002181;87;0.51288;2.2840383;0;1.70E-04
GO BP;CYTOCHROME COMPLEX ASSEMBLY;GO:0017004;34;0.61371726;2.2340353;0;3.96E-04
GO BP;VIRAL GENE EXPRESSION;GO:0019080;176;0.4274465;2.127069;0;0.002106314
GO BP;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY;GO:0033108;89;0.46220928;2.0485322;0;0.007493179
GO BP;OXIDATIVE PHOSPHORYLATION;GO:0006119;126;0.43586105;2.0463185;0;0.007182805
GO BP;PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX;GO:0030150;16;0.6766792;2.0194147;0.002232143;0.009223934
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE;GO:0090150;271;0.37968332;1.9936566;0;0.012278396
GO BP;RESPIRATORY CHAIN COMPLEX IV ASSEMBLY;GO:0008535;24;0.6077625;1.977724;0;0.01392247
GO BP;ATP SYNTHESIS COUPLED ELECTRON TRANSPORT;GO:0042773;85;0.4490646;1.9446614;0;0.018835362
GO BP;PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS;GO:0010499;18;0.62990516;1.9042821;0.004484305;0.028723955
GO BP;RESPIRATORY ELECTRON TRANSPORT CHAIN;GO:0022904;101;0.41838896;1.8964074;0;0.030052986
GO BP;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX IV ASSEMBLY;GO:0033617;20;0.60663855;1.8737983;0;0.036755122
GO BP;ELECTRON TRANSPORT CHAIN;GO:0022900;153;0.38589233;1.8634697;0;0.038889553
GO BP;RIBOSOME ASSEMBLY;GO:0042255;54;0.47090584;1.862894;0.002380953;0.037650175
GO BP;REGULATION OF CELLULAR AMINE METABOLIC PROCESS;GO:0033238;58;0.45571414;1.8450639;0;0.0440055
GO BP;REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS;GO:0006521;48;0.4676907;1.8210051;0.002512563;0.053576645
GO BP;RIBOSOMAL SMALL SUBUNIT BIOGENESIS;GO:0042274;64;0.43487525;1.81129;0;0.05660011
GO BP;CELLULAR PROTEIN COMPLEX DISASSEMBLY;#N/A;183;0.35802764;1.8095489;0;0.05573135
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE;#N/A;16;0.6090878;1.8051758;0.006550218;0.05624987
GO BP;INNER MITOCHONDRIAL MEMBRANE ORGANIZATION;GO:0007007;44;0.47165513;1.7888819;0.00477327;0.0629414
GO BP;ATP SYNTHESIS COUPLED PROTON TRANSPORT;GO:0015986;22;0.5323521;1.774465;0.006741573;0.07031991
GO BP;RNA CATABOLIC PROCESS;GO:0006401;343;0.33466175;1.770515;0;0.070816755
GO BP;ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS;GO:0031145;72;0.41233242;1.7701306;0.002518892;0.06906218
GO BP;PROTEIN TARGETING;GO:0006605;365;0.32576212;1.7255381;0;0.100829296
GO BP;MESENCHYME MORPHOGENESIS;#N/A;30;0.48602512;1.720276;0.006993007;0.10236843
GO BP;PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE;#N/A;30;0.4881973;1.69654;0.004494382;0.12316893
GO BP;NEGATIVE REGULATION OF AXON GUIDANCE;#N/A;18;0.5484297;1.6919289;0.02096436;0.12494777
GO BP;RIBOSOMAL SMALL SUBUNIT ASSEMBLY;GO:0000028;15;0.574883;1.6782655;0.02244898;0.13683179
GO BP;RIBOSOMAL LARGE SUBUNIT BIOGENESIS;GO:0042273;65;0.39454806;1.6597606;0;0.15548746
GO BP;AEROBIC ELECTRON TRANSPORT CHAIN;GO:0019646;17;0.5533075;1.654997;0.015486726;0.1576302
GO BP;RIBOSOME BIOGENESIS;GO:0042254;275;0.3110801;1.6314744;0.003030303;0.18645328
GO BP;PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS;#N/A;44;0.419875;1.630404;0.011574074;0.18382795
GO BP;PEPTIDYL ASPARAGINE MODIFICATION;#N/A;31;0.45424578;1.615331;0.01590909;0.20128752
GO BP;CRISTAE FORMATION;GO:0042407;32;0.4505153;1.6119423;0.01594533;0.2022852
GO BP;CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS;#N/A;469;0.2939635;1.6082523;0;0.20336449
GO BP;ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS;#N/A;500;0.289384;1.6004311;0;0.2116346
GO BP;CELLULAR RESPIRATION;GO:0045333;162;0.32598743;1.5932972;0;0.2190103
GO BP;TRNA METABOLIC PROCESS;GO:0006399;165;0.32059056;1.5833944;0;0.23127271
GO BP;REGULATION OF ANIMAL ORGAN FORMATION;GO:0003156;16;0.539879;1.5534902;0.034324944;0.28385472
GO BP;NADH DEHYDROGENASE COMPLEX ASSEMBLY;GO:0010257;60;0.3762022;1.5468601;0.011441648;0.29237953
GO BP;AXIS ELONGATION;GO:0003401;20;0.4879842;1.5459849;0.042372882;0.28875735
GO BP;PRIMARY ALCOHOL METABOLIC PROCESS;#N/A;40;0.41119152;1.5442469;0.026699029;0.28677595
GO BP;AMINE METABOLIC PROCESS;GO:0009308;83;0.35524482;1.5431461;0.012285012;0.28352576
GO BP;MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE;GO:0006120;49;0.3909191;1.5357883;0.013793103;0.2938107
GO BP;CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT;#N/A;20;0.49786213;1.5349869;0.037777778;0.29014736
GO BP;C21 STEROID HORMONE BIOSYNTHETIC PROCESS;GO:0006700;19;0.48900706;1.5261469;0.052511416;0.30353707
GO BP;INOSITOL TRISPHOSPHATE METABOLIC PROCESS;GO:0032957;18;0.49600157;1.5248863;0.045161292;0.301289
GO BP;RIBONUCLEOPROTEIN COMPLEX BIOGENESIS;#N/A;392;0.27939335;1.5229787;0;0.3002756
GO BP;POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION;GO:0010862;26;0.44281885;1.5144709;0.030837005;0.31285074
GO BP;MITOCHONDRIAL TRANSMEMBRANE TRANSPORT;GO:1990542;81;0.34728038;1.5114385;0.004854369;0.31414208
GO BP;RIBOSOMAL LARGE SUBUNIT ASSEMBLY;GO:0000027;26;0.44441625;1.5025498;0.028571429;0.32905862
GO BP;AEROBIC RESPIRATION;GO:0009060;79;0.3496298;1.5017527;0.009756098;0.32550082
GO BP;REGULATION OF STEM CELL POPULATION MAINTENANCE;GO:2000036;26;0.44152385;1.4993542;0.03846154;0.3259127
GO BP;CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY;#N/A;58;0.3690866;1.4969219;0.028639618;0.32613072
GO BP;MRNA CIS SPLICING VIA SPLICEOSOME;GO:0045292;29;0.43177813;1.4832875;0.054945055;0.35237464
GO BP;RRNA METABOLIC PROCESS;GO:0016072;208;0.2921823;1.4826717;0.003095975;0.3485949
GO BP;NEGATIVE REGULATION OF AXON EXTENSION;GO:0030517;24;0.43947595;1.4824154;0.054054055;0.34408358
GO BP;SKELETAL MUSCLE ADAPTATION;#N/A;15;0.5172341;1.4765716;0.06535948;0.35280263
GO BP;SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:0031146;82;0.33451357;1.4638394;0.021680217;0.3795016
GO BP;DIOL METABOLIC PROCESS;#N/A;18;0.47627625;1.4617528;0.070776254;0.37954202
GO BP;CILIUM MOVEMENT;GO:0003341;39;0.38667446;1.4561871;0.03837953;0.3886442
GO BP;NCRNA METABOLIC PROCESS;#N/A;419;0.2640313;1.4509696;0;0.39659882
GO BP;NEGATIVE CHEMOTAXIS;GO:0050919;25;0.425899;1.4374074;0.064444445;0.42826343
GO BP;AMINO ACID ACTIVATION;#N/A;45;0.37332147;1.4373897;0.03196347;0.4226801
GO BP;CERAMIDE CATABOLIC PROCESS;GO:0046514;17;0.47656316;1.4346724;0.068085104;0.4245923
GO BP;PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION;GO:0060389;38;0.38526323;1.4339284;0.054761905;0.4211639
GO BP;RESPONSE TO VITAMIN D;GO:0033280;18;0.47134483;1.4242755;0.0782241;0.44226968
GO BP;PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS;GO:0006221;36;0.39087328;1.4234989;0.044705883;0.43867654
GO BP;LENS MORPHOGENESIS IN CAMERA TYPE EYE;GO:0002089;15;0.48947576;1.4201126;0.08085106;0.4427976
GO BP;PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0032984;265;0.27227435;1.4188117;0.002985075;0.44090062
GO BP;INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT;GO:0065002;45;0.366058;1.4183598;0.03794643;0.43685853
GO BP;HYDROGEN PEROXIDE METABOLIC PROCESS;GO:0042743;29;0.40769908;1.4167606;0.06807512;0.43609622
GO BP;CELLULAR RESPONSE TO VITAMIN;#N/A;15;0.48419482;1.4134157;0.08108108;0.43974504
GO BP;ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE;GO:0061844;22;0.4368257;1.4124322;0.07488987;0.43727
GO BP;SPERM MOTILITY;#N/A;42;0.37005135;1.4114918;0.051764704;0.4351479
GO BP;POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;#N/A;66;0.3389475;1.4113219;0.029268293;0.43073326
GO BP;ANTIBIOTIC CATABOLIC PROCESS;#N/A;25;0.4178912;1.4046991;0.07809111;0.44402143
GO BP;PROTEIN TARGETING TO MITOCHONDRION;GO:0006626;87;0.31985494;1.4029756;0.037783377;0.44377303
GO BP;EXTRACELLULAR TRANSPORT;GO:0006858;20;0.44708836;1.4026358;0.07453416;0.43999138
GO BP;ENDOCARDIAL CUSHION MORPHOGENESIS;GO:0003203;19;0.45810667;1.3952857;0.09656652;0.45561048
GO BP;NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY;GO:0051444;16;0.47369114;1.3918554;0.098684214;0.46078148
GO BP;PROTEIN TRANSMEMBRANE TRANSPORT;GO:0071806;52;0.3468852;1.3878587;0.06235566;0.4668008
GO BP;POSITIVE REGULATION OF ORGAN GROWTH;GO:0046622;27;0.39953253;1.3838311;0.087759815;0.47346687
GO BP;PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS;GO:0006213;21;0.43816996;1.3828926;0.08742005;0.47119674
GO BP;MITOCHONDRIAL RNA METABOLIC PROCESS;GO:0000959;45;0.35554546;1.3812978;0.06699752;0.47082928
GO BP;ANIMAL ORGAN FORMATION;GO:0048645;37;0.3816312;1.3772792;0.07962529;0.47795194
GO BP;EMBRYO IMPLANTATION;GO:0007566;36;0.37287477;1.373506;0.06833713;0.48369223
GO BP;CLEAVAGE INVOLVED IN RRNA PROCESSING;GO:0000469;21;0.42778227;1.3657303;0.09698276;0.5021662
GO BP;MATURATION OF SSU RRNA;GO:0030490;46;0.34912473;1.3634181;0.06443914;0.5037863
GO BP;REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION;GO:1901532;69;0.3263506;1.3610318;0.06097561;0.5062824
GO BP;PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS;GO:0006778;31;0.38235322;1.3498856;0.08294931;0.5359536
GO BP;MIDBODY ABSCISSION;GO:0061952;17;0.44559425;1.3478634;0.11011236;0.53717077
GO BP;POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS;#N/A;21;0.4188046;1.3473881;0.10352423;0.5335469
GO BP;HEME METABOLIC PROCESS;GO:0042168;27;0.3951323;1.3464183;0.092857145;0.53145623
GO BP;CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER;#N/A;21;0.419942;1.3457077;0.1002331;0.5287338
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE;GO:0072594;473;0.24519192;1.3436698;0;0.5302463
GO BP;NERVE DEVELOPMENT;GO:0021675;39;0.3523468;1.342937;0.07256236;0.5275839
GO BP;RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION;#N/A;173;0.2735227;1.3373777;0.016260162;0.5403139
GO BP;PROTEIN LOCALIZATION TO MEMBRANE;GO:0072657;475;0.24242415;1.3367325;0.003546099;0.5374868
GO BP;MITOCHONDRION ORGANIZATION;GO:0007005;445;0.24085057;1.3325409;0;0.54603547
GO BP;POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST;GO:0002230;17;0.43369228;1.3312689;0.1416309;0.5451718
GO BP;CYTOPLASMIC TRANSLATIONAL INITIATION;GO:0002183;27;0.389948;1.3279792;0.0982906;0.55077046
GO BP;REGULATION OF SMOOTH MUSCLE CONTRACTION;GO:0006940;25;0.3923986;1.3228784;0.12200957;0.5621815
GO BP;RESPONSE TO INTERFERON BETA;GO:0035456;18;0.42532834;1.3221704;0.13544019;0.55959797
GO BP;RESPONSE TO GONADOTROPIN;#N/A;21;0.41976964;1.3214581;0.122727275;0.55715835
GO BP;POLYOL BIOSYNTHETIC PROCESS;#N/A;51;0.3337656;1.3162279;0.10243902;0.56968707
GO BP;MONONUCLEAR CELL MIGRATION;GO:0071674;32;0.36567163;1.3159508;0.10273973;0.56588477
GO BP;NCRNA PROCESSING;GO:0034470;340;0.24844599;1.3131753;0;0.5702431
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION;GO:0030857;25;0.38723564;1.3096044;0.1173913;0.57723975
GO BP;NEURAL CREST CELL MIGRATION;GO:0001755;29;0.37470433;1.3056029;0.12880562;0.5857943
GO BP;NEGATIVE REGULATION OF RNA SPLICING;GO:0033119;25;0.38568598;1.3045628;0.11971831;0.58457154
GO BP;PEPTIDYL L CYSTEINE S PALMITOYLATION;GO:0018230;18;0.42329848;1.303682;0.14316703;0.5830139
GO BP;PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS;GO:0006220;51;0.32769895;1.2974945;0.09192825;0.59909856
GO BP;TETRAPYRROLE METABOLIC PROCESS;#N/A;45;0.33323318;1.2888737;0.10401891;0.62478876
GO BP;CHROMATIN REMODELING AT CENTROMERE;#N/A;41;0.34518388;1.2864478;0.11876485;0.6285377
GO BP;HOMOLOGOUS CHROMOSOME SEGREGATION;GO:0045143;38;0.34246525;1.2839774;0.13084112;0.6324723
GO BP;NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE;#N/A;23;0.38917705;1.2839124;0.14823009;0.6278266
GO BP;INTRA GOLGI VESICLE MEDIATED TRANSPORT;GO:0006891;28;0.38145038;1.2827424;0.13695653;0.62737787
GO BP;NEGATIVE REGULATION OF DNA BINDING;GO:0043392;36;0.35335407;1.2752836;0.13501143;0.6495776
GO BP;RETINOL METABOLIC PROCESS;GO:0042572;16;0.43422282;1.2750194;0.19172113;0.64571893
GO BP;POLYOL METABOLIC PROCESS;#N/A;89;0.28688046;1.2701231;0.059431523;0.6586987
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC;GO:0000291;35;0.35014248;1.2688192;0.13824885;0.65856385
GO BP;CELLULAR RESPONSE TO DSRNA;GO:0071359;17;0.41691282;1.2660977;0.15473442;0.664057
GO BP;CELL REDOX HOMEOSTASIS;GO:0045454;59;0.31031665;1.2654278;0.09677419;0.6617048
GO BP;REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY;GO:0033146;32;0.3521654;1.2645593;0.13948497;0.660081
GO BP;VESICLE DOCKING INVOLVED IN EXOCYTOSIS;GO:0006904;37;0.3437901;1.2643229;0.12990196;0.65619594
GO BP;REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY;GO:1904666;19;0.40389547;1.2628822;0.14718615;0.6566944
GO BP;REGULATION OF STEM CELL DIFFERENTIATION;GO:2000736;92;0.2853642;1.262118;0.078431375;0.6548591
GO BP;PEPTIDYL GLUTAMIC ACID MODIFICATION;#N/A;19;0.39897096;1.2612227;0.19589977;0.6535921
GO BP;RRNA CATABOLIC PROCESS;GO:0016075;15;0.41848662;1.2604845;0.16885965;0.65179574
GO BP;SYNAPSIS;GO:0007129;31;0.361342;1.2593126;0.13414635;0.6514963
GO BP;ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS;#N/A;223;0.24267924;1.2577078;0.024844721;0.6528098
GO BP;MITOCHONDRIAL CALCIUM ION HOMEOSTASIS;GO:0051560;19;0.40675452;1.2563396;0.15848215;0.6531033
GO BP;ERYTHROCYTE DEVELOPMENT;GO:0048821;24;0.3780797;1.253763;0.17596567;0.65794474
GO BP;MITOCHONDRIAL TRANSCRIPTION;GO:0006390;15;0.42320883;1.2515529;0.1936937;0.66153514
GO BP;DOPAMINE METABOLIC PROCESS;GO:0042417;16;0.42713338;1.2483892;0.20338982;0.668888
GO BP;EMBRYONIC HINDLIMB MORPHOGENESIS;GO:0035116;15;0.4223;1.2478375;0.1965812;0.66639876
GO BP;STEROID CATABOLIC PROCESS;GO:0006706;17;0.4136647;1.24706;0.20134228;0.6648346
GO BP;RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC;GO:0090503;39;0.33668426;1.2444135;0.15254237;0.6703086
GO BP;STRIATED MUSCLE ADAPTATION;#N/A;27;0.35735464;1.2435982;0.16515838;0.6689101
GO BP;POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:1901798;20;0.3923146;1.2417152;0.18055555;0.67176014
GO BP;NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION;GO:2000042;16;0.42533362;1.2391675;0.19239905;0.6769215
GO BP;NCRNA 3 END PROCESSING;#N/A;34;0.34518686;1.2357402;0.15452538;0.6853614
GO BP;BONE GROWTH;GO:0098868;25;0.37154508;1.2353053;0.16589862;0.6826472
GO BP;MITOCHONDRIAL MEMBRANE ORGANIZATION;GO:0007006;113;0.26236755;1.2341397;0.06426735;0.6825861
GO BP;NEUROPEPTIDE SIGNALING PATHWAY;GO:0007218;21;0.39777416;1.2331975;0.16995074;0.68179166
GO BP;REGULATION OF HEART GROWTH;GO:0060420;38;0.3299992;1.2315841;0.15671642;0.6834345
GO BP;HISTONE EXCHANGE;GO:0043486;48;0.320478;1.2283038;0.1395881;0.6913011
GO BP;INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS;GO:0032958;26;0.36168626;1.2277439;0.19068736;0.6891633
GO BP;NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION;GO:1902750;87;0.28107607;1.226362;0.12244898;0.69028896
GO BP;TRNA PROCESSING;GO:0008033;115;0.26368922;1.2255645;0.09018568;0.68902117
GO BP;PIGMENT GRANULE LOCALIZATION;GO:0051875;21;0.38287592;1.221962;0.19534884;0.69818133
GO BP;RNA 5 END PROCESSING;#N/A;18;0.39546156;1.2207673;0.19026549;0.698233
GO BP;NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY;GO:0006294;27;0.3512101;1.2198545;0.17078651;0.6974271
GO BP;NEGATIVE REGULATION OF EXOCYTOSIS;GO:0045920;18;0.3976182;1.2195655;0.20177384;0.6942798
GO BP;CELL CELL ADHESION MEDIATED BY CADHERIN;GO:0044331;23;0.3710306;1.2191179;0.17400882;0.6918766
GO BP;REGULATION OF CYTOPLASMIC TRANSLATION;GO:2000765;24;0.36949077;1.2180274;0.17420815;0.69176084
GO BP;HYPEROSMOTIC RESPONSE;GO:0006972;20;0.37856817;1.2174925;0.20618556;0.68966526
GO BP;FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX;GO:0001732;15;0.41117144;1.2163631;0.22687225;0.68971634
GO BP;C21 STEROID HORMONE METABOLIC PROCESS;GO:0008207;24;0.3709521;1.2148738;0.18115942;0.6915083
GO BP;CELLULAR BIOGENIC AMINE METABOLIC PROCESS;GO:0006576;28;0.3490625;1.2147851;0.16055046;0.6878223
GO BP;NEUROTRANSMITTER UPTAKE;GO:0001504;21;0.37636906;1.2108594;0.2;0.699067
GO BP;DIACYLGLYCEROL METABOLIC PROCESS;GO:0046339;15;0.41346177;1.2079014;0.19419643;0.70619965
GO BP;PEPTIDYL TYROSINE DEPHOSPHORYLATION;GO:0035335;73;0.28375107;1.206689;0.13032581;0.7066141
GO BP;PHOSPHATE ION TRANSPORT;GO:0006817;17;0.40241987;1.2059339;0.23162584;0.7053966
GO BP;REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0055024;46;0.31051907;1.2054915;0.19158879;0.70315593
GO BP;SALIVARY GLAND DEVELOPMENT;GO:0007431;22;0.3749202;1.2028075;0.22125813;0.70941573
GO BP;CARDIAC MUSCLE CELL PROLIFERATION;GO:0060038;28;0.34715658;1.2023499;0.20581655;0.70719564
GO BP;NEURON MATURATION;GO:0042551;25;0.35499468;1.2011368;0.2264574;0.7077692
GO BP;PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;76;0.27603093;1.2003577;0.14823529;0.7068167
GO BP;REGULATION OF ESTABLISHMENT OF PLANAR POLARITY;GO:0090175;86;0.27223933;1.1983801;0.13589744;0.7099755
GO BP;PROTEIN PEPTIDYL PROLYL ISOMERIZATION;GO:0000413;33;0.33521682;1.198254;0.20479302;0.70659345
GO BP;EMBRYONIC FORELIMB MORPHOGENESIS;GO:0035115;15;0.41851887;1.1962407;0.2208589;0.7103616
GO BP;MITOCHONDRIAL TRANSPORT;GO:0006839;216;0.23740084;1.1962303;0.07164179;0.7065662
GO BP;ANTIBIOTIC METABOLIC PROCESS;GO:0016999;64;0.28658506;1.1946713;0.17048346;0.70834965
GO BP;PROTEIN PALMITOYLATION;GO:0018345;29;0.33663738;1.1945645;0.2004831;0.705008
GO BP;POSTSYNAPTIC SIGNAL TRANSDUCTION;#N/A;20;0.36968037;1.1849594;0.23043478;0.7377689
GO BP;REGULATION OF CARDIOCYTE DIFFERENTIATION;#N/A;33;0.32242814;1.1843615;0.19256018;0.7362636
GO BP;NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS;GO:0009142;60;0.28692877;1.1822159;0.18527316;0.7408032
GO BP;LIPOPROTEIN BIOSYNTHETIC PROCESS;GO:0042158;83;0.2715533;1.1800953;0.16120219;0.74535716
GO BP;PEPTIDYL ARGININE MODIFICATION;#N/A;20;0.3675501;1.1798482;0.23755656;0.74245024
GO BP;MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA;#N/A;34;0.33566582;1.178798;0.21860465;0.7425263
GO BP;CELLULAR ALDEHYDE METABOLIC PROCESS;GO:0006081;40;0.31557268;1.1784847;0.21377672;0.739862
GO BP;ERROR FREE TRANSLESION SYNTHESIS;GO:0070987;19;0.37097198;1.1783606;0.21029083;0.73655987
GO BP;PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS;#N/A;17;0.39333606;1.1773417;0.22972973;0.73672783
GO BP;MESENCHYMAL CELL PROLIFERATION;GO:0010463;24;0.35530007;1.1746286;0.25164112;0.7434221
GO BP;NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY;#N/A;16;0.39861166;1.172379;0.24255319;0.74820775
GO BP;OLIGOSACCHARIDE METABOLIC PROCESS;GO:0009311;30;0.33260003;1.1709819;0.23620309;0.75009984
GO BP;REGULATION OF MITOCHONDRIAL GENE EXPRESSION;#N/A;28;0.34402978;1.170716;0.23373494;0.7473306
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL;GO:0010524;18;0.37920934;1.1702646;0.25223213;0.7453681
GO BP;PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS;#N/A;20;0.37190348;1.1695791;0.24423963;0.74438983
GO BP;POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0055025;27;0.34378812;1.1692346;0.22765957;0.7420524
GO BP;FC EPSILON RECEPTOR SIGNALING PATHWAY;GO:0038095;92;0.26869902;1.1685829;0.19895288;0.7410022
GO BP;CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS;GO:0021955;21;0.3649593;1.1684252;0.24568966;0.7380017
GO BP;LUNG MORPHOGENESIS;GO:0060425;30;0.33273736;1.1662428;0.24342105;0.74281234
GO BP;CELLULAR RESPONSE TO NUTRIENT;GO:0031670;41;0.31040034;1.1654353;0.21666667;0.74239
GO BP;NEGATIVE REGULATION OF BLOOD CIRCULATION;GO:1903523;19;0.3724366;1.1626555;0.24631579;0.7495237
GO BP;PURINE CONTAINING COMPOUND CATABOLIC PROCESS;#N/A;38;0.3069868;1.1614437;0.22172949;0.75061095
GO BP;SOMATIC STEM CELL POPULATION MAINTENANCE;GO:0035019;55;0.28361437;1.1569307;0.19804402;0.7644804
GO BP;ALDITOL METABOLIC PROCESS;#N/A;16;0.3906085;1.1555512;0.25562373;0.7664044
GO BP;LIPOPROTEIN METABOLIC PROCESS;GO:0042157;103;0.25019225;1.1553888;0.16745283;0.76348823
GO BP;POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION;#N/A;19;0.37807614;1.1551551;0.2710084;0.76091146
GO BP;PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION;GO:0071459;21;0.36695722;1.1551303;0.26621923;0.7574858
GO BP;RAB PROTEIN SIGNAL TRANSDUCTION;GO:0032482;59;0.27868316;1.1527687;0.21393035;0.76293933
GO BP;NUCLEOTIDE EXCISION REPAIR DNA INCISION;GO:0033683;38;0.31095442;1.1515274;0.23990498;0.76434517
GO BP;NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY;#N/A;18;0.3690683;1.1476878;0.28540772;0.7758765
GO BP;GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR;#N/A;25;0.34290665;1.1471324;0.25223213;0.7744728
GO BP;NEGATIVE REGULATION OF NUCLEAR DIVISION;#N/A;48;0.29918242;1.1458106;0.23923445;0.77614677
GO BP;NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY;GO:1901185;46;0.2988799;1.1455122;0.24213076;0.773744
GO BP;SUPEROXIDE ANION GENERATION;GO:0042554;21;0.35479912;1.1437743;0.27494457;0.77707916
GO BP;ANATOMICAL STRUCTURE MATURATION;#N/A;95;0.25880545;1.1416086;0.2;0.78172165
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS;#N/A;81;0.26187244;1.1399637;0.21989529;0.78471345
GO BP;REGULATION OF CELLULAR KETONE METABOLIC PROCESS;GO:0010565;126;0.24540907;1.1394209;0.19414894;0.7832733
GO BP;NON CANONICAL WNT SIGNALING PATHWAY;GO:0035567;111;0.24722089;1.1383363;0.17874396;0.7840373
GO BP;IRON SULFUR CLUSTER ASSEMBLY;GO:0016226;20;0.35583484;1.1382854;0.27408993;0.7807338
GO BP;ATP BIOSYNTHETIC PROCESS;GO:0006754;41;0.29431945;1.1367613;0.25659472;0.78316975
GO BP;NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH;#N/A;60;0.27437344;1.1334018;0.21875;0.7931802
GO BP;SENSORY PERCEPTION OF CHEMICAL STIMULUS;GO:0007606;33;0.31605327;1.1310136;0.28502417;0.79909194
GO BP;SUPEROXIDE METABOLIC PROCESS;GO:0006801;43;0.28989154;1.1297542;0.26789838;0.8004063
GO BP;GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS;#N/A;32;0.3201082;1.1289068;0.27450982;0.8001018
GO BP;POSITIVE REGULATION OF COAGULATION;GO:0050820;17;0.37948856;1.1285468;0.29333332;0.79803175
GO BP;REGULATION OF PLATELET ACTIVATION;GO:0010543;19;0.35795435;1.1283987;0.30549452;0.79516023
GO BP;AMINE TRANSPORT;GO:0015837;31;0.31488052;1.1283873;0.28139535;0.7918215
GO BP;POSITIVE REGULATION OF BMP SIGNALING PATHWAY;GO:0030513;23;0.34176418;1.1278368;0.29333332;0.7906772
GO BP;REGULATION OF TRANSLATIONAL ELONGATION;GO:0006448;16;0.38653162;1.1274626;0.30222222;0.78890735
GO BP;REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY;GO:2000050;19;0.36341277;1.1266303;0.28854626;0.78890634
GO BP;REGULATION OF HEART MORPHOGENESIS;GO:2000826;24;0.3498935;1.1261255;0.28820962;0.7875757
GO BP;POSTREPLICATION REPAIR;GO:0006301;47;0.2943179;1.1241957;0.25635105;0.7920298
GO BP;REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST;GO:0050691;24;0.34880832;1.1228554;0.2968421;0.7940825
GO BP;HISTONE MRNA METABOLIC PROCESS;#N/A;24;0.33710358;1.1216018;0.28448275;0.7957229
GO BP;EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS;GO:0060441;16;0.37662286;1.1186693;0.30504587;0.8041496
GO BP;SEMAPHORIN PLEXIN SIGNALING PATHWAY;GO:0071526;23;0.3423314;1.1179484;0.27251184;0.8037787
GO BP;ADULT LOCOMOTORY BEHAVIOR;GO:0008344;38;0.30459112;1.1169138;0.29039812;0.80465794
GO BP;PROTEIN N LINKED GLYCOSYLATION;GO:0006487;63;0.26999134;1.1157295;0.26923078;0.8060558
GO BP;TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR;GO:0006283;70;0.26353252;1.1149657;0.25058547;0.80586463
GO BP;RESPONSE TO ELECTRICAL STIMULUS;GO:0051602;24;0.3429348;1.1146634;0.28865978;0.8039197
GO BP;SECRETORY GRANULE ORGANIZATION;GO:0033363;22;0.34250775;1.1137223;0.3028169;0.8044679
GO BP;POSITIVE REGULATION OF HEMOPOIESIS;#N/A;105;0.24295805;1.1112655;0.26876512;0.8111438
GO BP;NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY;GO:0061099;18;0.36422732;1.1090328;0.30309734;0.8167977
GO BP;GLAND MORPHOGENESIS;GO:0022612;72;0.25927627;1.1036805;0.26904762;0.8354118
GO BP;ATP METABOLIC PROCESS;GO:0046034;248;0.21495019;1.1009653;0.22222222;0.8430801
GO BP;STRIATED MUSCLE CELL PROLIFERATION;#N/A;35;0.30291328;1.0999024;0.30684328;0.84423906
GO BP;OUTFLOW TRACT SEPTUM MORPHOGENESIS;GO:0003148;18;0.36108232;1.0995847;0.31839624;0.8422148
GO BP;POSITIVE REGULATION OF HEART GROWTH;GO:0060421;22;0.3369906;1.0966513;0.31982943;0.85080856
GO BP;CELLULAR COMPONENT DISASSEMBLY;#N/A;427;0.19955197;1.0965875;0.13284133;0.8477488
GO BP;TRNA WOBBLE BASE MODIFICATION;#N/A;18;0.35791126;1.096363;0.3204301;0.84530544
GO BP;TRANSCYTOSIS;GO:0045056;17;0.36568558;1.0954154;0.35869566;0.8458762
GO BP;NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME;GO:0048025;20;0.35146648;1.0941523;0.33628318;0.8478127
GO BP;EXIT FROM MITOSIS;GO:0010458;26;0.31887686;1.0919311;0.3084112;0.8536397
GO BP;PHOTOTRANSDUCTION;GO:0007602;21;0.34102318;1.0912484;0.33263597;0.8530887
GO BP;SMOOTH MUSCLE CONTRACTION;GO:0006939;45;0.2828896;1.0885594;0.31494254;0.86083704
GO BP;CELLULAR RESPONSE TO OSMOTIC STRESS;GO:0071470;30;0.31148762;1.0874667;0.30242825;0.86187685
GO BP;REGULATION OF VASCULAR PERMEABILITY;GO:0043114;19;0.34659755;1.0861537;0.34497815;0.8640243
GO BP;BINDING OF SPERM TO ZONA PELLUCIDA;GO:0007339;15;0.37116334;1.0859783;0.3261339;0.86149687
GO BP;PROTON TRANSMEMBRANE TRANSPORT;GO:1902600;115;0.22809795;1.0847713;0.24543081;0.86312646
GO BP;SPLICEOSOMAL COMPLEX ASSEMBLY;GO:0000245;51;0.27278325;1.0841777;0.3043478;0.8623308
GO BP;EXOCRINE SYSTEM DEVELOPMENT;GO:0035272;30;0.30873793;1.0839436;0.32169577;0.8601161
GO BP;RESPONSE TO DSRNA;GO:0043331;29;0.31311795;1.0818249;0.3341346;0.86576957
GO BP;MULTIVESICULAR BODY SORTING PATHWAY;GO:0071985;31;0.30912036;1.0815489;0.32464454;0.8637301
GO BP;NEGATIVE REGULATION OF DENDRITE DEVELOPMENT;GO:2000171;19;0.35220283;1.0803595;0.34606206;0.865444
GO BP;RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS;#N/A;53;0.2691247;1.0799413;0.31376976;0.8639921
GO BP;NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT;GO:1901862;29;0.30426186;1.0797435;0.3340471;0.86164165
GO BP;NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION;GO:2000737;19;0.35115215;1.0776505;0.329718;0.867175
GO BP;REGULATION OF AXON GUIDANCE;GO:1902667;26;0.31538662;1.0763247;0.32949308;0.8695334
GO BP;ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION;#N/A;19;0.34929007;1.0761753;0.36305732;0.8670341
GO BP;CELLULAR DETOXIFICATION;GO:1990748;68;0.25230765;1.0755298;0.31435645;0.86662465
GO BP;PROTEIN LOCALIZATION TO MITOCHONDRION;GO:0070585;120;0.23010144;1.0755148;0.25405404;0.86359394
GO BP;AUTONOMIC NERVOUS SYSTEM DEVELOPMENT;GO:0048483;23;0.33431885;1.0752112;0.34801763;0.8617701
GO BP;POST TRANSLATIONAL PROTEIN MODIFICATION;GO:0043687;278;0.20604666;1.0739324;0.26666668;0.8640127
GO BP;NUCLEOBASE METABOLIC PROCESS;#N/A;30;0.29911813;1.0735669;0.3356009;0.862427
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I;GO:0042590;57;0.26283106;1.070408;0.31894484;0.87220085
GO BP;RECEPTOR INTERNALIZATION;GO:0031623;61;0.26334888;1.0695208;0.325;0.87275976
GO BP;MEIOTIC CHROMOSOME SEGREGATION;GO:0045132;64;0.25325736;1.0689696;0.31034482;0.8720023
GO BP;CELLULAR PIGMENTATION;GO:0033059;41;0.28111792;1.0667263;0.34318182;0.87799853
GO BP;CELLULAR HORMONE METABOLIC PROCESS;#N/A;64;0.25150496;1.0654867;0.3255814;0.87995046
GO BP;REGULATION OF RECEPTOR INTERNALIZATION;GO:0002090;32;0.30531317;1.0653228;0.36069113;0.87758076
GO BP;SPERMATID DIFFERENTIATION;GO:0048515;87;0.23887508;1.0627693;0.3272727;0.88488275
GO BP;GLYCOSYL COMPOUND METABOLIC PROCESS;#N/A;92;0.23796602;1.0595591;0.33962265;0.8953451
GO BP;DIENCEPHALON DEVELOPMENT;GO:0021536;26;0.3134489;1.0586559;0.36754176;0.89593756
GO BP;RESPONSE TO STEROL;#N/A;22;0.32548055;1.0566188;0.36;0.901123
GO BP;REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY;GO:0031664;16;0.36045146;1.0562654;0.3529412;0.8995131
GO BP;NEGATIVE REGULATION OF CHEMOTAXIS;GO:0050922;31;0.2950733;1.0550791;0.35523114;0.9012696
GO BP;SNRNA 3 END PROCESSING;#N/A;18;0.3463661;1.0547706;0.35421166;0.89961135
GO BP;RESPONSE TO CADMIUM ION;GO:0046686;42;0.28236678;1.0536841;0.36298078;0.9011387
GO BP;REGULATION OF ANION TRANSPORT;GO:0044070;46;0.26971176;1.0520844;0.34684685;0.9046053
GO BP;AXONEMAL DYNEIN COMPLEX ASSEMBLY;GO:0070286;17;0.34216276;1.0504378;0.38428876;0.90842897
GO BP;TETRAPYRROLE BIOSYNTHETIC PROCESS;GO:0033014;27;0.30851305;1.0495467;0.39503387;0.9091716
GO BP;NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION;#N/A;58;0.25609812;1.0487938;0.3675799;0.9091934
GO BP;REGULATION OF GLIAL CELL PROLIFERATION;#N/A;21;0.32986832;1.0480583;0.38169643;0.9091294
GO BP;REGULATION OF MORPHOGENESIS OF AN EPITHELIUM;#N/A;121;0.2244656;1.0476192;0.34933335;0.9079503
GO BP;RNA 3 END PROCESSING;#N/A;130;0.22056939;1.0471191;0.33152175;0.90695614
GO BP;NEUTROPHIL MIGRATION;GO:1990266;39;0.28358224;1.0465121;0.36764705;0.9064682
GO BP;REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA;#N/A;20;0.33191144;1.0459114;0.37417942;0.90595907
GO BP;ACTIVATION OF JUN KINASE ACTIVITY;GO:0007257;32;0.2967643;1.0458361;0.37362638;0.90328705
GO BP;SENSORY PERCEPTION OF SMELL;GO:0007608;20;0.33330122;1.044344;0.38864627;0.9066522
GO BP;RESPONSE TO INTERLEUKIN 12;GO:0070671;36;0.2856202;1.0438621;0.38407496;0.9058167
GO BP;CYTOSOLIC CALCIUM ION TRANSPORT;#N/A;91;0.23302735;1.0434232;0.36363637;0.90462935
GO BP;REGULATION OF DEFENSE RESPONSE TO VIRUS;GO:0050688;51;0.26758465;1.042403;0.35679612;0.9059256
GO BP;GLYCEROLIPID BIOSYNTHETIC PROCESS;#N/A;199;0.20610447;1.0423234;0.34065935;0.9033015
GO BP;ADULT BEHAVIOR;GO:0030534;63;0.25371274;1.0419692;0.34963325;0.9018848
GO BP;INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY;GO:0030520;42;0.27423397;1.0405356;0.3739496;0.90492356
GO BP;GERM CELL DEVELOPMENT;GO:0007281;149;0.2170139;1.0403758;0.36944443;0.90273666
GO BP;KERATINOCYTE PROLIFERATION;GO:0043616;31;0.29632348;1.0386904;0.3553531;0.9068521
GO BP;REGULATION OF PHAGOCYTOSIS;GO:0050764;47;0.263551;1.0369799;0.40144232;0.91097546
GO BP;ADRENAL GLAND DEVELOPMENT;GO:0030325;16;0.35451582;1.0364639;0.3836478;0.91027623
GO BP;MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA;#N/A;21;0.326095;1.0360196;0.3934066;0.9092979
GO BP;PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;70;0.24788158;1.034544;0.3764706;0.9123983
GO BP;ENDOCARDIAL CUSHION FORMATION;GO:0003272;15;0.35571894;1.0339198;0.41447368;0.9121094
GO BP;DIGESTIVE TRACT MORPHOGENESIS;GO:0048546;26;0.3077901;1.0321801;0.3881579;0.91643214
GO BP;REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS;GO:0042304;33;0.2846548;1.0285476;0.39420936;0.9285036
GO BP;REGULATION OF HORMONE METABOLIC PROCESS;GO:0032350;22;0.3181617;1.0283322;0.3902439;0.92649066
GO BP;KETONE BIOSYNTHETIC PROCESS;#N/A;32;0.29511508;1.0267847;0.41098902;0.9301191
GO BP;RNA PHOSPHODIESTER BOND HYDROLYSIS;GO:0090501;122;0.21763872;1.0254451;0.41450778;0.93291706
GO BP;NCRNA CATABOLIC PROCESS;#N/A;29;0.29660717;1.0254204;0.40444446;0.9301725
GO BP;PROTEIN K11 LINKED UBIQUITINATION;GO:0070979;26;0.3002035;1.0247798;0.40133038;0.92987865
GO BP;REGULATION OF MUSCLE ORGAN DEVELOPMENT;GO:0048634;77;0.24003337;1.0247365;0.39528796;0.9272609
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION;#N/A;23;0.31398806;1.023426;0.43207127;0.92963135
GO BP;LIPOSACCHARIDE METABOLIC PROCESS;#N/A;84;0.23231304;1.0214474;0.41432226;0.9347325
GO BP;INOSITOL PHOSPHATE METABOLIC PROCESS;GO:0043647;51;0.25909162;1.020599;0.41491842;0.93543
GO BP;REGULATION OF JUN KINASE ACTIVITY;GO:0043506;61;0.24684706;1.0183704;0.4225352;0.9418215
GO BP;NUCLEOSIDE CATABOLIC PROCESS;#N/A;18;0.3325592;1.0183363;0.43468952;0.9391433
GO BP;VENTRICULAR SEPTUM MORPHOGENESIS;GO:0060412;24;0.3061048;1.0162047;0.4203233;0.94513047
GO BP;AMMONIUM ION METABOLIC PROCESS;#N/A;128;0.21445857;1.0153065;0.40712467;0.94605094
GO BP;RNA SPLICING VIA TRANSESTERIFICATION REACTIONS;GO:0000375;308;0.19004826;1.0146592;0.43343654;0.94603556
GO BP;HEART FORMATION;GO:0060914;20;0.3193037;1.0131369;0.4186551;0.9495571
GO BP;SYNAPTIC VESICLE TRANSPORT;GO:0048489;34;0.27982143;1.0127971;0.42986426;0.9481593
GO BP;GLYCOSYL COMPOUND CATABOLIC PROCESS;#N/A;27;0.29474685;1.0126002;0.46750525;0.9461396
GO BP;OOGENESIS;GO:0048477;50;0.25562125;1.0110104;0.40705884;0.94984174
GO BP;NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION;GO:0000715;22;0.32194307;1.0093036;0.4364035;0.9540928
GO BP;PROTEIN LOCALIZATION TO KINETOCHORE;GO:0034501;17;0.32727742;1.0071517;0.44988865;0.96001244
GO BP;NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;87;0.22688803;1.0070677;0.40346536;0.9575388
GO BP;REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;GO:2000514;30;0.28200495;1.0065786;0.41855204;0.9566607
GO BP;NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY;GO:0045879;21;0.31508344;1.0039995;0.4103139;0.96447605
GO BP;RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY;GO:0051123;21;0.32076323;1.0036051;0.4580499;0.9633456
GO BP;HINDLIMB MORPHOGENESIS;GO:0035137;20;0.3176385;1.0021265;0.4472477;0.9664971
GO BP;REGULATION OF ANIMAL ORGAN MORPHOGENESIS;#N/A;154;0.20829014;0.99939257;0.45135134;0.9750888
GO BP;NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE;#N/A;34;0.2791392;0.998976;0.42117116;0.97399044
GO BP;REGULATION OF FILOPODIUM ASSEMBLY;GO:0051489;36;0.2716656;0.9975951;0.46370023;0.97678137
GO BP;REGULATION OF OXIDATIVE PHOSPHORYLATION;GO:0002082;26;0.29533678;0.9960396;0.45221445;0.9803169
GO BP;T CELL SELECTION;GO:0045058;20;0.3137914;0.9957609;0.45514223;0.97871476
GO BP;POSITIVE REGULATION OF JUN KINASE ACTIVITY;GO:0043507;53;0.24745429;0.99558973;0.4361446;0.9766455
GO BP;TERPENOID METABOLIC PROCESS;#N/A;58;0.2463045;0.9953666;0.45990565;0.9747427
GO BP;RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;66;0.24118927;0.99479604;0.4629156;0.97426635
GO BP;NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING;#N/A;21;0.31548697;0.9944115;0.4228972;0.9731088
GO BP;AXONEME ASSEMBLY;GO:0035082;36;0.2661565;0.99359393;0.46189377;0.9737106
GO BP;REGULATION OF ORGAN GROWTH;GO:0046620;59;0.24264896;0.9923023;0.4602804;0.97619706
GO BP;POSITIVE REGULATION OF P38MAPK CASCADE;GO:1900745;21;0.31480563;0.99048024;0.47379914;0.98091215
GO BP;EXTRACELLULAR VESICLE BIOGENESIS;GO:0140112;19;0.31831956;0.9894218;0.46910754;0.9824432
GO BP;INTERSTRAND CROSS LINK REPAIR;GO:0036297;50;0.24950685;0.98923904;0.45813954;0.9804003
GO BP;REGULATION OF COAGULATION;#N/A;48;0.2529874;0.98918176;0.48920864;0.97794795
GO BP;SIGNAL TRANSDUCTION INVOLVED IN CELLULAR RESPONSE TO AMMONIUM ION;#N/A;30;0.28462762;0.9875883;0.48086125;0.9817437
GO BP;NEUROEPITHELIAL CELL DIFFERENTIATION;GO:0060563;33;0.2762793;0.986494;0.45647058;0.9834542
GO BP;NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS;GO:1901292;55;0.24297087;0.98622644;0.47142857;0.9817896
GO BP;REGULATION OF RESPONSE TO DRUG;GO:2001023;43;0.25957385;0.98541015;0.45411766;0.9824142
GO BP;REGULATION OF HORMONE BIOSYNTHETIC PROCESS;GO:0046885;16;0.33870652;0.9847627;0.4547414;0.9823625
GO BP;POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION;GO:0046638;25;0.29965252;0.9844814;0.45578232;0.98086506
GO BP;RIBONUCLEOTIDE CATABOLIC PROCESS;#N/A;23;0.30374053;0.9825072;0.4826087;0.9861765
GO BP;CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM;#N/A;207;0.1948717;0.98164684;0.5295858;0.9869772
GO BP;HEMATOPOIETIC STEM CELL DIFFERENTIATION;GO:0060218;65;0.23367383;0.9807033;0.49069768;0.9881524
GO BP;PEPTIDYL PROLINE MODIFICATION;GO:0018208;46;0.25174618;0.9805217;0.49497488;0.9862488
GO BP;TRNA MODIFICATION;GO:0006400;75;0.23272961;0.98007184;0.50124687;0.9853712
GO BP;NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY;GO:0048011;20;0.31394687;0.98001474;0.47737557;0.98297983
GO BP;HEME BIOSYNTHETIC PROCESS;GO:0006783;21;0.30748087;0.9796814;0.4812362;0.98164725
GO BP;REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT;GO:2000641;18;0.3209218;0.97686523;0.49457702;0.9903748
GO BP;CERAMIDE METABOLIC PROCESS;GO:0006672;67;0.23421723;0.97674096;0.49275362;0.9882085
GO BP;VIRION ASSEMBLY;GO:0019068;37;0.26048315;0.9758869;0.49878934;0.98907524
GO BP;KINETOCHORE ASSEMBLY;GO:0051382;16;0.3398515;0.9756584;0.47379914;0.98737264
GO BP;TRANSLESION SYNTHESIS;GO:0019985;37;0.2691036;0.9744928;0.47807017;0.98941886
GO BP;POSITIVE REGULATION OF WNT SIGNALING PATHWAY;GO:0030177;139;0.20323399;0.9736904;0.52605456;0.99007255
GO BP;REGULATION OF VIRAL ENTRY INTO HOST CELL;GO:0046596;18;0.32514966;0.97222596;0.50319827;0.9932542
GO BP;GLYCOLIPID BIOSYNTHETIC PROCESS;GO:0009247;48;0.25059628;0.9719814;0.5185185;0.9916316
GO BP;NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS;GO:0051055;32;0.26655406;0.97148037;0.5095238;0.991039
GO BP;CELLULAR RESPONSE TO CHEMICAL STRESS;#N/A;254;0.18489107;0.9689417;0.5440252;0.9984305
GO BP;RESPONSE TO INTERLEUKIN 1;GO:0070555;129;0.20626666;0.9684436;0.55;0.9977197
GO BP;REGULATION OF MRNA 3 END PROCESSING;#N/A;27;0.28152546;0.96836036;0.49427918;0.9954631
GO BP;NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903051;59;0.23394807;0.9682472;0.5309524;0.9933836
GO BP;PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;16;0.32429707;0.96515685;0.50319827;1
GO BP;REGULATION OF NEUTROPHIL MIGRATION;GO:1902622;15;0.32964116;0.96509266;0.47628865;1
GO BP;MRNA SPLICE SITE SELECTION;GO:0006376;27;0.28622255;0.96090287;0.5070755;1
GO BP;CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE;GO:0070192;48;0.24690777;0.9605701;0.52771086;1
GO BP;LUNG EPITHELIUM DEVELOPMENT;GO:0060428;20;0.3060485;0.96011955;0.49482402;1
GO BP;INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY;GO:0070498;79;0.22100484;0.95988035;0.50961536;1
GO BP;SPLICEOSOMAL SNRNP ASSEMBLY;GO:0000387;37;0.26147777;0.9597151;0.51121074;1
GO BP;MEMBRANE DISASSEMBLY;#N/A;15;0.33404446;0.9596457;0.5167038;1
GO BP;POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION;GO:0045621;47;0.24788444;0.9595491;0.51376146;1
GO BP;MYELIN ASSEMBLY;GO:0032288;15;0.3326035;0.9593983;0.52665246;1
GO BP;REGULATION OF ORGANIC ACID TRANSPORT;#N/A;24;0.28839275;0.9571938;0.5221239;1
GO BP;NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS;GO:1901799;47;0.2426772;0.9566095;0.53110045;1
GO BP;MATURATION OF LSU RRNA;GO:0000470;21;0.297971;0.9563305;0.5630631;1
GO BP;PROTEASOMAL PROTEIN CATABOLIC PROCESS;GO:0010498;411;0.17333254;0.9563084;0.6754967;1
GO BP;POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION;GO:0032786;29;0.27682936;0.95538884;0.55263156;1
GO BP;POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT;#N/A;19;0.3079224;0.9552169;0.50769234;1
GO BP;MULTI ORGANISM CELLULAR PROCESS;#N/A;31;0.27085978;0.9552122;0.54229933;1
GO BP;HISTONE PHOSPHORYLATION;GO:0016572;30;0.2749423;0.95517904;0.49882352;0.9985561
GO BP;REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY;GO:0051438;45;0.24733293;0.9549225;0.54120266;0.99708
GO BP;POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION;GO:0032732;17;0.31836787;0.95474637;0.54418606;0.99535394
GO BP;HAIR CELL DIFFERENTIATION;GO:0035315;26;0.28156468;0.95470524;0.5229358;0.9930948
GO BP;POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT;GO:1904894;34;0.26232466;0.9542699;0.49776787;0.992275
GO BP;REGULATION OF MRNA SPLICING VIA SPLICEOSOME;GO:0048024;84;0.2180414;0.9534524;0.5638554;0.99297047
GO BP;POSITIVE REGULATION OF RESPONSE TO DRUG;#N/A;15;0.32836276;0.95252204;0.5336323;0.9940378
GO BP;NEUTRAL LIPID BIOSYNTHETIC PROCESS;#N/A;28;0.2748665;0.9519971;0.52527475;0.99363714
GO BP;GENITALIA DEVELOPMENT;GO:0048806;29;0.27320486;0.9515848;0.54347825;0.9928341
GO BP;CELLULAR KETONE METABOLIC PROCESS;GO:0042180;166;0.19272172;0.9507268;0.6023055;0.9936597
GO BP;PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE;#N/A;15;0.32707426;0.9505912;0.50438595;0.99179065
GO BP;REGULATION OF EPITHELIAL CELL DIFFERENTIATION;GO:0030856;78;0.21797259;0.9505797;0.530343;0.98944443
GO BP;CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL;GO:0097553;68;0.22723448;0.94959944;0.568;0.99060065
GO BP;POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION;GO:0070131;17;0.31772465;0.94896376;0.54;0.99055934
GO BP;REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;#N/A;142;0.19663139;0.94827706;0.5742297;0.9908181
GO BP;DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE;GO:0042769;36;0.26031888;0.9478323;0.53289473;0.99004924
GO BP;POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0010718;36;0.25964996;0.9465457;0.5135135;0.99229866
GO BP;RESPONSE TO AMINE;#N/A;22;0.30179614;0.9464163;0.53812635;0.99039394
GO BP;POSITIVE REGULATION OF REPRODUCTIVE PROCESS;#N/A;41;0.25256196;0.9462482;0.5269608;0.9886571
GO BP;STEM CELL DIFFERENTIATION;GO:0048863;165;0.19278923;0.94610435;0.6217765;0.98688036
GO BP;LIVER REGENERATION;GO:0097421;23;0.289702;0.9450514;0.52764976;0.98835075
GO BP;ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME;GO:0000380;65;0.22870325;0.944274;0.55851066;0.9888957
GO BP;NUCLEOSIDE METABOLIC PROCESS;GO:0009116;79;0.2213945;0.94294;0.6038186;0.9915469
GO BP;NEGATIVE REGULATION OF CHROMOSOME SEGREGATION;#N/A;40;0.24772589;0.9428976;0.5410959;0.98936105
GO BP;PIGMENT CELL DIFFERENTIATION;#N/A;24;0.2852926;0.9428439;0.54767185;0.9872577
GO BP;TRNA WOBBLE URIDINE MODIFICATION;GO:0002098;15;0.32529795;0.94237286;0.5388027;0.986735
GO BP;MULTICELLULAR ORGANISM AGING;GO:0010259;23;0.29161453;0.94184244;0.5315904;0.9863955
GO BP;INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION;GO:0042491;21;0.2916134;0.94169986;0.5536105;0.9845998
GO BP;CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS;#N/A;21;0.29199767;0.9403568;0.55450237;0.98712647
GO BP;GENERATION OF PRECURSOR METABOLITES AND ENERGY;GO:0006091;420;0.171075;0.94028956;0.73431736;0.98507804
GO BP;POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:1904358;34;0.26020768;0.9401995;0.5470852;0.98313713
GO BP;FC RECEPTOR SIGNALING PATHWAY;GO:0038093;142;0.19746852;0.94006747;0.6073446;0.9813508
GO BP;REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION;#N/A;16;0.32131967;0.93933046;0.52653927;0.9817321
GO BP;DETECTION OF VISIBLE LIGHT;GO:0009584;20;0.2969411;0.9376078;0.53104925;0.98542434
GO BP;NEGATIVE REGULATION OF MUSCLE CONTRACTION;GO:0045932;15;0.32208323;0.9369802;0.5225225;0.98531353
GO BP;NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION;GO:0045662;15;0.31765398;0.9361603;0.5426195;0.9860326
GO BP;ATRIOVENTRICULAR VALVE DEVELOPMENT;GO:0003171;17;0.31334147;0.93603605;0.5354691;0.984215
GO BP;REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT;GO:0048641;28;0.27936724;0.9357447;0.56941175;0.98292005
GO BP;RNA SPLICING;GO:0008380;386;0.17183892;0.9355156;0.722807;0.9815055
GO BP;DOPAMINERGIC NEURON DIFFERENTIATION;GO:0071542;17;0.30747473;0.9338089;0.55939525;0.98538417
GO BP;NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:2000059;41;0.24373713;0.93268776;0.57990867;0.9870285
GO BP;INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY;#N/A;78;0.21265662;0.9294179;0.605;0.9961569
GO BP;NEGATIVE REGULATION OF T CELL PROLIFERATION;GO:0042130;30;0.26995656;0.9289664;0.5714286;0.99553543
GO BP;GLUCOCORTICOID METABOLIC PROCESS;GO:0008211;16;0.30854905;0.9287784;0.5487288;0.99399465
GO BP;CANONICAL WNT SIGNALING PATHWAY;GO:0060070;234;0.17975889;0.92832625;0.6876877;0.993334
GO BP;SYNAPTIC TRANSMISSION GLUTAMATERGIC;GO:0035249;33;0.25636855;0.92830044;0.5804989;0.9912374
GO BP;POSITIVE REGULATION OF FILOPODIUM ASSEMBLY;GO:0051491;23;0.28500068;0.92768127;0.5612903;0.9911226
GO BP;CATECHOLAMINE METABOLIC PROCESS;GO:0006584;22;0.2924935;0.92620957;0.5862832;0.9939139
GO BP;GPI ANCHOR METABOLIC PROCESS;GO:0006505;29;0.26559308;0.9260124;0.5782609;0.9923985
GO BP;POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY;GO:1904874;15;0.32129472;0.9254434;0.56621003;0.99211615
GO BP;TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER;GO:0006368;73;0.21582013;0.9250298;0.6167076;0.9913967
GO BP;NEURAL CREST CELL DIFFERENTIATION;GO:0014033;51;0.23262735;0.92302907;0.61190474;0.99584275
GO BP;ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE;GO:0008608;30;0.26329893;0.9224536;0.5687204;0.9955974
GO BP;HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION;GO:0002244;122;0.19874811;0.9219185;0.64411026;0.9952943
GO BP;REGULATION OF GRANULOCYTE CHEMOTAXIS;GO:0071622;19;0.29510838;0.9214556;0.5667396;0.9946841
GO BP;EXOCYTIC PROCESS;#N/A;59;0.22365984;0.9214468;0.64608073;0.99255234
GO BP;KINETOCHORE ORGANIZATION;GO:0051383;21;0.28937435;0.92079175;0.55133927;0.99263066
GO BP;SNRNA PROCESSING;GO:0016180;24;0.27889815;0.9201225;0.5955056;0.9927448
GO BP;MELANOCYTE DIFFERENTIATION;GO:0030318;16;0.3136217;0.91940165;0.55429864;0.9929954
GO BP;POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE;GO:0002821;44;0.24196026;0.91840583;0.5995086;0.9941579
GO BP;POSITIVE REGULATION OF T CELL PROLIFERATION;GO:0042102;42;0.24058847;0.91821116;0.57078654;0.9926992
GO BP;NEGATIVE REGULATION OF MITOTIC CELL CYCLE;GO:0045930;259;0.17643276;0.9167669;0.7514451;0.9953809
GO BP;VESICLE DOCKING;GO:0048278;54;0.23065493;0.9166857;0.6188119;0.99352103
GO BP;NEGATIVE REGULATION OF MRNA PROCESSING;#N/A;29;0.26382315;0.9159848;0.60587;0.9936982
GO BP;MEMBRANE LIPID CATABOLIC PROCESS;GO:0046466;28;0.2691811;0.9153219;0.57543105;0.99375886
GO BP;REGULATION OF MRNA METABOLIC PROCESS;#N/A;270;0.17643934;0.91501296;0.7583082;0.9926478
GO BP;NEGATIVE REGULATION OF HORMONE SECRETION;GO:0046888;30;0.26276442;0.9145845;0.57270694;0.99201167
GO BP;ARACHIDONIC ACID SECRETION;GO:0050482;15;0.32382768;0.914317;0.5590717;0.990763
GO BP;GASTRULATION WITH MOUTH FORMING SECOND;GO:0001702;22;0.28368574;0.9140881;0.59070796;0.9894242
GO BP;MIDBRAIN DEVELOPMENT;GO:0030901;58;0.22243883;0.9137784;0.6141176;0.988298
GO BP;REGULATION OF MRNA PROCESSING;GO:0050684;119;0.19828176;0.91267204;0.67105263;0.9897569
GO BP;REGULATION OF FATTY ACID OXIDATION;GO:0046320;22;0.28245443;0.9120956;0.58605665;0.9895291
GO BP;NUCLEOTIDE EXCISION REPAIR DNA INCISION 3 TO LESION;#N/A;21;0.28612605;0.9119246;0.5852018;0.9879906
GO BP;REGULATION OF SUPEROXIDE METABOLIC PROCESS;#N/A;23;0.28288388;0.9117558;0.590604;0.98653346
GO BP;RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC;GO:0090502;62;0.22158411;0.9112486;0.63309354;0.9860084
GO BP;CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS;GO:0071549;25;0.27156836;0.9102335;0.58980584;0.9872937
GO BP;REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY;GO:0032925;15;0.3053916;0.9080062;0.6012931;0.9924115
GO BP;AMMONIUM TRANSPORT;GO:0015696;44;0.2364334;0.90618074;0.60089684;0.996236
GO BP;MATURATION OF 5 8S RRNA;#N/A;26;0.26881093;0.9054987;0.6138107;0.99628323
GO BP;PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS;GO:0006661;100;0.2001351;0.90526944;0.68475455;0.99494576
GO BP;RESPONSE TO AMPHETAMINE;GO:0001975;15;0.31375337;0.90439093;0.5747863;0.9956492
GO BP;MYELOID CELL DEVELOPMENT;GO:0061515;48;0.2299727;0.90390795;0.6286408;0.99511266
GO BP;ACID SECRETION;GO:0046717;54;0.224436;0.9020815;0.6315789;0.99871427
GO BP;ANTEROGRADE AXONAL TRANSPORT;GO:0008089;36;0.24544998;0.89970124;0.63555557;1
GO BP;PROTEIN K48 LINKED UBIQUITINATION;GO:0070936;50;0.229234;0.8966382;0.62653565;1
GO BP;POSITIVE REGULATION OF WOUND HEALING;GO:0090303;34;0.24776791;0.8966369;0.65848213;1
GO BP;CENTROMERE COMPLEX ASSEMBLY;GO:0034508;49;0.22828673;0.89654344;0.6566416;1
GO BP;RESPONSE TO LITHIUM ION;#N/A;16;0.30572936;0.8960722;0.6052632;1
GO BP;GLYCOLIPID CATABOLIC PROCESS;GO:0019377;15;0.30703565;0.89407784;0.6283784;1
GO BP;PRESYNAPSE ORGANIZATION;GO:0099172;15;0.3035905;0.8925474;0.61622804;1
GO BP;MRNA 3 END PROCESSING;#N/A;93;0.19812724;0.8919094;0.70430106;1
GO BP;REGULATION OF TELOMERE CAPPING;#N/A;22;0.27482256;0.89108384;0.6108696;1
GO BP;DICARBOXYLIC ACID TRANSPORT;GO:0006835;55;0.21891834;0.8900513;0.6690821;1
GO BP;REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL;GO:0010522;46;0.22806923;0.8893887;0.66079295;1
GO BP;MAINTENANCE OF CELL NUMBER;#N/A;129;0.18604101;0.88935804;0.7692308;1
GO BP;FATTY ACID DERIVATIVE TRANSPORT;#N/A;23;0.27471343;0.88887155;0.6404255;1
GO BP;ANTERIOR POSTERIOR AXIS SPECIFICATION;GO:0009948;28;0.25716546;0.8873948;0.6557377;1
GO BP;CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT;GO:0072111;15;0.3148778;0.8863259;0.5995671;1
GO BP;PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;27;0.2597043;0.88619906;0.66079295;1
GO BP;NEUROTROPHIN SIGNALING PATHWAY;GO:0038179;25;0.26493078;0.88486767;0.6504425;1
GO BP;RETINA HOMEOSTASIS;GO:0001895;37;0.24213333;0.88195735;0.6483254;1
GO BP;HEART GROWTH;#N/A;51;0.2238584;0.8818098;0.6754386;1
GO BP;NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL;#N/A;67;0.21209781;0.8814678;0.6839623;1
GO BP;VESICLE TARGETING TO FROM OR WITHIN GOLGI;GO:0048199;62;0.21438815;0.8812379;0.6839506;1
GO BP;PHOTORECEPTOR CELL MAINTENANCE;GO:0045494;23;0.26729178;0.8807925;0.6327014;1
GO BP;REGULATION OF NECROTIC CELL DEATH;GO:0010939;19;0.28175002;0.88067937;0.6345292;1
GO BP;RIG I SIGNALING PATHWAY;GO:0039529;15;0.3027588;0.8803255;0.62780267;1
GO BP;REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA;GO:0061418;70;0.20842773;0.87989855;0.72511846;1
GO BP;DOPAMINE TRANSPORT;GO:0015872;15;0.29990035;0.8796643;0.6183908;1
GO BP;PROTEIN INSERTION INTO MEMBRANE;GO:0051205;50;0.2223226;0.87948924;0.69953054;1
GO BP;RESPONSE TO DEXAMETHASONE;GO:0071548;30;0.25031534;0.87932396;0.6412777;1
GO BP;COMPLEMENT ACTIVATION;GO:0006956;22;0.27071258;0.8790012;0.64775413;1
GO BP;CHONDROCYTE DEVELOPMENT;GO:0002063;24;0.26736695;0.8788745;0.63484484;1
GO BP;REGULATION OF HOMOTYPIC CELL CELL ADHESION;#N/A;18;0.286934;0.8747786;0.6283784;1
GO BP;COFACTOR CATABOLIC PROCESS;#N/A;35;0.23581266;0.874552;0.65393794;1
GO BP;POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION;GO:0031954;16;0.29601306;0.87448937;0.6365591;1
GO BP;RESPONSE TO ESTRADIOL;GO:0032355;82;0.19996756;0.87232697;0.7415459;1
GO BP;POSITIVE REGULATION OF MRNA PROCESSING;#N/A;25;0.25671452;0.8722492;0.65700483;1
GO BP;REGULATION OF CHROMOSOME SEPARATION;GO:1905818;56;0.21623054;0.8707552;0.7132867;1
GO BP;NEGATIVE REGULATION OF RESPONSE TO DRUG;#N/A;15;0.30075464;0.8704339;0.6328829;1
GO BP;REGULATION OF WNT SIGNALING PATHWAY;GO:0030111;265;0.1653542;0.87038946;0.89028215;1
GO BP;ATP DEPENDENT CHROMATIN REMODELING;GO:0043044;74;0.20453611;0.87011313;0.71662766;1
GO BP;CARDIAC SEPTUM MORPHOGENESIS;GO:0060411;47;0.22215545;0.8697069;0.70046085;1
GO BP;NEGATIVE REGULATION OF DNA REPAIR;#N/A;28;0.2544188;0.8695977;0.6485849;1
GO BP;POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY;GO:0045880;27;0.25781912;0.86925;0.66976744;1
GO BP;ACTIN NUCLEATION;GO:0045010;35;0.23818244;0.868924;0.6713615;1
GO BP;CELLULAR RESPONSE TO OXYGEN RADICAL;#N/A;16;0.29011932;0.86862665;0.6469298;1
GO BP;PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007200;20;0.27560872;0.867287;0.6744186;1
GO BP;CELLULAR RESPONSE TO AMMONIUM ION;GO:0071242;50;0.21602263;0.8661703;0.6878173;1
GO BP;NEGATIVE REGULATION OF CELL CYCLE PROCESS;#N/A;273;0.16705692;0.86614114;0.9148265;1
GO BP;NEGATIVE REGULATION OF AXONOGENESIS;GO:0050771;37;0.23801169;0.8660002;0.70238096;1
GO BP;PIGMENTATION;GO:0043473;70;0.20497678;0.8656104;0.7302799;1
GO BP;NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE;#N/A;22;0.26730776;0.8644318;0.67800456;1
GO BP;CELLULAR RESPONSE TO STEROL;GO:0036315;16;0.29052016;0.8644206;0.6475584;1
GO BP;TRANSPOSITION;#N/A;15;0.29878008;0.86430234;0.6566125;1
GO BP;NEGATIVE REGULATION OF REPRODUCTIVE PROCESS;#N/A;32;0.24210657;0.86248946;0.6788321;1
GO BP;SNRNA METABOLIC PROCESS;GO:0016073;33;0.24408641;0.85898983;0.69083154;1
GO BP;POSITIVE REGULATION OF BLOOD PRESSURE;GO:0045777;15;0.29509377;0.8583357;0.6581197;1
GO BP;REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY;GO:0033143;62;0.20406108;0.8572048;0.74666667;1
GO BP;MESODERM MORPHOGENESIS;GO:0048332;41;0.22602959;0.856887;0.7193396;1
GO BP;DENDRITE EXTENSION;GO:0097484;17;0.28649512;0.85667056;0.6906475;1
GO BP;NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION;GO:0001937;19;0.28028077;0.8565305;0.66899765;1
GO BP;DETOXIFICATION;#N/A;77;0.19729446;0.85584795;0.77530867;1
GO BP;STEROID HORMONE BIOSYNTHETIC PROCESS;#N/A;40;0.23410371;0.85561484;0.7093822;1
GO BP;ISOPRENOID METABOLIC PROCESS;GO:0006720;74;0.20038408;0.8542554;0.77078086;1
GO BP;POSITIVE REGULATION OF STEROID METABOLIC PROCESS;#N/A;16;0.28542113;0.8542434;0.675;1
GO BP;EMBRYONIC PATTERN SPECIFICATION;GO:0009880;35;0.23211075;0.85348856;0.70308787;1
GO BP;MOTOR NEURON AXON GUIDANCE;GO:0008045;19;0.27617007;0.8532497;0.6752688;1
GO BP;REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:0043516;30;0.24389607;0.8518159;0.6979405;1
GO BP;SYNAPTIC VESICLE LOCALIZATION;#N/A;40;0.22496206;0.8512152;0.68599033;1
GO BP;POSITIVE REGULATION OF ANION TRANSPORT;#N/A;23;0.2544934;0.8486942;0.6770601;1
GO BP;VESICLE TARGETING;GO:0006903;79;0.19895795;0.84778225;0.7929293;1
GO BP;REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL;GO:0051881;53;0.21378434;0.8462345;0.74666667;1
GO BP;DNA SYNTHESIS INVOLVED IN DNA REPAIR;GO:0000731;45;0.21937293;0.84495395;0.7447796;1
GO BP;NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY;GO:2000272;25;0.25616696;0.843604;0.6972477;1
GO BP;GLYCOPROTEIN CATABOLIC PROCESS;GO:0006516;18;0.27794608;0.8433596;0.6748879;1
GO BP;NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION;GO:0050732;33;0.23470132;0.84303516;0.7323601;1
GO BP;NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS;GO:0090305;246;0.16341643;0.83871216;0.91818184;1
GO BP;CELLULAR RESPONSE TO KETONE;#N/A;61;0.20471093;0.83515686;0.7619048;1
GO BP;FOAM CELL DIFFERENTIATION;#N/A;22;0.26048014;0.8330377;0.68119264;1
GO BP;INACTIVATION OF MAPK ACTIVITY;GO:0000188;19;0.27023223;0.8326983;0.6882217;1
GO BP;MORPHOGENESIS OF AN EPITHELIAL SHEET;GO:0002011;44;0.21486728;0.83231825;0.79820627;1
GO BP;REGULATION OF TRANSLATIONAL FIDELITY;GO:0006450;17;0.2716369;0.83102125;0.69392526;1
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS;GO:0034656;31;0.23333253;0.8309935;0.73362446;1
GO BP;REGULATION OF SUPEROXIDE ANION GENERATION;GO:0032928;16;0.27898672;0.8305385;0.70742357;1
GO BP;GROWTH PLATE CARTILAGE DEVELOPMENT;GO:0003417;18;0.27662286;0.83032125;0.71028036;1
GO BP;VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS;#N/A;41;0.22129123;0.82910794;0.7723971;1
GO BP;TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER;GO:0006367;147;0.17168225;0.82898325;0.8716707;1
GO BP;CELL CELL SIGNALING BY WNT;GO:0198738;373;0.15453523;0.8272317;0.9775641;1
GO BP;POSITIVE REGULATION OF PHAGOCYTOSIS;GO:0050766;34;0.23252898;0.8260424;0.75;1
GO BP;CRANIAL NERVE DEVELOPMENT;GO:0021545;23;0.25394958;0.8255004;0.71681416;1
GO BP;MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:0006851;19;0.26963773;0.8248363;0.71115977;1
GO BP;POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS;#N/A;45;0.21499166;0.8247802;0.8037383;1
GO BP;GRANULOCYTE MIGRATION;GO:0097530;50;0.21184704;0.82438135;0.79859483;1
GO BP;NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0055026;18;0.26733944;0.82420427;0.72008544;1
GO BP;ACTIVIN RECEPTOR SIGNALING PATHWAY;GO:0032924;23;0.24900384;0.8233062;0.74364895;1
GO BP;ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION;GO:0040001;30;0.23689343;0.8221593;0.74588233;1
GO BP;PROTEIN DESTABILIZATION;GO:0031648;43;0.21827269;0.82073003;0.7494457;1
GO BP;ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION;GO:0034314;27;0.24094734;0.81958747;0.7242991;1
GO BP;PROTEIN K63 LINKED UBIQUITINATION;GO:0070534;38;0.2128606;0.8177606;0.8029925;1
GO BP;POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION;#N/A;64;0.19040503;0.8144803;0.8292683;1
GO BP;POSITIVE REGULATION OF RESPONSE TO WOUNDING;#N/A;42;0.2167472;0.81275654;0.78085643;1
GO BP;CELLULAR AMINO ACID METABOLIC PROCESS;GO:0006520;260;0.15753463;0.8125219;0.9662577;1
GO BP;MONOCYTE CHEMOTAXIS;GO:0002548;19;0.25994745;0.81148016;0.74883723;1
GO BP;REGULATION OF MESENCHYMAL CELL PROLIFERATION;GO:0010464;19;0.26119706;0.8106564;0.7494781;1
GO BP;RESPONSE TO NERVE GROWTH FACTOR;#N/A;40;0.2125996;0.80973214;0.7548077;1
GO BP;PROTEIN DEPHOSPHORYLATION;GO:0006470;240;0.15715428;0.8078149;0.9682081;1
GO BP;RESPONSE TO BMP;#N/A;103;0.17870401;0.8073497;0.89350647;1
GO BP;REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE;GO:1902473;16;0.27224997;0.8071528;0.7545045;1
GO BP;GLUTAMATE SECRETION;GO:0014047;21;0.25286752;0.8057232;0.7318182;1
GO BP;NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY;GO:0090090;128;0.17046125;0.805215;0.9142091;1
GO BP;MITOCHONDRIAL RNA PROCESSING;GO:0000963;16;0.27073994;0.80436987;0.7454128;1
GO BP;COFACTOR METABOLIC PROCESS;#N/A;329;0.15099585;0.8027375;0.9878049;1
GO BP;MORPHOGENESIS OF A POLARIZED EPITHELIUM;GO:0001738;111;0.17425433;0.80267936;0.90958905;1
GO BP;POSITIVE REGULATION OF ORGANELLE ASSEMBLY;GO:1902117;62;0.19785945;0.79960245;0.8321168;1
GO BP;MODULATION BY VIRUS OF HOST CELLULAR PROCESS;#N/A;15;0.27357042;0.7977873;0.7505721;1
GO BP;RRNA METHYLATION;GO:0031167;23;0.24286492;0.7966923;0.7671233;1
GO BP;PROTEIN HOMOTRIMERIZATION;GO:0070207;19;0.25651538;0.7962373;0.74229074;1
GO BP;NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY;#N/A;19;0.26439938;0.79560226;0.7644445;1
GO BP;REGULATION OF WOUND HEALING;GO:0061041;84;0.18006477;0.7936624;0.8798077;1
GO BP;REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION;GO:0010569;37;0.2140455;0.7931685;0.8049327;1
GO BP;NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION;#N/A;203;0.15759288;0.79309285;0.98176295;1
GO BP;MRNA PROCESSING;GO:0006397;445;0.14275935;0.7906602;0.9965035;1
GO BP;MAMMARY GLAND DUCT MORPHOGENESIS;GO:0060603;19;0.2612366;0.79061174;0.7532751;1
GO BP;PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS;#N/A;17;0.2610366;0.789437;0.78012687;1
GO BP;REGULATION OF CELL CYCLE G2 M PHASE TRANSITION;GO:1902749;192;0.1589143;0.7892823;0.96875;1
GO BP;POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS;#N/A;36;0.21644498;0.78906107;0.82289416;1
GO BP;REGULATION OF CAMP MEDIATED SIGNALING;GO:0043949;19;0.2530645;0.7883461;0.7709251;1
GO BP;WATER SOLUBLE VITAMIN METABOLIC PROCESS;#N/A;66;0.18933989;0.7863599;0.8665158;1
GO BP;MONOAMINE TRANSPORT;GO:0015844;30;0.22211453;0.7859111;0.8183962;1
GO BP;FORELIMB MORPHOGENESIS;GO:0035136;20;0.25627542;0.7857747;0.78401726;1
GO BP;ISOPRENOID BIOSYNTHETIC PROCESS;GO:0008299;19;0.256256;0.78551763;0.79241073;1
GO BP;REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER;GO:0034243;27;0.22817998;0.78533983;0.77751195;1
GO BP;REGULATION OF SYNAPTIC VESICLE RECYCLING;#N/A;19;0.25302354;0.7851312;0.7659091;1
GO BP;DNA REPLICATION INITIATION;GO:0006270;34;0.21575159;0.784927;0.8196721;1
GO BP;PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE;GO:1903539;23;0.23615214;0.78417796;0.77378434;1
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS;#N/A;474;0.14226693;0.78351504;1;1
GO BP;RESPONSE TO BRONCHODILATOR;#N/A;25;0.23706228;0.7807338;0.80349344;1
GO BP;CELL PROLIFERATION IN FOREBRAIN;GO:0021846;16;0.26829365;0.780555;0.74896264;1
GO BP;MULTIVESICULAR BODY ORGANIZATION;GO:0036257;30;0.22636034;0.7799516;0.79445726;1
GO BP;GTP METABOLIC PROCESS;GO:0046039;21;0.24547277;0.77749866;0.77223426;1
GO BP;POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT;GO:1901863;42;0.20570414;0.777189;0.8436019;1
GO BP;GLIAL CELL PROLIFERATION;GO:0014009;28;0.22940212;0.77637994;0.8388521;1
GO BP;PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS;GO:0006656;35;0.21475127;0.776292;0.8259912;1
GO BP;ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT;#N/A;26;0.23045844;0.7762171;0.8072562;1
GO BP;PURINE NUCLEOBASE METABOLIC PROCESS;GO:0006144;18;0.25188243;0.7754024;0.8160173;1
GO BP;CELLULAR COMPONENT MAINTENANCE;GO:0043954;39;0.2052672;0.77455866;0.85915494;1
GO BP;DNA STRAND ELONGATION;GO:0022616;24;0.23193252;0.7740776;0.81333333;1
GO BP;PROTEIN LOCALIZATION TO SYNAPSE;GO:0035418;43;0.20220712;0.7735342;0.8544153;1
GO BP;PIGMENT GRANULE ORGANIZATION;GO:0048753;21;0.24260883;0.7726673;0.80131006;1
GO BP;PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS;#N/A;18;0.25814307;0.7720873;0.773913;1
GO BP;NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903363;71;0.18371281;0.76924276;0.9392405;1
GO BP;DNA REPLICATION CHECKPOINT;GO:0000076;15;0.26511505;0.7689513;0.77111113;1
GO BP;REGULATION OF SYNAPSE ASSEMBLY;GO:0051963;38;0.21182387;0.7678648;0.8337292;1
GO BP;OLIGODENDROCYTE DEVELOPMENT;GO:0014003;23;0.23013613;0.7674296;0.8181818;1
GO BP;3 UTR MEDIATED MRNA STABILIZATION;#N/A;16;0.26230884;0.76635844;0.79613733;1
GO BP;PROSTATE GLAND MORPHOGENESIS;GO:0060512;15;0.2624565;0.76596904;0.79617834;1
GO BP;TRNA METHYLATION;GO:0030488;32;0.21566013;0.76515377;0.84101385;1
GO BP;PIGMENT METABOLIC PROCESS;#N/A;50;0.1931368;0.76398736;0.86885244;1
GO BP;REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL;#N/A;187;0.15308546;0.7632241;0.9773371;1
GO BP;NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;17;0.25642496;0.762608;0.81737196;1
GO BP;SYNAPTIC VESICLE RECYCLING;GO:0036465;51;0.19243626;0.7618326;0.8639456;1
GO BP;RESPONSE TO LEUKEMIA INHIBITORY FACTOR;GO:1990823;75;0.1788157;0.7594148;0.90225565;1
GO BP;TYROSINE PHOSPHORYLATION OF STAT PROTEIN;GO:0007260;33;0.21156512;0.7569601;0.8660714;1
GO BP;POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION;GO:1902808;39;0.1992899;0.7547738;0.89311165;1
GO BP;PLACENTA BLOOD VESSEL DEVELOPMENT;GO:0060674;24;0.23062795;0.7541852;0.8085586;1
GO BP;RESPONSE TO PROGESTERONE;GO:0032570;28;0.21853848;0.7540553;0.8466819;1
GO BP;NEGATIVE REGULATION OF MRNA METABOLIC PROCESS;#N/A;68;0.1786898;0.7536453;0.9097744;1
GO BP;NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:0032435;31;0.2151512;0.7522632;0.86577183;1
GO BP;PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA;#N/A;45;0.19353059;0.75175333;0.89756095;1
GO BP;RNA MODIFICATION;GO:0009451;136;0.15761219;0.7486234;0.97692305;1
GO BP;SPINDLE ASSEMBLY;GO:0051225;93;0.16852349;0.7470265;0.95308644;1
GO BP;POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN;GO:0042531;25;0.22760406;0.7465878;0.8380744;1
GO BP;RNA CAPPING;#N/A;33;0.20568976;0.7443373;0.87906975;1
GO BP;BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE;GO:0048754;83;0.16900754;0.74306726;0.9568528;1
GO BP;CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT;GO:0060706;20;0.23917677;0.741677;0.82185274;1
GO BP;TELOMERE CAPPING;GO:0016233;45;0.19341241;0.74074715;0.88148147;1
GO BP;RESPONSE TO OSMOTIC STRESS;GO:0006970;58;0.18386368;0.7404933;0.9321149;1
GO BP;RECEPTOR LOCALIZATION TO SYNAPSE;GO:0097120;31;0.21048395;0.74012864;0.8780488;1
GO BP;REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION;#N/A;24;0.21755846;0.7379897;0.8448276;1
GO BP;CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION;GO:0034629;19;0.23594856;0.7375159;0.82589287;1
GO BP;VITAMIN METABOLIC PROCESS;GO:0006766;87;0.16325122;0.73551834;0.95933014;1
GO BP;REGULATION OF RESPONSE TO WOUNDING;GO:1903034;105;0.16129903;0.7354694;0.9752475;1
GO BP;CHROMOSOME SEPARATION;GO:0051304;78;0.17055503;0.73359466;0.9559902;1
GO BP;REGULATION OF EPIDERMAL CELL DIFFERENTIATION;GO:0045604;40;0.1974204;0.7332328;0.8816964;1
GO BP;NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS;GO:0050687;21;0.22972335;0.73285013;0.87685776;1
GO BP;DETECTION OF LIGHT STIMULUS;GO:0009583;25;0.22249053;0.7326886;0.88487583;1
GO BP;RESPONSE TO DOPAMINE;#N/A;32;0.21227512;0.7310929;0.9026549;1
GO BP;NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION;#N/A;39;0.19323575;0.728215;0.88148147;1
GO BP;REGULATION OF ACTIN NUCLEATION;GO:0051125;19;0.23588145;0.7263528;0.84731185;1
GO BP;MESONEPHRIC TUBULE MORPHOGENESIS;#N/A;33;0.20540167;0.72631633;0.87703013;1
GO BP;PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS;#N/A;25;0.21799956;0.7230843;0.8608137;1
GO BP;SPECIFICATION OF ANIMAL ORGAN IDENTITY;GO:0010092;16;0.24832399;0.7222421;0.8827586;1
GO BP;CYCLIC NUCLEOTIDE METABOLIC PROCESS;#N/A;20;0.22686821;0.7218756;0.8780488;1
GO BP;NUCLEOTIDE SUGAR METABOLIC PROCESS;GO:0009225;32;0.20025909;0.72164345;0.88755983;1
GO BP;REGULATION OF AUTOPHAGOSOME ASSEMBLY;GO:2000785;35;0.19556078;0.71990323;0.9030733;1
GO BP;REGULATION OF MRNA CATABOLIC PROCESS;#N/A;165;0.14786342;0.7198983;0.99731183;1
GO BP;MITOCHONDRION MORPHOGENESIS;GO:0070584;21;0.22713323;0.7183981;0.8631347;1
GO BP;NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS;GO:1902042;26;0.21309651;0.718291;0.8800905;1
GO BP;MAMMARY GLAND MORPHOGENESIS;GO:0060443;27;0.21209759;0.71640104;0.89311165;1
GO BP;CGMP MEDIATED SIGNALING;GO:0019934;17;0.24212207;0.71348476;0.8666667;1
GO BP;RESPONSE TO ESTROGEN;GO:0043627;50;0.17819428;0.7129415;0.9437939;1
GO BP;ESTABLISHMENT OF EPITHELIAL CELL POLARITY;GO:0090162;24;0.2153434;0.7057793;0.8773585;1
GO BP;PYRIDINE NUCLEOTIDE METABOLIC PROCESS;#N/A;23;0.21653071;0.70528364;0.8969555;1
GO BP;NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051154;20;0.21974872;0.70296663;0.87946427;1
GO BP;MITOTIC CYTOKINETIC PROCESS;GO:1902410;23;0.21999645;0.7027981;0.87096775;1
GO BP;LENS DEVELOPMENT IN CAMERA TYPE EYE;GO:0002088;44;0.18064919;0.7023045;0.9347826;1
GO BP;SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA GERMLINE RECOMBINATION WITHIN A SINGLE LOCUS;#N/A;41;0.18702023;0.7021724;0.9348371;1
GO BP;MITOTIC G2 M TRANSITION CHECKPOINT;GO:0044818;27;0.20052834;0.69497615;0.91685915;1
GO BP;ERROR PRONE TRANSLESION SYNTHESIS;GO:0042276;19;0.22211559;0.689583;0.88505745;1
GO BP;CELLULAR METABOLIC COMPOUND SALVAGE;#N/A;26;0.2047364;0.688815;0.9078341;1
GO BP;MATING;#N/A;16;0.22900541;0.6859967;0.86624205;1
GO BP;BILE ACID BIOSYNTHETIC PROCESS;GO:0006699;25;0.2041347;0.68366456;0.9157428;1
GO BP;TRICARBOXYLIC ACID CYCLE;GO:0006099;33;0.18905419;0.68329394;0.9322034;1
GO BP;TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION;GO:0032201;25;0.20052664;0.68189514;0.9134199;1
GO BP;TELOMERASE RNA LOCALIZATION;#N/A;19;0.22245301;0.6815825;0.9063927;1
GO BP;ANTIGEN PROCESSING AND PRESENTATION;GO:0019882;159;0.14062858;0.6795136;0.994382;1
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I;GO:0002474;73;0.15831617;0.67650104;0.992268;1
GO BP;NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING;GO:0050849;18;0.22341211;0.671257;0.9156118;1
GO BP;RESPONSE TO THYROID HORMONE;GO:0097066;17;0.21939276;0.66875535;0.8764045;1
GO BP;SNRNA TRANSCRIPTION;GO:0009301;67;0.15790427;0.6673239;0.9705882;1
GO BP;TRABECULA FORMATION;#N/A;15;0.22675948;0.66275114;0.89451474;1
GO BP;POSITIVE REGULATION OF VIRAL LIFE CYCLE;GO:1903902;52;0.16624463;0.6621149;0.96683675;1
GO BP;POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING;#N/A;24;0.2002682;0.66176635;0.93932587;1
GO BP;GLUTAMATE METABOLIC PROCESS;GO:0006536;24;0.20090963;0.6612443;0.9301802;1
GO BP;POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS;GO:0010907;27;0.19186313;0.66059154;0.93043476;1
GO BP;BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS;GO:0060444;16;0.21583737;0.64998144;0.9237473;1
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY;GO:0000288;67;0.15213613;0.6468187;0.977887;1
GO BP;POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION;GO:0030838;67;0.15376657;0.6464716;0.99271846;1
GO BP;VIRAL BUDDING VIA HOST ESCRT COMPLEX;GO:0039702;20;0.20118524;0.6443495;0.9426752;1
GO BP;QUINONE METABOLIC PROCESS;#N/A;19;0.20625006;0.6415076;0.944206;1
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS;GO:0008631;36;0.17117132;0.63573515;0.9600939;1
GO BP;IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE;GO:0002381;33;0.17708667;0.6338268;0.95327103;1
GO BP;REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY;GO:0050855;16;0.21724746;0.6324168;0.93473685;1
GO BP;NUCLEOBASE BIOSYNTHETIC PROCESS;#N/A;17;0.20855428;0.63199735;0.94158876;1
GO BP;NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING;GO:0006297;22;0.19576862;0.6304459;0.9492274;1
GO BP;DICARBOXYLIC ACID METABOLIC PROCESS;#N/A;75;0.14548384;0.6303986;1;1
GO BP;MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0002756;24;0.18995507;0.6300547;0.9517241;1
GO BP;POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER;GO:0032968;17;0.21016651;0.6264344;0.93237704;1
GO BP;REGULATION OF ACUTE INFLAMMATORY RESPONSE;GO:0002673;15;0.21725325;0.6243297;0.9186295;1
GO BP;DEOXYRIBONUCLEOTIDE METABOLIC PROCESS;#N/A;30;0.17465366;0.6177346;0.9590909;1
GO BP;COENZYME A METABOLIC PROCESS;GO:0015936;15;0.21204276;0.6161533;0.93911004;1
GO BP;REGULATION OF LAMELLIPODIUM ORGANIZATION;#N/A;32;0.17293768;0.6137519;0.9741936;1
GO BP;GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS;#N/A;18;0.19905369;0.6071628;0.9655172;1
GO BP;CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT;GO:0061005;26;0.17907935;0.60637957;0.96682465;1
GO BP;REGULATION OF ERAD PATHWAY;GO:1904292;25;0.18333948;0.60626084;0.9698376;1
GO BP;VIRAL BUDDING;GO:0046755;24;0.18509717;0.6038879;0.96351933;1
GO BP;NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS;GO:0009226;20;0.18869998;0.6027393;0.9611231;1
GO BP;REGULATION OF MICROTUBULE BASED MOVEMENT;#N/A;18;0.19602996;0.60237116;0.95633185;1
GO BP;CELLULAR RESPONSE TO CADMIUM ION;GO:0071276;21;0.18429543;0.5910319;0.970852;1
GO BP;RNA METHYLATION;GO:0001510;70;0.13845432;0.58201134;1;1
GO BP;REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS;#N/A;23;0.17307507;0.57581514;0.97792494;1
GO BP;RRNA MODIFICATION;GO:0000154;33;0.16344857;0.56850314;0.9835681;1
GO BP;REGULATION OF ISOTYPE SWITCHING;GO:0045191;21;0.17355873;0.56753004;0.98122066;1
GO BP;ACTIVATION OF PROTEIN KINASE B ACTIVITY;GO:0032148;22;0.17948952;0.565487;0.9848485;1
GO BP;DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;GO:0009200;15;0.19142729;0.5651528;0.9601874;1
GO BP;ENDOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY;GO:0032509;25;0.17005698;0.563594;0.98511165;1
GO BP;LATE ENDOSOME TO VACUOLE TRANSPORT;GO:0045324;16;0.19323753;0.5615346;0.9603524;1
GO BP;DNA LIGATION;GO:0006266;17;0.1858877;0.559735;0.95758927;1
GO BP;MUSCLE FILAMENT SLIDING;GO:0030049;21;0.17366107;0.5411696;0.9856115;1
GO BP;BILE ACID METABOLIC PROCESS;GO:0008206;33;0.14988105;0.54106104;0.9934924;1
GO BP;REGULATION OF INTERLEUKIN 1 SECRETION;#N/A;19;0.16939808;0.5309039;0.9782135;1
GO BP;TOXIN TRANSPORT;GO:1901998;33;0.14313088;0.51398546;0.9951691;1
GO BP;L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT;GO:1902475;31;0.14467303;0.5080585;0.9977169;1
GO BP;MODIFIED AMINO ACID TRANSPORT;#N/A;18;0.15847015;0.49182266;0.9978678;0.99991703
GO BP;PIGMENT BIOSYNTHETIC PROCESS;#N/A;43;0.1215812;0.46510684;1;0.99988323
GO BP;POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME;GO:0048026;16;0.15245727;0.4504906;0.99785864;0.9990261
GO BP;REGULATION OF HISTONE H3 K9 METHYLATION;GO:0051570;18;-0.7190358;-2.1428769;0;0.030195208
GO BP;HISTONE H3 K9 MODIFICATION;GO:0061647;37;-0.59643537;-2.1114144;0;0.030203681
GO BP;HISTONE H3 K9 METHYLATION;GO:0051567;29;-0.6338898;-2.0786624;0;0.03799026
GO BP;SPINAL CORD DEVELOPMENT;GO:0021510;49;-0.546953;-2.0512621;0;0.04845704
GO BP;REGULATION OF CHROMATIN SILENCING;GO:0031935;31;-0.6027013;-2.031098;0;0.050841533
GO BP;VENTRAL SPINAL CORD DEVELOPMENT;GO:0021517;19;-0.6785183;-2.0309918;0;0.042367946
GO BP;REGULATION OF ACTION POTENTIAL;GO:0098900;31;-0.6057532;-2.025543;0;0.03856003
GO BP;RRNA TRANSCRIPTION;GO:0009303;32;-0.58220965;-2.0078616;0;0.045584116
GO BP;PEPTIDYL LYSINE TRIMETHYLATION;GO:0018023;40;-0.55833006;-2.0022697;0;0.044009946
GO BP;ACTION POTENTIAL;GO:0001508;59;-0.5083609;-1.9814574;0;0.053130362
GO BP;NEGATIVE REGULATION OF CHROMATIN ORGANIZATION;#N/A;47;-0.5359459;-1.9723629;0;0.05282378
GO BP;TRANSMISSION OF NERVE IMPULSE;GO:0019226;20;-0.64781827;-1.971324;0;0.049082633
GO BP;NEGATIVE REGULATION OF CHROMATIN SILENCING;GO:0031936;15;-0.70656514;-1.969891;0;0.046211798
GO BP;HYALURONAN METABOLIC PROCESS;GO:0030212;22;-0.6337741;-1.9694053;0;0.043098982
GO BP;POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC;GO:0045815;53;-0.51327044;-1.9289037;0;0.06543304
GO BP;REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:2000649;33;-0.561343;-1.9243757;0.001876173;0.06463118
GO BP;MEMBRANE BIOGENESIS;GO:0044091;23;-0.6017152;-1.908233;0.00189394;0.07434326
GO BP;ENDOTHELIAL CELL DEVELOPMENT;GO:0001885;40;-0.5299005;-1.903197;0;0.07603415
GO BP;ESTABLISHMENT OF ENDOTHELIAL BARRIER;GO:0061028;30;-0.5758541;-1.897965;0;0.07693184
GO BP;NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I;GO:0042790;17;-0.64384377;-1.8843703;0;0.08543303
GO BP;INCLUSION BODY ASSEMBLY;GO:0070841;19;-0.6275881;-1.8815308;0;0.08343381
GO BP;REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY;GO:1900449;20;-0.62261814;-1.8812447;0;0.079999
GO BP;HISTONE H3 K4 METHYLATION;GO:0051568;47;-0.49544945;-1.8692002;0;0.08753757
GO BP;RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN;#N/A;167;-0.40370524;-1.8688961;0;0.084216215
GO BP;REGULATION OF CELLULAR RESPONSE TO HEAT;GO:1900034;71;-0.47673562;-1.8655574;0;0.08378641
GO BP;POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I;GO:0045943;20;-0.5992035;-1.8543575;0.001908397;0.09221627
GO BP;ADIPOSE TISSUE DEVELOPMENT;GO:0060612;31;-0.55017394;-1.8542393;0.003571429;0.089043275
GO BP;REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT;GO:1902305;39;-0.5259316;-1.8510227;0;0.089247555
GO BP;COLLAGEN FIBRIL ORGANIZATION;GO:0030199;32;-0.5468256;-1.8488662;0;0.08843902
GO BP;POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY;#N/A;22;-0.58896947;-1.8458363;0.003597122;0.08846394
GO BP;DETECTION OF MECHANICAL STIMULUS;GO:0050982;15;-0.6505605;-1.8353103;0;0.09539121
GO BP;AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS;GO:0042982;51;-0.48102474;-1.8259834;0;0.103435226
GO BP;REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I;#N/A;29;-0.54986656;-1.819896;0.003442341;0.10773692
GO BP;HISTONE METHYLATION;GO:0016571;111;-0.41975853;-1.8173782;0;0.107228115
GO BP;REGULATION OF HISTONE METHYLATION;GO:0031060;53;-0.47349858;-1.8169498;0;0.10480152
GO BP;REGULATION OF CELL MATRIX ADHESION;GO:0001952;79;-0.43737686;-1.8158495;0;0.10374815
GO BP;MITOPHAGY;GO:0000423;21;-0.5988868;-1.8151453;0.00177305;0.10172756
GO BP;MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL;GO:0086010;16;-0.6341232;-1.8136398;0.005703422;0.10084332
GO BP;REGULATION OF CHROMATIN ORGANIZATION;GO:1902275;148;-0.39974985;-1.8116623;0;0.1007828
GO BP;MAINTENANCE OF PROTEIN LOCATION;GO:0045185;86;-0.43618944;-1.8048565;0;0.10552296
GO BP;UNSATURATED FATTY ACID METABOLIC PROCESS;GO:0033559;59;-0.4669381;-1.8046837;0;0.103174925
GO BP;NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT;#N/A;70;-0.4532755;-1.8002859;0.001724138;0.10555914
GO BP;CELL DIFFERENTIATION IN SPINAL CORD;GO:0021515;19;-0.59839296;-1.7985197;0.003773585;0.10481248
GO BP;ER NUCLEUS SIGNALING PATHWAY;GO:0006984;38;-0.5113475;-1.7984765;0.001631321;0.10243038
GO BP;NEGATIVE REGULATION OF GENE SILENCING;#N/A;29;-0.54106206;-1.7982664;0;0.10027173
GO BP;ACTIN FILAMENT BASED MOVEMENT;GO:0030048;84;-0.42884105;-1.7965758;0;0.1000037
GO BP;SULFUR COMPOUND CATABOLIC PROCESS;#N/A;37;-0.50931036;-1.7858841;0.003610108;0.11005532
GO BP;COLLAGEN METABOLIC PROCESS;GO:0032963;59;-0.46124473;-1.7826734;0;0.1112357
GO BP;REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL;#N/A;21;-0.5791009;-1.7798373;0.003717472;0.11201672
GO BP;PEPTIDYL LYSINE METHYLATION;GO:0018022;106;-0.4105325;-1.7773066;0;0.11292737
GO BP;CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN;GO:0035967;136;-0.3985334;-1.7735546;0;0.11548852
GO BP;REGULATION OF SPINDLE ORGANIZATION;#N/A;37;-0.49689922;-1.7715012;0.001851852;0.115464985
GO BP;ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE;GO:0030968;103;-0.41302928;-1.7682729;0;0.11754965
GO BP;POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS;GO:0036003;22;-0.566908;-1.7671388;0.00754717;0.116618626
GO BP;MULTICELLULAR ORGANISMAL SIGNALING;#N/A;78;-0.4277186;-1.7659578;0.001686341;0.11552917
GO BP;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0048010;68;-0.4408501;-1.765864;0.001694915;0.1135365
GO BP;T CELL APOPTOTIC PROCESS;GO:0070231;30;-0.5251288;-1.7625995;0.003539823;0.11571201
GO BP;STRIATED MUSCLE CELL APOPTOTIC PROCESS;#N/A;27;-0.5410565;-1.7513064;0;0.12815362
GO BP;PLATELET MORPHOGENESIS;GO:0036344;15;-0.6342027;-1.7489594;0.003773585;0.12921035
GO BP;LYMPH VESSEL DEVELOPMENT;GO:0001945;15;-0.6187801;-1.7483902;0.016513761;0.12771268
GO BP;MAINTENANCE OF PROTEIN LOCATION IN CELL;GO:0032507;60;-0.4513053;-1.7473814;0;0.126907
GO BP;LEUKOCYTE APOPTOTIC PROCESS;#N/A;62;-0.4411222;-1.7473049;0;0.1250309
GO BP;POSITIVE REGULATION OF CELL KILLING;#N/A;20;-0.5720788;-1.742206;0.007168459;0.12960504
GO BP;ACTOMYOSIN STRUCTURE ORGANIZATION;GO:0031032;137;-0.38799778;-1.7404962;0;0.13020547
GO BP;CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION;GO:0086019;15;-0.6161142;-1.7385609;0.005366726;0.13086537
GO BP;ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE;#N/A;16;-0.6009863;-1.7328898;0.016722407;0.13704008
GO BP;T CELL CYTOKINE PRODUCTION;GO:0002369;17;-0.599517;-1.7307868;0.010676157;0.13789172
GO BP;MITOTIC SISTER CHROMATID COHESION;GO:0007064;22;-0.5585007;-1.7273737;0.011299435;0.14059383
GO BP;EMBRYONIC DIGIT MORPHOGENESIS;GO:0042733;42;-0.47130358;-1.7251675;0.001831502;0.14169368
GO BP;POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING;GO:0014068;47;-0.45693034;-1.7214303;0.007054674;0.14483286
GO BP;REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY;GO:1901385;17;-0.5915203;-1.7197165;0.012681159;0.14539343
GO BP;CONNECTIVE TISSUE DEVELOPMENT;GO:0061448;142;-0.38375852;-1.718518;0;0.14468682
GO BP;CELL MATRIX ADHESION;GO:0007160;142;-0.3767817;-1.7144985;0;0.14850947
GO BP;AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS;GO:0042987;37;-0.48980603;-1.7129663;0.005357143;0.14870372
GO BP;NEGATIVE REGULATION OF LIPID TRANSPORT;GO:0032369;18;-0.5785934;-1.7110031;0.008833922;0.14939925
GO BP;REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0030947;23;-0.54643387;-1.7070664;0.009380863;0.15310231
GO BP;ENDOTHELIUM DEVELOPMENT;GO:0003158;74;-0.42096263;-1.7047418;0;0.15459663
GO BP;SUPRAMOLECULAR FIBER ORGANIZATION;GO:0097435;469;-0.33075905;-1.7010249;0;0.1573923
GO BP;SODIUM ION TRANSMEMBRANE TRANSPORT;GO:0035725;75;-0.42148998;-1.7005311;0.003418803;0.15616478
GO BP;CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS;GO:0035924;34;-0.48922458;-1.6991274;0.003430532;0.15636744
GO BP;REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS;GO:0045540;41;-0.46950573;-1.6990037;0.001712329;0.15461552
GO BP;INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE;#N/A;39;-0.4845297;-1.6988016;0.008291874;0.15306415
GO BP;NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS;GO:0010664;18;-0.58278054;-1.6975546;0.009090909;0.15287942
GO BP;NUCLEUS LOCALIZATION;GO:0051647;21;-0.5669665;-1.6965725;0.009398496;0.15260541
GO BP;REGULATION OF BIOMINERALIZATION;#N/A;48;-0.46056223;-1.6953819;0.001751314;0.15260221
GO BP;NON MOTILE CILIUM ASSEMBLY;GO:1905515;49;-0.44686884;-1.6929823;0.006734007;0.15416475
GO BP;REGULATION OF MITOPHAGY;#N/A;16;-0.59763676;-1.6923062;0.009505703;0.15335843
GO BP;REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION;#N/A;250;-0.34981513;-1.6920689;0;0.15200314
GO BP;IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE;GO:0036498;59;-0.43136033;-1.6898907;0.003424658;0.1529704
GO BP;RNA DESTABILIZATION;GO:0050779;28;-0.51289535;-1.6884;0.011090573;0.15360267
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:0070059;52;-0.44737914;-1.6865848;0.001718213;0.15445378
GO BP;POSITIVE REGULATION OF MRNA CATABOLIC PROCESS;GO:0061014;40;-0.47512627;-1.6858727;0.012237762;0.15380177
GO BP;COLLAGEN BIOSYNTHETIC PROCESS;GO:0032964;28;-0.50875366;-1.6795994;0.001785714;0.1616899
GO BP;REGULATION OF MEMBRANE DEPOLARIZATION;GO:0003254;24;-0.5325448;-1.6778795;0.012589928;0.16272208
GO BP;MAINTENANCE OF LOCATION IN CELL;GO:0051651;77;-0.4173022;-1.6778072;0;0.16109224
GO BP;SELECTIVE AUTOPHAGY;GO:0061912;45;-0.45471656;-1.6776521;0.005172414;0.15964612
GO BP;MAST CELL MEDIATED IMMUNITY;GO:0002448;30;-0.49046755;-1.6749617;0.013937282;0.1620089
GO BP;INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY;GO:0035735;38;-0.4729829;-1.6732881;0.005291005;0.16249962
GO BP;UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS;GO:0006636;35;-0.48211813;-1.6680491;0.003412969;0.16910413
GO BP;POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:2000651;15;-0.5932103;-1.6671753;0.021778584;0.16848896
GO BP;STEROL METABOLIC PROCESS;GO:0016125;116;-0.3767786;-1.6670909;0;0.16693714
GO BP;EPITHELIAL CELL MORPHOGENESIS;GO:0003382;21;-0.5407335;-1.6647843;0.014440433;0.16864203
GO BP;DORSAL VENTRAL PATTERN FORMATION;GO:0009953;43;-0.45441496;-1.6628665;0.007393715;0.1697649
GO BP;CARDIAC MUSCLE CELL CONTRACTION;GO:0086003;37;-0.47457406;-1.6582218;0.017211704;0.17511293
GO BP;STEROL BIOSYNTHETIC PROCESS;GO:0016126;67;-0.41243994;-1.6533647;0.001689189;0.18134074
GO BP;POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION;#N/A;17;-0.5653526;-1.6528137;0.014705882;0.18044697
GO BP;POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS;GO:0042108;33;-0.48806536;-1.651625;0.010221466;0.18049501
GO BP;CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE;GO:0002367;59;-0.4193867;-1.6490096;0.005319149;0.18295737
GO BP;REGULATION OF T CELL APOPTOTIC PROCESS;#N/A;18;-0.55414253;-1.6472988;0.014925373;0.18416971
GO BP;REGULATION OF ACTIN FILAMENT BASED MOVEMENT;#N/A;29;-0.49677894;-1.647189;0.019855596;0.18268712
GO BP;LYMPHOCYTE APOPTOTIC PROCESS;#N/A;44;-0.45324036;-1.6458622;0.005263158;0.18302673
GO BP;REGULATION OF CATION CHANNEL ACTIVITY;#N/A;65;-0.4107856;-1.6439399;0.003338898;0.18458278
GO BP;POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR;GO:2000781;25;-0.51516896;-1.6433786;0.02513465;0.1837875
GO BP;REGULATION OF TUBE SIZE;GO:0035150;62;-0.41507939;-1.6420308;0.007104796;0.18418278
GO BP;POSITIVE REGULATION OF ERBB SIGNALING PATHWAY;GO:1901186;21;-0.5267687;-1.6406736;0.026929982;0.18455224
GO BP;CARDIAC MUSCLE CELL ACTION POTENTIAL;GO:0086001;36;-0.47232324;-1.640562;0.013864818;0.18309677
GO BP;NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY;GO:0045746;31;-0.4859721;-1.6404878;0.010830325;0.18162222
GO BP;REGULATION OF LIPID CATABOLIC PROCESS;GO:0050994;32;-0.48297963;-1.6404517;0.012345679;0.18020588
GO BP;MEMBRANE DEPOLARIZATION;GO:0051899;42;-0.45307195;-1.6399827;0.007194245;0.17930956
GO BP;CELLULAR RESPONSE TO HEAT;GO:0034605;109;-0.3807184;-1.6388158;0.001574803;0.18014331
GO BP;REGULATION OF SODIUM ION TRANSPORT;GO:0002028;51;-0.4415715;-1.6382362;0.003454231;0.17948169
GO BP;COVALENT CHROMATIN MODIFICATION;GO:0016569;375;-0.32573494;-1.6372601;0;0.17949657
GO BP;EPITHELIAL CELL DEVELOPMENT;GO:0002064;134;-0.3633023;-1.636924;0;0.17859294
GO BP;TYPE 2 IMMUNE RESPONSE;GO:0042092;16;-0.57453966;-1.6367778;0.017953321;0.1773856
GO BP;POSITIVE REGULATION OF INTRACELLULAR TRANSPORT;GO:0032388;165;-0.35297567;-1.6317215;0;0.18372478
GO BP;REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY;GO:0099601;26;-0.50859886;-1.6290818;0.016885553;0.18651873
GO BP;CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE;GO:0002534;22;-0.51266396;-1.6286546;0.020295203;0.18581553
GO BP;LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE;#N/A;20;-0.52964455;-1.628323;0.026168223;0.18489714
GO BP;SPLEEN DEVELOPMENT;GO:0048536;23;-0.51544094;-1.627522;0.02037037;0.18476464
GO BP;NEURAL TUBE DEVELOPMENT;GO:0021915;129;-0.36619172;-1.626562;0;0.18486705
GO BP;PEPTIDYL LYSINE MODIFICATION;#N/A;322;-0.3262895;-1.6258526;0;0.18460779
GO BP;APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT;GO:1902742;18;-0.5459695;-1.6192211;0.02851711;0.19373472
GO BP;PHOTORECEPTOR CELL DEVELOPMENT;GO:0042461;19;-0.54796565;-1.6186196;0.007490637;0.19329545
GO BP;REGULATION OF CATION TRANSMEMBRANE TRANSPORT;GO:1904062;152;-0.35285366;-1.6178864;0;0.19314691
GO BP;REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;GO:0031110;62;-0.41767883;-1.6163999;0;0.19421534
GO BP;ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS;GO:0032469;19;-0.542144;-1.615844;0.02238806;0.1937349
GO BP;REGULATION OF CELL SUBSTRATE JUNCTION ASSEMBLY;#N/A;45;-0.43954423;-1.6143683;0.010471204;0.19465846
GO BP;NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;GO:0031111;30;-0.4737946;-1.6131941;0.012455516;0.19510171
GO BP;REGULATION OF CELL SIZE;GO:0008361;125;-0.3646673;-1.6129326;0.001615509;0.19413295
GO BP;NEGATIVE REGULATION OF HISTONE METHYLATION;GO:0031061;17;-0.56726253;-1.61289;0.019193858;0.192793
GO BP;SISTER CHROMATID COHESION;GO:0007062;53;-0.42776933;-1.6124157;0.003361345;0.19215304
GO BP;CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING;GO:0051085;24;-0.512768;-1.6117895;0.013207547;0.19167873
GO BP;REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION;#N/A;69;-0.4081585;-1.611729;0.013722127;0.19043906
GO BP;REGULATION OF TRANSPORTER ACTIVITY;#N/A;132;-0.36276126;-1.6115726;0;0.1892991
GO BP;MULTICELLULAR ORGANISM GROWTH;GO:0035264;106;-0.37172502;-1.6114575;0;0.18829297
GO BP;CIRCADIAN REGULATION OF GENE EXPRESSION;GO:0032922;48;-0.43440625;-1.611431;0.015075377;0.18703926
GO BP;COLLAGEN CATABOLIC PROCESS;GO:0030574;20;-0.52979845;-1.6095375;0.02014652;0.18882152
GO BP;REGULATION OF LEUKOCYTE APOPTOTIC PROCESS;#N/A;44;-0.43913352;-1.6084726;0.017006803;0.1891046
GO BP;REGULATION OF PROTEIN TARGETING;#N/A;62;-0.41451058;-1.6068404;0.003367003;0.19021122
GO BP;CELL VOLUME HOMEOSTASIS;GO:0006884;19;-0.5409287;-1.6046664;0.023049645;0.19251274
GO BP;CLATHRIN COAT ASSEMBLY;GO:0048268;15;-0.5714474;-1.6043031;0.037328094;0.19192441
GO BP;LUNG ALVEOLUS DEVELOPMENT;GO:0048286;27;-0.49554488;-1.6040511;0.016697587;0.19109274
GO BP;EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING;GO:0009792;450;-0.31188712;-1.600043;0;0.19620922
GO BP;SPINAL CORD MOTOR NEURON DIFFERENTIATION;GO:0021522;15;-0.5783869;-1.5982667;0.031539887;0.19781514
GO BP;CELL SUBSTRATE JUNCTION ORGANIZATION;#N/A;74;-0.39152312;-1.5953583;0.003294893;0.20139052
GO BP;REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0032231;71;-0.39903006;-1.5926007;0.003220612;0.20469485
GO BP;REGULATION OF LEUKOCYTE MIGRATION;GO:0002685;92;-0.38025388;-1.5919973;0.003184713;0.20422652
GO BP;REGULATION OF BONE MINERALIZATION;GO:0030500;38;-0.45687392;-1.591707;0.009433962;0.20334792
GO BP;RECEPTOR CATABOLIC PROCESS;GO:0032801;33;-0.46826473;-1.59028;0.015929203;0.20438108
GO BP;PROTEIN LOCALIZATION TO PLASMA MEMBRANE;GO:0072659;208;-0.33307225;-1.5887376;0;0.20578612
GO BP;REGULATION OF HISTONE MODIFICATION;GO:0031056;112;-0.36908928;-1.5887214;0.004792332;0.20454018
GO BP;MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;#N/A;90;-0.3803022;-1.5884781;0.006622517;0.20363519
GO BP;NEGATIVE REGULATION OF BIOMINERALIZATION;GO:0110150;16;-0.55024415;-1.5846548;0.02457467;0.20847154
GO BP;RESPONSE TO HYDROPEROXIDE;GO:0033194;16;-0.55947477;-1.5842909;0.024482109;0.20776008
GO BP;POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT;#N/A;17;-0.54856795;-1.5839453;0.016245488;0.20704097
GO BP;GLUTAMATE RECEPTOR SIGNALING PATHWAY;GO:0007215;32;-0.4715245;-1.5836533;0.007220217;0.20632488
GO BP;NEGATIVE REGULATION OF LIPID LOCALIZATION;#N/A;28;-0.476144;-1.5817806;0.019469026;0.2083219
GO BP;PROTEIN METHYLATION;GO:0006479;146;-0.34834558;-1.5803114;0.00152439;0.20961063
GO BP;REGULATION OF PROTEIN DEPOLYMERIZATION;GO:1901879;59;-0.40572405;-1.5796065;0.008361204;0.2094982
GO BP;INTERLEUKIN 8 PRODUCTION;GO:0032637;38;-0.44385922;-1.5783093;0.019064125;0.2106333
GO BP;CONTRACTILE ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0030038;76;-0.39058903;-1.5779169;0.003430532;0.21016125
GO BP;SKELETAL MUSCLE CELL DIFFERENTIATION;GO:0035914;39;-0.44252637;-1.577548;0.015734266;0.2096775
GO BP;DORSAL VENTRAL NEURAL TUBE PATTERNING;GO:0021904;19;-0.53412884;-1.5768893;0.02877698;0.20959279
GO BP;POSITIVE REGULATION OF CELL MATRIX ADHESION;GO:0001954;35;-0.44568387;-1.5766568;0.015625;0.20876656
GO BP;NEUROINFLAMMATORY RESPONSE;GO:0150076;31;-0.4623784;-1.576204;0.019197207;0.20824808
GO BP;PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS;#N/A;31;-0.46732882;-1.5757914;0.01923077;0.2077506
GO BP;PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER;#N/A;31;-0.46669003;-1.5755502;0.014545455;0.2068945
GO BP;XENOBIOTIC TRANSPORT;GO:0042908;15;-0.56006426;-1.5750922;0.036101084;0.20656715
GO BP;EMBRYONIC APPENDAGE MORPHOGENESIS;#N/A;79;-0.38274688;-1.5744691;0.006589786;0.20640433
GO BP;MEMBRANE PROTEIN PROTEOLYSIS;GO:0033619;42;-0.43379948;-1.5742252;0.02636204;0.20570268
GO BP;CORTICAL CYTOSKELETON ORGANIZATION;GO:0030865;41;-0.4341397;-1.5727043;0.017699115;0.20708896
GO BP;EXTRACELLULAR STRUCTURE ORGANIZATION;#N/A;215;-0.33127388;-1.5722634;0;0.2067166
GO BP;NEUROMUSCULAR JUNCTION DEVELOPMENT;GO:0007528;33;-0.45421508;-1.5721694;0.021032505;0.20573664
GO BP;REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS;GO:1902991;27;-0.47903895;-1.57213;0.01814882;0.20471126
GO BP;REGULATION OF CHROMOSOME ORGANIZATION;GO:0033044;292;-0.318691;-1.5716188;0;0.2043352
GO BP;REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS;GO:1900180;93;-0.3742329;-1.5699857;0.00317965;0.20573448
GO BP;REGULATION OF TRIGLYCERIDE METABOLIC PROCESS;GO:0090207;24;-0.49648854;-1.5689604;0.029360967;0.20627639
GO BP;BLOOD VESSEL ENDOTHELIAL CELL MIGRATION;GO:0043534;79;-0.37836248;-1.5669354;0.008431703;0.20818356
GO BP;MACROPHAGE ACTIVATION;GO:0042116;45;-0.4251599;-1.5669146;0.016891891;0.20710985
GO BP;PROTEIN KINASE B SIGNALING;GO:0043491;137;-0.35118356;-1.5665299;0.005067567;0.20657247
GO BP;MUSCLE CELL APOPTOTIC PROCESS;#N/A;48;-0.41766742;-1.5661775;0.00837521;0.20605436
GO BP;INTERFERON GAMMA PRODUCTION;GO:0032609;40;-0.4373967;-1.5640355;0.019784173;0.20857532
GO BP;REGULATION OF CYTOSKELETON ORGANIZATION;GO:0051493;396;-0.3066348;-1.560481;0;0.21358144
GO BP;AMYLOID BETA FORMATION;GO:0034205;28;-0.4702662;-1.5594999;0.021582734;0.21422677
GO BP;REGULATION OF CELL MORPHOGENESIS;GO:0022604;333;-0.30940598;-1.5593755;0;0.21332434
GO BP;PROTEIN LOCALIZATION TO CELL PERIPHERY;#N/A;242;-0.32158583;-1.5591344;0;0.21263734
GO BP;EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:0097191;157;-0.34071842;-1.5581;0;0.21333076
GO BP;NEGATIVE REGULATION OF ORGANELLE ORGANIZATION;#N/A;303;-0.3141862;-1.5560508;0;0.21568698
GO BP;NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT;#N/A;46;-0.42643312;-1.5554278;0.02108963;0.21546713
GO BP;LIPID DROPLET ORGANIZATION;GO:0034389;16;-0.535945;-1.5538762;0.042857144;0.21701305
GO BP;I KAPPAB KINASE NF KAPPAB SIGNALING;GO:0007249;190;-0.3304837;-1.5529938;0;0.21740876
GO BP;POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY;GO:1903307;33;-0.44945207;-1.5528666;0.029310346;0.21649547
GO BP;POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS;#N/A;296;-0.312962;-1.5528371;0;0.21548054
GO BP;PEPTIDE CATABOLIC PROCESS;GO:0043171;17;-0.5426387;-1.5526981;0.044483986;0.21465054
GO BP;MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE;#N/A;34;-0.44747025;-1.5513247;0.020477816;0.21612099
GO BP;HISTONE H3 K4 TRIMETHYLATION;GO:0080182;16;-0.5416472;-1.5505803;0.03195489;0.21629633
GO BP;POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY;GO:0051091;162;-0.33997285;-1.549168;0.001560062;0.21791661
GO BP;REGULATION OF CELLULAR PROTEIN LOCALIZATION;GO:1903827;415;-0.30481547;-1.5489515;0;0.21723431
GO BP;LYMPHOCYTE MIGRATION;GO:0072676;44;-0.42838204;-1.5488218;0.017953321;0.21641396
GO BP;NEURAL TUBE PATTERNING;GO:0021532;29;-0.46500975;-1.5480204;0.027923211;0.21683308
GO BP;REGULATION OF CELL SUBSTRATE ADHESION;GO:0010810;139;-0.34290195;-1.5466921;0.003241491;0.21809165
GO BP;TUMOR NECROSIS FACTOR SECRETION;GO:1990774;16;-0.54140055;-1.5453871;0.035460994;0.21907407
GO BP;CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION;#N/A;93;-0.36523646;-1.5425148;0.018549748;0.22317347
GO BP;REGULATION OF CILIUM ASSEMBLY;GO:1902017;45;-0.42932928;-1.5416117;0.015384615;0.22382875
GO BP;CELL JUNCTION ASSEMBLY;GO:0034329;174;-0.33478844;-1.5415136;0;0.22300081
GO BP;RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:0034976;240;-0.31846234;-1.5401909;0;0.22446716
GO BP;POSITIVE REGULATION OF AXON EXTENSION;GO:0045773;36;-0.4429154;-1.5382863;0.024561403;0.2267029
GO BP;MUCOPOLYSACCHARIDE METABOLIC PROCESS;#N/A;65;-0.38923866;-1.5382862;0.008116883;0.22566298
GO BP;INOSITOL PHOSPHATE CATABOLIC PROCESS;#N/A;15;-0.5519094;-1.5381287;0.04537205;0.2248601
GO BP;REGULATION OF CELL KILLING;#N/A;32;-0.45241892;-1.5362025;0.023809524;0.22717033
GO BP;ASYMMETRIC CELL DIVISION;GO:0008356;15;-0.54720336;-1.5359128;0.047016274;0.22664264
GO BP;POSITIVE REGULATION OF SODIUM ION TRANSPORT;GO:0010765;25;-0.47972146;-1.5358428;0.027829314;0.22574045
GO BP;CHROMATIN DISASSEMBLY;#N/A;17;-0.5227325;-1.5353973;0.037848607;0.22553985
GO BP;CELLULAR RESPONSE TO BIOTIC STIMULUS;#N/A;129;-0.34672073;-1.5346866;0.008064516;0.22575778
GO BP;POTASSIUM ION TRANSPORT;GO:0006813;77;-0.37607613;-1.534631;0.015332198;0.22488873
GO BP;REGULATION OF ION TRANSMEMBRANE TRANSPORT;GO:0034765;193;-0.3278362;-1.5345145;0;0.22409645
GO BP;REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE;GO:1900101;22;-0.5005586;-1.5343533;0.03914591;0.22329369
GO BP;REGULATION OF CELL SHAPE;GO:0008360;114;-0.3491463;-1.5343363;0.006472492;0.22234283
GO BP;CELL SUBSTRATE ADHESION;GO:0031589;225;-0.32052246;-1.5336889;0;0.22258742
GO BP;SYNCYTIUM FORMATION;GO:0006949;25;-0.47765023;-1.5334429;0.037906136;0.22203125
GO BP;NEUROBLAST PROLIFERATION;GO:0007405;36;-0.4401349;-1.5332083;0.029565217;0.22150157
GO BP;POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT;GO:0090316;123;-0.3476039;-1.532593;0.008576329;0.22160038
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE;GO:0008630;86;-0.36336595;-1.5322863;0.008403362;0.22115579
GO BP;CARDIOVASCULAR SYSTEM DEVELOPMENT;#N/A;445;-0.29862744;-1.53178;0;0.22122014
GO BP;RENAL SYSTEM DEVELOPMENT;#N/A;179;-0.32595736;-1.5305938;0;0.22237957
GO BP;PROTEIN LOCALIZATION TO CILIUM;GO:0061512;44;-0.41717467;-1.5304289;0.022727273;0.22182025
GO BP;MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS;GO:0051457;20;-0.50739115;-1.5303446;0.036363635;0.22103496
GO BP;NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY;GO:0031333;97;-0.35729486;-1.5295546;0.00805153;0.2215458
GO BP;REGULATION OF MICROTUBULE BASED PROCESS;GO:0032886;179;-0.32897082;-1.5294839;0;0.22072871
GO BP;PHOSPHOLIPID DEPHOSPHORYLATION;GO:0046839;30;-0.461845;-1.5291333;0.03125;0.22033456
GO BP;AORTIC VALVE DEVELOPMENT;GO:0003176;21;-0.49750334;-1.5282369;0.039076377;0.22081557
GO BP;SEMI LUNAR VALVE DEVELOPMENT;GO:1905314;23;-0.489221;-1.5281001;0.037906136;0.2201303
GO BP;CYTOPLASMIC SEQUESTERING OF PROTEIN;GO:0051220;22;-0.49435818;-1.527238;0.031578947;0.22065003
GO BP;CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT;GO:0030705;152;-0.33328512;-1.5262921;0.003294893;0.2213816
GO BP;SODIUM ION TRANSPORT;GO:0006814;116;-0.34772858;-1.5244976;0.003231018;0.22359219
GO BP;MICROTUBULE DEPOLYMERIZATION;GO:0007019;34;-0.44968256;-1.5244557;0.028368793;0.2227636
GO BP;POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION;GO:1903829;256;-0.3100546;-1.5215951;0.001455604;0.22705202
GO BP;POSITIVE REGULATION OF AXONOGENESIS;GO:0050772;60;-0.39021742;-1.5208138;0.01754386;0.22758596
GO BP;RESPONSE TO ALKALOID;#N/A;63;-0.3853552;-1.520206;0.018900344;0.22767077
GO BP;SYNAPTIC TRANSMISSION GABAERGIC;GO:0051932;19;-0.5064188;-1.5189755;0.041666668;0.2289512
GO BP;REGULATION OF COLLAGEN METABOLIC PROCESS;#N/A;24;-0.47476292;-1.5177634;0.050373133;0.23026802
GO BP;REGULATION OF AMYLOID BETA FORMATION;GO:1902003;22;-0.49256727;-1.517754;0.030411448;0.2293701
GO BP;NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION;GO:1902904;96;-0.35879737;-1.5175182;0.008503402;0.22882625
GO BP;REGULATION OF NUCLEOTIDE METABOLIC PROCESS;#N/A;84;-0.3672963;-1.5172166;0.010050251;0.22831976
GO BP;POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS;#N/A;15;-0.53528994;-1.5159148;0.05970149;0.22968899
GO BP;POSITIVE REGULATION OF CHROMATIN ORGANIZATION;#N/A;85;-0.36684746;-1.5158528;0.003378379;0.2288843
GO BP;REGULATION OF ACTIN FILAMENT BASED PROCESS;GO:0032970;266;-0.3105401;-1.5158384;0;0.22802445
GO BP;REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY;GO:0032878;23;-0.4859511;-1.5157793;0.038394414;0.22722173
GO BP;REGULATION OF GENE EXPRESSION EPIGENETIC;GO:0040029;276;-0.30783045;-1.5134917;0;0.23030388
GO BP;NEGATIVE REGULATION OF HISTONE MODIFICATION;#N/A;32;-0.43563855;-1.5130965;0.034423407;0.23018518
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME;#N/A;27;-0.45864767;-1.5104033;0.034358047;0.23411106
GO BP;RESPONSE TO HEAT;GO:0009408;134;-0.33549288;-1.5082383;0.004754358;0.23699507
GO BP;REGULATION OF GENE SILENCING;#N/A;129;-0.33747762;-1.5065116;0.012779553;0.23907591
GO BP;NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION;#N/A;123;-0.34300283;-1.5056871;0.00330033;0.23968838
GO BP;HISTONE H4 ACETYLATION;GO:0043967;57;-0.3866924;-1.5038372;0.023255814;0.24188714
GO BP;ENDOTHELIAL CELL MIGRATION;GO:0043542;135;-0.33458483;-1.5036656;0.001644737;0.24123998
GO BP;IN UTERO EMBRYONIC DEVELOPMENT;GO:0001701;292;-0.30920517;-1.5036125;0;0.2404348
GO BP;REGULATION OF LYMPHOCYTE MIGRATION;GO:2000401;30;-0.45524266;-1.5036056;0.023508137;0.23955238
GO BP;POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0032233;49;-0.39412266;-1.5030273;0.024647888;0.23967405
GO BP;NEGATIVE REGULATION OF DNA METABOLIC PROCESS;#N/A;94;-0.34873426;-1.5027921;0.009787928;0.23927256
GO BP;POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS;#N/A;17;-0.5203996;-1.5021005;0.048262548;0.23958011
GO BP;HISTONE H4 K16 ACETYLATION;GO:0043984;20;-0.5093932;-1.5001903;0.040219378;0.24204572
GO BP;MALE SEX DIFFERENTIATION;GO:0046661;109;-0.3471793;-1.4998034;0.011456628;0.24182193
GO BP;POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION;GO:0043923;16;-0.5340315;-1.4997566;0.036231883;0.2410164
GO BP;ACTIN FILAMENT BUNDLE ORGANIZATION;GO:0061572;116;-0.34355667;-1.4992961;0.009433962;0.24096584
GO BP;FOREBRAIN DEVELOPMENT;GO:0030900;219;-0.3155937;-1.4990183;0;0.24063337
GO BP;NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION;GO:0043537;20;-0.5016827;-1.4972752;0.04238921;0.24289082
GO BP;VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY;GO:0038084;23;-0.48768145;-1.4971472;0.027829314;0.24228652
GO BP;REGULATION OF CHOLESTEROL METABOLIC PROCESS;GO:0090181;51;-0.39372668;-1.4967681;0.027444255;0.24218439
GO BP;HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE;GO:0048873;17;-0.5147645;-1.4962709;0.056140352;0.24227263
GO BP;POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT;GO:0010828;25;-0.46493658;-1.4960042;0.041894354;0.241952
GO BP;REGULATION OF METAL ION TRANSPORT;#N/A;182;-0.31902677;-1.4951578;0.003062787;0.24270444
GO BP;AMYLOID BETA METABOLIC PROCESS;GO:0050435;37;-0.42261484;-1.4947842;0.024866786;0.24250017
GO BP;POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT;#N/A;94;-0.35285354;-1.4946606;0.011058452;0.24184054
GO BP;REGULATION OF PROTEIN TARGETING TO MEMBRANE;#N/A;26;-0.4673728;-1.4936273;0.047957372;0.24268076
GO BP;REGULATION OF INTRACELLULAR PROTEIN TRANSPORT;GO:0033157;181;-0.3244142;-1.493024;0.00620155;0.24292561
GO BP;INTRACILIARY TRANSPORT;GO:0042073;46;-0.40375605;-1.4914638;0.037099496;0.24493736
GO BP;VACUOLAR TRANSPORT;GO:0007034;125;-0.33280814;-1.4897314;0.004807693;0.24729341
GO BP;RESPONSE TO PH;GO:0009268;20;-0.49244544;-1.4890805;0.05376344;0.2476734
GO BP;HISTONE DEACETYLATION;GO:0016575;62;-0.37895638;-1.4890332;0.02451839;0.24690576
GO BP;T CELL MIGRATION;GO:0072678;32;-0.44699892;-1.4885345;0.03577513;0.24698679
GO BP;POSITIVE REGULATION OF CATABOLIC PROCESS;#N/A;346;-0.29779792;-1.4876935;0.001432665;0.24767067
GO BP;AMINOGLYCAN METABOLIC PROCESS;#N/A;96;-0.35090452;-1.4872311;0.01;0.24767688
GO BP;NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE;GO:1902230;23;-0.4670988;-1.4872047;0.04291045;0.24687466
GO BP;POSITIVE REGULATION OF DNA BINDING;GO:0043388;40;-0.42311567;-1.4871866;0.018181818;0.24606907
GO BP;REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902235;28;-0.44966862;-1.486452;0.058614563;0.24655612
GO BP;REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS;#N/A;26;-0.45725778;-1.4863867;0.0460177;0.24580032
GO BP;CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS;#N/A;23;-0.46533272;-1.4856259;0.059590317;0.24629381
GO BP;POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT;GO:0010976;191;-0.31566718;-1.4847496;0.00955414;0.2469604
GO BP;MYOTUBE DIFFERENTIATION;GO:0014902;54;-0.38736498;-1.4844289;0.013864818;0.24671471
GO BP;ANTIMICROBIAL HUMORAL RESPONSE;GO:0019730;38;-0.41795108;-1.4842204;0.03963964;0.24623188
GO BP;POSITIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY;#N/A;15;-0.52877295;-1.4840692;0.04393673;0.24560802
GO BP;REGULATION OF ENDOTHELIAL CELL MIGRATION;GO:0010594;108;-0.34397233;-1.4839199;0.014446228;0.245044
GO BP;UROGENITAL SYSTEM DEVELOPMENT;GO:0001655;203;-0.3176766;-1.4835378;0.006097561;0.24486868
GO BP;NEGATIVE REGULATION OF TRANSPORTER ACTIVITY;GO:0032410;36;-0.42133382;-1.4827752;0.02578269;0.24532245
GO BP;POSITIVE REGULATION OF STRESS FIBER ASSEMBLY;GO:0051496;43;-0.40564653;-1.4825289;0.03564728;0.24496679
GO BP;SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND;#N/A;45;-0.4019392;-1.4824212;0.021996615;0.24441724
GO BP;BONE MINERALIZATION;GO:0030282;65;-0.37296885;-1.4820995;0.022727273;0.24421513
GO BP;LYSOSOMAL TRANSPORT;GO:0007041;90;-0.35564345;-1.4813254;0.008695652;0.24480532
GO BP;REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS;#N/A;15;-0.524468;-1.4799356;0.06728972;0.24642503
GO BP;POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS;#N/A;25;-0.4616178;-1.4784224;0.060491495;0.24830975
GO BP;POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY;GO:0051092;100;-0.3454503;-1.4776374;0.004862237;0.24893565
GO BP;POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS;#N/A;34;-0.4298806;-1.4776224;0.054006968;0.24816118
GO BP;SMOOTHENED SIGNALING PATHWAY;GO:0007224;104;-0.3466685;-1.4774271;0.00953895;0.24774729
GO BP;PROTEIN TARGETING TO VACUOLE;GO:0006623;37;-0.42154935;-1.4754504;0.03874539;0.25075376
GO BP;POSITIVE REGULATION OF AUTOPHAGY;GO:0010508;102;-0.3440756;-1.4739552;0.013114754;0.25273523
GO BP;MONOVALENT INORGANIC CATION HOMEOSTASIS;#N/A;96;-0.3434524;-1.4734013;0.006622517;0.25303546
GO BP;LONG CHAIN FATTY ACID METABOLIC PROCESS;GO:0001676;62;-0.37634134;-1.4733444;0.019927537;0.25236368
GO BP;LEUKOCYTE DIFFERENTIATION;GO:0002521;268;-0.30120292;-1.4721315;0;0.25373682
GO BP;RESPONSE TO LEAD ION;GO:0010288;19;-0.48385113;-1.4720975;0.056057867;0.25303438
GO BP;REGULATION OF SISTER CHROMATID COHESION;GO:0007063;22;-0.48170003;-1.4706247;0.066176474;0.2548883
GO BP;REGULATION OF CARDIAC MUSCLE CONTRACTION;GO:0055117;44;-0.39648747;-1.4704802;0.03275862;0.25436568
GO BP;POLYOL CATABOLIC PROCESS;#N/A;22;-0.46890366;-1.4703457;0.055555556;0.25379694
GO BP;REGULATION OF TRANSMEMBRANE TRANSPORT;#N/A;247;-0.30527636;-1.4698783;0.004470939;0.2537998
GO BP;NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY;GO:2001258;16;-0.5061134;-1.4696707;0.063716814;0.25336978
GO BP;HEART DEVELOPMENT;GO:0007507;371;-0.29133585;-1.4695244;0.001420455;0.25286227
GO BP;CENTRIOLE ASSEMBLY;GO:0098534;34;-0.42677438;-1.4685022;0.040350877;0.25382024
GO BP;REGULATION OF STEROID BIOSYNTHETIC PROCESS;GO:0050810;67;-0.36528888;-1.4670892;0.031034483;0.255604
GO BP;PLASMINOGEN ACTIVATION;GO:0031639;19;-0.48516488;-1.4667927;0.054006968;0.25538206
GO BP;CELL AGING;GO:0007569;84;-0.3508459;-1.4667348;0.018739352;0.25471926
GO BP;REGULATION OF INTRACELLULAR TRANSPORT;GO:0032386;271;-0.30030054;-1.4664041;0.001488095;0.25464728
GO BP;POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001238;34;-0.427264;-1.4661038;0.03350084;0.25447083
GO BP;FOCAL ADHESION ASSEMBLY;GO:0048041;61;-0.3724649;-1.4654874;0.027223231;0.25488177
GO BP;NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION;GO:0008285;423;-0.28757605;-1.4654146;0;0.25422046
GO BP;VACUOLAR ACIDIFICATION;GO:0007035;20;-0.48228857;-1.4646075;0.05719557;0.25499856
GO BP;REGULATION OF VASCULATURE DEVELOPMENT;GO:1901342;190;-0.31452075;-1.4644729;0.00953895;0.2544579
GO BP;ASSOCIATIVE LEARNING;GO:0008306;38;-0.40823558;-1.4643497;0.041450776;0.2539209
GO BP;REGULATION OF MICROTUBULE DEPOLYMERIZATION;GO:0031114;25;-0.4530132;-1.4625164;0.044905007;0.25651577
GO BP;POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION;GO:0010595;71;-0.3620042;-1.4618796;0.027687296;0.25689742
GO BP;CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION;GO:0086002;25;-0.45838144;-1.4602058;0.055655297;0.25908998
GO BP;CELL JUNCTION ORGANIZATION;#N/A;208;-0.307841;-1.4601128;0.0144;0.25856906
GO BP;RHYTHMIC BEHAVIOR;GO:0007622;25;-0.45719945;-1.459187;0.05;0.2595679
GO BP;NEURAL PRECURSOR CELL PROLIFERATION;GO:0061351;88;-0.3483867;-1.4584442;0.024509804;0.26027122
GO BP;CARTILAGE DEVELOPMENT;GO:0051216;100;-0.3426427;-1.4580123;0.020168068;0.26025102
GO BP;GLIAL CELL ACTIVATION;#N/A;26;-0.4569999;-1.4579638;0.05075188;0.25958455
GO BP;RESPONSE TO PURINE CONTAINING COMPOUND;#N/A;89;-0.34880424;-1.4577545;0.020547945;0.2592638
GO BP;ENDOPLASMIC RETICULUM ORGANIZATION;GO:0007029;48;-0.40225855;-1.4577011;0.0455312;0.2586335
GO BP;RETINOIC ACID RECEPTOR SIGNALING PATHWAY;GO:0048384;21;-0.47153947;-1.4561232;0.068716094;0.26078433
GO BP;POSITIVE REGULATION OF ORGANELLE ORGANIZATION;GO:0010638;488;-0.28253177;-1.4560152;0;0.2602333
GO BP;REGULATION OF STEROL TRANSPORT;#N/A;30;-0.43306175;-1.455693;0.050522648;0.26004076
GO BP;POTASSIUM ION HOMEOSTASIS;GO:0055075;15;-0.5203335;-1.4556438;0.071813285;0.25937837
GO BP;PROTEIN DEPOLYMERIZATION;GO:0051261;80;-0.3582041;-1.4555346;0.030303031;0.2587914
GO BP;NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS;GO:0010656;28;-0.43746373;-1.4554628;0.047272727;0.25817388
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION;GO:0010634;102;-0.33961138;-1.4553639;0.017857144;0.2576149
GO BP;APPENDAGE DEVELOPMENT;#N/A;110;-0.33643487;-1.455078;0.01718213;0.25747377
GO BP;REGULATION OF NEURONAL SYNAPTIC PLASTICITY;GO:0048168;25;-0.4583742;-1.4549724;0.056537103;0.2569315
GO BP;MEMORY;GO:0007613;60;-0.3729897;-1.454876;0.029259896;0.2564034
GO BP;RESPONSE TO ZINC ION;GO:0010043;22;-0.46623424;-1.4546988;0.042201836;0.25599167
GO BP;LYSOSOME LOCALIZATION;GO:0032418;53;-0.38037556;-1.4527247;0.03407155;0.2586514
GO BP;REGULATION OF VASOCONSTRICTION;GO:0019229;20;-0.4772916;-1.4527091;0.065836295;0.25795835
GO BP;ACTIN MEDIATED CELL CONTRACTION;GO:0070252;64;-0.36641997;-1.4526359;0.028862478;0.25737152
GO BP;NEUROMUSCULAR PROCESS;GO:0050905;48;-0.39480597;-1.4525597;0.03949731;0.25679475
GO BP;NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC;GO:0045814;99;-0.3408548;-1.4520594;0.030351438;0.25707275
GO BP;PROTEIN LOCALIZATION TO VACUOLE;GO:0072665;56;-0.37789166;-1.4519515;0.025337838;0.25657627
GO BP;METHYLATION DEPENDENT CHROMATIN SILENCING;#N/A;17;-0.49497712;-1.4518125;0.08196721;0.2561318
GO BP;APPENDAGE MORPHOGENESIS;#N/A;92;-0.34830287;-1.4511231;0.018092105;0.25678545
GO BP;CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES;GO:0098742;93;-0.3461615;-1.4497175;0.020967742;0.2586196
GO BP;POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE;GO:1990573;20;-0.4736706;-1.4495645;0.07326008;0.25816998
GO BP;POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT;#N/A;310;-0.2922987;-1.4493419;0.001436782;0.25787154
GO BP;REGULATION OF AUTOPHAGY OF MITOCHONDRION;GO:1903146;37;-0.41395938;-1.4492688;0.041739132;0.25732002
GO BP;PROTEIN AUTOPHOSPHORYLATION;GO:0046777;168;-0.31450176;-1.448699;0.00792393;0.25760832
GO BP;POSITIVE REGULATION OF VASCULATURE DEVELOPMENT;#N/A;105;-0.33644724;-1.4485103;0.01577287;0.25725782
GO BP;MAINTENANCE OF LOCATION;#N/A;223;-0.30304003;-1.4476174;0.004405286;0.2582125
GO BP;REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE;GO:2000008;28;-0.42894608;-1.4474387;0.055855855;0.25784808
GO BP;PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE;GO:0002532;36;-0.41886702;-1.4458277;0.038528897;0.26025116
GO BP;REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY;#N/A;36;-0.41702187;-1.4458207;0.055555556;0.25956953
GO BP;POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS;GO:1900078;16;-0.51214695;-1.4454894;0.07054674;0.25949645
GO BP;SKELETAL SYSTEM MORPHOGENESIS;GO:0048705;127;-0.33061773;-1.4454414;0.019138755;0.25890732
GO BP;REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING;GO:2001032;17;-0.4971719;-1.4440255;0.06417112;0.26075077
GO BP;RHO PROTEIN SIGNAL TRANSDUCTION;GO:0007266;143;-0.31934255;-1.4439586;0.019354839;0.2602063
GO BP;SKELETAL MUSCLE ORGAN DEVELOPMENT;GO:0060538;94;-0.3432154;-1.4434748;0.021812081;0.26049766
GO BP;RESPONSE TO MITOCHONDRIAL DEPOLARISATION;GO:0098780;19;-0.4871572;-1.4426551;0.084990956;0.26136518
GO BP;REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS;GO:0070228;30;-0.42826688;-1.4415932;0.056410257;0.2625961
GO BP;REGULATION OF LIPID METABOLIC PROCESS;GO:0019216;279;-0.29230487;-1.4401392;0.008849558;0.26457575
GO BP;REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT;GO:0046822;89;-0.34032288;-1.4399458;0.035472974;0.26424724
GO BP;POSITIVE REGULATION OF CHROMOSOME ORGANIZATION;GO:2001252;150;-0.32236874;-1.4389601;0.012422361;0.2653751
GO BP;REGULATION OF NEUROBLAST PROLIFERATION;GO:1902692;18;-0.4885776;-1.4385238;0.06104129;0.26544246
GO BP;PROTEOGLYCAN BIOSYNTHETIC PROCESS;GO:0030166;34;-0.42214224;-1.438423;0.049488056;0.26496127
GO BP;PROTEIN DNA COMPLEX DISASSEMBLY;GO:0032986;18;-0.49097958;-1.4378905;0.06764168;0.26527533
GO BP;MEMBRANE INVAGINATION;GO:0010324;43;-0.4006162;-1.4378201;0.053380784;0.26472333
GO BP;POSITIVE REGULATION OF INTERFERON BETA PRODUCTION;GO:0032728;25;-0.45050427;-1.4378141;0.05206463;0.26405624
GO BP;PROTEIN LOCALIZATION TO NUCLEUS;GO:0034504;210;-0.30212614;-1.437707;0.007541478;0.2635503
GO BP;PROTEIN LOCALIZATION TO CYTOSKELETON;GO:0044380;54;-0.37523854;-1.4376342;0.03852596;0.26301336
GO BP;PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0048008;47;-0.38774467;-1.437611;0.034904014;0.2623826
GO BP;NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER;GO:0097756;33;-0.41614932;-1.4374065;0.0460177;0.2621303
GO BP;VISUAL BEHAVIOR;GO:0007632;27;-0.44165778;-1.4370592;0.06227758;0.26211253
GO BP;NEURON MIGRATION;GO:0001764;86;-0.34033942;-1.4364994;0.013223141;0.2625181
GO BP;CHROMOSOME CONDENSATION;GO:0030261;36;-0.40830103;-1.4358222;0.030520646;0.26306656
GO BP;TRIGLYCERIDE CATABOLIC PROCESS;GO:0019433;19;-0.48027632;-1.4356418;0.073937155;0.26269972
GO BP;NOTCH SIGNALING PATHWAY;GO:0007219;122;-0.32739896;-1.4335945;0.011128776;0.26560625
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE;GO:0072666;42;-0.39570493;-1.4328326;0.050086357;0.26639634
GO BP;MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS;GO:0031293;17;-0.49324706;-1.4328113;0.06842105;0.2657729
GO BP;CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR;GO:0042994;15;-0.50904703;-1.4322791;0.068265684;0.2660479
GO BP;POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE;GO:0002720;30;-0.4208354;-1.4309232;0.048327137;0.2678009
GO BP;NCRNA EXPORT FROM NUCLEUS;#N/A;36;-0.40720573;-1.4307071;0.05734767;0.26748675
GO BP;EMBRYONIC MORPHOGENESIS;GO:0048598;362;-0.28114665;-1.4306704;0;0.26690865
GO BP;ENTRAINMENT OF CIRCADIAN CLOCK BY PHOTOPERIOD;GO:0043153;19;-0.47964925;-1.430366;0.07224335;0.26685587
GO BP;FATTY ACID DERIVATIVE METABOLIC PROCESS;#N/A;93;-0.34075165;-1.4297496;0.019138755;0.2672208
GO BP;MODIFICATION OF POSTSYNAPTIC STRUCTURE;GO:0099010;15;-0.5148657;-1.4296287;0.08490566;0.26683056
GO BP;POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS;GO:0035774;20;-0.47363907;-1.4285386;0.07441016;0.26820138
GO BP;REGULATION OF MAST CELL ACTIVATION;GO:0033003;24;-0.44621995;-1.4282689;0.07329843;0.26806974
GO BP;CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS;GO:0002042;39;-0.3954574;-1.4280279;0.055658627;0.26792964
GO BP;REGULATION OF T HELPER CELL DIFFERENTIATION;#N/A;15;-0.5217394;-1.427325;0.08918406;0.26860854
GO BP;CELLULAR POLYSACCHARIDE CATABOLIC PROCESS;#N/A;18;-0.47832513;-1.42682;0.078947365;0.26893312
GO BP;MICROTUBULE BASED MOVEMENT;GO:0007018;210;-0.29737416;-1.426178;0.003072197;0.2693672
GO BP;REGULATION OF PROTEIN OLIGOMERIZATION;#N/A;22;-0.4685421;-1.4260001;0.06517691;0.269045
GO BP;CELL GROWTH;#N/A;321;-0.28803197;-1.4258602;0.004411765;0.26864165
GO BP;RESPONSE TO MECHANICAL STIMULUS;GO:0009612;123;-0.32067478;-1.4258243;0.017741935;0.26807722
GO BP;NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION;GO:2000178;16;-0.5021745;-1.425624;0.061930783;0.26785427
GO BP;MYOBLAST FUSION;GO:0007520;18;-0.48998922;-1.4254596;0.079422385;0.2675013
GO BP;PHOSPHATIDYLSERINE METABOLIC PROCESS;GO:0006658;22;-0.46002695;-1.4250636;0.07169118;0.26753643
GO BP;SENSORY SYSTEM DEVELOPMENT;GO:0048880;211;-0.30069977;-1.4246255;0.009022556;0.2677646
GO BP;BLOOD VESSEL MORPHOGENESIS;GO:0048514;353;-0.2837179;-1.4242742;0.002820875;0.26775837
GO BP;PHOTORECEPTOR CELL DIFFERENTIATION;#N/A;26;-0.437014;-1.4241484;0.055456173;0.26737487
GO BP;ACTIVATION OF GTPASE ACTIVITY;GO:0090630;70;-0.35722005;-1.4239038;0.033043478;0.2671897
GO BP;REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III;GO:0006359;18;-0.47737527;-1.4227785;0.08514493;0.26860267
GO BP;NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION;GO:0010823;45;-0.38685054;-1.4222394;0.046678636;0.26892552
GO BP;CYTOKINE METABOLIC PROCESS;GO:0042107;60;-0.36507797;-1.4222176;0.033391915;0.2683522
GO BP;CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS;#N/A;21;-0.45461187;-1.4221573;0.0856102;0.26783988
GO BP;CELLULAR RESPONSE TO MECHANICAL STIMULUS;GO:0071260;52;-0.37118518;-1.4209348;0.04712042;0.26945215
GO BP;RETINA DEVELOPMENT IN CAMERA TYPE EYE;GO:0060041;85;-0.34523338;-1.4201583;0.02020202;0.2703286
GO BP;PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION;GO:0046856;23;-0.4515831;-1.419686;0.08362989;0.2705382
GO BP;REGULATION OF MEMBRANE POTENTIAL;GO:0042391;183;-0.3025843;-1.4193597;0.010819165;0.27045
GO BP;NEGATIVE REGULATION OF ION TRANSPORT;GO:0043271;66;-0.3541931;-1.4185927;0.027072757;0.27126127
GO BP;POSITIVE REGULATION OF NEURON DIFFERENTIATION;GO:0045666;232;-0.29739863;-1.418197;0.007194245;0.27139488
GO BP;REGULATION OF LONG TERM SYNAPTIC POTENTIATION;GO:1900271;24;-0.4440828;-1.4167798;0.08348135;0.2732954
GO BP;PROTEIN KINASE C SIGNALING;GO:0070528;16;-0.48511162;-1.4164791;0.104672894;0.27321053
GO BP;POSITIVE REGULATION OF NUCLEAR DIVISION;#N/A;45;-0.3922202;-1.4158434;0.05235602;0.2737823
GO BP;REGULATION OF SYNAPTIC PLASTICITY;GO:0048167;97;-0.33049205;-1.4155657;0.024630541;0.27372032
GO BP;POSITIVE REGULATION OF KIDNEY DEVELOPMENT;GO:0090184;20;-0.45935273;-1.4150897;0.080789946;0.27384806
GO BP;REGULATION OF EPITHELIAL CELL MIGRATION;GO:0010632;154;-0.3144669;-1.4149511;0.01510574;0.27352187
GO BP;RESPONSE TO STARVATION;GO:0042594;145;-0.317659;-1.4139115;0.018957347;0.2748328
GO BP;REGULATION OF GTPASE ACTIVITY;GO:0043087;332;-0.284109;-1.4133613;0.007042253;0.2752216
GO BP;NEGATIVE REGULATION OF VIRAL LIFE CYCLE;#N/A;46;-0.38504547;-1.4132948;0.056027167;0.27472296
GO BP;SYNAPSE MATURATION;GO:0060074;15;-0.5051085;-1.4119313;0.08122744;0.27665174
GO BP;REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION;GO:0051150;21;-0.46362737;-1.4117166;0.082746476;0.27636996
GO BP;REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION;GO:0046578;169;-0.30803716;-1.4112273;0.014285714;0.2766553
GO BP;NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION;#N/A;103;-0.32534334;-1.4108176;0.024311183;0.2767518
GO BP;HEPATICOBILIARY SYSTEM DEVELOPMENT;#N/A;104;-0.32622775;-1.4104759;0.025083613;0.27682647
GO BP;NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION;#N/A;48;-0.3766457;-1.4104023;0.043782838;0.27636045
GO BP;TELENCEPHALON DEVELOPMENT;GO:0021537;150;-0.30987838;-1.4098245;0.020092735;0.2767239
GO BP;RESPIRATORY SYSTEM DEVELOPMENT;GO:0060541;128;-0.31862682;-1.4094647;0.020537125;0.27671456
GO BP;REGULATION OF LEUKOCYTE DEGRANULATION;#N/A;29;-0.42569724;-1.4093398;0.065099455;0.27637303
GO BP;POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;51;-0.37449428;-1.4088814;0.045378152;0.27659854
GO BP;REGULATION OF INFLAMMATORY RESPONSE;GO:0050727;168;-0.30490032;-1.4078171;0.015576324;0.27791205
GO BP;ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS;#N/A;19;-0.47690868;-1.4072375;0.083179295;0.2783936
GO BP;T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE;GO:0002292;31;-0.41188732;-1.4071511;0.05719557;0.27793664
GO BP;REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0051056;241;-0.29220662;-1.4058132;0.010432191;0.2797462
GO BP;REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001236;105;-0.32830578;-1.405162;0.03497615;0.280382
GO BP;REGULATION OF CELL AGING;#N/A;38;-0.3956897;-1.404807;0.07092199;0.2803467
GO BP;CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION;GO:0000904;466;-0.2749763;-1.4047526;0.001328021;0.27982104
GO BP;TISSUE MIGRATION;#N/A;198;-0.29731482;-1.4047338;0.011146497;0.27925244
GO BP;MAST CELL ACTIVATION;GO:0045576;35;-0.4023314;-1.4039737;0.06896552;0.28004175
GO BP;CELLULAR RESPONSE TO EXTERNAL STIMULUS;#N/A;233;-0.29453743;-1.4026833;0.009022556;0.28191638
GO BP;REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING;GO:0014066;76;-0.34497225;-1.4020221;0.037931036;0.2824882
GO BP;ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE;GO:0002251;18;-0.47695082;-1.400803;0.088607594;0.2843355
GO BP;TRANSCRIPTION BY RNA POLYMERASE I;GO:0006360;59;-0.36041796;-1.4006306;0.03380783;0.28410017
GO BP;REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL;GO:0003044;18;-0.4786686;-1.4001257;0.099115044;0.28442246
GO BP;PROTEIN TRANSPORT ALONG MICROTUBULE;GO:0098840;57;-0.3654746;-1.3996332;0.041594453;0.28468716
GO BP;MULTICELLULAR ORGANISMAL HOMEOSTASIS;GO:0048871;283;-0.28360656;-1.3991187;0.004273505;0.28508982
GO BP;REGULATION OF NEURON MIGRATION;GO:2001222;22;-0.45682672;-1.3987609;0.09864604;0.2851591
GO BP;REGULATION OF HEART RATE BY CARDIAC CONDUCTION;GO:0086091;17;-0.47719258;-1.3986617;0.07663552;0.28475198
GO BP;VASCULAR PROCESS IN CIRCULATORY SYSTEM;#N/A;78;-0.34066096;-1.398615;0.036484245;0.28424412
GO BP;BASE EXCISION REPAIR;GO:0006284;41;-0.38785788;-1.3983425;0.053264603;0.28417367
GO BP;TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY;GO:0007169;478;-0.27268434;-1.3979968;0;0.28419432
GO BP;NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:2000378;40;-0.39506114;-1.3970606;0.05467372;0.28537232
GO BP;POLYSACCHARIDE CATABOLIC PROCESS;#N/A;18;-0.47832513;-1.3964883;0.09375;0.2858372
GO BP;REGULATION OF NIK NF KAPPAB SIGNALING;GO:1901222;61;-0.3590344;-1.3951678;0.04217926;0.28790691
GO BP;NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0051058;41;-0.38705546;-1.3948361;0.055555556;0.28795284
GO BP;INTEGRIN ACTIVATION;GO:0033622;15;-0.48821566;-1.3942102;0.08695652;0.28851992
GO BP;REGULATION OF ION TRANSPORT;GO:0043269;291;-0.27990636;-1.3938864;0.00723589;0.2885216
GO BP;MONOCARBOXYLIC ACID TRANSPORT;GO:0015718;94;-0.32962543;-1.3931909;0.03697479;0.28923315
GO BP;RESPONSE TO EPIDERMAL GROWTH FACTOR;GO:0070849;37;-0.40435863;-1.3927072;0.06349207;0.28944916
GO BP;CHEMOKINE PRODUCTION;GO:0032602;43;-0.3790929;-1.3925614;0.0761062;0.2890901
GO BP;HEAD DEVELOPMENT;GO:0060322;485;-0.2688983;-1.3923945;0.001369863;0.28883022
GO BP;NEGATIVE REGULATION OF CALCIUM ION TRANSPORT;GO:0051926;24;-0.4364259;-1.3920727;0.07575758;0.28883803
GO BP;BONE DEVELOPMENT;GO:0060348;127;-0.31177518;-1.3918737;0.021035599;0.28862235
GO BP;MUSCLE ORGAN DEVELOPMENT;GO:0007517;214;-0.2921353;-1.3912591;0.010687023;0.2892339
GO BP;POSITIVE REGULATION OF DNA REPAIR;GO:0045739;51;-0.37047;-1.3907064;0.052364863;0.28959283
GO BP;REGULATION OF MYOTUBE DIFFERENTIATION;GO:0010830;23;-0.4413915;-1.3904961;0.09864604;0.28936863
GO BP;GLYCEROLIPID CATABOLIC PROCESS;#N/A;41;-0.38764364;-1.3901546;0.05820106;0.28942013
GO BP;POSITIVE REGULATION OF CELL CYCLE;GO:0045787;294;-0.28148594;-1.3900802;0.006033183;0.28903198
GO BP;POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY;#N/A;61;-0.35828623;-1.3899657;0.05199307;0.2886374
GO BP;REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:1901019;46;-0.38097394;-1.3898144;0.05831904;0.28835905
GO BP;NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:1903170;16;-0.4983911;-1.3892901;0.092057765;0.28873804
GO BP;NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0043242;55;-0.3656408;-1.3892779;0.05059022;0.2881903
GO BP;PHOSPHATIDYLINOSITOL PHOSPHORYLATION;GO:0046854;39;-0.38910368;-1.3892121;0.0703259;0.28775617
GO BP;POSITIVE REGULATION OF CELL DEVELOPMENT;GO:0010720;331;-0.27748513;-1.3891467;0.002886003;0.28730765
GO BP;MUSCLE STRUCTURE DEVELOPMENT;GO:0061061;372;-0.27543837;-1.3878554;0.001438849;0.2892468
GO BP;OSTEOBLAST DIFFERENTIATION;GO:0001649;135;-0.30653855;-1.3873222;0.028052805;0.2896109
GO BP;POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS;GO:1902993;15;-0.50775546;-1.3872993;0.09576427;0.2890773
GO BP;MICROTUBULE CYTOSKELETON ORGANIZATION;GO:0000226;445;-0.26842758;-1.3864706;0.004103967;0.28999373
GO BP;REGULATION OF DNA METABOLIC PROCESS;#N/A;273;-0.28626028;-1.3859305;0.005908419;0.29046953
GO BP;CHROMATIN ASSEMBLY OR DISASSEMBLY;GO:0006333;141;-0.30594006;-1.3855009;0.01724138;0.2908044
GO BP;AUTOPHAGY OF MITOCHONDRION;GO:0000422;65;-0.35000914;-1.3853875;0.042881645;0.29048055
GO BP;PROTEIN SUMOYLATION;GO:0016925;67;-0.34896892;-1.3851006;0.04769737;0.29041815
GO BP;STRIATED MUSCLE CONTRACTION;GO:0006941;93;-0.3275826;-1.3848808;0.049423393;0.29028356
GO BP;COLLATERAL SPROUTING;GO:0048668;19;-0.4489796;-1.3842281;0.10412926;0.2908851
GO BP;BIOMINERALIZATION;#N/A;90;-0.33022147;-1.3842036;0.047217537;0.29035732
GO BP;EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS;GO:0048704;44;-0.37740606;-1.3835857;0.06457242;0.2909349
GO BP;GENE SILENCING;GO:0016458;227;-0.28890884;-1.38334;0.005943536;0.29080507
GO BP;EPITHELIAL CELL APOPTOTIC PROCESS;GO:1904019;68;-0.34817395;-1.3821893;0.03517588;0.2924049
GO BP;CARDIAC CONDUCTION;GO:0061337;61;-0.3516576;-1.3821743;0.05882353;0.29187053
GO BP;IMPORT ACROSS PLASMA MEMBRANE;GO:0098739;61;-0.35780272;-1.381556;0.04631218;0.2923944
GO BP;FATTY ACID TRANSMEMBRANE TRANSPORT;#N/A;17;-0.4702028;-1.3812203;0.0979021;0.29248247
GO BP;ZINC ION HOMEOSTASIS;GO:0055069;20;-0.45807233;-1.380854;0.09041591;0.29269135
GO BP;FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS;#N/A;62;-0.34637576;-1.3800918;0.05882353;0.2936006
GO BP;CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS;#N/A;37;-0.39574787;-1.378802;0.06451613;0.29549217
GO BP;ACETYL COA METABOLIC PROCESS;GO:0006084;34;-0.39624655;-1.3787239;0.066317625;0.29505968
GO BP;POSITIVE REGULATION OF TRANSPORTER ACTIVITY;GO:0032411;54;-0.36298817;-1.3787197;0.061728396;0.29450223
GO BP;PLASMA MEMBRANE ORGANIZATION;GO:0007009;68;-0.34105775;-1.3783172;0.043252595;0.29475334
GO BP;REGULATION OF OSSIFICATION;GO:0030278;110;-0.31656915;-1.3779695;0.029459901;0.29490685
GO BP;POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION;GO:0010822;92;-0.32653025;-1.3774333;0.029411765;0.29549515
GO BP;SERTOLI CELL DIFFERENTIATION;GO:0060008;15;-0.49081057;-1.3773156;0.10285714;0.29514688
GO BP;NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION;GO:0048662;26;-0.4163181;-1.3772141;0.08211679;0.2947444
GO BP;REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;#N/A;21;-0.4441817;-1.3759853;0.09409594;0.29658008
GO BP;HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS;GO:0015012;17;-0.47450563;-1.3754255;0.09461967;0.29709443
GO BP;MODIFICATION OF SYNAPTIC STRUCTURE;GO:0099563;19;-0.4640412;-1.3735967;0.09807356;0.30002415
GO BP;TUBE FORMATION;GO:0035148;108;-0.31822488;-1.3732946;0.025806451;0.30004713
GO BP;NEURON FATE COMMITMENT;GO:0048663;18;-0.4658348;-1.3726469;0.10671937;0.3007998
GO BP;REGULATION OF MICROTUBULE POLYMERIZATION;GO:0031113;40;-0.37131667;-1.3719294;0.05818182;0.30165958
GO BP;T CELL DIFFERENTIATION IN THYMUS;GO:0033077;37;-0.39469907;-1.3719021;0.08064516;0.3011517
GO BP;REGULATION OF ANATOMICAL STRUCTURE SIZE;#N/A;309;-0.2757524;-1.3716346;0.005532504;0.30113274
GO BP;PROTEIN O LINKED GLYCOSYLATION;GO:0006493;73;-0.33979094;-1.3709416;0.050522648;0.30193964
GO BP;POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE;GO:0090314;22;-0.44625977;-1.3708657;0.10299625;0.3015447
GO BP;REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE;GO:0002718;46;-0.37504217;-1.3704022;0.072790295;0.30194035
GO BP;SKELETAL SYSTEM DEVELOPMENT;GO:0001501;286;-0.27907234;-1.3700453;0.003053435;0.30198961
GO BP;NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION;GO:0010812;45;-0.36986098;-1.3699851;0.072222225;0.30154952
GO BP;POSITIVE REGULATION OF DNA METABOLIC PROCESS;#N/A;150;-0.30160946;-1.3693477;0.031496063;0.30226284
GO BP;REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:1905897;73;-0.335259;-1.3690349;0.03820598;0.30228627
GO BP;NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS;#N/A;397;-0.26955563;-1.3683952;0.004037685;0.30304587
GO BP;RESPONSE TO FLUID SHEAR STRESS;GO:0034405;27;-0.4176318;-1.366595;0.08672567;0.3061801
GO BP;PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING;GO:0014065;90;-0.32315412;-1.3657168;0.036666665;0.30727226
GO BP;ARTERY DEVELOPMENT;GO:0060840;56;-0.35821038;-1.3653816;0.061433446;0.3074004
GO BP;POSITIVE REGULATION OF CARTILAGE DEVELOPMENT;GO:0061036;19;-0.4500212;-1.3650076;0.098615915;0.3075929
GO BP;HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES;GO:0007156;45;-0.37567437;-1.3650018;0.07226891;0.30703437
GO BP;REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001242;130;-0.30286053;-1.3647766;0.032051284;0.306901
GO BP;EMBRYONIC SKELETAL SYSTEM DEVELOPMENT;GO:0048706;61;-0.35166544;-1.363953;0.04841402;0.30797118
GO BP;ANION HOMEOSTASIS;#N/A;38;-0.3831072;-1.3625364;0.06993007;0.31015822
GO BP;REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY;GO:0010803;40;-0.38171473;-1.3620696;0.08394161;0.3104737
GO BP;GLIAL CELL MIGRATION;GO:0008347;32;-0.40483195;-1.3617078;0.09586466;0.3106618
GO BP;REGULATION OF NOTCH SIGNALING PATHWAY;GO:0008593;71;-0.33458728;-1.3614012;0.069565214;0.31074727
GO BP;CELL RECOGNITION;GO:0008037;58;-0.34965348;-1.3612338;0.060344826;0.3105109
GO BP;PINOCYTOSIS;GO:0006907;16;-0.47538564;-1.360484;0.12109375;0.31137466
GO BP;CYTOKINE PRODUCTION;GO:0001816;429;-0.26517937;-1.3584236;0.004026846;0.31483817
GO BP;INFLAMMATORY RESPONSE;GO:0006954;328;-0.27161533;-1.3580999;0.010159652;0.31493014
GO BP;HISTONE H3 DEACETYLATION;GO:0070932;16;-0.47890657;-1.3578203;0.123893805;0.31493813
GO BP;HEAD MORPHOGENESIS;GO:0060323;27;-0.41161293;-1.357465;0.09208103;0.31506565
GO BP;NEURON DEATH;GO:0070997;236;-0.28292003;-1.3573592;0.011922504;0.31471506
GO BP;NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS;GO:1900181;19;-0.44819042;-1.3571745;0.10357816;0.3145309
GO BP;G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER;GO:0007187;67;-0.3338352;-1.3570637;0.06168831;0.3141716
GO BP;METHYLATION;GO:0032259;292;-0.2753783;-1.3568113;0.01754386;0.31408256
GO BP;REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION;GO:2000177;50;-0.3670159;-1.3565792;0.06776557;0.31399113
GO BP;AMINOGLYCAN CATABOLIC PROCESS;#N/A;40;-0.37769532;-1.3565515;0.07733813;0.3134927
GO BP;LEUKOCYTE MIGRATION;GO:0050900;207;-0.285337;-1.3559474;0.015337423;0.31402218
GO BP;REGULATION OF MITOCHONDRION ORGANIZATION;GO:0010821;145;-0.29854515;-1.3557034;0.03599374;0.31388518
GO BP;POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS;GO:0060760;32;-0.39346042;-1.3556023;0.09908257;0.31350717
GO BP;RESPONSE TO GAMMA RADIATION;GO:0010332;49;-0.359253;-1.3555968;0.07011686;0.3129713
GO BP;INTRASPECIES INTERACTION BETWEEN ORGANISMS;#N/A;21;-0.44691023;-1.3554335;0.11347517;0.31272566
GO BP;REGULATION OF ACTIN FILAMENT ORGANIZATION;GO:0110053;181;-0.2921251;-1.355102;0.021341464;0.3128567
GO BP;POSITIVE REGULATION OF LEUKOCYTE MIGRATION;GO:0002687;62;-0.34441513;-1.3544126;0.053067993;0.31365746
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT;#N/A;34;-0.38936302;-1.3539802;0.08671587;0.3139219
GO BP;ENDOCRINE PROCESS;#N/A;34;-0.39945722;-1.3534374;0.099115044;0.31440315
GO BP;RESPONSE TO TRANSFORMING GROWTH FACTOR BETA;GO:0071559;160;-0.29441988;-1.3533244;0.01857585;0.31409144
GO BP;LEARNING;GO:0007612;70;-0.33702612;-1.3533051;0.0626087;0.31358653
GO BP;PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS;#N/A;17;-0.4604963;-1.3525507;0.110124335;0.31464675
GO BP;POSITIVE REGULATION OF TISSUE REMODELING;#N/A;18;-0.4432171;-1.3515456;0.11700183;0.3161258
GO BP;REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS;#N/A;50;-0.35862672;-1.3515131;0.067911714;0.31563815
GO BP;IRON ION TRANSPORT;GO:0006826;58;-0.35315573;-1.351377;0.081803;0.31538135
GO BP;MAMMARY GLAND DEVELOPMENT;GO:0030879;93;-0.32231328;-1.351053;0.05210084;0.31551665
GO BP;ADAPTIVE IMMUNE RESPONSE;GO:0002250;179;-0.29036963;-1.3504431;0.02472952;0.31621358
GO BP;EPITHELIAL CELL DIFFERENTIATION;GO:0030855;370;-0.2656995;-1.3500061;0.011379801;0.3164938
GO BP;NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION;GO:0030835;28;-0.4013522;-1.3485397;0.08592322;0.31877586
GO BP;EXECUTION PHASE OF APOPTOSIS;GO:0097194;55;-0.35734138;-1.3484039;0.08126037;0.31847066
GO BP;POSITIVE REGULATION OF CELL SUBSTRATE ADHESION;GO:0010811;79;-0.3273448;-1.3481288;0.060457516;0.31848955
GO BP;REGULATION OF GROWTH;GO:0040008;426;-0.26182145;-1.3478789;0.005517242;0.31842998
GO BP;METAL ION TRANSPORT;GO:0030001;444;-0.2621566;-1.3477991;0.001369863;0.31806853
GO BP;CELL COMMUNICATION BY ELECTRICAL COUPLING;GO:0010644;17;-0.46434373;-1.3477833;0.11524164;0.3175521
GO BP;REGULATION OF HISTONE DEACETYLATION;GO:0031063;22;-0.43618456;-1.3477701;0.10299625;0.3170265
GO BP;POSITIVE REGULATION OF MUSCLE HYPERTROPHY;#N/A;21;-0.4373351;-1.3474386;0.11290322;0.31715637
GO BP;LYMPHOCYTE COSTIMULATION;#N/A;26;-0.4157869;-1.3466203;0.104347825;0.31823084
GO BP;REGULATION OF AXONOGENESIS;GO:0050770;115;-0.3093717;-1.3461558;0.02992126;0.318665
GO BP;T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;GO:0002286;46;-0.37068763;-1.3457173;0.08614865;0.31897002
GO BP;SMOOTH MUSCLE CELL PROLIFERATION;GO:0048659;87;-0.32039666;-1.3452684;0.06125828;0.31937474
GO BP;MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS;GO:0006509;30;-0.40319008;-1.3449581;0.09796673;0.31949484
GO BP;MULTICELLULAR ORGANISMAL MOVEMENT;#N/A;30;-0.4012792;-1.3447652;0.08480565;0.31938666
GO BP;CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS;GO:0006575;126;-0.3036641;-1.3445072;0.036484245;0.31932643
GO BP;AMINOGLYCAN BIOSYNTHETIC PROCESS;#N/A;68;-0.33750132;-1.3442507;0.058430716;0.31934106
GO BP;RENAL SYSTEM PROCESS;GO:0003014;60;-0.34591532;-1.3439653;0.0688;0.31937724
GO BP;POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS;GO:0048260;35;-0.38691336;-1.3435143;0.088926174;0.319711
GO BP;DE NOVO PROTEIN FOLDING;#N/A;33;-0.39667645;-1.3426756;0.10265487;0.3208122
GO BP;STEM CELL PROLIFERATION;GO:0072089;72;-0.33131504;-1.3416426;0.07035176;0.32242364
GO BP;REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT;GO:1901379;31;-0.3941283;-1.3415536;0.10265487;0.32204372
GO BP;ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007189;40;-0.37597445;-1.3409772;0.094339624;0.3226229
GO BP;IMPORT INTO CELL;#N/A;445;-0.26125398;-1.3409503;0.002808989;0.32214147
GO BP;POSITIVE REGULATION OF BLOOD VESSEL DIAMETER;GO:0097755;28;-0.39967233;-1.3404707;0.10654206;0.32253477
GO BP;REGULATION OF SMOOTHENED SIGNALING PATHWAY;GO:0008589;60;-0.34372845;-1.3388072;0.06495727;0.3253842
GO BP;PROTEOGLYCAN METABOLIC PROCESS;GO:0006029;49;-0.36076114;-1.3387674;0.078397214;0.3249398
GO BP;G0 TO G1 TRANSITION;#N/A;42;-0.37008947;-1.3387384;0.086666666;0.32448143
GO BP;NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902236;16;-0.46909422;-1.338728;0.12750456;0.32397953
GO BP;NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0010719;17;-0.45501402;-1.3384681;0.13051471;0.3239612
GO BP;NEGATIVE REGULATION OF CELL GROWTH;GO:0030308;116;-0.30582815;-1.3381944;0.050613496;0.32398584
GO BP;POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION;GO:0045840;38;-0.3746303;-1.3376629;0.0961183;0.32454166
GO BP;EPIDERMIS MORPHOGENESIS;GO:0048730;16;-0.47031653;-1.336834;0.14638783;0.32579613
GO BP;MACROMOLECULE METHYLATION;#N/A;253;-0.27416348;-1.3365636;0.01884058;0.3258318
GO BP;ASTROCYTE DEVELOPMENT;GO:0014002;22;-0.43395972;-1.3364712;0.11071429;0.325503
GO BP;POSITIVE REGULATION OF GTPASE ACTIVITY;GO:0043547;277;-0.27193084;-1.3360754;0.016129032;0.32577562
GO BP;T CELL DIFFERENTIATION;GO:0030217;117;-0.30245993;-1.3353387;0.049099836;0.3268228
GO BP;INTERLEUKIN 6 SECRETION;#N/A;20;-0.44540736;-1.3350674;0.12;0.32682264
GO BP;PROTEIN LOCALIZATION TO CHROMATIN;GO:0071168;27;-0.4137728;-1.3350286;0.12041885;0.32636318
GO BP;POSITIVE REGULATION OF HISTONE DEACETYLATION;GO:0031065;15;-0.4769711;-1.334925;0.13309352;0.3260406
GO BP;ACTIVATION OF PROTEIN KINASE ACTIVITY;GO:0032147;233;-0.275673;-1.3348118;0.022900764;0.3257763
GO BP;BASEMENT MEMBRANE ORGANIZATION;GO:0071711;23;-0.42961562;-1.334616;0.110707805;0.3256822
GO BP;CELLULAR RESPONSE TO CALCIUM ION;GO:0071277;45;-0.35704294;-1.3338336;0.079422385;0.32677993
GO BP;MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY;GO:0060135;40;-0.37158436;-1.3337656;0.098305084;0.32640615
GO BP;NEGATIVE REGULATION OF PHOSPHORYLATION;GO:0042326;314;-0.26935768;-1.332025;0.019830028;0.32938972
GO BP;LYMPHOCYTE DIFFERENTIATION;GO:0030098;175;-0.28768358;-1.3318913;0.031045752;0.32914248
GO BP;REGULATION OF PH;GO:0006885;70;-0.328328;-1.3316574;0.056603774;0.32911083
GO BP;REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY;#N/A;25;-0.41294146;-1.3312837;0.115606934;0.3293416
GO BP;SEX DIFFERENTIATION;GO:0007548;167;-0.28897318;-1.3312762;0.036682617;0.32882923
GO BP;POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION;GO:0032729;20;-0.4395465;-1.3312404;0.114754096;0.32837665
GO BP;VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL;GO:0086005;17;-0.45773298;-1.331119;0.1335807;0.32811248
GO BP;POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT;GO:0046824;55;-0.34322584;-1.3310812;0.080267556;0.3276833
GO BP;REGULATION OF LIPID BIOSYNTHETIC PROCESS;GO:0046890;138;-0.29643956;-1.330932;0.038772214;0.32747468
GO BP;DENDRITIC SPINE DEVELOPMENT;GO:0060996;71;-0.3316664;-1.3307928;0.074074075;0.32721317
GO BP;RESPONSE TO CAMP;GO:0051591;59;-0.33771786;-1.3300793;0.092150174;0.32810974
GO BP;MICROVILLUS ORGANIZATION;GO:0032528;17;-0.4656542;-1.3298068;0.1252372;0.32817075
GO BP;POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION;GO:0031346;270;-0.27235183;-1.3296492;0.02052786;0.3279691
GO BP;REGULATION OF REGULATED SECRETORY PATHWAY;GO:1903305;87;-0.31466988;-1.3289913;0.056896552;0.32881248
GO BP;TRIGLYCERIDE METABOLIC PROCESS;GO:0006641;63;-0.34107462;-1.3284644;0.07312925;0.3294364
GO BP;SENSORY ORGAN DEVELOPMENT;GO:0007423;302;-0.272217;-1.3280662;0.02130898;0.3297479
GO BP;DENDRITE DEVELOPMENT;GO:0016358;163;-0.28961098;-1.3279492;0.028169014;0.3294451
GO BP;MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002573;115;-0.30241236;-1.3275687;0.049668875;0.32971904
GO BP;HISTONE H3 K27 METHYLATION;GO:0070734;17;-0.46327165;-1.3274062;0.13711151;0.32955298
GO BP;MICROTUBULE BASED TRANSPORT;GO:0099111;150;-0.29103607;-1.3272831;0.045385778;0.3293408
GO BP;NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION;GO:1903556;26;-0.40422708;-1.3271719;0.121323526;0.32906047
GO BP;POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS;GO:0043525;42;-0.3742866;-1.3269149;0.09457093;0.32907405
GO BP;INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0048009;21;-0.43813127;-1.326705;0.13825758;0.32900774
GO BP;CELLULAR SENESCENCE;GO:0090398;51;-0.35023582;-1.3266052;0.09201389;0.32873315
GO BP;OSSIFICATION;GO:0001503;231;-0.27892536;-1.3264151;0.026234567;0.32861117
GO BP;POSITIVE REGULATION OF DNA RECOMBINATION;GO:0045911;27;-0.41293132;-1.3256036;0.11663808;0.32987392
GO BP;MONONUCLEAR CELL DIFFERENTIATION;#N/A;19;-0.4400348;-1.3253855;0.13793103;0.3298387
GO BP;REGULATION OF CELL ADHESION;GO:0030155;400;-0.2633762;-1.3253443;0.011095701;0.32942984
GO BP;CELLULAR RESPONSE TO STARVATION;GO:0009267;120;-0.30573812;-1.3249649;0.057189543;0.3297212
GO BP;GLOMERULUS DEVELOPMENT;GO:0032835;32;-0.39164144;-1.3243979;0.104982205;0.33029217
GO BP;POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II;GO:1902895;22;-0.4244873;-1.3239121;0.120567374;0.33073488
GO BP;ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS;#N/A;40;-0.36889398;-1.323746;0.07486631;0.330573
GO BP;REGULATION OF OLIGODENDROCYTE DIFFERENTIATION;GO:0048713;21;-0.43079647;-1.3232093;0.121818185;0.33115137
GO BP;PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;119;-0.30267346;-1.3228693;0.0543131;0.33140424
GO BP;CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION;GO:0048667;358;-0.26314646;-1.3221762;0.011019284;0.3322545
GO BP;NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0034122;22;-0.4301987;-1.3219627;0.13394496;0.33218038
GO BP;POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE;GO:1905477;88;-0.31621036;-1.3209921;0.0647986;0.33360168
GO BP;REGULATION OF NEURON DIFFERENTIATION;GO:0045664;402;-0.26126426;-1.3209624;0.016393442;0.33318743
GO BP;MUSCLE CONTRACTION;GO:0006936;179;-0.2864648;-1.3208712;0.0368;0.33290288
GO BP;REGULATION OF SIGNALING RECEPTOR ACTIVITY;GO:0010469;80;-0.3215117;-1.3204324;0.05851979;0.33336315
GO BP;LIPID MODIFICATION;GO:0030258;177;-0.2876896;-1.3203723;0.03894081;0.33296692
GO BP;REGULATION OF HISTONE H3 K4 METHYLATION;GO:0051569;23;-0.42858312;-1.3189387;0.13644524;0.33540174
GO BP;NEURON APOPTOTIC PROCESS;GO:0051402;160;-0.2856248;-1.3185785;0.041867957;0.33560085
GO BP;REGULATION OF NUCLEAR DIVISION;#N/A;152;-0.28850475;-1.3184047;0.031298906;0.3354368
GO BP;AMEBOIDAL TYPE CELL MIGRATION;GO:0001667;259;-0.27130818;-1.318188;0.0346908;0.33534592
GO BP;REGULATION OF STEROID METABOLIC PROCESS;GO:0019218;85;-0.31699884;-1.3178949;0.061120544;0.33544645
GO BP;CHROMATIN ASSEMBLY;GO:0031497;120;-0.29834157;-1.3178167;0.052980132;0.33510542
GO BP;APOPTOTIC SIGNALING PATHWAY;GO:0097190;452;-0.25721398;-1.3167905;0.006684492;0.33663514
GO BP;ANATOMICAL STRUCTURE HOMEOSTASIS;#N/A;291;-0.2695609;-1.3164598;0.018597998;0.33679044
GO BP;ENDOCYTOSIS;GO:0006897;369;-0.25980803;-1.3161451;0.015691869;0.33696994
GO BP;POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION;#N/A;112;-0.30693877;-1.3156989;0.05756579;0.3374934
GO BP;RESPONSE TO MORPHINE;GO:0043278;15;-0.4681296;-1.3149259;0.121993124;0.3385388
GO BP;REGULATION OF NEURON PROJECTION DEVELOPMENT;GO:0010975;324;-0.2661877;-1.3146663;0.015492958;0.33854958
GO BP;POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION;GO:2000144;20;-0.433969;-1.3146594;0.125;0.3380702
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS;GO:1904036;29;-0.38635057;-1.3146102;0.0961183;0.33768302
GO BP;NEGATIVE REGULATION OF TOR SIGNALING;GO:0032007;35;-0.3844826;-1.3145045;0.13333334;0.33740172
GO BP;REGULATION OF CELL JUNCTION ASSEMBLY;GO:1901888;66;-0.33238158;-1.3143003;0.098305084;0.3373475
GO BP;POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING;GO:1901224;44;-0.35527548;-1.3137593;0.09756097;0.33793956
GO BP;MONOVALENT INORGANIC ANION HOMEOSTASIS;#N/A;16;-0.45158663;-1.3129941;0.14869888;0.3390764
GO BP;REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE;#N/A;31;-0.39077276;-1.3129793;0.12321428;0.3386121
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;#N/A;24;-0.41929412;-1.312638;0.12137681;0.33875132
GO BP;POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION;GO:0033138;60;-0.3346755;-1.312265;0.11355932;0.3389732
GO BP;POLYSACCHARIDE METABOLIC PROCESS;#N/A;75;-0.32007268;-1.3119102;0.08121827;0.33919132
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:0097193;233;-0.2743539;-1.3116499;0.021341464;0.33929065
GO BP;REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND;GO:2001239;24;-0.41126513;-1.3112915;0.12939002;0.33962497
GO BP;NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION;GO:0014912;18;-0.4436883;-1.31086;0.11669659;0.34005117
GO BP;AORTA DEVELOPMENT;GO:0035904;37;-0.37893915;-1.3108417;0.10619469;0.3395902
GO BP;PROTEIN HYDROXYLATION;GO:0018126;22;-0.4244604;-1.3105946;0.14498141;0.3396611
GO BP;NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS;GO:0120163;33;-0.3788791;-1.3102608;0.12655972;0.33982423
GO BP;NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY;GO:0033144;28;-0.39533278;-1.3097801;0.125;0.34033892
GO BP;REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0043244;85;-0.31571907;-1.3094978;0.07438017;0.34045038
GO BP;RESPONSE TO GROWTH FACTOR;GO:0070848;462;-0.25351444;-1.3094467;0.007989348;0.34003574
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSPORT;GO:0051928;55;-0.34362215;-1.3090988;0.09499136;0.34026173
GO BP;REGULATION OF MACROPHAGE MIGRATION;GO:1905521;20;-0.4339931;-1.3081355;0.14836223;0.34171015
GO BP;POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS;#N/A;107;-0.29970264;-1.3080322;0.05977383;0.34145463
GO BP;REGULATION OF ENDOCYTOSIS;GO:0030100;146;-0.2866097;-1.3077374;0.05421687;0.34163043
GO BP;BODY MORPHOGENESIS;GO:0010171;38;-0.36924198;-1.307192;0.106571935;0.3423015
GO BP;RECEPTOR BIOSYNTHETIC PROCESS;#N/A;15;-0.4706949;-1.3066505;0.14669052;0.3429621
GO BP;REGIONALIZATION;GO:0003002;171;-0.28418308;-1.3061385;0.0466563;0.34346792
GO BP;POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION;GO:0032757;24;-0.41567117;-1.3057588;0.119349;0.34379274
GO BP;INSULIN RECEPTOR SIGNALING PATHWAY;GO:0008286;105;-0.30426708;-1.3057126;0.06414474;0.3433871
GO BP;POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT;GO:0034767;67;-0.33033538;-1.3053193;0.07622504;0.34364784
GO BP;LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS;GO:0035338;15;-0.46838188;-1.3048059;0.13084112;0.34431332
GO BP;POSITIVE REGULATION OF MEIOTIC CELL CYCLE;#N/A;15;-0.46502498;-1.304646;0.16696915;0.344168
GO BP;REGULATION OF T CELL MIGRATION;GO:2000404;23;-0.41076472;-1.3037416;0.108892925;0.34558764
GO BP;MULTI ORGANISM BEHAVIOR;#N/A;28;-0.39749005;-1.3032054;0.13172542;0.34625068
GO BP;B CELL APOPTOTIC PROCESS;GO:0001783;19;-0.4350093;-1.3025299;0.14312267;0.34716523
GO BP;REGULATION OF POLYSACCHARIDE METABOLIC PROCESS;#N/A;31;-0.3824394;-1.3024943;0.12568305;0.34673542
GO BP;REGULATION OF EXECUTION PHASE OF APOPTOSIS;#N/A;21;-0.42747682;-1.3021013;0.16878402;0.34708428
GO BP;FATTY ACYL COA BIOSYNTHETIC PROCESS;#N/A;27;-0.39574888;-1.3020096;0.11786372;0.34675163
GO BP;FIBROBLAST MIGRATION;GO:0010761;28;-0.3914377;-1.301695;0.12609456;0.3469001
GO BP;CILIUM ORGANIZATION;GO:0044782;306;-0.26224267;-1.3016617;0.025954198;0.3464913
GO BP;CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION;GO:0086065;29;-0.39208356;-1.3012885;0.13240418;0.34678328
GO BP;POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY;GO:1901890;23;-0.4130532;-1.3010445;0.13857678;0.3468246
GO BP;CELLULAR EXTRAVASATION;GO:0045123;26;-0.39747906;-1.300726;0.13051471;0.34701368
GO BP;VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION;#N/A;18;-0.44602075;-1.3005573;0.16123189;0.34689775
GO BP;POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION;#N/A;18;-0.4482482;-1.2999595;0.14230019;0.34768233
GO BP;RESPONSE TO SALT STRESS;GO:0009651;16;-0.4541088;-1.2995223;0.14857143;0.34810233
GO BP;POSITIVE REGULATION OF PROTEOLYSIS;GO:0045862;260;-0.26872543;-1.2990876;0.032608695;0.34852764
GO BP;PROTEIN LOCALIZATION TO LYSOSOME;GO:0061462;33;-0.37895507;-1.298998;0.12724014;0.34825313
GO BP;ACTIN FILAMENT ORGANIZATION;GO:0007015;276;-0.26460195;-1.2986706;0.017191976;0.34842196
GO BP;ZYMOGEN ACTIVATION;GO:0031638;38;-0.37087193;-1.298581;0.13003664;0.34812516
GO BP;ACTIN FILAMENT DEPOLYMERIZATION;GO:0030042;37;-0.3698544;-1.2984693;0.11443662;0.34789205
GO BP;STEROID METABOLIC PROCESS;GO:0008202;202;-0.27538013;-1.2982777;0.04407295;0.3478639
GO BP;MYELOID LEUKOCYTE CYTOKINE PRODUCTION;#N/A;23;-0.40942538;-1.2971352;0.13903743;0.34978226
GO BP;POSITIVE REGULATION OF BINDING;GO:0051099;135;-0.288947;-1.2966104;0.06279435;0.35044557
GO BP;REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION;GO:0035023;100;-0.3014852;-1.2961112;0.07754443;0.35100374
GO BP;NEGATIVE REGULATION OF GTPASE ACTIVITY;GO:0034260;37;-0.36958858;-1.2957788;0.11623932;0.35117245
GO BP;ENDOSOME TO LYSOSOME TRANSPORT;GO:0008333;48;-0.3502608;-1.2955817;0.10769231;0.35112995
GO BP;REGULATION OF PROTEOLYSIS;GO:0030162;476;-0.25053406;-1.2950803;0.008253095;0.35167947
GO BP;RESPONSE TO TUMOR NECROSIS FACTOR;GO:0034612;186;-0.28150097;-1.2944099;0.045655377;0.3526252
GO BP;REGULATION OF PROTEIN IMPORT;#N/A;47;-0.34997842;-1.2940922;0.114922814;0.35279903
GO BP;RESPONSE TO ANGIOTENSIN;GO:1990776;16;-0.448624;-1.293531;0.16917293;0.3535139
GO BP;LEUKOCYTE HOMEOSTASIS;GO:0001776;49;-0.3457692;-1.2934871;0.11282051;0.3531278
GO BP;P38MAPK CASCADE;GO:0038066;34;-0.3772033;-1.2932221;0.12041885;0.35322222
GO BP;CENTROSOME DUPLICATION;GO:0051298;61;-0.32805055;-1.2930783;0.08635578;0.35302687
GO BP;CELL CELL ADHESION;GO:0098609;415;-0.25321868;-1.2927469;0.018156424;0.3532048
GO BP;POSITIVE REGULATION OF LIPID STORAGE;GO:0010884;15;-0.45724156;-1.2925482;0.17055656;0.3531621
GO BP;NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY;#N/A;17;-0.45240173;-1.2924547;0.14473684;0.35286227
GO BP;NEGATIVE REGULATION OF VIRAL GENOME REPLICATION;GO:0045071;30;-0.3762177;-1.2911533;0.12043796;0.3552615
GO BP;RAS PROTEIN SIGNAL TRANSDUCTION;GO:0007265;325;-0.26068437;-1.2901955;0.03125;0.3567925
GO BP;REGULATION OF APOPTOTIC SIGNALING PATHWAY;#N/A;303;-0.26196912;-1.2900689;0.022284122;0.35659775
GO BP;REGULATION OF CELL PROJECTION ORGANIZATION;GO:0031344;462;-0.25094017;-1.2899331;0.021947874;0.35645142
GO BP;CYCLIC NUCLEOTIDE MEDIATED SIGNALING;#N/A;78;-0.31649017;-1.2892915;0.08614865;0.35736436
GO BP;REGULATION OF MULTICELLULAR ORGANISM GROWTH;GO:0040014;39;-0.36544135;-1.2887356;0.14383562;0.35803574
GO BP;ORGANIC ACID BIOSYNTHETIC PROCESS;#N/A;229;-0.26730013;-1.2887317;0.03377386;0.35756427
GO BP;CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS;#N/A;71;-0.32071078;-1.288729;0.09813875;0.357094
GO BP;ALPHA AMINO ACID BIOSYNTHETIC PROCESS;#N/A;51;-0.34163415;-1.2884393;0.10689655;0.35724843
GO BP;NEGATIVE REGULATION OF GROWTH;GO:0045926;148;-0.28430808;-1.287831;0.0477707;0.3581046
GO BP;NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION;GO:1902532;352;-0.2540227;-1.2870827;0.02425107;0.3592355
GO BP;NEGATIVE REGULATION OF PROTEIN POLYMERIZATION;GO:0032272;52;-0.34013763;-1.2865926;0.10918544;0.3597038
GO BP;CELL PART MORPHOGENESIS;#N/A;425;-0.25209835;-1.2860391;0.027859237;0.3604361
GO BP;POST EMBRYONIC DEVELOPMENT;GO:0009791;65;-0.32496578;-1.2859154;0.1092437;0.36021194
GO BP;POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION;GO:2000179;26;-0.39546695;-1.2857876;0.13928571;0.36002076
GO BP;SODIUM ION HOMEOSTASIS;GO:0055078;23;-0.4139986;-1.2854803;0.15839694;0.36019313
GO BP;MICROTUBULE POLYMERIZATION;GO:0046785;63;-0.3258868;-1.2851132;0.114922814;0.36048883
GO BP;REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY;GO:0043467;125;-0.28980106;-1.2849355;0.05235602;0.36038664
GO BP;REGULATION OF MITOTIC SPINDLE ASSEMBLY;GO:1901673;19;-0.42929804;-1.2841821;0.17391305;0.36151892
GO BP;REGULATION OF MUSCLE ADAPTATION;#N/A;57;-0.32968932;-1.2841576;0.095744684;0.36108372
GO BP;RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS;#N/A;40;-0.35820538;-1.2834266;0.1312608;0.36214808
GO BP;POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;#N/A;28;-0.3952349;-1.2830942;0.13197026;0.36239326
GO BP;CIRCADIAN RHYTHM;GO:0007623;137;-0.2841212;-1.2830833;0.051968504;0.3619448
GO BP;REGULATION OF DOUBLE STRAND BREAK REPAIR;GO:2000779;61;-0.3299114;-1.2830573;0.110754415;0.36152157
GO BP;POSITIVE REGULATION OF CATION CHANNEL ACTIVITY;GO:2001259;23;-0.40523598;-1.2827103;0.14188035;0.3618321
GO BP;REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS;GO:0043620;103;-0.2979464;-1.28268;0.08237232;0.36144057
GO BP;REGULATION OF CARBOHYDRATE CATABOLIC PROCESS;#N/A;67;-0.3207905;-1.2819953;0.10410095;0.36255983
GO BP;POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION;GO:0032755;40;-0.35662666;-1.2814779;0.13974592;0.36317396
GO BP;NEGATIVE REGULATION OF CELL MATRIX ADHESION;GO:0001953;27;-0.39854547;-1.281413;0.15436241;0.36283016
GO BP;CELL PROJECTION ASSEMBLY;GO:0030031;442;-0.25034893;-1.2803543;0.013642564;0.36460626
GO BP;CELL ADHESION MEDIATED BY INTEGRIN;GO:0033627;44;-0.3507595;-1.2800485;0.12746859;0.36476627
GO BP;DENDRITIC SPINE MORPHOGENESIS;GO:0060997;39;-0.35894084;-1.2798873;0.1119403;0.36463803
GO BP;PROTEIN HETEROOLIGOMERIZATION;GO:0051291;71;-0.3201043;-1.279532;0.110552765;0.36492124
GO BP;EYE PHOTORECEPTOR CELL DIFFERENTIATION;GO:0001754;19;-0.43616554;-1.2793198;0.1553398;0.364898
GO BP;POSITIVE REGULATION OF CELL CYCLE PROCESS;GO:0090068;228;-0.2671677;-1.2790389;0.034795765;0.36502156
GO BP;MITOTIC CYTOKINESIS;GO:0000281;65;-0.32366583;-1.2771723;0.10207613;0.36848232
GO BP;NEPHRON DEVELOPMENT;GO:0072006;77;-0.31353274;-1.2766595;0.09421488;0.36909962
GO BP;DEVELOPMENTAL GROWTH;GO:0048589;408;-0.25020492;-1.2765875;0.024285715;0.3688025
GO BP;EMBRYONIC ORGAN MORPHOGENESIS;GO:0048562;159;-0.27872437;-1.2764777;0.062015504;0.36853793
GO BP;SECOND MESSENGER MEDIATED SIGNALING;GO:0019932;184;-0.2763758;-1.2758048;0.061417323;0.369504
GO BP;REGULATION OF LEUKOCYTE MEDIATED IMMUNITY;#N/A;98;-0.30135426;-1.2756155;0.093959734;0.36945128
GO BP;ENDOCHONDRAL BONE MORPHOGENESIS;GO:0060350;40;-0.35717523;-1.2756103;0.13504274;0.36899292
GO BP;REGULATION OF DNA METHYLATION;GO:0044030;21;-0.42158476;-1.2755661;0.18;0.36861578
GO BP;REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE;GO:0003073;38;-0.35283563;-1.2754161;0.13194445;0.3684571
GO BP;REGULATION OF POTASSIUM ION TRANSPORT;GO:0043266;35;-0.3740759;-1.2753;0.13286713;0.36825
GO BP;POSITIVE REGULATION OF CHEMOKINE PRODUCTION;GO:0032722;31;-0.37951297;-1.2752887;0.12727273;0.36781892
GO BP;MATURE B CELL DIFFERENTIATION;GO:0002335;17;-0.4369089;-1.2750328;0.17921147;0.3678533
GO BP;CYTOSKELETON DEPENDENT CYTOKINESIS;GO:0061640;83;-0.30648905;-1.2749355;0.099326596;0.36759803
GO BP;DETECTION OF ABIOTIC STIMULUS;#N/A;44;-0.34990424;-1.2748843;0.12307692;0.36723563
GO BP;NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT;GO:0034763;61;-0.33030018;-1.2744921;0.12393888;0.36757314
GO BP;BARBED END ACTIN FILAMENT CAPPING;GO:0051016;15;-0.4554911;-1.2743351;0.17708333;0.36743897
GO BP;REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN;GO:0033628;31;-0.3666557;-1.2739742;0.13427562;0.36779204
GO BP;POSITIVE REGULATION OF CYTOKINE PRODUCTION;GO:0001819;237;-0.26371735;-1.2734616;0.04992436;0.36842674
GO BP;REGULATION OF ORGANELLE ASSEMBLY;GO:1902115;157;-0.27608725;-1.2732731;0.063897766;0.36837953
GO BP;POSITIVE REGULATION OF STEROL TRANSPORT;#N/A;17;-0.43834737;-1.2728064;0.16876122;0.36885285
GO BP;CARDIAC MUSCLE CONTRACTION;GO:0060048;74;-0.31335956;-1.27249;0.107317075;0.36908892
GO BP;MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0002755;22;-0.41415825;-1.2719865;0.14917128;0.3697101
GO BP;REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0010640;17;-0.43723515;-1.2710886;0.15734266;0.37119156
GO BP;REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION;GO:0033135;85;-0.30622047;-1.2710764;0.114617944;0.37075377
GO BP;LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE;#N/A;93;-0.3030644;-1.2706673;0.09448819;0.37116703
GO BP;SMOOTH MUSCLE CELL DIFFERENTIATION;GO:0051145;35;-0.36865672;-1.2704216;0.15551537;0.37117404
GO BP;POSITIVE REGULATION OF PROTEIN ACETYLATION;GO:1901985;32;-0.37310022;-1.2697741;0.16283186;0.3720444
GO BP;RESPONSE TO PLATELET DERIVED GROWTH FACTOR;GO:0036119;17;-0.4395997;-1.2694573;0.17667845;0.37230784
GO BP;INTEGRIN MEDIATED SIGNALING PATHWAY;GO:0007229;69;-0.31852728;-1.2693578;0.10726073;0.37203884
GO BP;POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051155;27;-0.3839719;-1.269301;0.14678898;0.37167513
GO BP;REGULATION OF BLOOD CIRCULATION;GO:1903522;126;-0.28380978;-1.2680614;0.078025475;0.37388474
GO BP;REGULATION OF INSULIN SECRETION;GO:0050796;104;-0.29091424;-1.2674524;0.077441074;0.3747264
GO BP;INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY;#N/A;19;-0.41324908;-1.2671998;0.1764706;0.37479553
GO BP;NCRNA TRANSCRIPTION;GO:0098781;100;-0.29620197;-1.266818;0.097133756;0.3751996
GO BP;PROTEIN ACETYLATION;GO:0006473;160;-0.27860764;-1.2667482;0.06885759;0.37489352
GO BP;ORGANIC HYDROXY COMPOUND TRANSPORT;GO:0015850;121;-0.28974256;-1.2666721;0.093851134;0.37457547
GO BP;REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002761;60;-0.3279273;-1.2658684;0.116838485;0.37589213
GO BP;INSULIN SECRETION;GO:0030073;123;-0.28773144;-1.2648858;0.0928;0.37764645
GO BP;REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:2000377;118;-0.28891483;-1.2648355;0.07692308;0.37729546
GO BP;SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0007264;410;-0.25066766;-1.2647843;0.033850495;0.37695017
GO BP;CELLULAR RESPONSE TO INSULIN STIMULUS;GO:0032869;163;-0.27345204;-1.2638705;0.073619634;0.37849474
GO BP;REGULATION OF CENTROSOME CYCLE;GO:0046605;51;-0.33777082;-1.2636099;0.14098361;0.37860674
GO BP;REGULATION OF GLYCOPROTEIN METABOLIC PROCESS;#N/A;30;-0.37417486;-1.2634909;0.15480427;0.37842903
GO BP;INTRACELLULAR LIPID TRANSPORT;#N/A;39;-0.35963798;-1.2633715;0.13019891;0.37824854
GO BP;INTERLEUKIN 6 PRODUCTION;GO:0032635;68;-0.31689367;-1.2631197;0.10227273;0.3783417
GO BP;THIOESTER BIOSYNTHETIC PROCESS;#N/A;49;-0.33601886;-1.2625302;0.1453958;0.3792572
GO BP;CELLULAR RESPONSE TO CAMP;GO:0071320;30;-0.37503815;-1.2624248;0.16994633;0.37900367
GO BP;LIPID PHOSPHORYLATION;GO:0046834;46;-0.34109905;-1.2621211;0.1271777;0.3792103
GO BP;MYOFIBRIL ASSEMBLY;GO:0030239;36;-0.35983583;-1.2620169;0.13227513;0.37898216
GO BP;NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION;GO:0035024;17;-0.4407401;-1.261627;0.20071685;0.3794508
GO BP;RESPONSE TO ANESTHETIC;GO:0072347;38;-0.36251944;-1.2615205;0.13761468;0.37924895
GO BP;REGULATION OF CELLULAR COMPONENT SIZE;#N/A;253;-0.25936902;-1.2615157;0.04373178;0.3788036
GO BP;SKIN DEVELOPMENT;GO:0043588;180;-0.27070943;-1.2614545;0.083333336;0.37846217
GO BP;FATTY ACYL COA METABOLIC PROCESS;#N/A;33;-0.36792037;-1.2612141;0.15236427;0.37853402
GO BP;OLFACTORY LOBE DEVELOPMENT;GO:0021988;19;-0.43116543;-1.2609383;0.17345133;0.3786748
GO BP;LIPID STORAGE;GO:0019915;49;-0.33239833;-1.2600871;0.13286713;0.38016436
GO BP;PROTEIN LOCALIZATION TO CELL SURFACE;GO:0034394;45;-0.34335196;-1.2598184;0.13864818;0.3802849
GO BP;NEGATIVE REGULATION OF JNK CASCADE;GO:0046329;27;-0.3889505;-1.2597299;0.16261682;0.3800201
GO BP;REGULATION OF CALCIUM ION TRANSPORT;GO:0051924;117;-0.28934878;-1.259623;0.09967846;0.37978593
GO BP;NEUROMUSCULAR PROCESS CONTROLLING BALANCE;GO:0050885;26;-0.38448796;-1.259159;0.16871704;0.38037255
GO BP;REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY;GO:0051090;270;-0.25613466;-1.2589074;0.05263158;0.38048175
GO BP;HEART MORPHOGENESIS;GO:0003007;163;-0.27344576;-1.258905;0.071539655;0.38003397
GO BP;REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS;#N/A;53;-0.33367965;-1.2585713;0.14918032;0.38032192
GO BP;KILLING OF CELLS OF OTHER ORGANISM;GO:0031640;16;-0.44448483;-1.2585264;0.18245614;0.37996265
GO BP;NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS;GO:2000279;30;-0.3799298;-1.257965;0.15535714;0.3807953
GO BP;POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION;GO:0051149;48;-0.33708894;-1.2574143;0.14336284;0.38158315
GO BP;POSITIVE REGULATION OF CELL GROWTH;GO:0030307;116;-0.29151958;-1.2573388;0.09478673;0.38128164
GO BP;REGULATION OF LEUKOCYTE DIFFERENTIATION;#N/A;138;-0.28190553;-1.2570237;0.07608695;0.38153806
GO BP;REGULATION OF CARTILAGE DEVELOPMENT;GO:0061035;38;-0.35733733;-1.2561156;0.17460318;0.38315842
GO BP;REGULATION OF PHOSPHOLIPASE C ACTIVITY;#N/A;18;-0.42669407;-1.256044;0.18888889;0.3828775
GO BP;DNA METHYLATION OR DEMETHYLATION;#N/A;72;-0.31072462;-1.2557884;0.103960395;0.38299578
GO BP;POSITIVE REGULATION OF ENDOCYTOSIS;GO:0045807;74;-0.3093999;-1.2553904;0.11904762;0.38344562
GO BP;CARDIAC CHAMBER DEVELOPMENT;#N/A;112;-0.29317266;-1.2544812;0.089141004;0.38494214
GO BP;MORPHOGENESIS OF EMBRYONIC EPITHELIUM;GO:0016331;107;-0.28703162;-1.2541269;0.10152284;0.38528776
GO BP;REGULATION OF PROTEIN ACETYLATION;#N/A;53;-0.32990077;-1.2539465;0.13728814;0.38522398
GO BP;LIPID LOCALIZATION;GO:0010876;248;-0.2591828;-1.2539277;0.059970014;0.38481945
GO BP;REGULATION OF MACROPHAGE ACTIVATION;GO:0043030;25;-0.3981934;-1.2538565;0.17798164;0.3845434
GO BP;MITOTIC SPINDLE ORGANIZATION;GO:0007052;99;-0.29719242;-1.2537621;0.1013289;0.38430125
GO BP;HORMONE TRANSPORT;#N/A;174;-0.2720834;-1.253537;0.07042254;0.38435254
GO BP;VESICLE CARLOADING;#N/A;19;-0.41850868;-1.2533696;0.19332162;0.38429004
GO BP;SULFUR COMPOUND BIOSYNTHETIC PROCESS;#N/A;134;-0.28337678;-1.2524635;0.088141024;0.3858772
GO BP;MYELOID CELL DIFFERENTIATION;GO:0030099;275;-0.25719184;-1.2522175;0.049327355;0.38594764
GO BP;POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS;GO:1900182;62;-0.31432453;-1.2520925;0.14165261;0.38578185
GO BP;CELLULAR AMINO ACID BIOSYNTHETIC PROCESS;GO:0008652;63;-0.31859508;-1.2520789;0.1184669;0.38537285
GO BP;POSITIVE REGULATION OF LOCOMOTION;GO:0040017;361;-0.24979268;-1.2517697;0.04057971;0.3856164
GO BP;REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:1903169;72;-0.31168875;-1.251352;0.13099042;0.38611042
GO BP;EMBRYONIC CRANIAL SKELETON MORPHOGENESIS;GO:0048701;28;-0.38345796;-1.25129;0.17770036;0.38577384
GO BP;NEGATIVE REGULATION OF CELL DIFFERENTIATION;GO:0045596;392;-0.24684007;-1.2511493;0.04680851;0.3856101
GO BP;RESPONSE TO INTERLEUKIN 6;GO:0070741;24;-0.39998236;-1.2508012;0.19538188;0.38594338
GO BP;REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION;GO:0010769;199;-0.26489618;-1.2507349;0.074074075;0.38564113
GO BP;AXON DEVELOPMENT;GO:0061564;309;-0.25353464;-1.2507163;0.06025825;0.38523862
GO BP;REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS;GO:1900076;48;-0.32983136;-1.2507006;0.13412564;0.38484156
GO BP;LIPID HOMEOSTASIS;GO:0055088;93;-0.29450879;-1.2506549;0.11392405;0.38449526
GO BP;PROTEIN K48 LINKED DEUBIQUITINATION;GO:0071108;30;-0.36951107;-1.2506058;0.16946308;0.38417518
GO BP;POSITIVE REGULATION OF HISTONE METHYLATION;GO:0031062;32;-0.36955875;-1.250537;0.17717206;0.38388395
GO BP;REGULATION OF TELOMERE MAINTENANCE;GO:0032204;75;-0.3085426;-1.2504872;0.11519199;0.38357407
GO BP;TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY;GO:0070897;34;-0.36317936;-1.2502339;0.15480427;0.38363957
GO BP;RESPONSE TO GROWTH HORMONE;GO:0060416;23;-0.4001192;-1.250143;0.17967331;0.38339552
GO BP;ADAPTIVE THERMOGENESIS;GO:1990845;100;-0.29597595;-1.2498451;0.11470113;0.38352957
GO BP;POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS;GO:1903020;15;-0.43494672;-1.2497343;0.20229007;0.38331154
GO BP;REGULATION OF TOR SIGNALING;GO:0032006;78;-0.3057518;-1.2494316;0.114529915;0.38355184
GO BP;REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION;GO:0043370;23;-0.4001202;-1.2485855;0.19314079;0.384944
GO BP;MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION;#N/A;32;-0.36537144;-1.2480671;0.15241636;0.38562712
GO BP;POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS;GO:0045732;179;-0.2671565;-1.247608;0.08;0.38622054
GO BP;NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS;#N/A;122;-0.28408897;-1.2472522;0.082125604;0.386598
GO BP;IMPORT INTO NUCLEUS;GO:0051170;127;-0.28206593;-1.246822;0.0944;0.38714403
GO BP;POSITIVE REGULATION OF OSSIFICATION;GO:0045778;51;-0.3236478;-1.2466396;0.1446208;0.38708207
GO BP;RESPONSE TO TEMPERATURE STIMULUS;GO:0009266;169;-0.2700068;-1.246629;0.08044164;0.38667244
GO BP;REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS;GO:2001020;179;-0.2681109;-1.2461848;0.086021505;0.38724563
GO BP;RESPONSE TO ACTIVITY;GO:0014823;43;-0.3427243;-1.2450356;0.15438597;0.3892488
GO BP;PROTEIN LOCALIZATION TO ENDOSOME;GO:0036010;24;-0.3942236;-1.2441431;0.16551724;0.39074287
GO BP;ESTABLISHMENT OF CELL POLARITY;GO:0030010;113;-0.28446227;-1.2436423;0.10276074;0.39148697
GO BP;REGULATION OF DNA RECOMBINATION;GO:0000018;77;-0.30363533;-1.2433093;0.11716171;0.39184532
GO BP;MICROTUBULE NUCLEATION;GO:0007020;24;-0.39659795;-1.2431374;0.18336484;0.39174885
GO BP;POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001244;47;-0.33503315;-1.2430952;0.15136054;0.39139464
GO BP;MALE GAMETE GENERATION;GO:0048232;316;-0.2503612;-1.2430513;0.050445102;0.39103794
GO BP;TEMPERATURE HOMEOSTASIS;GO:0001659;104;-0.29113618;-1.2429972;0.121753246;0.39071122
GO BP;O GLYCAN PROCESSING;GO:0016266;34;-0.36401233;-1.2426934;0.1724138;0.3909793
GO BP;PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY;GO:0002221;126;-0.2787812;-1.2426666;0.09262166;0.39060098
GO BP;POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS;GO:0044089;370;-0.24458022;-1.2420053;0.042194095;0.39159325
GO BP;TISSUE REMODELING;GO:0048771;94;-0.2985609;-1.24088;0.1179402;0.3937476
GO BP;RESPONSE TO NICOTINE;GO:0035094;23;-0.40250245;-1.2408531;0.20689656;0.3933646
GO BP;NEGATIVE REGULATION OF CELL AGING;GO:0090344;19;-0.4179251;-1.2408475;0.17830883;0.39294016
GO BP;EPITHELIAL TUBE FORMATION;#N/A;100;-0.29079202;-1.2405162;0.106687896;0.39328295
GO BP;DENDRITE MORPHOGENESIS;GO:0048813;95;-0.2917564;-1.2402239;0.11093248;0.39347395
GO BP;EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS;GO:0008625;66;-0.30965254;-1.2398978;0.12807018;0.39375016
GO BP;ONE CARBON METABOLIC PROCESS;GO:0006730;21;-0.3974524;-1.2396418;0.16399287;0.39380443
GO BP;MUSCLE SYSTEM PROCESS;GO:0003012;236;-0.25840473;-1.2396239;0.060294118;0.39340645
GO BP;REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY;GO:0043254;321;-0.25011525;-1.2387872;0.06362379;0.39490503
GO BP;POSITIVE REGULATION OF MRNA METABOLIC PROCESS;#N/A;63;-0.31540972;-1.2387235;0.14091681;0.39458868
GO BP;POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION;GO:0032727;16;-0.4377927;-1.2386767;0.21335807;0.39425147
GO BP;NEURON PROJECTION ORGANIZATION;#N/A;61;-0.31593758;-1.2383248;0.1338843;0.39452305
GO BP;REGULATION OF MUSCLE SYSTEM PROCESS;GO:0090257;129;-0.2793071;-1.2380348;0.07528642;0.39475045
GO BP;CELLULAR RESPONSE TO GLUCOSE STARVATION;GO:0042149;34;-0.3553631;-1.237817;0.17525773;0.3947957
GO BP;NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS;#N/A;431;-0.24455367;-1.2374291;0.03434066;0.3952349
GO BP;MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION;#N/A;77;-0.3026756;-1.2373608;0.12609456;0.39494234
GO BP;REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;78;-0.3037796;-1.2371945;0.12048193;0.39485273
GO BP;SYNAPTONEMAL COMPLEX ORGANIZATION;GO:0070193;18;-0.4189302;-1.2369925;0.18959108;0.39484742
GO BP;LIMBIC SYSTEM DEVELOPMENT;GO:0021761;62;-0.30990195;-1.2368069;0.13810316;0.39484787
GO BP;RESPONSE TO OXYGEN LEVELS;#N/A;283;-0.2513419;-1.2367029;0.06942393;0.3946479
GO BP;GLYCOPROTEIN BIOSYNTHETIC PROCESS;GO:0009101;221;-0.25899917;-1.236508;0.07385524;0.3946402
GO BP;REGULATION OF ADAPTIVE IMMUNE RESPONSE;GO:0002819;77;-0.30688822;-1.2356093;0.122689076;0.3961118
GO BP;GLAND DEVELOPMENT;GO:0048732;280;-0.25279862;-1.2355548;0.05936073;0.3957804
GO BP;POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY;GO:2001235;134;-0.27452672;-1.2351065;0.11198738;0.39631885
GO BP;REGULATION OF CENTRIOLE REPLICATION;GO:0046599;19;-0.41825;-1.2350788;0.20637898;0.39594942
GO BP;DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS;GO:0045137;138;-0.2766555;-1.2337798;0.10501567;0.39851633
GO BP;NEGATIVE REGULATION OF VIRAL PROCESS;GO:0048525;58;-0.32093373;-1.2337261;0.13255033;0.39818117
GO BP;POSITIVE REGULATION OF CELL ADHESION;GO:0045785;228;-0.25757256;-1.2336931;0.07604017;0.39782393
GO BP;TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0002224;94;-0.2907111;-1.2336593;0.107615896;0.3974745
GO BP;POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS;GO:0045923;18;-0.42322424;-1.2333612;0.18315019;0.39765456
GO BP;DNA BIOSYNTHETIC PROCESS;GO:0071897;159;-0.2666464;-1.2327543;0.077389985;0.39870164
GO BP;TAXIS;#N/A;312;-0.24713628;-1.2327193;0.048104957;0.39834505
GO BP;MICROTUBULE ORGANIZING CENTER LOCALIZATION;#N/A;28;-0.37471172;-1.2324858;0.185567;0.39849034
GO BP;REGULATION OF BLOOD PRESSURE;GO:0008217;83;-0.29899037;-1.232389;0.12;0.39828315
GO BP;POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION;#N/A;147;-0.2717975;-1.2316164;0.08446456;0.39962283
GO BP;DETERMINATION OF HEART LEFT RIGHT ASYMMETRY;GO:0061371;44;-0.3436646;-1.2314972;0.16302522;0.39944515
GO BP;BEHAVIOR;GO:0007610;286;-0.25096196;-1.2313977;0.06866953;0.39922357
GO BP;NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:1903573;36;-0.35659918;-1.2311542;0.1696751;0.3993213
GO BP;POSITIVE REGULATION OF PHOSPHATASE ACTIVITY;GO:0010922;19;-0.40684006;-1.2308336;0.1949807;0.39966437
GO BP;CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION;GO:0043367;34;-0.36268434;-1.2305584;0.19525547;0.3998663
GO BP;POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT;GO:0045684;21;-0.39112455;-1.2297789;0.19419238;0.40113032
GO BP;B CELL PROLIFERATION;GO:0042100;42;-0.33529025;-1.2295126;0.17589577;0.40135652
GO BP;VIRAL LIFE CYCLE;GO:0019058;236;-0.25698876;-1.2293856;0.05637982;0.4012421
GO BP;HOMOLOGOUS RECOMBINATION;GO:0035825;42;-0.3394706;-1.2289524;0.15275311;0.40183565
GO BP;DNA METHYLATION;GO:0006306;58;-0.31567305;-1.2284262;0.14808363;0.40267166
GO BP;SMOOTH MUSCLE CELL MIGRATION;GO:0014909;51;-0.32571363;-1.2282108;0.15439856;0.40275753
GO BP;CARBOHYDRATE METABOLIC PROCESS;GO:0005975;432;-0.24087831;-1.2281141;0.03537415;0.40254405
GO BP;CELL CHEMOTAXIS;GO:0060326;127;-0.2780552;-1.2280844;0.1028481;0.40221024
GO BP;CEREBELLAR CORTEX DEVELOPMENT;GO:0021695;30;-0.36324528;-1.2280803;0.18455744;0.40179428
GO BP;NERVOUS SYSTEM PROCESS;GO:0050877;444;-0.24011151;-1.226852;0.037142858;0.40409923
GO BP;MITOTIC RECOMBINATION;GO:0006312;20;-0.40498477;-1.2265844;0.21928166;0.40427327
GO BP;STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051146;158;-0.2677428;-1.2261789;0.096;0.4047577
GO BP;CELL CELL RECOGNITION;#N/A;27;-0.37713763;-1.22612;0.17495395;0.40444428
GO BP;LYMPHOCYTE HOMEOSTASIS;GO:0002260;38;-0.34805575;-1.2259327;0.18243243;0.40440348
GO BP;PROTEIN LOCALIZATION TO GOLGI APPARATUS;GO:0034067;24;-0.39175618;-1.2255319;0.20526315;0.4048661
GO BP;NEUTRAL LIPID CATABOLIC PROCESS;#N/A;27;-0.37551907;-1.2253703;0.20437956;0.4048305
GO BP;REGULATION OF PROTEIN BINDING;GO:0043393;153;-0.269954;-1.2253349;0.1097561;0.40448415
GO BP;REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0034121;37;-0.34856227;-1.2249995;0.16575591;0.40478235
GO BP;ACTIVATION OF MAPKK ACTIVITY;GO:0000186;43;-0.3384452;-1.224651;0.15469614;0.40512103
GO BP;REGULATION OF LIPID LOCALIZATION;#N/A;82;-0.2952756;-1.2245133;0.14864865;0.40504146
GO BP;REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE;GO:1905475;134;-0.2751589;-1.2244636;0.1016129;0.4047484
GO BP;GLYCOSYLATION;GO:0070085;182;-0.26247814;-1.2234027;0.09259259;0.40661067
GO BP;CELLULAR RESPONSE TO FLUID SHEAR STRESS;GO:0071498;15;-0.429069;-1.2230144;0.22037037;0.40710407
GO BP;POSITIVE REGULATION OF EXOCYTOSIS;GO:0045921;62;-0.31067285;-1.222558;0.15321252;0.40772197
GO BP;CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS;GO:0031668;188;-0.26281837;-1.222152;0.10856269;0.40824762
GO BP;CIRCULATORY SYSTEM PROCESS;#N/A;263;-0.2502227;-1.2215487;0.083936326;0.40919074
GO BP;MACROPHAGE MIGRATION;GO:1905517;26;-0.380493;-1.2213746;0.1879845;0.40916812
GO BP;NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS;GO:2000107;24;-0.3870968;-1.2207737;0.21818182;0.41018468
GO BP;PYRUVATE METABOLIC PROCESS;GO:0006090;119;-0.27784416;-1.2202704;0.11551155;0.410935
GO BP;HISTONE H3 ACETYLATION;GO:0043966;49;-0.32431415;-1.2200654;0.1590106;0.4109838
GO BP;REGULATION OF PROTEIN TARGETING TO MITOCHONDRION;GO:1903214;35;-0.34802663;-1.2194991;0.20226844;0.4118657
GO BP;POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;GO:0070304;116;-0.28152537;-1.218858;0.13166666;0.4129157
GO BP;MULTI ORGANISM LOCALIZATION;#N/A;53;-0.31939062;-1.2173742;0.16493055;0.415896
GO BP;RESPONSE TO INTERLEUKIN 7;#N/A;30;-0.36515465;-1.2166879;0.20572451;0.4170464
GO BP;MUSCLE CELL DIFFERENTIATION;GO:0042692;210;-0.25594395;-1.216644;0.08598726;0.41672075
GO BP;CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;#N/A;444;-0.23658532;-1.2159337;0.054570258;0.41794568
GO BP;REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION;#N/A;58;-0.31061292;-1.2158931;0.14946619;0.4176064
GO BP;POSITIVE REGULATION OF TRANSFERASE ACTIVITY;#N/A;456;-0.23714486;-1.2157636;0.051282052;0.41747972
GO BP;RHYTHMIC PROCESS;GO:0048511;188;-0.25947315;-1.2156662;0.10339734;0.41727456
GO BP;MYELOID LEUKOCYTE ACTIVATION;#N/A;403;-0.23900764;-1.2153523;0.054913294;0.4175971
GO BP;PLATELET DEGRANULATION;GO:0002576;82;-0.29424134;-1.2153031;0.14212328;0.41730887
GO BP;RESPONSE TO ATP;GO:0033198;16;-0.43141907;-1.2150731;0.2263056;0.41740546
GO BP;CHAPERONE MEDIATED PROTEIN FOLDING;GO:0061077;49;-0.32385615;-1.2147328;0.17028986;0.41778487
GO BP;INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION;GO:0060122;17;-0.41743565;-1.214506;0.20833333;0.4179033
GO BP;TRANSFORMING GROWTH FACTOR BETA PRODUCTION;GO:0071604;22;-0.38959107;-1.2141663;0.19782214;0.41823778
GO BP;ALPHA BETA T CELL DIFFERENTIATION;GO:0046632;50;-0.32398117;-1.2141647;0.18055555;0.41781583
GO BP;MUSCLE CELL MIGRATION;#N/A;59;-0.31509092;-1.2141283;0.1609589;0.41747448
GO BP;RECEPTOR SIGNALING PATHWAY VIA STAT;#N/A;67;-0.30531985;-1.2130607;0.15823817;0.41952965
GO BP;PEPTIDYL LYSINE ACETYLATION;GO:0018394;136;-0.27125424;-1.2130091;0.13198757;0.41921002
GO BP;RECEPTOR MEDIATED ENDOCYTOSIS;GO:0006898;165;-0.26474893;-1.2128391;0.107361965;0.41918036
GO BP;STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;GO:0031098;207;-0.25635844;-1.212415;0.09785933;0.41973898
GO BP;ION HOMEOSTASIS;GO:0050801;426;-0.23655355;-1.2122315;0.050847456;0.41974625
GO BP;POSITIVE REGULATION OF PROTEIN DEACETYLATION;GO:0090312;18;-0.41907576;-1.2118747;0.19656488;0.4201307
GO BP;NON RECOMBINATIONAL REPAIR;GO:0000726;79;-0.29689434;-1.2117821;0.12727273;0.4199099
GO BP;MONOCARBOXYLIC ACID METABOLIC PROCESS;GO:0032787;437;-0.2364327;-1.211502;0.045454547;0.42012918
GO BP;METANEPHRIC NEPHRON DEVELOPMENT;GO:0072210;17;-0.4207676;-1.2112845;0.22141561;0.42019364
GO BP;REGULATION OF PROTEIN DEACETYLATION;GO:0090311;34;-0.3520107;-1.2112831;0.19210054;0.4197718
GO BP;SPHINGOLIPID BIOSYNTHETIC PROCESS;GO:0030148;81;-0.29398704;-1.2112758;0.16861436;0.4193706
GO BP;CELL CELL JUNCTION ASSEMBLY;GO:0007043;87;-0.28990665;-1.2108324;0.13660245;0.41996685
GO BP;GAMETE GENERATION;GO:0007276;401;-0.2385681;-1.2105494;0.04761905;0.4202071
GO BP;REGULATION OF LIPID STORAGE;GO:0010883;32;-0.35349497;-1.2101643;0.18928571;0.42074144
GO BP;PERK MEDIATED UNFOLDED PROTEIN RESPONSE;GO:0036499;15;-0.42879018;-1.2101332;0.22803739;0.42040518
GO BP;REACTIVE NITROGEN SPECIES METABOLIC PROCESS;#N/A;44;-0.33100787;-1.2092648;0.18103448;0.42193902
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR;GO:0042771;37;-0.34720352;-1.2092042;0.19310345;0.4216479
GO BP;SYNAPSE ORGANIZATION;GO:0050808;213;-0.2570111;-1.2091519;0.083936326;0.42135385
GO BP;RESPONSE TO ORGANOPHOSPHORUS;GO:0046683;78;-0.2969621;-1.2091311;0.15275311;0.42098156
GO BP;CELLULAR RESPONSE TO NITROGEN COMPOUND;#N/A;437;-0.23576844;-1.208714;0.056179777;0.42147276
GO BP;PEPTIDYL TYROSINE MODIFICATION;#N/A;219;-0.25496817;-1.20808;0.09550562;0.4224951
GO BP;SARCOMERE ORGANIZATION;GO:0045214;22;-0.39237523;-1.2079368;0.19744058;0.42240474
GO BP;REGULATION OF MEMBRANE REPOLARIZATION;GO:0060306;15;-0.43737978;-1.207566;0.23941068;0.42285055
GO BP;REGULATION OF CARBOHYDRATE METABOLIC PROCESS;#N/A;143;-0.26719597;-1.2073864;0.12087912;0.42286396
GO BP;CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS;GO:0071375;220;-0.25453323;-1.2073327;0.097637795;0.42257816
GO BP;CARBOHYDRATE TRANSPORT;GO:0008643;92;-0.28411832;-1.2072964;0.11677632;0.42223987
GO BP;CARDIAC VENTRICLE DEVELOPMENT;GO:0003231;80;-0.29160777;-1.2069929;0.14052288;0.42251876
GO BP;REGULATION OF LYMPHOCYTE DIFFERENTIATION;GO:0045619;84;-0.2883756;-1.2069759;0.15826087;0.42214465
GO BP;CELL CELL JUNCTION ORGANIZATION;GO:0045216;127;-0.2709253;-1.2069314;0.123809524;0.4218245
GO BP;MEMBRANE RAFT ORGANIZATION;GO:0031579;16;-0.42343664;-1.2067289;0.21454546;0.42189512
GO BP;HINDBRAIN DEVELOPMENT;GO:0030902;84;-0.29148185;-1.2066101;0.1543514;0.42173204
GO BP;ENERGY HOMEOSTASIS;GO:0097009;24;-0.38380837;-1.2057062;0.2080292;0.42331323
GO BP;REGULATION OF MAPK CASCADE;GO:0043408;443;-0.23495747;-1.2052269;0.042918455;0.42403612
GO BP;MULTICELLULAR ORGANISM REPRODUCTION;#N/A;482;-0.23356861;-1.2048167;0.059556786;0.424523
GO BP;REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY;GO:2000116;153;-0.261921;-1.204812;0.12599681;0.42411366
GO BP;NEGATIVE REGULATION OF TELOMERE MAINTENANCE;GO:0032205;33;-0.35145435;-1.2045614;0.18558559;0.42429733
GO BP;REGULATION OF STRIATED MUSCLE CONTRACTION;GO:0006942;51;-0.3232806;-1.2044383;0.18739353;0.42419288
GO BP;DEFENSE RESPONSE TO BACTERIUM;GO:0042742;85;-0.29084542;-1.2036004;0.14432989;0.4256862
GO BP;NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING;GO:0051898;31;-0.36297098;-1.2027203;0.21378092;0.42717838
GO BP;CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS;GO:0042219;17;-0.4196911;-1.2026061;0.22816399;0.42703983
GO BP;NEGATIVE REGULATION OF LEUKOCYTE MIGRATION;GO:0002686;16;-0.41395137;-1.2022858;0.22574627;0.42735872
GO BP;PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II;#N/A;31;-0.35577494;-1.201913;0.19494584;0.42779243
GO BP;NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION;GO:0030837;41;-0.33650455;-1.20141;0.19931272;0.42857617
GO BP;HOMEOSTASIS OF NUMBER OF CELLS;GO:0048872;170;-0.26080924;-1.2013067;0.11942675;0.42838973
GO BP;POSITIVE REGULATION OF INFLAMMATORY RESPONSE;GO:0050729;61;-0.31041002;-1.201046;0.1919192;0.42859155
GO BP;DNA PACKAGING;GO:0006323;153;-0.2669201;-1.200874;0.12324493;0.42855886
GO BP;REGULATION OF LIPID TRANSPORT;#N/A;60;-0.30698892;-1.2007385;0.17491166;0.42847756
GO BP;CELLULAR RESPONSE TO PEPTIDE;GO:1901653;260;-0.24729308;-1.2005564;0.092920355;0.4284788
GO BP;CELLULAR RESPONSE TO ALKALOID;GO:0071312;20;-0.39465335;-1.2004093;0.2236842;0.4284246
GO BP;REGULATION OF ATP METABOLIC PROCESS;GO:1903578;95;-0.28352198;-1.2002653;0.14740369;0.42836055
GO BP;MIRNA METABOLIC PROCESS;GO:0010586;29;-0.35872868;-1.1998612;0.22286822;0.42892748
GO BP;MUSCLE TISSUE DEVELOPMENT;GO:0060537;226;-0.25148374;-1.1996408;0.10324484;0.42901367
GO BP;ANION TRANSMEMBRANE TRANSPORT;GO:0098656;171;-0.2621211;-1.1993617;0.13821138;0.429243
GO BP;POSITIVE REGULATION OF BLOOD CIRCULATION;#N/A;32;-0.3534538;-1.1990223;0.21693122;0.42960304
GO BP;SIGNAL RELEASE;GO:0023061;251;-0.24774778;-1.1989231;0.084070794;0.42943797
GO BP;POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION;GO:0043536;39;-0.33064836;-1.1988616;0.18336163;0.42918926
GO BP;NEGATIVE REGULATION OF HEMOPOIESIS;GO:1903707;82;-0.2949001;-1.1987909;0.15490533;0.42894793
GO BP;HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS;GO:0030201;20;-0.39439195;-1.1984572;0.21715328;0.429303
GO BP;REPRODUCTIVE SYSTEM DEVELOPMENT;GO:0061458;288;-0.24544592;-1.1983688;0.081871346;0.4290957
GO BP;ENDOCARDIAL CUSHION DEVELOPMENT;GO:0003197;26;-0.3695828;-1.1974546;0.21238938;0.43079102
GO BP;PROTEIN TARGETING TO LYSOSOME;GO:0006622;20;-0.39609012;-1.1970364;0.21731123;0.43139544
GO BP;SMOOTH MUSCLE CELL APOPTOTIC PROCESS;#N/A;16;-0.43052542;-1.1966441;0.22610295;0.4318834
GO BP;NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION;GO:1903828;85;-0.28783897;-1.1963587;0.14754099;0.43210855
GO BP;JNK CASCADE;GO:0007254;146;-0.2639976;-1.1963189;0.1328125;0.43179044
GO BP;ENDOTHELIAL CELL APOPTOTIC PROCESS;GO:0072577;29;-0.36422047;-1.1960912;0.21269296;0.4318982
GO BP;ENDOCRINE PANCREAS DEVELOPMENT;GO:0031018;29;-0.35688943;-1.1959544;0.20833333;0.4318271
GO BP;REGULATION OF MUSCLE HYPERTROPHY;#N/A;40;-0.33378664;-1.1957506;0.18434782;0.4318746
GO BP;VERY LONG CHAIN FATTY ACID METABOLIC PROCESS;GO:0000038;23;-0.3811594;-1.194834;0.21755725;0.43360046
GO BP;LONG TERM SYNAPTIC POTENTIATION;GO:0060291;43;-0.33135688;-1.1945002;0.17883211;0.43396568
GO BP;POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION;GO:0048661;57;-0.31094876;-1.1944225;0.17931035;0.4337234
GO BP;NEUTRAL LIPID METABOLIC PROCESS;GO:0006638;79;-0.293435;-1.1942118;0.14451827;0.43379903
GO BP;T CELL HOMEOSTASIS;GO:0043029;23;-0.3840376;-1.1937827;0.20950705;0.43442726
GO BP;BLASTOCYST DEVELOPMENT;GO:0001824;77;-0.29701158;-1.193695;0.18707483;0.43420807
GO BP;REGULATION OF OSTEOCLAST DIFFERENTIATION;GO:0045670;28;-0.36376187;-1.193606;0.2123412;0.4340313
GO BP;B CELL DIFFERENTIATION;GO:0030183;74;-0.29118323;-1.1935799;0.175;0.43367046
GO BP;DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS;GO:0046545;57;-0.31091613;-1.1927571;0.18563923;0.43511477
GO BP;REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS;#N/A;69;-0.29753888;-1.1926928;0.17435898;0.43485
GO BP;RESPONSE TO ANTINEOPLASTIC AGENT;#N/A;74;-0.29534146;-1.1922822;0.18373984;0.4353976
GO BP;REGULATION OF ALPHA BETA T CELL ACTIVATION;#N/A;48;-0.31735447;-1.1922008;0.1724138;0.4351797
GO BP;CHONDROCYTE DIFFERENTIATION;GO:0002062;64;-0.30035463;-1.192192;0.2043551;0.43479136
GO BP;SKELETAL MUSCLE CONTRACTION;GO:0003009;20;-0.39873764;-1.1920587;0.22710623;0.43470472
GO BP;CARBOHYDRATE CATABOLIC PROCESS;GO:0016052;154;-0.2616642;-1.1920565;0.12868217;0.43430015
GO BP;NEGATIVE REGULATION OF OSSIFICATION;GO:0030279;41;-0.33222696;-1.1918298;0.19107144;0.43446344
GO BP;RESPONSE TO ARSENIC CONTAINING SUBSTANCE;GO:0046685;31;-0.3549671;-1.1916652;0.2283737;0.4344453
GO BP;MICROTUBULE ORGANIZING CENTER ORGANIZATION;GO:0031023;118;-0.2740408;-1.1915774;0.15103339;0.43426025
GO BP;LEUKOCYTE MEDIATED CYTOTOXICITY;GO:0001909;44;-0.32192212;-1.1913614;0.19270833;0.43434498
GO BP;VIRAL RNA GENOME REPLICATION;GO:0039694;23;-0.3845618;-1.1912819;0.23076923;0.43411753
GO BP;REGULATION OF HORMONE SECRETION;GO:0046883;141;-0.26461518;-1.1912158;0.12745099;0.43383807
GO BP;NEGATIVE REGULATION OF MACROAUTOPHAGY;GO:0016242;31;-0.35638982;-1.1909239;0.21261261;0.4341547
GO BP;ENDOMEMBRANE SYSTEM ORGANIZATION;GO:0010256;336;-0.23942946;-1.1908329;0.09852941;0.43395635
GO BP;NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001243;76;-0.29210535;-1.1908108;0.18135594;0.4336082
GO BP;POSITIVE REGULATION OF DENDRITE DEVELOPMENT;GO:1900006;58;-0.3062947;-1.1907712;0.17777778;0.4333143
GO BP;REGULATION OF MUSCLE CELL DIFFERENTIATION;GO:0051147;90;-0.28538412;-1.1907172;0.16343042;0.43301728
GO BP;EPITHELIAL TUBE MORPHOGENESIS;GO:0060562;211;-0.2497599;-1.1906296;0.09202454;0.43278793
GO BP;FEMALE SEX DIFFERENTIATION;#N/A;67;-0.29387838;-1.1904362;0.17307693;0.4328201
GO BP;LONG CHAIN FATTY ACYL COA METABOLIC PROCESS;GO:0035336;19;-0.40133643;-1.1900444;0.21965317;0.4333371
GO BP;NEURON RECOGNITION;GO:0008038;24;-0.3792522;-1.1892838;0.22299652;0.43470615
GO BP;NEGATIVE REGULATION OF PROTEIN BINDING;GO:0032091;60;-0.30899245;-1.1892818;0.20200334;0.43431237
GO BP;REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS;GO:0045428;32;-0.35064325;-1.189138;0.22651933;0.43426022
GO BP;FATTY ACID BETA OXIDATION;GO:0006635;61;-0.3051925;-1.1887422;0.1737649;0.43479982
GO BP;LABYRINTHINE LAYER DEVELOPMENT;GO:0060711;33;-0.34339526;-1.1883316;0.208413;0.43540466
GO BP;SEXUAL REPRODUCTION;GO:0019953;465;-0.23139597;-1.1876357;0.06506365;0.43669012
GO BP;RESPONSE TO INSULIN;GO:0032868;197;-0.25274566;-1.1864672;0.11384615;0.43903515
GO BP;ANOIKIS;GO:0043276;24;-0.37944186;-1.1859473;0.21636364;0.4398681
GO BP;NEGATIVE REGULATION OF CATALYTIC ACTIVITY;GO:0043086;495;-0.22972636;-1.1858917;0.052054796;0.43958914
GO BP;NATURAL KILLER CELL ACTIVATION;GO:0030101;30;-0.35190165;-1.1854621;0.22735675;0.44017228
GO BP;POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:2000379;60;-0.31050903;-1.1853474;0.19587629;0.44005743
GO BP;CELLULAR RESPONSE TO INORGANIC SUBSTANCE;GO:0071241;134;-0.2637583;-1.1852342;0.15576324;0.43991134
GO BP;CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS;GO:0060351;24;-0.3692228;-1.1850749;0.23308271;0.4398967
GO BP;NEURON PROJECTION GUIDANCE;GO:0097485;147;-0.25937715;-1.1846769;0.12850082;0.44046742
GO BP;HIPPOCAMPUS DEVELOPMENT;GO:0021766;50;-0.3176586;-1.1840863;0.20168068;0.44150636
GO BP;REGULATION OF PROTEIN EXPORT FROM NUCLEUS;GO:0046825;34;-0.34663394;-1.1837982;0.19384058;0.44174242
GO BP;REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY;GO:0071900;361;-0.23576702;-1.1837952;0.08794326;0.44134405
GO BP;NEGATIVE REGULATION OF MULTI ORGANISM PROCESS;#N/A;124;-0.27155823;-1.1837245;0.15905245;0.44113538
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS;#N/A;17;-0.40302947;-1.1835302;0.2532833;0.44119653
GO BP;PROTEIN ACYLATION;GO:0043543;198;-0.2486344;-1.1831814;0.12244898;0.44164887
GO BP;CARDIAC SEPTUM DEVELOPMENT;GO:0003279;76;-0.29268733;-1.182884;0.19071311;0.4419211
GO BP;REGULATION OF ALPHA BETA T CELL DIFFERENTIATION;#N/A;34;-0.34327286;-1.1827016;0.2254025;0.44196233
GO BP;CELLULAR RESPONSE TO HORMONE STIMULUS;GO:0032870;451;-0.2309874;-1.1824006;0.083215795;0.44228667
GO BP;HEART VALVE DEVELOPMENT;GO:0003170;41;-0.32716843;-1.1815026;0.21699819;0.44408968
GO BP;HISTONE H4 K5 ACETYLATION;GO:0043981;16;-0.4169033;-1.181406;0.24670433;0.4439235
GO BP;REGULATION OF SMALL MOLECULE METABOLIC PROCESS;#N/A;303;-0.23817927;-1.181352;0.09942363;0.44366598
GO BP;REGULATION OF T CELL DIFFERENTIATION;GO:0045580;67;-0.29821497;-1.1813364;0.19435216;0.44330847
GO BP;RESPONSE TO INTERLEUKIN 4;GO:0070670;23;-0.3737664;-1.1812559;0.25405404;0.44310552
GO BP;POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS;GO:0046827;19;-0.39548823;-1.1804923;0.22794117;0.44458443
GO BP;STEROID BIOSYNTHETIC PROCESS;GO:0006694;140;-0.26434404;-1.1804557;0.1453125;0.44426146
GO BP;POSITIVE REGULATION OF MITOTIC CELL CYCLE;GO:0045931;126;-0.2659775;-1.1798073;0.1664;0.44536203
GO BP;EMBRYONIC ORGAN DEVELOPMENT;GO:0048568;254;-0.24310477;-1.1793607;0.0952381;0.4459956
GO BP;POSITIVE REGULATION OF KINASE ACTIVITY;GO:0033674;394;-0.23335576;-1.1793408;0.07744565;0.44564864
GO BP;REGULATION OF DNA BIOSYNTHETIC PROCESS;GO:2000278;89;-0.28056926;-1.1787388;0.17839608;0.44668254
GO BP;POSITIVE REGULATION OF ION TRANSPORT;GO:0043270;121;-0.26830325;-1.1784443;0.17301588;0.44695014
GO BP;REGULATION OF CENTROSOME DUPLICATION;GO:0010824;39;-0.33279926;-1.1781253;0.21746576;0.44729707
GO BP;ORGANELLE DISASSEMBLY;GO:1903008;85;-0.2821266;-1.1779121;0.1815235;0.4473927
GO BP;POSITIVE CHEMOTAXIS;GO:0050918;23;-0.3724428;-1.177775;0.23853211;0.4473453
GO BP;REGENERATION;#N/A;118;-0.2678157;-1.1776155;0.1699029;0.44729027
GO BP;MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS;GO:1902850;122;-0.26806936;-1.1775095;0.16059603;0.44714677
GO BP;NEGATIVE REGULATION OF ORGANELLE ASSEMBLY;#N/A;33;-0.34278283;-1.1773283;0.23381294;0.44718796
GO BP;NEURAL TUBE FORMATION;GO:0001841;91;-0.2826831;-1.1772517;0.1638796;0.4469825
GO BP;RESPONSE TO INORGANIC SUBSTANCE;GO:0010035;359;-0.23237221;-1.1770823;0.09;0.44700214
GO BP;POSITIVE REGULATION OF CELL DEATH;GO:0010942;479;-0.22626078;-1.1770496;0.07489598;0.44668922
GO BP;CATION TRANSMEMBRANE TRANSPORT;GO:0098655;438;-0.22987717;-1.176883;0.09327846;0.44666505
GO BP;TOR SIGNALING;GO:0031929;96;-0.27767393;-1.176225;0.16260162;0.44785535
GO BP;ERBB2 SIGNALING PATHWAY;GO:0038128;25;-0.3665878;-1.1760304;0.21933086;0.44793662
GO BP;ROOF OF MOUTH DEVELOPMENT;GO:0060021;54;-0.30735004;-1.1756724;0.20100503;0.44837743
GO BP;REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION;GO:0070201;483;-0.22883482;-1.1745198;0.0738255;0.45070514
GO BP;AGING;GO:0007568;224;-0.24893172;-1.1744275;0.13403614;0.4505086
GO BP;CELLULAR LIPID CATABOLIC PROCESS;GO:0044242;157;-0.25535274;-1.174025;0.1583851;0.45106024
GO BP;PEPTIDYL TYROSINE AUTOPHOSPHORYLATION;GO:0038083;21;-0.38456613;-1.1739829;0.2380137;0.45076862
GO BP;POSITIVE REGULATION OF CHROMOSOME SEGREGATION;GO:0051984;27;-0.35865942;-1.1739055;0.23448277;0.4505576
GO BP;REGULATION OF PROTON TRANSPORT;GO:0010155;17;-0.39314222;-1.1721739;0.25095057;0.45435107
GO BP;POLYSACCHARIDE BIOSYNTHETIC PROCESS;GO:0000271;52;-0.30934256;-1.171911;0.22542372;0.45455426
GO BP;REGULATION OF SPINDLE ASSEMBLY;GO:0090169;25;-0.36485857;-1.1717194;0.25581396;0.4546094
GO BP;BLASTOCYST FORMATION;GO:0001825;32;-0.3510162;-1.1717012;0.25;0.4542575
GO BP;REGULATION OF MEIOTIC CELL CYCLE;GO:0051445;33;-0.33839193;-1.1715213;0.24162258;0.45431638
GO BP;REGULATION OF PEPTIDE HORMONE SECRETION;GO:0090276;119;-0.26468316;-1.171138;0.17833333;0.45480046
GO BP;PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY;GO:0001844;24;-0.36892045;-1.1708255;0.23948811;0.45510408
GO BP;LONG TERM MEMORY;GO:0007616;17;-0.40029868;-1.1704429;0.26258993;0.45562485
GO BP;PATTERN SPECIFICATION PROCESS;GO:0007389;230;-0.2438097;-1.1700766;0.116347566;0.4560243
GO BP;HORMONE MEDIATED SIGNALING PATHWAY;GO:0009755;154;-0.25856316;-1.1696486;0.16486903;0.45663384
GO BP;MITOCHONDRION LOCALIZATION;GO:0051646;38;-0.32996154;-1.1695378;0.24573378;0.45648566
GO BP;VESICLE CYTOSKELETAL TRAFFICKING;GO:0099518;44;-0.3144915;-1.1690645;0.22183098;0.4572341
GO BP;LEUKOCYTE MEDIATED IMMUNITY;GO:0002443;464;-0.22834906;-1.1686453;0.091530055;0.45782715
GO BP;SISTER CHROMATID SEGREGATION;GO:0000819;167;-0.24838908;-1.168538;0.14064915;0.45768887
GO BP;RESPONSE TO IRON ION;GO:0010039;24;-0.3638079;-1.1682233;0.2623574;0.45803776
GO BP;REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;GO:0070302;165;-0.25462428;-1.167903;0.15241058;0.45841166
GO BP;REGULATION OF OXIDOREDUCTASE ACTIVITY;GO:0051341;63;-0.29757634;-1.1670539;0.21709402;0.46003014
GO BP;POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY;#N/A;46;-0.31359142;-1.166915;0.20683761;0.45994547
GO BP;NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY;#N/A;28;-0.35769764;-1.1657833;0.24300699;0.46236274
GO BP;REGULATION OF PEPTIDASE ACTIVITY;GO:0052547;252;-0.23975924;-1.1651428;0.12778603;0.4635283
GO BP;RESPONSE TO RADIATION;GO:0009314;308;-0.23585169;-1.1633831;0.125;0.4673282
GO BP;REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY;GO:0061097;51;-0.30706304;-1.1633272;0.20683454;0.46705702
GO BP;RESPONSE TO MANGANESE ION;GO:0010042;15;-0.423114;-1.1632808;0.26164874;0.46677265
GO BP;NEGATIVE REGULATION OF CELL ADHESION;GO:0007162;163;-0.25416803;-1.1631805;0.1486698;0.4666105
GO BP;CELL KILLING;GO:0001906;60;-0.29699656;-1.1629133;0.18353345;0.46685043
GO BP;CARBOHYDRATE TRANSMEMBRANE TRANSPORT;GO:0034219;72;-0.28745094;-1.1623886;0.20735785;0.46771953
GO BP;SOMATIC STEM CELL DIVISION;GO:0048103;16;-0.41567576;-1.1601039;0.2597865;0.47282735
GO BP;STEROL TRANSPORT;GO:0015918;62;-0.29613823;-1.1600147;0.21174377;0.47266275
GO BP;REGULATION OF HORMONE LEVELS;GO:0010817;273;-0.23738642;-1.1593437;0.13343328;0.47393084
GO BP;DNA CATABOLIC PROCESS;GO:0006308;32;-0.34899288;-1.1592977;0.2375;0.47364244
GO BP;ICOSANOID METABOLIC PROCESS;GO:0006690;52;-0.30407375;-1.1591944;0.2347973;0.47349045
GO BP;NUCLEOSOME ORGANIZATION;GO:0034728;137;-0.258462;-1.1590558;0.18789808;0.47343153
GO BP;REGULATION OF MEIOTIC NUCLEAR DIVISION;GO:0040020;17;-0.3957688;-1.1590079;0.26220614;0.47313312
GO BP;CHOLESTEROL EFFLUX;GO:0033344;30;-0.34212357;-1.1588385;0.26206896;0.4731363
GO BP;DOUBLE STRAND BREAK REPAIR;GO:0006302;212;-0.24251825;-1.1586843;0.14069591;0.47311455
GO BP;RENAL SYSTEM VASCULATURE DEVELOPMENT;#N/A;18;-0.39224675;-1.1586777;0.25714287;0.47272947
GO BP;DIGESTIVE SYSTEM DEVELOPMENT;GO:0055123;80;-0.2819035;-1.1584446;0.20757826;0.47286594
GO BP;REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM;#N/A;159;-0.25368673;-1.1577737;0.1622465;0.4741272
GO BP;REGULATION OF IMMUNE EFFECTOR PROCESS;#N/A;210;-0.24405994;-1.157555;0.1497006;0.4742793
GO BP;POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY;GO:0032770;16;-0.40256652;-1.1573756;0.25;0.47424752
GO BP;REGULATION OF DEVELOPMENTAL GROWTH;GO:0048638;198;-0.24777566;-1.1573503;0.16640253;0.47389895
GO BP;FOREBRAIN NEURON DIFFERENTIATION;GO:0021879;22;-0.37293813;-1.157168;0.25233644;0.47394404
GO BP;REGULATION OF STEM CELL PROLIFERATION;GO:0072091;42;-0.3220724;-1.1569219;0.23024055;0.47411975
GO BP;POSITIVE REGULATION OF LIPID METABOLIC PROCESS;GO:0045834;86;-0.27576864;-1.1568952;0.1969178;0.4737754
GO BP;FATTY ACID METABOLIC PROCESS;GO:0006631;253;-0.24102579;-1.1564852;0.13839285;0.47439215
GO BP;REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY;#N/A;17;-0.39363372;-1.1564416;0.2797075;0.47410932
GO BP;POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION;GO:0051495;166;-0.25015396;-1.1562186;0.17563291;0.47425574
GO BP;RESPONSE TO LIGHT STIMULUS;GO:0009416;203;-0.24285325;-1.1559037;0.1710731;0.47460347
GO BP;REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION;#N/A;32;-0.33678162;-1.155693;0.24156305;0.47473723
GO BP;NEGATIVE REGULATION OF HYDROLASE ACTIVITY;GO:0051346;265;-0.23863937;-1.1552517;0.1460177;0.47541615
GO BP;LEUKOCYTE PROLIFERATION;GO:0070661;148;-0.25246292;-1.1549703;0.18649517;0.47566074
GO BP;GLYCEROPHOSPHOLIPID CATABOLIC PROCESS;GO:0046475;16;-0.40136766;-1.1546263;0.292196;0.47613683
GO BP;MITOTIC DNA REPLICATION;GO:1902969;15;-0.4216316;-1.153884;0.27829313;0.4776683
GO BP;THIOESTER METABOLIC PROCESS;#N/A;86;-0.27843454;-1.1536524;0.19491525;0.47781208
GO BP;POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0051057;40;-0.31852853;-1.1528987;0.2329247;0.47918746
GO BP;PHOTOPERIODISM;#N/A;21;-0.3757652;-1.1527113;0.27894738;0.4792502
GO BP;LYMPHOCYTE ACTIVATION;GO:0046649;351;-0.2305786;-1.1525769;0.13857143;0.4792048
GO BP;ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY;GO:0061339;17;-0.40360898;-1.1525393;0.27083334;0.47888565
GO BP;RESPONSE TO TYPE I INTERFERON;GO:0034340;55;-0.29577067;-1.1517987;0.20848057;0.480367
GO BP;CYTOKINE MEDIATED SIGNALING PATHWAY;GO:0019221;412;-0.22588763;-1.1515012;0.11141305;0.48068005
GO BP;EPIDERMIS DEVELOPMENT;GO:0008544;200;-0.24217702;-1.1513048;0.17431192;0.48075327
GO BP;RESPONSE TO ISCHEMIA;GO:0002931;33;-0.3351875;-1.1509899;0.25090253;0.48113385
GO BP;NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY;GO:2000117;60;-0.2933582;-1.1509098;0.23129252;0.48096246
GO BP;PALLIUM DEVELOPMENT;GO:0021543;111;-0.2650165;-1.1508384;0.19480519;0.48072135
GO BP;RESPONSE TO PEPTIDE HORMONE;GO:0043434;291;-0.23443837;-1.150296;0.13980028;0.48158935
GO BP;PEPTIDE HORMONE SECRETION;GO:0030072;144;-0.2549416;-1.1498125;0.19412725;0.48236725
GO BP;LEUKOCYTE CELL CELL ADHESION;GO:0007159;166;-0.24987623;-1.1497686;0.19659443;0.48207718
GO BP;INTERACTION WITH SYMBIONT;GO:0051702;51;-0.30709508;-1.1497442;0.23339012;0.48174182
GO BP;CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION;GO:0021953;89;-0.28035897;-1.1494913;0.19614148;0.48197848
GO BP;REGULATION OF RESPONSE TO CYTOKINE STIMULUS;#N/A;113;-0.26410988;-1.1492065;0.20289855;0.48230836
GO BP;NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS;GO:2000352;18;-0.38915905;-1.1491501;0.27734375;0.482029
GO BP;ADP METABOLIC PROCESS;GO:0046031;96;-0.27222553;-1.1490774;0.21335505;0.4818046
GO BP;REGULATION OF EXTENT OF CELL GROWTH;#N/A;76;-0.27826548;-1.148875;0.23697479;0.48190185
GO BP;FATTY ACID BIOSYNTHETIC PROCESS;GO:0006633;100;-0.2683004;-1.1481276;0.23706177;0.48330447
GO BP;POSITIVE REGULATION OF JNK CASCADE;GO:0046330;92;-0.27452388;-1.1480106;0.21342513;0.48322746
GO BP;TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION;#N/A;79;-0.28544962;-1.1475273;0.1984252;0.48407578
GO BP;NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS;GO:0002683;242;-0.23834303;-1.1473144;0.15671642;0.48425758
GO BP;ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS;GO:0002460;123;-0.2598498;-1.1469758;0.2197615;0.48468933
GO BP;MEMBRANE REPOLARIZATION;GO:0086009;19;-0.37636936;-1.1466614;0.27158272;0.4850719
GO BP;POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS;GO:1901522;18;-0.38842136;-1.146584;0.28774422;0.48482803
GO BP;UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY;GO:0043162;20;-0.37895444;-1.1463345;0.25092936;0.48504338
GO BP;POSITIVE REGULATION OF DENDRITE MORPHOGENESIS;GO:0050775;32;-0.33900166;-1.1454644;0.26050422;0.48676598
GO BP;TISSUE HOMEOSTASIS;GO:0001894;123;-0.259713;-1.1452094;0.21163167;0.48695722
GO BP;MONOVALENT INORGANIC CATION TRANSPORT;GO:0015672;267;-0.23491563;-1.1446669;0.13323353;0.4879322
GO BP;GLUCOSE METABOLIC PROCESS;GO:0006006;157;-0.2514404;-1.1442866;0.1918239;0.48850346
GO BP;REGULATION OF MUSCLE CONTRACTION;GO:0006937;82;-0.27533698;-1.1442547;0.21314387;0.48817676
GO BP;POSITIVE REGULATION OF SYNAPTIC TRANSMISSION;GO:0050806;75;-0.2773699;-1.1440351;0.19584055;0.48835096
GO BP;ORGANELLE FISSION;GO:0048285;363;-0.22622526;-1.143896;0.12732475;0.4883138
GO BP;NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002762;22;-0.37153873;-1.1435853;0.2890909;0.48865747
GO BP;NIK NF KAPPAB SIGNALING;GO:0038061;112;-0.26587248;-1.1433259;0.21111111;0.4888824
GO BP;MACROMOLECULE DEACYLATION;#N/A;85;-0.27429762;-1.1428227;0.22483222;0.48977917
GO BP;POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION;GO:1904951;291;-0.23339948;-1.1422127;0.14389534;0.49091694
GO BP;INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS;GO:0035773;44;-0.31049028;-1.1421242;0.26490065;0.49072722
GO BP;POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION;GO:0001938;54;-0.3014564;-1.1417831;0.2347826;0.49119627
GO BP;BLOOD VESSEL REMODELING;GO:0001974;20;-0.3753095;-1.1416565;0.28725314;0.49110132
GO BP;ACTIN CYTOSKELETON REORGANIZATION;GO:0031532;76;-0.28363633;-1.1411476;0.22479339;0.491988
GO BP;POSITIVE REGULATION OF PEPTIDASE ACTIVITY;GO:0010952;128;-0.25607458;-1.1411022;0.19554849;0.49168876
GO BP;HETEROTYPIC CELL CELL ADHESION;GO:0034113;35;-0.32835317;-1.1404207;0.27068967;0.49296126
GO BP;REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION;GO:0060390;20;-0.36860684;-1.1403486;0.27169812;0.49272323
GO BP;RENAL WATER HOMEOSTASIS;GO:0003091;19;-0.38094756;-1.1401314;0.28235295;0.4928509
GO BP;CEREBRAL CORTEX DEVELOPMENT;GO:0021987;81;-0.27491748;-1.1398687;0.22913256;0.4931377
GO BP;POSITIVE REGULATION OF BONE MINERALIZATION;GO:0030501;20;-0.38517857;-1.1397444;0.25974026;0.4930344
GO BP;PEPTIDE HORMONE PROCESSING;GO:0016486;17;-0.39156726;-1.139366;0.28330207;0.4935384
GO BP;REGULATION OF CELL ACTIVATION;GO:0050865;290;-0.23342612;-1.138695;0.14761215;0.49478647
GO BP;MYELOID LEUKOCYTE MEDIATED IMMUNITY;#N/A;366;-0.2261166;-1.1386425;0.1452514;0.49451888
GO BP;DNA MODIFICATION;GO:0006304;93;-0.2683982;-1.1385912;0.22719449;0.49423975
GO BP;CARBOHYDRATE DERIVATIVE TRANSPORT;#N/A;57;-0.29579833;-1.1385654;0.25211507;0.49391142
GO BP;PROTEIN IMPORT;GO:0017038;152;-0.2532258;-1.1385639;0.21169037;0.49351618
GO BP;CELLULAR RESPONSE TO LIPID;GO:0071396;364;-0.22555216;-1.1377524;0.15239477;0.49514878
GO BP;TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;GO:0007178;216;-0.23862883;-1.1370493;0.19025876;0.49654502
GO BP;NEGATIVE REGULATION OF NEURON DEATH;GO:1901215;133;-0.25518528;-1.1369617;0.20727848;0.49636018
GO BP;POSITIVE REGULATION OF GROWTH;GO:0045927;167;-0.24814843;-1.136602;0.19061583;0.49682936
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION;GO:0045620;27;-0.3529766;-1.1363405;0.29129663;0.49709177
GO BP;RESPONSE TO EXTRACELLULAR STIMULUS;GO:0009991;343;-0.228781;-1.1359379;0.15948276;0.4976622
GO BP;VASCULOGENESIS;GO:0001570;50;-0.30066398;-1.1354808;0.24531516;0.49841097
GO BP;MATERNAL PLACENTA DEVELOPMENT;GO:0001893;26;-0.35594398;-1.135108;0.2870036;0.49888688
GO BP;REGULATION OF GLIAL CELL DIFFERENTIATION;#N/A;35;-0.33434737;-1.1349591;0.26666668;0.49888408
GO BP;VIRAL GENOME REPLICATION;GO:0019079;83;-0.27019975;-1.1344534;0.2358804;0.49975124
GO BP;REGULATION OF PEPTIDYL LYSINE ACETYLATION;#N/A;44;-0.3110139;-1.1339445;0.26223776;0.50065666
GO BP;GLUCOSE CATABOLIC PROCESS;GO:0006007;31;-0.33871242;-1.1338983;0.26408452;0.50038636
GO BP;LIPID CATABOLIC PROCESS;GO:0016042;219;-0.23825002;-1.1338515;0.16740741;0.5001114
GO BP;CELL MATURATION;GO:0048469;90;-0.26845267;-1.1337212;0.2337884;0.5000339
GO BP;REGULATION OF DEPHOSPHORYLATION;GO:0035303;157;-0.24588007;-1.1336906;0.19242902;0.49970132
GO BP;POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS;GO:2001022;80;-0.27257857;-1.1332892;0.2361809;0.5003322
GO BP;GLYCOPROTEIN METABOLIC PROCESS;GO:0009100;271;-0.23217909;-1.1331366;0.16640987;0.5003206
GO BP;REGULATION OF PHOSPHATASE ACTIVITY;GO:0010921;128;-0.25264132;-1.1327509;0.19512194;0.50083154
GO BP;PANCREAS DEVELOPMENT;GO:0031016;47;-0.3060954;-1.1320189;0.25210086;0.5022337
GO BP;POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION;GO:0032735;16;-0.39524326;-1.1311713;0.29281768;0.50391173
GO BP;REGULATION OF CELL PROJECTION ASSEMBLY;GO:0060491;137;-0.25283453;-1.1307849;0.21555915;0.5045
GO BP;NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS;#N/A;55;-0.30185527;-1.130107;0.24866785;0.5057958
GO BP;RESPONSE TO TOXIC SUBSTANCE;GO:0009636;319;-0.22670624;-1.1296741;0.1511976;0.506476
GO BP;PERIPHERAL NERVOUS SYSTEM DEVELOPMENT;GO:0007422;38;-0.31813;-1.1288222;0.2691622;0.50819916
GO BP;TELOMERE ORGANIZATION;GO:0032200;153;-0.24724837;-1.128006;0.20062695;0.50995
GO BP;REGULATION OF ACTIN CYTOSKELETON REORGANIZATION;GO:2000249;27;-0.34880784;-1.1279845;0.27648115;0.5095988
GO BP;POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT;GO:0060999;34;-0.3309136;-1.1276394;0.28648648;0.5100522
GO BP;NEGATIVE REGULATION OF BLOOD PRESSURE;GO:0045776;16;-0.39947248;-1.1273637;0.31616342;0.5103589
GO BP;REGULATION OF SYSTEM PROCESS;#N/A;271;-0.23166403;-1.1272793;0.18075801;0.5101774
GO BP;TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER;GO:0006361;34;-0.33049637;-1.1269505;0.26519337;0.51064587
GO BP;REGULATION OF CALCIUM ION IMPORT;GO:0090279;16;-0.3980003;-1.1267865;0.30535713;0.51065254
GO BP;BETA CATENIN TCF COMPLEX ASSEMBLY;#N/A;27;-0.33968192;-1.1267754;0.30541012;0.51028293
GO BP;T CELL ACTIVATION;GO:0042110;233;-0.23516038;-1.1264541;0.17917305;0.51071566
GO BP;POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION;GO:1903039;105;-0.25842613;-1.1262695;0.21782178;0.5107707
GO BP;BONE MORPHOGENESIS;GO:0060349;62;-0.29262394;-1.1262537;0.24475524;0.5104018
GO BP;POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION;GO:0032743;19;-0.3854262;-1.1252043;0.32867134;0.5126179
GO BP;SECONDARY METABOLITE BIOSYNTHETIC PROCESS;#N/A;15;-0.40290707;-1.124976;0.33390412;0.51277477
GO BP;POSITIVE REGULATION OF MUSCLE CONTRACTION;#N/A;19;-0.36413702;-1.1249726;0.28623852;0.5123796
GO BP;RESPONSE TO PEPTIDE;#N/A;340;-0.22544673;-1.1249679;0.1661721;0.5119932
GO BP;NUCLEAR EXPORT;GO:0051168;183;-0.24137889;-1.1249334;0.20579268;0.51167923
GO BP;REGULATION OF CHOLESTEROL EFFLUX;GO:0010874;18;-0.3832059;-1.1241188;0.29795158;0.5133239
GO BP;ORGANIC ACID CATABOLIC PROCESS;#N/A;209;-0.23745163;-1.1240647;0.19472913;0.5130747
GO BP;CELLULAR RESPONSE TO ESTRADIOL STIMULUS;GO:0071392;20;-0.37685478;-1.1236697;0.30245748;0.5136248
GO BP;HISTONE DEUBIQUITINATION;GO:0016578;21;-0.36686683;-1.1233436;0.31842577;0.51399994
GO BP;POSITIVE REGULATION OF DEVELOPMENTAL GROWTH;GO:0048639;103;-0.26116332;-1.1232879;0.22940226;0.5137353
GO BP;CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC;#N/A;42;-0.31198028;-1.1232159;0.28146854;0.51351833
GO BP;MUSCLE CELL PROLIFERATION;GO:0033002;114;-0.2547361;-1.1226391;0.23015873;0.51461875
GO BP;ALPHA BETA T CELL ACTIVATION;GO:0046631;67;-0.28321427;-1.1222143;0.28067228;0.51528
GO BP;NUCLEOTIDE TRANSPORT;GO:0006862;18;-0.384767;-1.1222119;0.30671507;0.5148833
GO BP;NUCLEAR TRANSPORT;GO:0051169;294;-0.22702411;-1.1218687;0.18417266;0.5153767
GO BP;REGULATION OF MYELINATION;GO:0031641;28;-0.33460787;-1.1218596;0.28947368;0.51500183
GO BP;INOSITOL LIPID MEDIATED SIGNALING;GO:0048017;117;-0.25703365;-1.1208811;0.25;0.5170508
GO BP;POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER;GO:0060261;15;-0.40551838;-1.1208684;0.3216266;0.51668113
GO BP;SENSORY PERCEPTION OF MECHANICAL STIMULUS;GO:0050954;77;-0.27823004;-1.1201586;0.27662957;0.5181343
GO BP;NEGATIVE REGULATION OF DNA REPLICATION;GO:0008156;30;-0.33151305;-1.1200793;0.28494623;0.5179345
GO BP;NEGATIVE REGULATION OF PROTEOLYSIS;GO:0045861;199;-0.23983328;-1.1195711;0.19619326;0.5188014
GO BP;MUSCLE CELL DEVELOPMENT;GO:0055001;100;-0.2642567;-1.1193558;0.2475083;0.51895326
GO BP;MITOTIC NUCLEAR DIVISION;GO:0140014;232;-0.23266701;-1.119255;0.20494185;0.5187983
GO BP;POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS;GO:0120162;61;-0.28595996;-1.1191118;0.28691274;0.5187819
GO BP;REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION;GO:2000142;27;-0.34215075;-1.1190811;0.29528984;0.5184695
GO BP;MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM;#N/A;88;-0.2671155;-1.1190503;0.23913044;0.5181544
GO BP;MYELOID CELL HOMEOSTASIS;GO:0002262;111;-0.25487146;-1.1178674;0.24056605;0.5207697
GO BP;TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY;GO:0007179;128;-0.25158355;-1.1176364;0.22385621;0.5209877
GO BP;ARTERY MORPHOGENESIS;GO:0048844;38;-0.3139194;-1.1175045;0.3090278;0.52088237
GO BP;ENTEROENDOCRINE CELL DIFFERENTIATION;GO:0035883;19;-0.36896303;-1.1174678;0.3057554;0.52058053
GO BP;REGULATION OF MACROAUTOPHAGY;GO:0016241;149;-0.24627374;-1.1173646;0.21507065;0.52046347
GO BP;MYOTUBE CELL DEVELOPMENT;GO:0014904;20;-0.3618451;-1.1171826;0.31514084;0.5204918
GO BP;NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING;#N/A;30;-0.32777196;-1.1170251;0.27758622;0.52049303
GO BP;PHOSPHOLIPID CATABOLIC PROCESS;GO:0009395;30;-0.33490312;-1.1169349;0.29422066;0.52034897
GO BP;RESPONSE TO CORTICOSTEROID;GO:0031960;95;-0.26045945;-1.1160861;0.24796085;0.52212435
GO BP;AXON EXTENSION;GO:0048675;87;-0.26910898;-1.115621;0.26644182;0.5229507
GO BP;REGULATION OF AUTOPHAGY;GO:0010506;264;-0.22957532;-1.1153599;0.20588236;0.5232
GO BP;REGULATION OF GLIOGENESIS;GO:0014013;63;-0.2817888;-1.1151724;0.26086956;0.52329636
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE;GO:0070200;18;-0.37639895;-1.1150486;0.2920354;0.5232297
GO BP;POSITIVE REGULATION OF MEMBRANE PERMEABILITY;GO:1905710;50;-0.2946804;-1.1149535;0.27079645;0.5231003
GO BP;ARACHIDONIC ACID METABOLIC PROCESS;GO:0019369;22;-0.36563674;-1.1148329;0.31150442;0.523023
GO BP;COGNITION;GO:0050890;149;-0.24636711;-1.1144161;0.21406728;0.5236725
GO BP;REGULATION OF PROTEIN CATABOLIC PROCESS;GO:0042176;311;-0.22501326;-1.114375;0.1938326;0.5233813
GO BP;RESPONSE TO CARBOHYDRATE;GO:0009743;157;-0.2440653;-1.1142523;0.24801272;0.5232995
GO BP;SPINDLE ORGANIZATION;GO:0007051;151;-0.24516238;-1.114203;0.240625;0.52303314
GO BP;DEVELOPMENTAL CELL GROWTH;GO:0048588;144;-0.24556491;-1.1137093;0.23510972;0.52387106
GO BP;THYMUS DEVELOPMENT;GO:0048538;31;-0.3292053;-1.1127174;0.3059034;0.52595973
GO BP;NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE;GO:0002820;21;-0.35859793;-1.1120538;0.31382978;0.52727914
GO BP;FACE DEVELOPMENT;GO:0060324;38;-0.3160161;-1.111864;0.2975352;0.5273895
GO BP;INTERFERON BETA PRODUCTION;GO:0032608;40;-0.30590352;-1.1116272;0.30717862;0.52759516
GO BP;FEAR RESPONSE;GO:0042596;18;-0.3809555;-1.1115943;0.3167939;0.5272813
GO BP;NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;#N/A;36;-0.31489903;-1.1114047;0.30103806;0.5273557
GO BP;REGULATION OF DNA REPAIR;GO:0006282;97;-0.2629843;-1.1113776;0.25245902;0.5270265
GO BP;MICROTUBULE ANCHORING;GO:0034453;24;-0.3540802;-1.1110597;0.3079646;0.52742445
GO BP;NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS;GO:0009132;120;-0.25269815;-1.1109357;0.255;0.5273388
GO BP;SPHINGOLIPID METABOLIC PROCESS;GO:0006665;120;-0.2515848;-1.11048;0.22705314;0.5280406
GO BP;NEGATIVE REGULATION OF TRANSPORT;GO:0051051;266;-0.22910099;-1.1097682;0.1908284;0.5294017
GO BP;RESPONSE TO MISFOLDED PROTEIN;GO:0051788;23;-0.35440278;-1.109677;0.32976827;0.52924174
GO BP;CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY;GO:0033962;19;-0.36458486;-1.1096352;0.31034482;0.52896446
GO BP;POSTSYNAPSE ORGANIZATION;GO:0099173;95;-0.26299366;-1.1094441;0.2629032;0.52904207
GO BP;ORGANIC ANION TRANSPORT;GO:0015711;296;-0.22701703;-1.1093688;0.2122571;0.5288339
GO BP;REGULATION OF PROTEIN MATURATION;#N/A;47;-0.3041985;-1.1092002;0.29946524;0.52887833
GO BP;POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY;GO:0071902;233;-0.23087992;-1.109184;0.21637426;0.52853304
GO BP;NEGATIVE REGULATION OF DEPHOSPHORYLATION;GO:0035305;83;-0.26700294;-1.1091584;0.26256078;0.5282077
GO BP;REGULATION OF B CELL PROLIFERATION;GO:0030888;34;-0.31479362;-1.1089743;0.30569947;0.52828765
GO BP;POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION;#N/A;30;-0.32734498;-1.1087722;0.29818183;0.5283864
GO BP;REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION;GO:0045601;18;-0.38524994;-1.1087095;0.3153153;0.52814233
GO BP;POSITIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION;#N/A;21;-0.36583367;-1.1086117;0.32136446;0.52801234
GO BP;REGULATION OF B CELL DIFFERENTIATION;GO:0045577;20;-0.3688479;-1.1084224;0.3003663;0.5281276
GO BP;REGULATION OF DENDRITIC SPINE MORPHOGENESIS;GO:0061001;32;-0.32464078;-1.1081907;0.30018082;0.5282973
GO BP;ALCOHOL BIOSYNTHETIC PROCESS;#N/A;125;-0.25113565;-1.1081251;0.2652733;0.528059
GO BP;POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903052;101;-0.26023212;-1.1081076;0.24879615;0.5276999
GO BP;RESPONSE TO CHEMOKINE;#N/A;21;-0.36302266;-1.1073976;0.31296295;0.52912056
GO BP;POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0043243;24;-0.34896353;-1.1073601;0.29307282;0.52882427
GO BP;MAMMARY GLAND EPITHELIUM DEVELOPMENT;GO:0061180;46;-0.30146557;-1.1066977;0.31499052;0.53009856
GO BP;REGULATION OF PROTEIN POLYMERIZATION;#N/A;156;-0.24215426;-1.1065624;0.22152886;0.5300619
GO BP;REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS;GO:0090049;27;-0.3358913;-1.1052427;0.3180212;0.5330996
GO BP;POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION;GO:0045669;39;-0.30974826;-1.1048843;0.30054644;0.5336259
GO BP;SMALL MOLECULE CATABOLIC PROCESS;#N/A;323;-0.2195106;-1.1048257;0.21367522;0.5333992
GO BP;NEGATIVE REGULATION OF CELL MOTILITY;GO:2000146;162;-0.23828602;-1.1047499;0.24090908;0.53322375
GO BP;MONOSACCHARIDE METABOLIC PROCESS;GO:0005996;210;-0.23204578;-1.1045892;0.22829582;0.5332189
GO BP;POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH;GO:0040018;16;-0.39293823;-1.1044952;0.34229392;0.533063
GO BP;POSITIVE REGULATION OF MACROAUTOPHAGY;GO:0016239;57;-0.28478295;-1.1043713;0.27561837;0.53295416
GO BP;METAL ION HOMEOSTASIS;GO:0055065;321;-0.22213003;-1.1043658;0.20694445;0.5325743
GO BP;REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS;GO:0017158;25;-0.3409171;-1.1043347;0.31501833;0.53225267
GO BP;REGULATION OF DNA DAMAGE CHECKPOINT;GO:2000001;16;-0.39116117;-1.1040103;0.3283582;0.5327395
GO BP;REGULATION OF DENDRITIC SPINE DEVELOPMENT;GO:0060998;57;-0.2874029;-1.1037937;0.28042328;0.5329221
GO BP;PROTEIN DEMETHYLATION;GO:0006482;25;-0.3419389;-1.1036747;0.31203008;0.53281945
GO BP;CELLULAR RESPONSE TO ANTIBIOTIC;GO:0071236;101;-0.26076305;-1.1036364;0.2714055;0.53252196
GO BP;REGULATION OF EMBRYONIC DEVELOPMENT;GO:0045995;93;-0.2622507;-1.1036117;0.26547232;0.5321893
GO BP;HEART PROCESS;GO:0003015;136;-0.244722;-1.1028874;0.2612903;0.5336178
GO BP;MACROPHAGE DIFFERENTIATION;GO:0030225;26;-0.34050855;-1.1028342;0.3074074;0.53335387
GO BP;INNATE IMMUNE RESPONSE;GO:0045087;486;-0.21428058;-1.1019247;0.16826266;0.53534347
GO BP;LEFT RIGHT PATTERN FORMATION;GO:0060972;17;-0.380837;-1.10172;0.3646409;0.5354827
GO BP;MOLTING CYCLE;#N/A;66;-0.2795332;-1.1009064;0.31764707;0.5371326
GO BP;POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903364;120;-0.25498956;-1.1008195;0.25496688;0.53697056
GO BP;ESTABLISHMENT OF ORGANELLE LOCALIZATION;GO:0051656;329;-0.22067283;-1.1007913;0.2087447;0.5366515
GO BP;REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY;GO:0007176;22;-0.3527925;-1.1005036;0.31628788;0.53699064
GO BP;ASTROCYTE DIFFERENTIATION;GO:0048708;38;-0.3092637;-1.1004933;0.32330826;0.5366283
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR;GO:0072332;64;-0.27950746;-1.099779;0.30717862;0.53803396
GO BP;POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING;GO:0051897;88;-0.26354495;-1.0997294;0.24707846;0.53776556
GO BP;CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT;GO:0021680;18;-0.38510585;-1.0995389;0.3258427;0.5378674
GO BP;REGULATION OF DEFENSE RESPONSE;#N/A;424;-0.21541855;-1.0993916;0.18053597;0.5378421
GO BP;PROTEIN POLYMERIZATION;GO:0051258;203;-0.2309281;-1.0990942;0.23787878;0.5382204
GO BP;REGULATION OF MEGAKARYOCYTE DIFFERENTIATION;GO:0045652;56;-0.28018767;-1.098935;0.29401994;0.5382363
GO BP;AORTA MORPHOGENESIS;GO:0035909;20;-0.3650819;-1.0988777;0.32264152;0.53799427
GO BP;INTRACELLULAR STEROL TRANSPORT;GO:0032366;21;-0.35703376;-1.0982594;0.33989266;0.5392334
GO BP;MUSCLE HYPERTROPHY;GO:0014896;57;-0.28478515;-1.097876;0.3107639;0.53981835
GO BP;CELLULAR RESPONSE TO XENOBIOTIC STIMULUS;GO:0071466;96;-0.2599007;-1.0972575;0.2847571;0.5410555
GO BP;REGULATION OF CELL CYCLE G1 S PHASE TRANSITION;GO:1902806;136;-0.24492215;-1.0971967;0.24409449;0.54080206
GO BP;POSITIVE REGULATION OF BIOMINERALIZATION;GO:0110151;24;-0.34708443;-1.0969902;0.29891303;0.54097986
GO BP;BONE CELL DEVELOPMENT;#N/A;21;-0.3648556;-1.096967;0.34545454;0.5406549
GO BP;POSITIVE REGULATION OF CELL CELL ADHESION;GO:0022409;134;-0.24672084;-1.096906;0.26634768;0.5404169
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION;GO:0010633;44;-0.30162734;-1.0962647;0.30677965;0.54169416
GO BP;RESPONSE TO XENOBIOTIC STIMULUS;GO:0009410;155;-0.24260838;-1.0960236;0.26817447;0.5419316
GO BP;EMBRYONIC CAMERA TYPE EYE DEVELOPMENT;GO:0031076;19;-0.36427364;-1.0959448;0.31809524;0.54175305
GO BP;RESPONSE TO ANTIBIOTIC;GO:0046677;211;-0.23135173;-1.095515;0.25567323;0.5424934
GO BP;CELLULAR DEFENSE RESPONSE;GO:0006968;15;-0.39972815;-1.0945692;0.34;0.5445369
GO BP;N TERMINAL PROTEIN AMINO ACID MODIFICATION;GO:0031365;24;-0.3476154;-1.094329;0.3179396;0.5447528
GO BP;POSITIVE REGULATION OF MAPK CASCADE;GO:0043410;313;-0.222056;-1.0942857;0.2395693;0.544458
GO BP;NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS;#N/A;193;-0.23527628;-1.0934666;0.2678843;0.54614764
GO BP;DIVALENT INORGANIC CATION TRANSPORT;#N/A;247;-0.2252925;-1.0932238;0.23802395;0.54638
GO BP;REGULATION OF BINDING;GO:0051098;265;-0.22330636;-1.0930433;0.21681416;0.5464938
GO BP;REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY;GO:0050856;23;-0.34916633;-1.0930188;0.323049;0.54616314
GO BP;NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY;GO:0071901;101;-0.2547471;-1.0929852;0.27786753;0.54586715
GO BP;FIBRINOLYSIS;GO:0042730;18;-0.37713945;-1.0926619;0.32156134;0.54627043
GO BP;REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA;GO:0090199;37;-0.30902582;-1.0925825;0.32347825;0.5460857
GO BP;CELLULAR CARBOHYDRATE CATABOLIC PROCESS;#N/A;35;-0.31400168;-1.0919628;0.33507854;0.5472937
GO BP;POSITIVE REGULATION OF FAT CELL DIFFERENTIATION;GO:0045600;42;-0.30251884;-1.0918412;0.30141845;0.547194
GO BP;POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION;GO:1903599;18;-0.37389585;-1.0915695;0.33639705;0.5475047
GO BP;REGULATION OF GASTRULATION;GO:0010470;28;-0.32737157;-1.0915532;0.32740214;0.54715055
GO BP;REGULATION OF MYELOID CELL DIFFERENTIATION;GO:0045637;157;-0.23675533;-1.0910152;0.2689211;0.54816043
GO BP;RESPONSE TO IONIZING RADIATION;GO:0010212;124;-0.24713807;-1.0907626;0.2730159;0.5484229
GO BP;MAMMARY GLAND EPITHELIAL CELL PROLIFERATION;GO:0033598;23;-0.34668094;-1.090077;0.32976827;0.54980564
GO BP;TRANSITION METAL ION HOMEOSTASIS;#N/A;93;-0.2610477;-1.0893676;0.29402262;0.55123085
GO BP;EAR DEVELOPMENT;GO:0043583;114;-0.25111616;-1.0889037;0.2976;0.5520905
GO BP;OSTEOBLAST PROLIFERATION;GO:0033687;16;-0.3753479;-1.0888026;0.35036495;0.551958
GO BP;VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION;GO:1904738;16;-0.38066462;-1.0870465;0.34644195;0.55608165
GO BP;NEGATIVE REGULATION OF LOCOMOTION;GO:0040013;195;-0.23097529;-1.0861214;0.25965998;0.5580782
GO BP;TRANSITION METAL ION TRANSPORT;#N/A;91;-0.26103547;-1.0859736;0.31438127;0.5581079
GO BP;ERK1 AND ERK2 CASCADE;GO:0070371;162;-0.23888978;-1.0859076;0.29057187;0.55787396
GO BP;MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL;GO:0098815;18;-0.3750205;-1.0856069;0.3382353;0.55833536
GO BP;REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE;GO:0000083;24;-0.34197646;-1.0854917;0.34463277;0.558216
GO BP;T CELL MEDIATED IMMUNITY;GO:0002456;46;-0.294986;-1.0839794;0.3402778;0.5616072
GO BP;MOLTING CYCLE PROCESS;#N/A;55;-0.28690916;-1.0838405;0.3237288;0.561567
GO BP;POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002763;30;-0.31979692;-1.0837572;0.3471223;0.5613892
GO BP;REGULATION OF TRANSLATION IN RESPONSE TO STRESS;#N/A;15;-0.3750723;-1.0833522;0.35231316;0.5620097
GO BP;WALKING BEHAVIOR;GO:0090659;16;-0.3757578;-1.083005;0.3544776;0.56255424
GO BP;ORGANIC ACID TRANSMEMBRANE TRANSPORT;GO:1903825;87;-0.26322722;-1.0823954;0.30313015;0.5637918
GO BP;RESPONSE TO AMINO ACID STARVATION;#N/A;42;-0.29212147;-1.0821358;0.33739132;0.5640517
GO BP;AXO DENDRITIC TRANSPORT;GO:0008088;53;-0.2843519;-1.0817188;0.3291592;0.56480104
GO BP;RESPONSE TO MURAMYL DIPEPTIDE;GO:0032495;15;-0.39461046;-1.0812583;0.34402853;0.5656515
GO BP;MUSCLE ADAPTATION;#N/A;69;-0.26960868;-1.081104;0.29895106;0.5656429
GO BP;SOMITE DEVELOPMENT;GO:0061053;47;-0.29452264;-1.0806509;0.32561985;0.5664462
GO BP;TRANSCRIPTION BY RNA POLYMERASE III;GO:0006383;47;-0.2936996;-1.0805117;0.3251318;0.56643647
GO BP;EXTRACELLULAR MATRIX DISASSEMBLY;GO:0022617;49;-0.29020566;-1.0800086;0.33161512;0.5674235
GO BP;ENDOCRINE HORMONE SECRETION;#N/A;20;-0.36005604;-1.0799563;0.34798536;0.5671508
GO BP;DNA INTEGRITY CHECKPOINT;#N/A;145;-0.23815282;-1.079882;0.2944882;0.5669422
GO BP;RESPONSE TO INTERFERON GAMMA;GO:0034341;100;-0.2559563;-1.0796916;0.28756058;0.56706136
GO BP;B CELL HOMEOSTASIS;GO:0001782;19;-0.3633927;-1.0796883;0.35283992;0.56667805
GO BP;SENSORY PERCEPTION OF PAIN;GO:0019233;36;-0.30959767;-1.0796709;0.32021466;0.5663372
GO BP;PROTEIN STABILIZATION;GO:0050821;151;-0.23873036;-1.0789773;0.28615862;0.56767756
GO BP;ORGANELLE TRANSPORT ALONG MICROTUBULE;GO:0072384;68;-0.26975933;-1.078491;0.33955857;0.5685871
GO BP;REGULATION OF CHONDROCYTE DIFFERENTIATION;GO:0032330;25;-0.33809462;-1.0784883;0.342155;0.5681965
GO BP;DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION;GO:0050906;27;-0.32728204;-1.0781528;0.33333334;0.5686661
GO BP;NEGATIVE REGULATION OF MAPK CASCADE;GO:0043409;115;-0.24821788;-1.0771801;0.3105691;0.57085043
GO BP;POSITIVE REGULATION OF VIRAL TRANSCRIPTION;GO:0050434;39;-0.29787147;-1.0768327;0.3602941;0.5713481
GO BP;FATTY ACID CATABOLIC PROCESS;GO:0009062;83;-0.26065683;-1.0768011;0.31206897;0.5710355
GO BP;G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007186;308;-0.21915555;-1.076399;0.27132866;0.57170665
GO BP;POSITIVE REGULATION OF NEURON DEATH;GO:1901216;70;-0.26957127;-1.0762786;0.31840795;0.571605
GO BP;CELLULAR TRANSITION METAL ION HOMEOSTASIS;#N/A;76;-0.26353413;-1.0759248;0.31669536;0.5721546
GO BP;CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND;GO:0071407;374;-0.2131985;-1.0756247;0.2716593;0.57254577
GO BP;POSITIVE REGULATION OF PROTEIN IMPORT;GO:1904591;33;-0.3190963;-1.0754896;0.3714789;0.5725043
GO BP;EMBRYONIC PLACENTA DEVELOPMENT;GO:0001892;66;-0.27064884;-1.0754405;0.31786942;0.57223207
GO BP;MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS;#N/A;144;-0.2382659;-1.0747272;0.31308413;0.5737485
GO BP;POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS;#N/A;79;-0.26110098;-1.0745264;0.32554257;0.57388574
GO BP;NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT;GO:0032387;41;-0.2978197;-1.0743942;0.3246528;0.5738464
GO BP;REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY;GO:0060338;29;-0.32079786;-1.0742687;0.35614035;0.57377917
GO BP;RESPONSE TO INCREASED OXYGEN LEVELS;#N/A;23;-0.33562604;-1.0740763;0.358047;0.57386684
GO BP;REGULATION OF VIRAL TRANSCRIPTION;GO:0046782;56;-0.27947247;-1.0735295;0.33277026;0.57496125
GO BP;CYTOKINESIS;#N/A;134;-0.23959069;-1.0731332;0.29107982;0.5756086
GO BP;GRANULOCYTE DIFFERENTIATION;GO:0030851;18;-0.3673116;-1.0730711;0.3633157;0.57539845
GO BP;POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION;#N/A;46;-0.28588504;-1.0726011;0.34146342;0.5762644
GO BP;GLYCEROLIPID METABOLIC PROCESS;GO:0046486;299;-0.21895021;-1.0720186;0.25663716;0.5773799
GO BP;OSTEOCLAST DIFFERENTIATION;GO:0030316;53;-0.28379115;-1.072;0.33152175;0.5770302
GO BP;REGULATION OF CYCLASE ACTIVITY;GO:0031279;15;-0.3915699;-1.0718979;0.36678833;0.5768619
GO BP;RESPONSE TO TESTOSTERONE;GO:0033574;26;-0.3343698;-1.0713189;0.36878216;0.57796586
GO BP;SPECIFICATION OF SYMMETRY;#N/A;85;-0.25734922;-1.0707004;0.31893688;0.5792089
GO BP;PROTEIN HOMOTETRAMERIZATION;GO:0051289;60;-0.27592698;-1.0704945;0.33507854;0.5793802
GO BP;REGULATION OF ANOIKIS;GO:2000209;15;-0.3871835;-1.0703393;0.3798165;0.5794198
GO BP;CELL DIVISION;GO:0051301;488;-0.20786807;-1.0700277;0.2351314;0.5798805
GO BP;RELEASE OF CYTOCHROME C FROM MITOCHONDRIA;GO:0001836;45;-0.28859034;-1.0700188;0.34079173;0.579512
GO BP;PROTEIN CONTAINING COMPLEX LOCALIZATION;GO:0031503;235;-0.22405642;-1.0700128;0.29907975;0.579126
GO BP;NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION;GO:1902807;86;-0.25629884;-1.0684085;0.32371795;0.5829967
GO BP;NEGATIVE REGULATION OF T CELL DIFFERENTIATION;GO:0045581;22;-0.3488459;-1.0683947;0.38122606;0.58262676
GO BP;GASTRULATION;GO:0007369;122;-0.24082182;-1.0682619;0.33692306;0.58255297
GO BP;POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY;GO:0061098;29;-0.31964126;-1.068099;0.3614035;0.58259225
GO BP;XENOBIOTIC METABOLIC PROCESS;GO:0006805;56;-0.27721667;-1.0676231;0.36593592;0.5833928
GO BP;NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION;GO:0045638;52;-0.2872717;-1.0671773;0.3378608;0.5842072
GO BP;NEGATIVE REGULATION OF KINASE ACTIVITY;GO:0033673;180;-0.22976007;-1.0671326;0.3069909;0.5839336
GO BP;LYMPHOCYTE MEDIATED IMMUNITY;#N/A;116;-0.24488361;-1.0667853;0.3261944;0.5844511
GO BP;PROTEIN REFOLDING;GO:0042026;29;-0.31916735;-1.0661908;0.36944938;0.585621
GO BP;CELLULAR RESPONSE TO AMYLOID BETA;GO:1904646;22;-0.3458572;-1.0659376;0.39107144;0.5858729
GO BP;ALCOHOL METABOLIC PROCESS;#N/A;244;-0.21953827;-1.0656382;0.29749632;0.5862815
GO BP;CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS;GO:1901137;476;-0.20471331;-1.0655658;0.24590164;0.5860799
GO BP;REGULATION OF OSTEOBLAST DIFFERENTIATION;GO:0045667;70;-0.2651749;-1.0653664;0.3590164;0.58621323
GO BP;POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY;GO:0051353;37;-0.3062545;-1.0648472;0.35775128;0.58713317
GO BP;LIPID TRANSLOCATION;GO:0034204;26;-0.33233243;-1.0646851;0.3575419;0.58715975
GO BP;NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND;#N/A;17;-0.3662237;-1.064552;0.37659964;0.5871075
GO BP;DIVALENT INORGANIC CATION HOMEOSTASIS;GO:0072507;223;-0.2222598;-1.0644449;0.2943787;0.5869796
GO BP;REGULATION OF T CELL MEDIATED IMMUNITY;#N/A;29;-0.31621534;-1.0641958;0.3690909;0.58723545
GO BP;ANION TRANSPORT;GO:0006820;366;-0.21268275;-1.0622513;0.29320112;0.59194916
GO BP;POSITIVE REGULATION OF PROTEIN BINDING;GO:0032092;72;-0.2673482;-1.0618865;0.33394834;0.5924957
GO BP;RESPONSE TO METAL ION;GO:0010038;230;-0.22080153;-1.061721;0.31407407;0.59251946
GO BP;FAT SOLUBLE VITAMIN METABOLIC PROCESS;#N/A;19;-0.3531159;-1.0615299;0.35571688;0.59262955
GO BP;DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION;#N/A;17;-0.36544463;-1.0614297;0.40347826;0.59251326
GO BP;REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT;#N/A;15;-0.37867197;-1.0612228;0.39177102;0.5926653
GO BP;REGULATION OF MAP KINASE ACTIVITY;GO:0043405;226;-0.220537;-1.0609035;0.29104477;0.59312403
GO BP;POLARIZED EPITHELIAL CELL DIFFERENTIATION;GO:0030859;15;-0.3759194;-1.0600382;0.38162544;0.5951197
GO BP;FAT CELL DIFFERENTIATION;GO:0045444;139;-0.2351083;-1.059572;0.33225283;0.5959858
GO BP;ACTIVATION OF IMMUNE RESPONSE;GO:0002253;355;-0.21065663;-1.0595318;0.30758226;0.5956841
GO BP;RESPONSE TO UV;GO:0009411;116;-0.24360438;-1.0594928;0.3328;0.59537965
GO BP;REGULATION OF SECRETION;GO:0051046;428;-0.20751086;-1.0583214;0.2805049;0.5981237
GO BP;CELLULAR RESPONSE TO OXYGEN LEVELS;GO:0071453;172;-0.22805661;-1.0582951;0.3216;0.5977892
GO BP;CELL FATE COMMITMENT;GO:0045165;110;-0.2472515;-1.0575889;0.34380165;0.59928554
GO BP;ACYLGLYCEROL HOMEOSTASIS;GO:0055090;18;-0.36252156;-1.0573325;0.3812825;0.59956723
GO BP;REGULATION OF CELL DIVISION;GO:0051302;112;-0.24134104;-1.0566559;0.33441558;0.601022
GO BP;CELLULAR RESPONSE TO STEROID HORMONE STIMULUS;GO:0071383;172;-0.22803919;-1.0566131;0.32329637;0.6007285
GO BP;DNA TEMPLATED TRANSCRIPTION INITIATION;GO:0006352;197;-0.22484577;-1.0563545;0.32824427;0.6010399
GO BP;ALPHA AMINO ACID METABOLIC PROCESS;GO:1901605;145;-0.2337946;-1.0562457;0.33280757;0.6009474
GO BP;NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS;#N/A;35;-0.30473837;-1.056023;0.3809524;0.6011542
GO BP;PROTEIN COMPLEX OLIGOMERIZATION;GO:0051259;324;-0.21367666;-1.0554656;0.31259045;0.60227066
GO BP;POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION;GO:1903955;25;-0.32575095;-1.0554551;0.37294334;0.60189545
GO BP;NEGATIVE REGULATION OF CATABOLIC PROCESS;GO:0009895;224;-0.22101916;-1.0547351;0.33028919;0.603354
GO BP;POSITIVE REGULATION OF INSULIN SECRETION;GO:0032024;44;-0.2910003;-1.0546075;0.36379927;0.6032864
GO BP;REGULATION OF FAT CELL DIFFERENTIATION;GO:0045598;81;-0.2584794;-1.0537173;0.34053156;0.60538876
GO BP;INTERFERON GAMMA MEDIATED SIGNALING PATHWAY;GO:0060333;46;-0.28611982;-1.053668;0.37457627;0.60511756
GO BP;PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION;#N/A;226;-0.22209235;-1.0536333;0.34036145;0.60481524
GO BP;INTERFERON ALPHA PRODUCTION;GO:0032607;20;-0.35115656;-1.0536054;0.38979962;0.6045075
GO BP;NEURON PROJECTION ARBORIZATION;GO:0140058;18;-0.362342;-1.0535172;0.38086304;0.6043408
GO BP;REGULATION OF RESPONSE TO OXIDATIVE STRESS;GO:1902882;61;-0.2707845;-1.0534735;0.38250428;0.6040643
GO BP;G2 DNA DAMAGE CHECKPOINT;#N/A;27;-0.32095793;-1.0531169;0.39605734;0.60460407
GO BP;ORGANOPHOSPHATE ESTER TRANSPORT;#N/A;83;-0.25959724;-1.0529053;0.35785952;0.6047691
GO BP;PROTEIN MONOUBIQUITINATION;GO:0006513;66;-0.268538;-1.0524805;0.37088388;0.6054949
GO BP;CHROMOSOME SEGREGATION;GO:0007059;275;-0.21366678;-1.0524026;0.3283582;0.6053085
GO BP;CALCIUM ION REGULATED EXOCYTOSIS;GO:0017156;39;-0.29314405;-1.0522956;0.3846154;0.6051831
GO BP;DNA CONFORMATION CHANGE;GO:0071103;257;-0.2172533;-1.0521427;0.31277534;0.6051648
GO BP;REGULATION OF VESICLE MEDIATED TRANSPORT;GO:0060627;355;-0.21049033;-1.0515771;0.31204644;0.60625976
GO BP;PROTEIN O LINKED MANNOSYLATION;GO:0035269;18;-0.36377868;-1.0512967;0.3715342;0.60662854
GO BP;POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION;GO:0002639;21;-0.34488797;-1.0508128;0.3889943;0.6075623
GO BP;ORGANIC HYDROXY COMPOUND METABOLIC PROCESS;#N/A;333;-0.21149558;-1.0503476;0.3499268;0.6084522
GO BP;STEROID HORMONE MEDIATED SIGNALING PATHWAY;GO:0043401;134;-0.23623537;-1.0502653;0.35085008;0.60825104
GO BP;CLATHRIN DEPENDENT ENDOCYTOSIS;GO:0072583;37;-0.29831117;-1.0500728;0.3853211;0.6083647
GO BP;SOMITOGENESIS;GO:0001756;35;-0.2982529;-1.0490429;0.3970856;0.61067456
GO BP;ORGANIC ACID TRANSPORT;#N/A;191;-0.22398202;-1.0486385;0.34597155;0.61131346
GO BP;REGULATION OF MEMBRANE PERMEABILITY;GO:0090559;65;-0.26565233;-1.0482571;0.37696335;0.61194056
GO BP;CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS;#N/A;38;-0.29832175;-1.0480945;0.38327527;0.61198056
GO BP;NEGATIVE REGULATION OF INFLAMMATORY RESPONSE;GO:0050728;73;-0.25900334;-1.0478755;0.38142622;0.61215067
GO BP;PROSTANOID METABOLIC PROCESS;#N/A;25;-0.3307549;-1.0478407;0.4021164;0.61184204
GO BP;MRNA TRANSCRIPTION;GO:0009299;20;-0.3550057;-1.0477322;0.39329806;0.6117246
GO BP;FATTY ACID TRANSPORT;GO:0015908;60;-0.2661177;-1.0475953;0.35215947;0.6116659
GO BP;RESPONSE TO AMMONIUM ION;#N/A;85;-0.24772558;-1.047415;0.35157546;0.61174494
GO BP;PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING;GO:0036152;15;-0.37295255;-1.04721;0.4039146;0.6119157
GO BP;REGULATION OF DENDRITE MORPHOGENESIS;GO:0048814;65;-0.26354727;-1.0469823;0.36227044;0.6121302
GO BP;DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM;GO:0050829;21;-0.34137326;-1.0465473;0.40867993;0.6129648
GO BP;POSITIVE REGULATION OF TRANSLATIONAL INITIATION;GO:0045948;21;-0.33809492;-1.0465231;0.3970856;0.61262673
GO BP;VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0003229;35;-0.29863706;-1.0463679;0.3754717;0.6126442
GO BP;NEGATIVE REGULATION OF AUTOPHAGY;GO:0010507;62;-0.268711;-1.0461373;0.36764705;0.61286134
GO BP;NEGATIVE REGULATION OF BMP SIGNALING PATHWAY;GO:0030514;28;-0.3114616;-1.0461094;0.38652483;0.61254585
GO BP;CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS;#N/A;16;-0.3686457;-1.045687;0.38404453;0.6132636
GO BP;MEIOTIC CELL CYCLE PROCESS;#N/A;134;-0.23414072;-1.0447943;0.35691825;0.6152399
GO BP;INORGANIC ION TRANSMEMBRANE TRANSPORT;#N/A;431;-0.20358884;-1.0440695;0.3328823;0.6168007
GO BP;REGULATION OF CHROMOSOME SEGREGATION;GO:0051983;93;-0.24989918;-1.044047;0.39314845;0.6164532
GO BP;RESPONSE TO BACTERIUM;GO:0009617;295;-0.20956455;-1.043446;0.35209236;0.6176811
GO BP;REGULATION OF CELL CELL ADHESION;GO:0022407;222;-0.21848674;-1.0418104;0.35768646;0.62165123
GO BP;NEGATIVE REGULATION OF DNA RECOMBINATION;GO:0045910;36;-0.29526246;-1.0417876;0.39019963;0.621302
GO BP;CHLORIDE TRANSPORT;GO:0006821;49;-0.2771164;-1.0412806;0.3614035;0.6223138
GO BP;LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS;#N/A;19;-0.34725893;-1.0411589;0.39488116;0.6222656
GO BP;REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS;GO:1902108;48;-0.27388677;-1.0411074;0.3892857;0.62201166
GO BP;TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY;GO:0033209;107;-0.2389064;-1.0409653;0.35930046;0.6220137
GO BP;RESPONSE TO MOLECULE OF BACTERIAL ORIGIN;GO:0002237;179;-0.22531593;-1.0409015;0.35787922;0.6217768
GO BP;CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;GO:0035710;44;-0.28466666;-1.0408319;0.39208633;0.6215606
GO BP;POSITIVE REGULATION OF CELL ACTIVATION;#N/A;166;-0.22734828;-1.0403577;0.35916543;0.62241876
GO BP;GLANDULAR EPITHELIAL CELL DEVELOPMENT;GO:0002068;18;-0.3537403;-1.0403395;0.4148148;0.62207234
GO BP;LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE;GO:0034383;29;-0.31103396;-1.0399402;0.3834197;0.6227532
GO BP;ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT;GO:0006888;166;-0.2239495;-1.0397657;0.35714287;0.62282276
GO BP;CELLULAR RESPONSE TO UV;GO:0034644;66;-0.25895956;-1.0392433;0.3936;0.62382674
GO BP;DEMETHYLATION;GO:0070988;46;-0.28361732;-1.0390224;0.38351256;0.62402815
GO BP;B CELL ACTIVATION;GO:0042113;138;-0.23176861;-1.0389687;0.35387045;0.62379164
GO BP;HUMORAL IMMUNE RESPONSE;GO:0006959;82;-0.25162986;-1.0386757;0.39256865;0.62420356
GO BP;METENCEPHALON DEVELOPMENT;GO:0022037;65;-0.26450357;-1.0384357;0.3762712;0.6244132
GO BP;RESPONSE TO VIRUS;GO:0009615;195;-0.22216733;-1.0383162;0.3761468;0.6243457
GO BP;REGULATION OF PROTEIN SUMOYLATION;GO:0033233;16;-0.36592948;-1.038258;0.41020793;0.6240939
GO BP;CELLULAR ION HOMEOSTASIS;GO:0006873;335;-0.20771085;-1.0382056;0.35235378;0.6238403
GO BP;MUSCLE CELL CELLULAR HOMEOSTASIS;GO:0046716;15;-0.37572384;-1.0379838;0.41651377;0.6240191
GO BP;TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY;GO:0034142;21;-0.3422649;-1.0375701;0.42124543;0.62479246
GO BP;NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS;#N/A;203;-0.22187716;-1.0372548;0.3611111;0.62523127
GO BP;POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING;GO:0050850;20;-0.34025058;-1.0372148;0.3973384;0.62494874
GO BP;NEGATIVE REGULATION OF PEPTIDASE ACTIVITY;GO:0010466;124;-0.23395349;-1.0370013;0.39490446;0.625102
GO BP;NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS;#N/A;63;-0.26482183;-1.0368302;0.37815127;0.6251499
GO BP;DNA GEOMETRIC CHANGE;GO:0032392;105;-0.24279124;-1.0368218;0.37896493;0.62477887
GO BP;REGULATION OF MEMBRANE LIPID DISTRIBUTION;GO:0097035;31;-0.31058967;-1.0349746;0.41852486;0.6292923
GO BP;GLANDULAR EPITHELIAL CELL DIFFERENTIATION;GO:0002067;28;-0.322937;-1.0342599;0.4188192;0.63078237
GO BP;REGULATION OF FATTY ACID METABOLIC PROCESS;GO:0019217;61;-0.26709265;-1.0341312;0.40308747;0.6306969
GO BP;POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA;GO:0090200;24;-0.32195714;-1.0339491;0.406518;0.630819
GO BP;SPROUTING ANGIOGENESIS;GO:0002040;76;-0.25374603;-1.0334278;0.38196722;0.6318109
GO BP;ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY;GO:0007163;170;-0.22382554;-1.0327681;0.37007874;0.6332118
GO BP;HIPPO SIGNALING;GO:0035329;36;-0.29429573;-1.03268;0.41256368;0.6330633
GO BP;REGULATION OF B CELL ACTIVATION;GO:0050864;72;-0.25810793;-1.032333;0.37913907;0.6336329
GO BP;REGULATION OF VIRAL LIFE CYCLE;#N/A;97;-0.24290934;-1.0320305;0.39794168;0.6340595
GO BP;EMBRYONIC PLACENTA MORPHOGENESIS;GO:0060669;19;-0.35185692;-1.031879;0.42133814;0.6340948
GO BP;REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:0072593;172;-0.22074859;-1.0313739;0.3765625;0.6350552
GO BP;ALPHA BETA T CELL PROLIFERATION;GO:0046633;17;-0.3529323;-1.0305145;0.4003795;0.63701373
GO BP;POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION;GO:0032481;65;-0.2593739;-1.0304672;0.40397352;0.63675714
GO BP;OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS;GO:0006490;17;-0.35196608;-1.030243;0.425;0.6368839
GO BP;NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT;#N/A;173;-0.22080824;-1.0301927;0.3885449;0.6366155
GO BP;REGULATION OF TISSUE REMODELING;GO:0034103;40;-0.28588575;-1.030173;0.40863788;0.63628477
GO BP;RESPONSE TO STEROID HORMONE;GO:0048545;251;-0.21253526;-1.0295559;0.3794163;0.63752204
GO BP;NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS;#N/A;55;-0.26820832;-1.0294954;0.39419794;0.63727576
GO BP;ORGAN GROWTH;GO:0035265;105;-0.24097037;-1.0294802;0.3867121;0.63692284
GO BP;ACTIVATION OF INNATE IMMUNE RESPONSE;GO:0002218;206;-0.21839958;-1.029202;0.3800298;0.637262
GO BP;MEIOSIS I CELL CYCLE PROCESS;#N/A;84;-0.24726078;-1.0291682;0.40584415;0.6369533
GO BP;HISTONE H2A UBIQUITINATION;GO:0033522;24;-0.32183477;-1.0290468;0.40394974;0.63689935
GO BP;REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION;GO:0051480;133;-0.23084001;-1.028259;0.39872408;0.6386192
GO BP;CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS;#N/A;66;-0.25904033;-1.0281123;0.38793105;0.63860154
GO BP;FIBROBLAST APOPTOTIC PROCESS;GO:0044346;17;-0.35430148;-1.0280215;0.4148148;0.63844705
GO BP;CALCIUM MEDIATED SIGNALING;GO:0019722;102;-0.23923452;-1.0279442;0.4042879;0.6382869
GO BP;REGULATION OF PROTEIN AUTOPHOSPHORYLATION;GO:0031952;31;-0.3097468;-1.0276372;0.41043478;0.63873434
GO BP;MORPHOGENESIS OF AN EPITHELIUM;GO:0002009;360;-0.20470768;-1.0271441;0.36363637;0.639591
GO BP;RESPONSE TO RETINOIC ACID;GO:0032526;73;-0.2550961;-1.0265378;0.4023569;0.6408251
GO BP;PROTEIN PROCESSING;GO:0016485;149;-0.22606549;-1.0264891;0.39291465;0.6405571
GO BP;AXIS SPECIFICATION;GO:0009798;55;-0.27206698;-1.0264862;0.41144902;0.6401739
GO BP;CELLULAR RESPONSE TO ABIOTIC STIMULUS;#N/A;218;-0.21440946;-1.0263475;0.38586158;0.6401344
GO BP;REGULATION OF SISTER CHROMATID SEGREGATION;GO:0033045;74;-0.25306678;-1.0262424;0.39644012;0.64000773
GO BP;SPINDLE LOCALIZATION;GO:0051653;41;-0.28278756;-1.0260404;0.4027778;0.6401956
GO BP;TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY;GO:0034138;16;-0.36225984;-1.0259181;0.43130434;0.6401474
GO BP;NEURON PROJECTION EXTENSION;GO:1990138;110;-0.23410596;-1.0254769;0.41826922;0.6409744
GO BP;POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION;GO:0050731;103;-0.23687133;-1.0250312;0.41038525;0.64178556
GO BP;CARDIAC CELL DEVELOPMENT;GO:0055006;49;-0.27818322;-1.0242553;0.41549295;0.6434296
GO BP;POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:2000060;79;-0.24881458;-1.0241795;0.4231405;0.6432225
GO BP;MRNA MODIFICATION;GO:0016556;20;-0.33693385;-1.023271;0.40734264;0.6454205
GO BP;DNA CATABOLIC PROCESS ENDONUCLEOLYTIC;GO:0000737;25;-0.32214758;-1.023162;0.4235501;0.6453178
GO BP;CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS;GO:0071322;97;-0.24537452;-1.0230343;0.41509435;0.64529437
GO BP;GLUCOSE IMPORT;GO:0046323;43;-0.28051987;-1.0230219;0.41767764;0.6449372
GO BP;INOSITOL PHOSPHATE MEDIATED SIGNALING;GO:0048016;36;-0.29165667;-1.0225523;0.39892665;0.6458092
GO BP;POSITIVE REGULATION OF IMMUNE RESPONSE;GO:0050778;435;-0.19959652;-1.0225499;0.40082645;0.6454203
GO BP;ANIMAL ORGAN REGENERATION;GO:0031100;50;-0.27121106;-1.0222803;0.42144176;0.64576095
GO BP;PROTEIN FOLDING;GO:0006457;175;-0.22173718;-1.0220565;0.40729;0.64596653
GO BP;CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT;GO:0021954;45;-0.27897182;-1.021733;0.40521738;0.6464197
GO BP;PHOSPHOLIPID METABOLIC PROCESS;GO:0006644;328;-0.20428781;-1.02172;0.3800298;0.64606464
GO BP;NEGATIVE REGULATION OF DEFENSE RESPONSE;#N/A;116;-0.23376434;-1.0215633;0.4117647;0.6460914
GO BP;CYTOPLASMIC MICROTUBULE ORGANIZATION;GO:0031122;45;-0.2810157;-1.0215139;0.41975307;0.6458271
GO BP;REGULATION OF DENDRITE DEVELOPMENT;GO:0050773;109;-0.2352679;-1.0213686;0.42620233;0.64582914
GO BP;OUTFLOW TRACT MORPHOGENESIS;GO:0003151;48;-0.26983666;-1.0212255;0.41197184;0.6458358
GO BP;MALE MEIOTIC NUCLEAR DIVISION;GO:0007140;31;-0.30443457;-1.0207043;0.4283154;0.6468573
GO BP;REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051153;53;-0.26859513;-1.0207027;0.41455162;0.64646304
GO BP;C4 DICARBOXYLATE TRANSPORT;#N/A;15;-0.36740068;-1.0204613;0.43843284;0.6466677
GO BP;NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:1904357;25;-0.32223627;-1.0202311;0.44464946;0.6469034
GO BP;POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING;GO:0043123;129;-0.22814232;-1.0201193;0.38853502;0.646779
GO BP;INNER EAR RECEPTOR CELL DEVELOPMENT;GO:0060119;26;-0.32057884;-1.0199863;0.45058626;0.6467578
GO BP;HEART TRABECULA MORPHOGENESIS;GO:0061384;22;-0.32420596;-1.0195678;0.41385767;0.64750165
GO BP;POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT;GO:0040019;24;-0.31657583;-1.0192376;0.43939394;0.6479879
GO BP;ACTIVATED T CELL PROLIFERATION;GO:0050798;20;-0.33246106;-1.0188726;0.4283088;0.6486149
GO BP;HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES;GO:0007157;18;-0.34625688;-1.0187073;0.43248177;0.64866465
GO BP;NEUROTRANSMITTER BIOSYNTHETIC PROCESS;GO:0042136;52;-0.27041483;-1.0175772;0.42387542;0.6513194
GO BP;REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0010717;59;-0.26169842;-1.0169734;0.43257442;0.6525716
GO BP;REGULATION OF LYMPHOCYTE ACTIVATION;GO:0051249;221;-0.21296898;-1.0165415;0.42080745;0.65333754
GO BP;HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN;GO:0002455;21;-0.3369307;-1.0165336;0.44912282;0.6529628
GO BP;ERBB SIGNALING PATHWAY;GO:0038127;109;-0.2364133;-1.0161865;0.4044234;0.6534887
GO BP;PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS;GO:0046337;17;-0.35122383;-1.0154791;0.43656716;0.65497196
GO BP;ODONTOGENESIS OF DENTIN CONTAINING TOOTH;GO:0042475;51;-0.2721543;-1.0154375;0.4253472;0.6546845
GO BP;T CELL RECEPTOR SIGNALING PATHWAY;GO:0050852;122;-0.22968996;-1.0152187;0.4192;0.6548967
GO BP;MYOBLAST DIFFERENTIATION;GO:0045445;50;-0.27092478;-1.0143183;0.43053174;0.6569431
GO BP;ENDOTHELIAL CELL CHEMOTAXIS;GO:0035767;15;-0.366745;-1.0142093;0.4264151;0.65685785
GO BP;KERATINIZATION;GO:0031424;45;-0.27741745;-1.0140932;0.42273533;0.65677476
GO BP;CARDIAC VENTRICLE MORPHOGENESIS;GO:0003208;42;-0.28283986;-1.0140523;0.4431438;0.6564934
GO BP;RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS;GO:0009156;26;-0.3125418;-1.012752;0.442029;0.65966153
GO BP;SULFUR COMPOUND METABOLIC PROCESS;GO:0006790;267;-0.20793322;-1.0125568;0.42813918;0.6598156
GO BP;T CELL PROLIFERATION;GO:0042098;98;-0.23647916;-1.0123085;0.43001688;0.66006666
GO BP;REGULATION OF MULTI ORGANISM PROCESS;#N/A;481;-0.19665824;-1.0116962;0.42307693;0.6613553
GO BP;MICROTUBULE BUNDLE FORMATION;GO:0001578;58;-0.2640133;-1.011567;0.42564103;0.6613029
GO BP;GLIOGENESIS;GO:0042063;163;-0.22162871;-1.0114892;0.4456693;0.6610807
GO BP;ENDOCYTIC RECYCLING;GO:0032456;40;-0.28356877;-1.0111175;0.42434782;0.6616622
GO BP;AMYLOID BETA CLEARANCE;GO:0097242;24;-0.3133478;-1.0110933;0.43257442;0.6613503
GO BP;TYPE I INTERFERON PRODUCTION;GO:0032606;101;-0.23766978;-1.0109122;0.4089404;0.6614534
GO BP;ALPHA AMINO ACID CATABOLIC PROCESS;#N/A;76;-0.2457138;-1.0106951;0.43278688;0.66162014
GO BP;TORC1 SIGNALING;GO:0038202;36;-0.28772432;-1.0103475;0.4304762;0.6621489
GO BP;POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION;GO:1903055;15;-0.3670028;-1.0097809;0.44206774;0.6632735
GO BP;NUCLEAR CHROMOSOME SEGREGATION;GO:0098813;220;-0.21194401;-1.0094227;0.41798106;0.6638137
GO BP;REGULATION OF BMP SIGNALING PATHWAY;GO:0030510;55;-0.26408657;-1.0093818;0.42783505;0.6635215
GO BP;KERATINOCYTE DIFFERENTIATION;GO:0030216;103;-0.2337448;-1.0091691;0.41945773;0.66369134
GO BP;RESPONSE TO AMYLOID BETA;GO:1904645;23;-0.32363653;-1.0089096;0.4365942;0.6639779
GO BP;CARBOHYDRATE HOMEOSTASIS;#N/A;156;-0.22235867;-1.0080565;0.4437401;0.66588587
GO BP;REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH;#N/A;45;-0.2748055;-1.007993;0.4364261;0.66564924
GO BP;SUBSTRATE DEPENDENT CELL MIGRATION;GO:0006929;17;-0.3416961;-1.0077294;0.45540798;0.6659502
GO BP;PHOSPHATIDYLGLYCEROL METABOLIC PROCESS;GO:0046471;22;-0.32091528;-1.0077103;0.45736435;0.66560036
GO BP;PEPTIDE SECRETION;GO:0002790;338;-0.20201744;-1.0075233;0.43571427;0.6656961
GO BP;HOMOTYPIC CELL CELL ADHESION;GO:0034109;57;-0.2587437;-1.0073285;0.42439863;0.66581565
GO BP;REPLACEMENT OSSIFICATION;#N/A;16;-0.35669726;-1.0066451;0.45338207;0.6673121
GO BP;RNA DEPENDENT DNA BIOSYNTHETIC PROCESS;GO:0006278;67;-0.25677815;-1.0057966;0.4312394;0.66912633
GO BP;POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING;GO:2000679;16;-0.36309522;-1.0045606;0.46254683;0.6720826
GO BP;PROCESS UTILIZING AUTOPHAGIC MECHANISM;#N/A;409;-0.19823131;-1.0040879;0.4550484;0.6729679
GO BP;ENTRAINMENT OF CIRCADIAN CLOCK;GO:0009649;23;-0.32530576;-1.0038959;0.4301887;0.6731141
GO BP;REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS;#N/A;16;-0.3575039;-1.0038812;0.46055046;0.6727515
GO BP;POSITIVE REGULATION OF TELOMERE MAINTENANCE;GO:0032206;46;-0.26791242;-1.0036429;0.46391752;0.67297524
GO BP;REGULATION OF DNA REPLICATION;GO:0006275;90;-0.23974152;-1.0033588;0.45516074;0.6733727
GO BP;REPLICATION FORK PROCESSING;GO:0031297;31;-0.29395828;-1.0032063;0.42266187;0.67337745
GO BP;LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY;GO:0031663;37;-0.28649876;-1.0030006;0.4358108;0.67356217
GO BP;POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS;GO:1904407;21;-0.3261913;-1.0029702;0.42956522;0.6732468
GO BP;NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION;GO:0051148;32;-0.29585883;-1.0026975;0.44833624;0.67358875
GO BP;FOREBRAIN CELL MIGRATION;GO:0021885;32;-0.28691605;-1.0023382;0.4550562;0.674149
GO BP;DNA RECOMBINATION;GO:0006310;231;-0.20669037;-1.002297;0.43543544;0.6738606
GO BP;RESPONSE TO WOUNDING;GO:0009611;400;-0.19866145;-1.0021691;0.45702004;0.6738056
GO BP;ALCOHOL CATABOLIC PROCESS;#N/A;34;-0.29285893;-1.0018592;0.45605308;0.6742609
GO BP;POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY;GO:2001056;95;-0.23733248;-1.0011948;0.4378981;0.67576456
GO BP;INTERLEUKIN 2 PRODUCTION;GO:0032623;38;-0.2830854;-1.000519;0.44507575;0.677092
GO BP;ACTIN POLYMERIZATION OR DEPOLYMERIZATION;GO:0008154;143;-0.22373648;-1.0004746;0.44674087;0.67681926
GO BP;IMMUNE RESPONSE REGULATING SIGNALING PATHWAY;GO:0002764;340;-0.20038198;-1.0003823;0.46551725;0.67667824
GO BP;ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS;#N/A;17;-0.34421042;-1.0002383;0.4834559;0.6766569
GO BP;CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0060317;19;-0.3337565;-0.99864334;0.45405406;0.680545
GO BP;TRABECULA MORPHOGENESIS;GO:0061383;32;-0.28953886;-0.99788636;0.44954127;0.68219024
GO BP;MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION;GO:0097345;45;-0.27055046;-0.9978133;0.47237077;0.6819749
GO BP;MITOTIC SISTER CHROMATID SEGREGATION;GO:0000070;140;-0.22198194;-0.997679;0.44620255;0.68192315
GO BP;NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS;GO:2001021;66;-0.25252956;-0.99753755;0.48414025;0.68190813
GO BP;COCHLEA DEVELOPMENT;GO:0090102;26;-0.30842227;-0.9973666;0.45072994;0.68197626
GO BP;POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION;#N/A;42;-0.27124262;-0.9971583;0.44791666;0.6821624
GO BP;PLASMA MEMBRANE TUBULATION;GO:0097320;16;-0.34348226;-0.99622667;0.46542057;0.6843816
GO BP;TIGHT JUNCTION ORGANIZATION;GO:0120193;51;-0.26364598;-0.99609643;0.44991213;0.684316
GO BP;PROTEIN LOCALIZATION TO CHROMOSOME;GO:0034502;81;-0.24454834;-0.99595916;0.48387095;0.6842979
GO BP;POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION;GO:2000758;25;-0.31476575;-0.9958886;0.45144805;0.68408835
GO BP;INTRACELLULAR RECEPTOR SIGNALING PATHWAY;GO:0030522;201;-0.21135393;-0.99584585;0.4544025;0.68379474
GO BP;NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION;GO:0048147;20;-0.32611224;-0.9956662;0.44507575;0.68385154
GO BP;NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS;GO:0043524;91;-0.23680715;-0.9956378;0.459375;0.6835323
GO BP;POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS;#N/A;124;-0.22487007;-0.99543023;0.4644013;0.68372434
GO BP;EXCRETION;GO:0007588;30;-0.29738194;-0.9953454;0.45825604;0.68356496
GO BP;POSITIVE REGULATION OF HEART CONTRACTION;GO:0045823;21;-0.32199243;-0.9952852;0.46666667;0.68332064
GO BP;EMBRYONIC HEART TUBE DEVELOPMENT;GO:0035050;54;-0.2607862;-0.9947764;0.48035714;0.68429494
GO BP;EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0007173;92;-0.236492;-0.9945462;0.48392555;0.6845292
GO BP;PROTEIN LOCALIZATION TO MICROTUBULE;GO:0035372;16;-0.34795153;-0.9935731;0.47037703;0.6867254
GO BP;BONE RESORPTION;GO:0045453;38;-0.27727062;-0.9935411;0.46902654;0.68639356
GO BP;NEUROTRANSMITTER METABOLIC PROCESS;GO:0042133;79;-0.24000905;-0.99309754;0.47403684;0.68717796
GO BP;GLYCOSPHINGOLIPID METABOLIC PROCESS;GO:0006687;48;-0.2635521;-0.9930479;0.45111492;0.68692315
GO BP;DEVELOPMENTAL MATURATION;#N/A;152;-0.21896039;-0.99297386;0.47633588;0.6867116
GO BP;REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS;#N/A;210;-0.21078627;-0.9928862;0.46818182;0.6865596
GO BP;MANNOSYLATION;GO:0097502;31;-0.29074037;-0.9922784;0.4698795;0.6877863
GO BP;REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS;GO:2000300;38;-0.27803683;-0.9921828;0.47487003;0.6876556
GO BP;POSITIVE REGULATION OF DNA REPLICATION;GO:0045740;31;-0.2952565;-0.99155885;0.45689654;0.6889127
GO BP;MACROAUTOPHAGY;GO:0016236;258;-0.20322081;-0.99138886;0.4651163;0.68895483
GO BP;TISSUE MORPHOGENESIS;GO:0048729;420;-0.19412059;-0.9908283;0.50208044;0.69007427
GO BP;LOCALIZATION WITHIN MEMBRANE;GO:0051668;56;-0.25699043;-0.990601;0.49137932;0.6902919
GO BP;MEMBRANE LIPID BIOSYNTHETIC PROCESS;#N/A;115;-0.22876713;-0.9905626;0.46307692;0.6899876
GO BP;INTERACTION WITH HOST;#N/A;148;-0.21805264;-0.99047345;0.47196263;0.68983984
GO BP;POSITIVE REGULATION OF MULTI ORGANISM PROCESS;#N/A;354;-0.19794871;-0.99025977;0.4842857;0.69001955
GO BP;ZINC ION TRANSMEMBRANE TRANSPORT;GO:0071577;17;-0.34375042;-0.989656;0.47435898;0.6912633
GO BP;COENZYME BIOSYNTHETIC PROCESS;#N/A;123;-0.22450252;-0.98920834;0.46850997;0.6920258
GO BP;SMAD PROTEIN SIGNAL TRANSDUCTION;GO:0060395;42;-0.27256685;-0.9889999;0.48415494;0.69218254
GO BP;PLACENTA DEVELOPMENT;GO:0001890;110;-0.22584079;-0.9885169;0.47327045;0.6930634
GO BP;CARDIAC MUSCLE CELL DIFFERENTIATION;GO:0055007;72;-0.24687083;-0.98827636;0.46837607;0.69334424
GO BP;REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:1904356;57;-0.2540598;-0.98768765;0.4974093;0.69458115
GO BP;TUBE CLOSURE;GO:0060606;79;-0.24041049;-0.98712975;0.47727272;0.6957204
GO BP;RESPONSE TO HYPEROXIA;#N/A;16;-0.34873867;-0.98662084;0.4890511;0.69670355
GO BP;REGULATION OF VIRAL GENOME REPLICATION;GO:0045069;61;-0.2542407;-0.98616;0.4781145;0.69755423
GO BP;RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM;GO:0007585;31;-0.2917632;-0.9859163;0.4695652;0.69780993
GO BP;PHENOL CONTAINING COMPOUND METABOLIC PROCESS;GO:0018958;42;-0.26691967;-0.9856874;0.4616695;0.6980382
GO BP;NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS;GO:0045922;17;-0.34041706;-0.98407704;0.47495362;0.70202273
GO BP;DETECTION OF STIMULUS;GO:0051606;111;-0.22727609;-0.9839081;0.49369085;0.70210606
GO BP;DEFENSE RESPONSE TO VIRUS;GO:0051607;143;-0.2203605;-0.98346835;0.49339935;0.7029032
GO BP;TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:0010833;74;-0.24048942;-0.98326063;0.4949833;0.7030313
GO BP;NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY;GO:2001234;170;-0.21324748;-0.9831483;0.518797;0.70295393
GO BP;NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION;GO:0045668;26;-0.3055696;-0.9822676;0.49586776;0.7049261
GO BP;MITOTIC SPINDLE ASSEMBLY;GO:0090307;52;-0.264377;-0.9821755;0.48397976;0.7047667
GO BP;ODONTOGENESIS;GO:0042476;77;-0.2431033;-0.9820859;0.49158248;0.7045952
GO BP;MEGAKARYOCYTE DIFFERENTIATION;GO:0030219;66;-0.24891536;-0.98189694;0.47406083;0.7047128
GO BP;NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:1901797;24;-0.3153989;-0.98178464;0.4623656;0.7046284
GO BP;IRON ION TRANSMEMBRANE TRANSPORT;GO:0034755;15;-0.34659135;-0.981362;0.45970696;0.7053513
GO BP;PHOSPHOLIPID TRANSPORT;GO:0015914;59;-0.2528547;-0.981349;0.4974705;0.7049925
GO BP;CHROMATIN REMODELING;GO:0006338;137;-0.21828969;-0.98073775;0.49016392;0.7062501
GO BP;RECEPTOR RECYCLING;GO:0001881;28;-0.29434213;-0.9799361;0.48415494;0.7079912
GO BP;DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS;GO:0060560;148;-0.21576084;-0.9799093;0.48867315;0.70766884
GO BP;POSITIVE REGULATION OF LIPID LOCALIZATION;#N/A;46;-0.26847732;-0.9792287;0.46689895;0.70914763
GO BP;POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION;GO:0045639;55;-0.25472498;-0.9789812;0.47931033;0.7094068
GO BP;CORNIFICATION;GO:0070268;39;-0.27700832;-0.9787493;0.5076142;0.7096043
GO BP;NEURON PROJECTION REGENERATION;GO:0031102;37;-0.28135586;-0.9786274;0.47894737;0.7095335
GO BP;NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING;GO:0043124;31;-0.2890215;-0.9785284;0.48658317;0.7094101
GO BP;RESPONSE TO FATTY ACID;GO:0070542;49;-0.26235265;-0.97832245;0.50177306;0.7095607
GO BP;POSITIVE REGULATION OF STEM CELL PROLIFERATION;GO:2000648;25;-0.30171192;-0.9782891;0.4972875;0.7092458
GO BP;CELLULAR RESPONSE TO VIRUS;GO:0098586;34;-0.2801422;-0.9781706;0.4857143;0.70914775
GO BP;POSITIVE REGULATION OF DEFENSE RESPONSE;#N/A;284;-0.19806899;-0.9780461;0.5446559;0.70905066
GO BP;REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION;GO:0050730;144;-0.21783479;-0.9779009;0.5048544;0.70902014
GO BP;CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS;#N/A;132;-0.21940441;-0.97771025;0.50080514;0.70913863
GO BP;NUCLEOTIDE PHOSPHORYLATION;GO:0046939;103;-0.22761995;-0.9773521;0.5057283;0.70967627
GO BP;NEGATIVE REGULATION OF VIRAL TRANSCRIPTION;GO:0032897;20;-0.31797254;-0.9768382;0.5070422;0.7106673
GO BP;PLASMA LIPOPROTEIN PARTICLE CLEARANCE;GO:0034381;40;-0.273637;-0.97590834;0.48833033;0.712783
GO BP;RECEPTOR METABOLIC PROCESS;GO:0043112;124;-0.22030963;-0.9758014;0.4928;0.71265143
GO BP;REGULATION OF PEPTIDE SECRETION;#N/A;262;-0.20045877;-0.9753159;0.50449103;0.7135356
GO BP;NEGATIVE REGULATION OF SECRETION;GO:0051048;107;-0.22248776;-0.97519445;0.5232;0.713467
GO BP;RESPONSE TO CALCIUM ION;GO:0051592;86;-0.23690952;-0.9742243;0.5050505;0.71570873
GO BP;SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE;GO:0042770;117;-0.2206435;-0.9739494;0.5216;0.71605635
GO BP;RESPONSE TO REACTIVE OXYGEN SPECIES;GO:0000302;156;-0.21135525;-0.97300565;0.5098361;0.71812475
GO BP;NADPH REGENERATION;GO:0006740;15;-0.34736794;-0.9724261;0.48357666;0.71925056
GO BP;CELLULAR RESPONSE TO ACID CHEMICAL;#N/A;124;-0.22001469;-0.9724079;0.5295031;0.7188985
GO BP;REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL;GO:0060078;47;-0.25870225;-0.97224504;0.49050087;0.71892947
GO BP;REGULATION OF GLUCOSE METABOLIC PROCESS;GO:0010906;83;-0.23406354;-0.9719848;0.53288364;0.7192482
GO BP;NEUTRAL AMINO ACID TRANSPORT;GO:0015804;23;-0.30253908;-0.97179955;0.49001816;0.71931875
GO BP;NEPHRON MORPHOGENESIS;GO:0072028;40;-0.26868123;-0.9715449;0.53162396;0.71959096
GO BP;POSITIVE REGULATION OF MAP KINASE ACTIVITY;GO:0043406;176;-0.20878099;-0.97151256;0.5405405;0.7192658
GO BP;NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY;#N/A;18;-0.32297692;-0.97144085;0.5089109;0.71907264
GO BP;REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING;GO:0010882;15;-0.34632245;-0.9711138;0.5187266;0.7195579
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION;GO:0050680;83;-0.23686042;-0.97103703;0.5186916;0.71937495
GO BP;DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY;#N/A;39;-0.27254882;-0.9702163;0.4795539;0.721199
GO BP;POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY;GO:0120034;78;-0.23377915;-0.9697022;0.5113636;0.7222154
GO BP;LONG CHAIN FATTY ACID TRANSPORT;GO:0015909;46;-0.26310912;-0.96915245;0.50956523;0.7232596
GO BP;NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION;GO:1903038;58;-0.2512415;-0.96895176;0.5068493;0.7233492
GO BP;NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR;GO:1902254;16;-0.34458566;-0.96889555;0.51606804;0.7230891
GO BP;REGULATION OF GLUCAN BIOSYNTHETIC PROCESS;#N/A;20;-0.32094184;-0.9686132;0.48432055;0.7234669
GO BP;CORONARY VASCULATURE DEVELOPMENT;GO:0060976;34;-0.2824112;-0.96778125;0.5122807;0.7253132
GO BP;NEGATIVE REGULATION OF CELL DEVELOPMENT;GO:0010721;187;-0.20601346;-0.9674714;0.54037267;0.7257514
GO BP;LEUKOCYTE CHEMOTAXIS;GO:0030595;92;-0.2303971;-0.9673829;0.51565075;0.7255871
GO BP;MITOTIC DNA INTEGRITY CHECKPOINT;GO:0044774;96;-0.22602655;-0.967293;0.5308219;0.72545195
GO BP;POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION;#N/A;17;-0.33123222;-0.9672838;0.49908257;0.7250761
GO BP;MEIOTIC CELL CYCLE;GO:0051321;178;-0.20963961;-0.9671737;0.5458787;0.72498417
GO BP;POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION;#N/A;78;-0.2406419;-0.9671096;0.53895074;0.7247414
GO BP;REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION;GO:1903053;26;-0.29733697;-0.9666478;0.49270073;0.72555584
GO BP;SYNAPTIC VESICLE EXOCYTOSIS;GO:0016079;62;-0.24515432;-0.9658427;0.5152027;0.72725505
GO BP;NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS;#N/A;15;-0.34650704;-0.96567756;0.48741007;0.727326
GO BP;REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER;#N/A;20;-0.31545186;-0.9648895;0.4908759;0.7289685
GO BP;NUCLEOBASE CONTAINING COMPOUND TRANSPORT;#N/A;212;-0.20130675;-0.9645844;0.55873495;0.72937876
GO BP;PROTEIN MANNOSYLATION;GO:0035268;22;-0.31477812;-0.96440095;0.50357145;0.72947943
GO BP;NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS;#N/A;109;-0.22231723;-0.9642489;0.50930625;0.72945076
GO BP;CEREBELLAR CORTEX MORPHOGENESIS;GO:0021696;18;-0.33442968;-0.96382356;0.5117541;0.73020524
GO BP;VENTRICULAR SEPTUM DEVELOPMENT;GO:0003281;48;-0.2539837;-0.963415;0.52097905;0.73087233
GO BP;REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY;#N/A;61;-0.24384879;-0.9633961;0.5319149;0.73052144
GO BP;NEGATIVE REGULATION OF ATP METABOLIC PROCESS;#N/A;17;-0.32947734;-0.9628852;0.5202206;0.73151547
GO BP;SYNAPTIC SIGNALING;GO:0099536;328;-0.1926945;-0.9626917;0.5693642;0.73163366
GO BP;REGULATION OF T CELL ACTIVATION;GO:0050863;159;-0.21120283;-0.9625337;0.5294118;0.7316818
GO BP;CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS;GO:0003413;17;-0.33151317;-0.9618928;0.5212766;0.73299325
GO BP;NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS;#N/A;94;-0.23186542;-0.9613196;0.5195008;0.7341142
GO BP;RESPONSE TO FUNGUS;GO:0009620;17;-0.33192763;-0.9604219;0.51301116;0.7360862
GO BP;MESODERM DEVELOPMENT;GO:0007498;71;-0.23582986;-0.960227;0.5103448;0.73620075
GO BP;SULFUR AMINO ACID METABOLIC PROCESS;#N/A;30;-0.28608075;-0.95991206;0.4982639;0.73669446
GO BP;KERATAN SULFATE METABOLIC PROCESS;GO:0042339;23;-0.30434397;-0.95988655;0.5327586;0.7363434
GO BP;LIPID OXIDATION;GO:0034440;82;-0.23383395;-0.9593952;0.55160743;0.73721886
GO BP;ENERGY RESERVE METABOLIC PROCESS;GO:0006112;57;-0.2435887;-0.9593796;0.51870745;0.7368495
GO BP;NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS;GO:0036475;19;-0.31885657;-0.95930743;0.5244123;0.73664796
GO BP;RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM;GO:0006890;76;-0.23347889;-0.9592254;0.52151465;0.7364731
GO BP;REGULATION OF MITOCHONDRIAL FISSION;GO:0090140;20;-0.31706408;-0.95839196;0.491921;0.738308
GO BP;NEGATIVE REGULATION OF CELL ACTIVATION;GO:0050866;98;-0.22671941;-0.9580546;0.54632586;0.7388312
GO BP;WATER HOMEOSTASIS;GO:0030104;45;-0.25696138;-0.95804775;0.50642204;0.7384488
GO BP;CELLULAR CARBOHYDRATE METABOLIC PROCESS;GO:0044262;201;-0.20072499;-0.9579335;0.5709779;0.738346
GO BP;POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION;GO:1902751;28;-0.2874236;-0.95748883;0.53500897;0.7391513
GO BP;CELLULAR AMINO ACID CATABOLIC PROCESS;GO:0009063;93;-0.22465765;-0.95691425;0.54137933;0.74028426
GO BP;VACUOLE ORGANIZATION;GO:0007033;143;-0.21369264;-0.9565355;0.5562701;0.7408883
GO BP;CELL CYCLE ARREST;GO:0007050;181;-0.20453894;-0.95627385;0.5632716;0.7411512
GO BP;NEGATIVE REGULATION OF CYTOKINE PRODUCTION;GO:0001818;146;-0.21240188;-0.9561907;0.5518293;0.74096084
GO BP;EAR MORPHOGENESIS;GO:0042471;56;-0.24886331;-0.9557257;0.51318103;0.74179167
GO BP;POSITIVE REGULATION OF CELL CYCLE ARREST;GO:0071158;66;-0.242397;-0.95554256;0.53289473;0.74185544
GO BP;REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS;#N/A;62;-0.24364941;-0.95538485;0.548718;0.7418534
GO BP;EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0001837;90;-0.22532968;-0.955368;0.54344124;0.7414946
GO BP;ESTABLISHMENT OF LOCALIZATION IN CELL;GO:0051649;374;-0.18914802;-0.9551744;0.59011626;0.74162936
GO BP;MUSCLE ORGAN MORPHOGENESIS;GO:0048644;42;-0.2617999;-0.95497006;0.50956523;0.7417529
GO BP;POSITIVE REGULATION OF TOR SIGNALING;GO:0032008;29;-0.28206873;-0.9548175;0.5017668;0.74176043
GO BP;FOREBRAIN GENERATION OF NEURONS;GO:0021872;31;-0.28408453;-0.95356447;0.5072464;0.74473
GO BP;POSITIVE REGULATION OF DEPHOSPHORYLATION;GO:0035306;39;-0.26954404;-0.95295113;0.53691274;0.7459435
GO BP;POSITIVE REGULATION OF HORMONE SECRETION;GO:0046887;67;-0.23880677;-0.95243824;0.53267974;0.7469491
GO BP;TRANSFERRIN TRANSPORT;GO:0033572;31;-0.28084224;-0.95222706;0.5452899;0.7471099
GO BP;EXTRACELLULAR MATRIX ASSEMBLY;GO:0085029;26;-0.2964999;-0.95222455;0.518851;0.7467105
GO BP;RIBOSE PHOSPHATE METABOLIC PROCESS;GO:0019693;324;-0.19224238;-0.95201004;0.6022409;0.7468831
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION;GO:0050679;112;-0.2195463;-0.95194757;0.5602504;0.7466409
GO BP;REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY;#N/A;84;-0.22732633;-0.95188445;0.5640599;0.7464016
GO BP;ENDOSOMAL TRANSPORT;GO:0016197;196;-0.2013301;-0.9514805;0.5897833;0.7470577
GO BP;NUCLEUS ORGANIZATION;GO:0006997;104;-0.22307359;-0.94997215;0.5452992;0.75077504
GO BP;RESPONSE TO MINERALOCORTICOID;#N/A;16;-0.33074373;-0.94985396;0.5268817;0.75067526
GO BP;REGULATION OF ENDOCRINE PROCESS;#N/A;15;-0.3386054;-0.9495186;0.51672864;0.7511711
GO BP;EMBRYONIC AXIS SPECIFICATION;GO:0000578;19;-0.3131509;-0.9493582;0.52230483;0.75119406
GO BP;CELLULAR RESPONSE TO RETINOIC ACID;GO:0071300;37;-0.27301562;-0.94929886;0.51318103;0.7509558
GO BP;CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:0070588;158;-0.20718427;-0.94767267;0.6012862;0.7548491
GO BP;NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;GO:1903427;21;-0.30970103;-0.94745;0.53752184;0.7550415
GO BP;LYMPHOCYTE CHEMOTAXIS;GO:0048247;19;-0.31390306;-0.94663566;0.5362319;0.7567513
GO BP;APICAL JUNCTION ASSEMBLY;GO:0043297;54;-0.24757566;-0.9466243;0.54810995;0.7563743
GO BP;REGULATION OF NERVOUS SYSTEM PROCESS;GO:0031644;57;-0.24660888;-0.94658923;0.54884547;0.75606006
GO BP;APOPTOTIC CELL CLEARANCE;GO:0043277;24;-0.2998692;-0.94582254;0.5262206;0.7576425
GO BP;RESPONSE TO ACID CHEMICAL;#N/A;221;-0.19796257;-0.9442347;0.6171516;0.7615637
GO BP;CARDIAC ATRIUM DEVELOPMENT;#N/A;19;-0.31756905;-0.9440707;0.52994555;0.7615885
GO BP;REGULATION OF ERBB SIGNALING PATHWAY;GO:1901184;72;-0.23309448;-0.9439965;0.5574614;0.76136476
GO BP;REGULATION OF TRANS SYNAPTIC SIGNALING;#N/A;223;-0.19931705;-0.94396937;0.60643184;0.7610307
GO BP;RESPONSE TO COCAINE;GO:0042220;27;-0.28870064;-0.94351405;0.5608856;0.7617995
GO BP;REGULATION OF METALLOPEPTIDASE ACTIVITY;GO:1905048;15;-0.3343023;-0.9431202;0.5174954;0.7624267
GO BP;RELAXATION OF MUSCLE;GO:0090075;17;-0.32760704;-0.94307506;0.5323475;0.76214904
GO BP;RESPONSE TO FOOD;GO:0032094;17;-0.31453186;-0.9428338;0.5434381;0.7623918
GO BP;PROTEIN K63 LINKED DEUBIQUITINATION;GO:0070536;28;-0.28382617;-0.94266886;0.5472371;0.76246196
GO BP;OVARIAN FOLLICLE DEVELOPMENT;GO:0001541;27;-0.2847453;-0.9422911;0.5457876;0.7630223
GO BP;BRANCHED CHAIN AMINO ACID METABOLIC PROCESS;GO:0009081;20;-0.31002292;-0.9420412;0.5303571;0.76330096
GO BP;REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS;#N/A;168;-0.2024072;-0.94194907;0.60625;0.7631289
GO BP;NEPHRON EPITHELIUM DEVELOPMENT;#N/A;55;-0.24330528;-0.94179064;0.56;0.7631445
GO BP;MESENCHYME DEVELOPMENT;GO:0060485;161;-0.20635857;-0.9416975;0.58945686;0.76298046
GO BP;SCHWANN CELL DIFFERENTIATION;GO:0014037;27;-0.28752208;-0.94057804;0.55094993;0.7655767
GO BP;CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0048738;127;-0.21235675;-0.9402801;0.59771985;0.76594526
GO BP;UBIQUITIN DEPENDENT ERAD PATHWAY;GO:0030433;70;-0.23638128;-0.9393369;0.5767285;0.7679788
GO BP;MRNA EXPORT FROM NUCLEUS;GO:0006406;104;-0.21518043;-0.93917125;0.59013605;0.7680435
GO BP;SUBSTANTIA NIGRA DEVELOPMENT;GO:0021762;33;-0.27368844;-0.9391686;0.5641026;0.7676407
GO BP;REGULATION OF MYOBLAST DIFFERENTIATION;GO:0045661;28;-0.28361967;-0.9384296;0.5428051;0.76921326
GO BP;CELLULAR GLUCOSE HOMEOSTASIS;GO:0001678;100;-0.21865794;-0.9380035;0.6003289;0.7699478
GO BP;REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY;GO:0050803;122;-0.21560629;-0.93720096;0.59277505;0.7716575
GO BP;NEGATIVE REGULATION OF GLIOGENESIS;#N/A;21;-0.30267605;-0.9370691;0.5510949;0.7715987
GO BP;CHROMOSOME LOCALIZATION;#N/A;67;-0.23451689;-0.9368752;0.55480605;0.7717232
GO BP;NEGATIVE REGULATION OF TRANSFERASE ACTIVITY;#N/A;206;-0.19893987;-0.93684477;0.6081081;0.77139866
GO BP;POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY;GO:0031334;178;-0.20388211;-0.9363731;0.6147799;0.77227217
GO BP;REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES;GO:1901031;23;-0.29343516;-0.93601817;0.5589837;0.7727334
GO BP;INNER EAR MORPHOGENESIS;GO:0042472;45;-0.25211814;-0.9357701;0.5704467;0.772995
GO BP;ICOSANOID BIOSYNTHETIC PROCESS;GO:0046456;27;-0.2858983;-0.9355712;0.54744524;0.7730727
GO BP;EPIBOLY;#N/A;26;-0.28706768;-0.9353534;0.5531915;0.77322286
GO BP;AMINO ACID TRANSPORT;GO:0006865;79;-0.22744554;-0.9350132;0.58305645;0.7737003
GO BP;POSITIVE REGULATION OF T CELL MIGRATION;GO:2000406;17;-0.32029507;-0.93475103;0.5419708;0.7739694
GO BP;VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION;GO:0010573;21;-0.30324128;-0.9345579;0.56137186;0.77409506
GO BP;HISTONE UBIQUITINATION;GO:0016574;43;-0.2595045;-0.9345451;0.5669014;0.77371407
GO BP;NEGATIVE REGULATION OF ENDOCYTOSIS;GO:0045806;27;-0.28411964;-0.93408203;0.57632935;0.77454734
GO BP;COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT;GO:0002066;36;-0.26733744;-0.934001;0.56347823;0.77435213
GO BP;VESICLE MEDIATED TRANSPORT IN SYNAPSE;GO:0099003;122;-0.21375722;-0.93393755;0.599018;0.77410936
GO BP;DRUG TRANSPORT;#N/A;94;-0.2188182;-0.9331162;0.60169494;0.7758495
GO BP;PROTEIN TETRAMERIZATION;GO:0051262;104;-0.21754119;-0.93281275;0.6151468;0.77621776
GO BP;ENDODERM DEVELOPMENT;GO:0007492;51;-0.24790749;-0.9325491;0.5652921;0.776499
GO BP;POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY;GO:1901030;30;-0.2810845;-0.9316957;0.56084657;0.7782649
GO BP;REGULATION OF REPRODUCTIVE PROCESS;#N/A;88;-0.22483617;-0.9313784;0.58721936;0.77867514
GO BP;PEPTIDYL SERINE MODIFICATION;#N/A;219;-0.19819352;-0.93133;0.62063736;0.77838165
GO BP;MEMBRANE LIPID METABOLIC PROCESS;GO:0006643;158;-0.20153844;-0.9299525;0.638806;0.7816165
GO BP;CELLULAR RESPONSE TO DRUG;GO:0035690;256;-0.19292532;-0.92969996;0.6513353;0.7818646
GO BP;ZINC ION TRANSPORT;GO:0006829;20;-0.30987865;-0.9296122;0.5224416;0.7816746
GO BP;RIBONUCLEOSIDE METABOLIC PROCESS;#N/A;51;-0.25224254;-0.92923087;0.5860215;0.7822697
GO BP;DEPHOSPHORYLATION;GO:0016311;359;-0.18471187;-0.92902565;0.6718529;0.782388
GO BP;WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY;GO:0007223;26;-0.28765872;-0.92886704;0.5677083;0.78239167
GO BP;MYELIN MAINTENANCE;GO:0043217;15;-0.33210617;-0.9288336;0.55494505;0.7820588
GO BP;GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;15;-0.33630836;-0.9287194;0.5687023;0.78194684
GO BP;WOUND HEALING;GO:0042060;332;-0.18694595;-0.9286474;0.67321175;0.78173906
GO BP;REGULATION OF LIPID KINASE ACTIVITY;GO:0043550;44;-0.25486484;-0.9283307;0.5856164;0.7821442
GO BP;REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:1901016;20;-0.3112426;-0.9280423;0.55871886;0.782479
GO BP;SECRETION BY TISSUE;#N/A;16;-0.32490683;-0.92790455;0.5607477;0.78241754
GO BP;REGULATION OF ATPASE ACTIVITY;GO:0043462;69;-0.22966747;-0.9278934;0.6177924;0.78203493
GO BP;CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS;#N/A;57;-0.23924497;-0.92744356;0.58714044;0.7828103
GO BP;AUTOPHAGOSOME ORGANIZATION;GO:1905037;84;-0.22427174;-0.92729056;0.61702126;0.78282195
GO BP;SENSORY ORGAN MORPHOGENESIS;#N/A;132;-0.20830594;-0.92697203;0.5968;0.78321594
GO BP;B CELL MEDIATED IMMUNITY;GO:0019724;60;-0.23862241;-0.92676336;0.5900515;0.78331393
GO BP;REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY;#N/A;37;-0.26510832;-0.92662305;0.55871886;0.78328174
GO BP;REGULATION OF EXOCYTOSIS;GO:0017157;134;-0.2068695;-0.9260479;0.63084114;0.78435135
GO BP;NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT;GO:0090317;32;-0.27479297;-0.92599416;0.57513916;0.7840935
GO BP;POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS;GO:0061003;16;-0.3288494;-0.92595834;0.55725193;0.7837796
GO BP;ANTERIOR POSTERIOR PATTERN SPECIFICATION;GO:0009952;104;-0.21573329;-0.9254571;0.61083746;0.7847125
GO BP;DNA REPLICATION;GO:0006260;241;-0.19226815;-0.92533433;0.6657102;0.784625
GO BP;PH REDUCTION;GO:0045851;42;-0.25572035;-0.9251065;0.57651246;0.78483164
GO BP;POSITIVE REGULATION OF SPROUTING ANGIOGENESIS;GO:1903672;24;-0.2975185;-0.9250739;0.5709091;0.78451616
GO BP;POSITIVE REGULATION OF GLIOGENESIS;GO:0014015;38;-0.26162434;-0.92483294;0.5771812;0.7847341
GO BP;REGULATION OF HAIR CYCLE;GO:0042634;19;-0.31577325;-0.92464936;0.5735294;0.78479946
GO BP;SUBSTRATE ADHESION DEPENDENT CELL SPREADING;GO:0034446;77;-0.22715168;-0.92459154;0.6009934;0.7845566
GO BP;SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT;GO:0072395;65;-0.23422888;-0.9245404;0.597973;0.78427815
GO BP;MUSCLE FIBER DEVELOPMENT;GO:0048747;35;-0.26268;-0.92451245;0.5724382;0.7839333
GO BP;REGULATION OF DNA DEPENDENT DNA REPLICATION;GO:0090329;43;-0.2567847;-0.9241496;0.5671141;0.78443563
GO BP;REGULATION OF KIDNEY DEVELOPMENT;#N/A;27;-0.2830553;-0.9237733;0.5522648;0.78501904
GO BP;COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION;#N/A;69;-0.2323222;-0.9236523;0.59807074;0.78492695
GO BP;CRANIAL SKELETAL SYSTEM DEVELOPMENT;GO:1904888;42;-0.2554825;-0.92363346;0.59965634;0.7845641
GO BP;NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT;#N/A;17;-0.31428736;-0.92349136;0.547486;0.7845257
GO BP;MISMATCH REPAIR;GO:0006298;30;-0.27858233;-0.9231884;0.5711645;0.7849071
GO BP;MONOCARBOXYLIC ACID CATABOLIC PROCESS;#N/A;99;-0.21544969;-0.923077;0.6169844;0.78479236
GO BP;DNA REPAIR;GO:0006281;479;-0.17871585;-0.9230522;0.72888285;0.78445524
GO BP;ENDOCRINE SYSTEM DEVELOPMENT;GO:0035270;65;-0.23310389;-0.92216897;0.6094571;0.78630537
GO BP;EYE MORPHOGENESIS;GO:0048592;81;-0.22377759;-0.92200047;0.615257;0.78634673
GO BP;CYTOKINETIC PROCESS;GO:0032506;38;-0.25925958;-0.9219667;0.56360424;0.7860373
GO BP;RESPONSE TO HYDROGEN PEROXIDE;GO:0042542;101;-0.21345863;-0.9219649;0.6138614;0.78563774
GO BP;PHOSPHATIDYLCHOLINE METABOLIC PROCESS;GO:0046470;58;-0.24184686;-0.9215222;0.60738254;0.7863954
GO BP;PROTEIN LIPID COMPLEX ASSEMBLY;GO:0065005;26;-0.28311214;-0.92060214;0.601476;0.78838646
GO BP;GLYCEROPHOSPHOLIPID METABOLIC PROCESS;GO:0006650;247;-0.19038479;-0.92032033;0.6791367;0.78873223
GO BP;REGULATION OF LYASE ACTIVITY;#N/A;18;-0.3169901;-0.9199541;0.56360424;0.7892269
GO BP;ERYTHROCYTE HOMEOSTASIS;GO:0034101;95;-0.21984944;-0.91953933;0.63366336;0.7899054
GO BP;LYTIC VACUOLE ORGANIZATION;#N/A;54;-0.24236141;-0.91945493;0.59412783;0.7897131
GO BP;NEGATIVE REGULATION OF MAP KINASE ACTIVITY;GO:0043407;50;-0.24402644;-0.9194145;0.5863248;0.7893974
GO BP;ACTIN FILAMENT POLYMERIZATION;GO:0030041;125;-0.20910656;-0.91931725;0.634375;0.78927386
GO BP;INTERLEUKIN 12 PRODUCTION;GO:0032615;26;-0.28167287;-0.9188876;0.6169429;0.78999746
GO BP;REGULATION OF MRNA POLYADENYLATION;GO:1900363;16;-0.32283044;-0.91868794;0.57495254;0.7901458
GO BP;INTERLEUKIN 10 PRODUCTION;GO:0032613;24;-0.29086828;-0.9186015;0.5952381;0.78996277
GO BP;FEMALE GAMETE GENERATION;GO:0007292;81;-0.22238185;-0.918175;0.6296296;0.790625
GO BP;DRUG METABOLIC PROCESS;GO:0017144;366;-0.18172441;-0.91816455;0.7274074;0.79024637
GO BP;DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:0030330;96;-0.21928301;-0.91811615;0.6276423;0.78997004
GO BP;MODIFICATION BY SYMBIONT OF HOST MORPHOLOGY OR PHYSIOLOGY;#N/A;32;-0.26680672;-0.9180673;0.58992803;0.78967965
GO BP;REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT;GO:0010827;48;-0.24626571;-0.91802627;0.6111111;0.7893843
GO BP;VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE;#N/A;82;-0.2254321;-0.91765267;0.63316584;0.78992105
GO BP;REGULATION OF BODY FLUID LEVELS;GO:0050878;288;-0.18648604;-0.91752;0.717873;0.78982
GO BP;TYPE B PANCREATIC CELL DEVELOPMENT;GO:0003323;15;-0.32546818;-0.9174801;0.55839413;0.78953284
GO BP;PURINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;346;-0.18364553;-0.9174661;0.7202797;0.7891615
GO BP;REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING;#N/A;97;-0.21577413;-0.91714746;0.6254125;0.7895865
GO BP;RESPONSE TO OXIDATIVE STRESS;GO:0006979;328;-0.1835447;-0.916923;0.7227723;0.78973514
GO BP;NADP METABOLIC PROCESS;GO:0006739;29;-0.27330855;-0.9167617;0.5974026;0.78975207
GO BP;KIDNEY EPITHELIUM DEVELOPMENT;GO:0072073;73;-0.2263421;-0.9167615;0.6197411;0.78935075
GO BP;GLIAL CELL DEVELOPMENT;GO:0021782;66;-0.22876048;-0.9163301;0.63039726;0.79004294
GO BP;CELLULAR RESPONSE TO TOXIC SUBSTANCE;GO:0097237;155;-0.20129518;-0.9162503;0.6331738;0.78982234
GO BP;POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS;#N/A;345;-0.18416172;-0.9160964;0.735007;0.789757
GO BP;REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;GO:1903426;51;-0.24500173;-0.9160247;0.6231884;0.78952724
GO BP;TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER;GO:0006362;28;-0.27976745;-0.9157974;0.58363634;0.7896722
GO BP;MONOSACCHARIDE CATABOLIC PROCESS;#N/A;54;-0.24343646;-0.91565824;0.6010453;0.7896215
GO BP;NADH METABOLIC PROCESS;GO:0006734;35;-0.2630996;-0.91495144;0.60952383;0.79098296
GO BP;PURINE NUCLEOSIDE METABOLIC PROCESS;GO:0042278;51;-0.2431048;-0.9148545;0.6055846;0.7908242
GO BP;POSITIVE REGULATION OF POTASSIUM ION TRANSPORT;GO:0043268;15;-0.32337773;-0.91463816;0.5735294;0.7910091
GO BP;NEUROTRANSMITTER TRANSPORT;GO:0006836;127;-0.206506;-0.9145615;0.6528418;0.7908049
GO BP;PHOSPHOLIPID BIOSYNTHETIC PROCESS;GO:0008654;217;-0.19072248;-0.9142406;0.69076926;0.7912049
GO BP;PHOSPHATIDYLINOSITOL METABOLIC PROCESS;GO:0046488;137;-0.20149495;-0.91409785;0.6714976;0.7911771
GO BP;PROTEIN MATURATION;GO:0051604;209;-0.19266608;-0.91255885;0.688351;0.7945905
GO BP;REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:2000058;126;-0.20726854;-0.9117129;0.65434086;0.7963174
GO BP;IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY;GO:0002768;232;-0.18779899;-0.9107494;0.71016693;0.79829293
GO BP;CELLULAR RESPONSE TO HYDROGEN PEROXIDE;GO:0070301;68;-0.2264371;-0.91059357;0.61669505;0.7982944
GO BP;POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY;GO:1904031;26;-0.27899805;-0.91051453;0.5989305;0.7980944
GO BP;NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS;GO:0042177;101;-0.21293466;-0.9098337;0.65953946;0.79941154
GO BP;RESPONSE TO ETHANOL;GO:0045471;74;-0.23072584;-0.9097771;0.6115843;0.79916936
GO BP;ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE;GO:0006086;16;-0.31396264;-0.9091353;0.5887372;0.8003133
GO BP;RNA EXPORT FROM NUCLEUS;GO:0006405;129;-0.2050879;-0.909047;0.66402537;0.8001248
GO BP;REGULATION OF CARDIAC CONDUCTION;GO:1903779;37;-0.26077625;-0.9079869;0.60831887;0.80234486
GO BP;REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;#N/A;62;-0.23400141;-0.90794545;0.62827224;0.8020424
GO BP;PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION;GO:0070198;29;-0.2722446;-0.90790063;0.59731543;0.80175406
GO BP;AUTOPHAGOSOME MATURATION;GO:0097352;30;-0.27218747;-0.9077333;0.58916086;0.80175465
GO BP;INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY;GO:0030518;102;-0.21485691;-0.90713066;0.64811784;0.8029338
GO BP;PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING;GO:0036151;16;-0.31942046;-0.9069853;0.57007575;0.80284846
GO BP;IMMUNOGLOBULIN PRODUCTION;GO:0002377;65;-0.22825481;-0.9068569;0.6079447;0.8027547
GO BP;POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS;#N/A;241;-0.18904656;-0.9065791;0.70852715;0.8030298
GO BP;POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS;#N/A;27;-0.28018293;-0.9062781;0.6018018;0.8033979
GO BP;BODY FLUID SECRETION;GO:0007589;54;-0.23813508;-0.90532476;0.6237458;0.80526257
GO BP;REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE;GO:1903076;69;-0.22678113;-0.9036412;0.64846414;0.80892634
GO BP;PEPTIDYL THREONINE MODIFICATION;#N/A;93;-0.21250552;-0.9034005;0.69814503;0.8091269
GO BP;CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY;GO:0002753;48;-0.2453588;-0.90301853;0.62586206;0.80965525
GO BP;REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS;GO:0061136;155;-0.19947347;-0.90275156;0.70422536;0.80993384
GO BP;REGULATION OF CELL CYCLE ARREST;GO:0071156;82;-0.21892963;-0.9020426;0.6639478;0.8112429
GO BP;REGULATION OF CELL CYCLE CHECKPOINT;#N/A;29;-0.27001634;-0.89963245;0.60573477;0.81680983
GO BP;ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS;#N/A;38;-0.25628063;-0.8992313;0.6437177;0.81735814
GO BP;POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS;#N/A;48;-0.24248807;-0.89900786;0.6354344;0.81752175
GO BP;PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS;#N/A;158;-0.19706136;-0.8989762;0.7060653;0.8171978
GO BP;REGULATION OF CIRCADIAN RHYTHM;GO:0042752;79;-0.21992102;-0.8989698;0.6625874;0.8168095
GO BP;GOLGI VESICLE TRANSPORT;GO:0048193;308;-0.18214276;-0.89893126;0.7556818;0.8165018
GO BP;POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;#N/A;15;-0.31476903;-0.89885867;0.5900735;0.8162463
GO BP;REGULATION OF PROTEIN STABILITY;GO:0031647;241;-0.18536358;-0.8988383;0.75744045;0.81588733
GO BP;MEMBRANE DOCKING;#N/A;166;-0.19546697;-0.8981815;0.71806854;0.8170371
GO BP;ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS;GO:0006919;55;-0.23568378;-0.8978669;0.6433692;0.81738716
GO BP;RESPONSE TO AMINO ACID;GO:0043200;84;-0.21823737;-0.8974754;0.66174054;0.81794775
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II;GO:0002504;77;-0.21830444;-0.8964891;0.6770294;0.81989807
GO BP;COENZYME METABOLIC PROCESS;#N/A;208;-0.18854862;-0.89603615;0.73938507;0.8205907
GO BP;POSITIVE REGULATION OF FIBROBLAST PROLIFERATION;GO:0048146;36;-0.25197527;-0.8955213;0.6070234;0.821446
GO BP;COFACTOR TRANSPORT;#N/A;33;-0.2615869;-0.8947156;0.6017391;0.82302964
GO BP;RESPIRATORY SYSTEM PROCESS;GO:0003016;18;-0.30387086;-0.89469427;0.59586465;0.8226756
GO BP;DNA REPLICATION DEPENDENT NUCLEOSOME ORGANIZATION;#N/A;21;-0.2910162;-0.894157;0.5966851;0.8235932
GO BP;ACTIVATION OF MAPK ACTIVITY;GO:0000187;104;-0.20774345;-0.8933623;0.70084035;0.82511115
GO BP;NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;GO:0090101;73;-0.21946181;-0.89306295;0.67720467;0.82545125
GO BP;ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY;GO:0050851;147;-0.19863074;-0.8923375;0.7156398;0.82681036
GO BP;GENETIC IMPRINTING;GO:0071514;23;-0.28749076;-0.89159495;0.63992536;0.8281759
GO BP;PROSTANOID BIOSYNTHETIC PROCESS;#N/A;16;-0.31575435;-0.89121866;0.60390764;0.82866424
GO BP;MRNA TRANSPORT;GO:0051028;136;-0.20108354;-0.8911273;0.6786885;0.8284703
GO BP;REGULATION OF GLYCOGEN METABOLIC PROCESS;GO:0070873;25;-0.28046972;-0.8907914;0.6179159;0.8289151
GO BP;POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION;GO:0090277;54;-0.23216774;-0.89014596;0.6520979;0.8300735
GO BP;DNA TEMPLATED TRANSCRIPTION ELONGATION;GO:0006354;100;-0.20710349;-0.88996804;0.6919355;0.8301153
GO BP;INORGANIC ANION TRANSMEMBRANE TRANSPORT;#N/A;58;-0.22871436;-0.88990945;0.6472727;0.8298569
GO BP;POSITIVE REGULATION OF CELL DIVISION;GO:0051781;47;-0.23978522;-0.8896688;0.66092944;0.8300317
GO BP;HORMONE METABOLIC PROCESS;GO:0042445;115;-0.20202313;-0.8895462;0.69477236;0.8299184
GO BP;GOLGI TO PLASMA MEMBRANE TRANSPORT;GO:0006893;55;-0.22855717;-0.8894504;0.6365188;0.8297448
GO BP;NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE;GO:0070373;41;-0.2504484;-0.8894208;0.651865;0.8294037
GO BP;OVULATION CYCLE PROCESS;GO:0022602;26;-0.27738282;-0.8889529;0.6184211;0.830125
GO BP;RUFFLE ASSEMBLY;GO:0097178;35;-0.25525722;-0.88847584;0.6537162;0.83087564
GO BP;RESPONSE TO AXON INJURY;GO:0048678;49;-0.2352171;-0.8884278;0.65337956;0.83058417
GO BP;NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS;GO:1902883;33;-0.2607391;-0.88839257;0.64825046;0.83027095
GO BP;SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:0072331;232;-0.1836017;-0.8881932;0.7599411;0.8303384
GO BP;POSITIVE REGULATION OF PEPTIDE SECRETION;#N/A;144;-0.19751585;-0.8876961;0.688958;0.83111715
GO BP;REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0008277;60;-0.22765219;-0.8864463;0.65445024;0.8335851
GO BP;POSITIVE REGULATION OF ATP METABOLIC PROCESS;GO:1903580;30;-0.2655971;-0.8862969;0.6306306;0.83352584
GO BP;STEROL HOMEOSTASIS;GO:0055092;58;-0.23014496;-0.88623464;0.6619965;0.83325845
GO BP;ESTABLISHMENT OF SPINDLE ORIENTATION;GO:0051294;31;-0.2614792;-0.88612145;0.6472727;0.833128
GO BP;PHOSPHATIDIC ACID METABOLIC PROCESS;GO:0046473;29;-0.26908404;-0.88519;0.658363;0.83483416
GO BP;NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0032232;15;-0.32381263;-0.8850349;0.6056604;0.8347831
GO BP;DRUG TRANSMEMBRANE TRANSPORT;GO:0006855;45;-0.2384027;-0.88487244;0.6861702;0.83478326
GO BP;RESPONSE TO VITAMIN;#N/A;57;-0.23069568;-0.8848131;0.6791444;0.83454573
GO BP;REGULATION OF RESPONSE TO BIOTIC STIMULUS;#N/A;311;-0.17888375;-0.88447946;0.8041237;0.83492774
GO BP;PLATELET AGGREGATION;GO:0070527;44;-0.24209327;-0.88275796;0.6672474;0.8385036
GO BP;MESODERMAL CELL DIFFERENTIATION;GO:0048333;16;-0.3076894;-0.8826151;0.65474063;0.83843803
GO BP;GLIAL CELL DIFFERENTIATION;GO:0010001;117;-0.20166185;-0.88210005;0.71335506;0.83921844
GO BP;RESPONSE TO KETONE;#N/A;119;-0.20162036;-0.8818318;0.7171875;0.83943594
GO BP;REGULATION OF MONOOXYGENASE ACTIVITY;#N/A;34;-0.25543904;-0.8807275;0.62254024;0.8416694
GO BP;CELLULAR RESPONSE TO IONIZING RADIATION;GO:0071479;60;-0.22690667;-0.8806509;0.6852792;0.84144974
GO BP;FIBROBLAST PROLIFERATION;#N/A;58;-0.2255224;-0.8805392;0.681736;0.84129626
GO BP;PROTEIN HOMOOLIGOMERIZATION;GO:0051260;200;-0.18623818;-0.87977964;0.7722474;0.8426515
GO BP;SKELETAL MUSCLE TISSUE REGENERATION;GO:0043403;23;-0.2799037;-0.87968224;0.64835167;0.84247917
GO BP;NEGATIVE REGULATION OF LIPID METABOLIC PROCESS;GO:0045833;49;-0.23514357;-0.8783056;0.6611842;0.8453211
GO BP;CALCINEURIN MEDIATED SIGNALING;GO:0097720;32;-0.25496092;-0.87819743;0.6513761;0.84517294
GO BP;REGULATION OF HETEROTYPIC CELL CELL ADHESION;#N/A;15;-0.31070223;-0.877812;0.63567364;0.84564894
GO BP;NUCLEAR ENVELOPE ORGANIZATION;GO:0006998;44;-0.24012634;-0.8772059;0.68705034;0.84666336
GO BP;REGULATION OF DNA BINDING;GO:0051101;86;-0.20748018;-0.87691456;0.74172187;0.8469593
GO BP;NEGATIVE REGULATION OF IMMUNE RESPONSE;GO:0050777;73;-0.21676143;-0.87656087;0.7006579;0.84736526
GO BP;ENDOTHELIAL CELL PROLIFERATION;GO:0001935;81;-0.21065353;-0.87651145;0.72156197;0.84706604
GO BP;REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:0032434;105;-0.20437187;-0.87639034;0.73906;0.84692365
GO BP;ADHERENS JUNCTION ORGANIZATION;GO:0034332;44;-0.24000108;-0.876383;0.69801086;0.8465307
GO BP;DNA TEMPLATED TRANSCRIPTION TERMINATION;GO:0006353;71;-0.21671417;-0.8763009;0.7040134;0.84632283
GO BP;POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS;GO:0046889;53;-0.22705089;-0.8752649;0.6719577;0.848291
GO BP;GENE SILENCING BY RNA;GO:0031047;155;-0.19129717;-0.87523586;0.777439;0.84794647
GO BP;NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS;#N/A;15;-0.31328824;-0.875076;0.6363636;0.8478933
GO BP;ENTRY INTO HOST;#N/A;87;-0.20652002;-0.87475896;0.72575253;0.84817696
GO BP;MEMBRANE FUSION;GO:0061025;110;-0.20071436;-0.8744175;0.73754156;0.8485611
GO BP;REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS;GO:1902041;42;-0.24095371;-0.8737331;0.65776294;0.84972703
GO BP;CELLULAR RESPONSE TO AMINO ACID STIMULUS;GO:0071230;50;-0.23190585;-0.8737255;0.68126094;0.84933454
GO BP;EPITHELIAL CELL PROLIFERATION;GO:0050673;243;-0.18062557;-0.8729863;0.81424147;0.850544
GO BP;RETINA MORPHOGENESIS IN CAMERA TYPE EYE;GO:0060042;27;-0.2646405;-0.8726947;0.65585583;0.85079336
GO BP;CELLULAR GLUCAN METABOLIC PROCESS;#N/A;55;-0.22842458;-0.8726785;0.6894198;0.8504197
GO BP;TISSUE REGENERATION;GO:0042246;40;-0.24437135;-0.87264794;0.65172416;0.85007316
GO BP;POST GOLGI VESICLE MEDIATED TRANSPORT;GO:0006892;93;-0.20675737;-0.87256247;0.7227414;0.8498664
GO BP;REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY;GO:1901028;38;-0.24790025;-0.8713803;0.67826086;0.85220534
GO BP;REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC;GO:0051966;25;-0.26561195;-0.87129205;0.6496479;0.85200757
GO BP;CELL CYCLE G1 S PHASE TRANSITION;GO:0044843;217;-0.1824478;-0.87113965;0.7966102;0.8519372
GO BP;CARDIAC CHAMBER MORPHOGENESIS;#N/A;80;-0.2143107;-0.8711147;0.7127846;0.85158205
GO BP;NEGATIVE REGULATION OF CELL CELL ADHESION;GO:0022408;98;-0.20309083;-0.87092894;0.71125615;0.85161954
GO BP;PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION;#N/A;34;-0.25413367;-0.870781;0.6578483;0.8515307
GO BP;GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE;GO:0061615;24;-0.27669144;-0.8705108;0.67662567;0.85171926
GO BP;POSITIVE REGULATION OF SECRETION;GO:0051047;218;-0.18387061;-0.8704239;0.7849624;0.85153115
GO BP;RECOMBINATIONAL REPAIR;GO:0000725;118;-0.19910748;-0.8700817;0.7484277;0.85189587
GO BP;POSITIVE REGULATION OF ATPASE ACTIVITY;GO:0032781;51;-0.22792499;-0.869746;0.70714283;0.8522441
GO BP;POSITIVE REGULATION OF CHEMOTAXIS;GO:0050921;61;-0.2227857;-0.8693969;0.70711976;0.85260653
GO BP;NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT;#N/A;17;-0.29912367;-0.8689658;0.6457143;0.8531543
GO BP;PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE;#N/A;39;-0.24102855;-0.86850876;0.6708861;0.85381585
GO BP;NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS;GO:0060761;37;-0.24119045;-0.867664;0.6684492;0.8553791
GO BP;PEPTIDYL CYSTEINE MODIFICATION;#N/A;35;-0.24769832;-0.866974;0.68097013;0.85658664
GO BP;NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION;GO:0031345;115;-0.1979443;-0.8668082;0.7458194;0.8565429
GO BP;POSITIVE REGULATION OF CYTOKINESIS;GO:0032467;25;-0.26808676;-0.8666326;0.65789473;0.8565418
GO BP;METANEPHROS DEVELOPMENT;GO:0001656;44;-0.23805203;-0.8666202;0.6728499;0.8561609
GO BP;POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE;GO:0070374;98;-0.20689617;-0.86649096;0.74626863;0.8560199
GO BP;GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;34;-0.25227082;-0.8661379;0.6807339;0.85639375
GO BP;REGULATION OF CYTOKINESIS;GO:0032465;66;-0.21915367;-0.8658007;0.7226754;0.8567301
GO BP;REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY;#N/A;80;-0.21101578;-0.8651938;0.74453783;0.8576974
GO BP;REGULATION OF VESICLE FUSION;GO:0031338;20;-0.28524286;-0.8650262;0.65867156;0.85766125
GO BP;B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;GO:0002312;46;-0.23935719;-0.86488575;0.6939502;0.85756725
GO BP;NEGATIVE REGULATION OF CELL CYCLE;GO:0045786;493;-0.16724029;-0.8634879;0.9037139;0.8602774
GO BP;ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS;#N/A;179;-0.18347943;-0.8626417;0.8271605;0.8618273
GO BP;NAD METABOLIC PROCESS;GO:0019674;41;-0.23754267;-0.86252207;0.67777777;0.8616866
GO BP;POSITIVE REGULATION OF PROTEIN POLYMERIZATION;GO:0032273;94;-0.20268643;-0.8623186;0.7227564;0.86170596
GO BP;CELLULAR RESPONSE TO LIGHT STIMULUS;GO:0071482;81;-0.20960122;-0.86173093;0.7436333;0.8625539
GO BP;HISTONE MONOUBIQUITINATION;GO:0010390;28;-0.26112026;-0.86046815;0.671875;0.8649488
GO BP;REGULATION OF HUMORAL IMMUNE RESPONSE;#N/A;23;-0.27461842;-0.8604319;0.6852518;0.8646132
GO BP;REGULATION OF HEMOPOIESIS;GO:1903706;288;-0.17574959;-0.8600726;0.8607407;0.8649834
GO BP;CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES;GO:0034614;116;-0.1954843;-0.85947514;0.780446;0.86589295
GO BP;CELLULAR RESPONSE TO GAMMA RADIATION;GO:0071480;29;-0.25688943;-0.85918194;0.68716097;0.8661611
GO BP;RNA LOCALIZATION;GO:0006403;211;-0.1814867;-0.85913557;0.81591266;0.8658467
GO BP;CELL CYCLE DNA REPLICATION;#N/A;59;-0.22205436;-0.8587404;0.7095652;0.86625296
GO BP;APOPTOTIC MITOCHONDRIAL CHANGES;GO:0008637;93;-0.2051968;-0.8587377;0.7576737;0.8658495
GO BP;EPIDERMAL CELL DIFFERENTIATION;GO:0009913;139;-0.18988876;-0.8583063;0.78642386;0.8664215
GO BP;REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS;#N/A;93;-0.20245606;-0.8582265;0.7752443;0.8661862
GO BP;DECIDUALIZATION;GO:0046697;16;-0.30124748;-0.8553703;0.69101125;0.87201935
GO BP;DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM;GO:0050830;34;-0.25061327;-0.8547367;0.6821306;0.8729868
GO BP;CARDIOCYTE DIFFERENTIATION;GO:0035051;92;-0.2013713;-0.85465455;0.7488152;0.87275857
GO BP;REGULATION OF KERATINOCYTE DIFFERENTIATION;GO:0045616;27;-0.26208413;-0.8542601;0.6798493;0.87323475
GO BP;ORGANOPHOSPHATE BIOSYNTHETIC PROCESS;#N/A;465;-0.16604452;-0.8539325;0.9026798;0.8734988
GO BP;FILOPODIUM ASSEMBLY;GO:0046847;45;-0.22755282;-0.8533199;0.7191413;0.87436575
GO BP;REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION;#N/A;34;-0.24899231;-0.8530158;0.73703706;0.8745794
GO BP;REGULATION OF LEUKOCYTE PROLIFERATION;GO:0070663;112;-0.19617817;-0.85251296;0.78115016;0.87527066
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION;GO:0051250;72;-0.21231493;-0.85190165;0.7415541;0.8761915
GO BP;POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION;GO:0045687;23;-0.26909536;-0.85015875;0.6596558;0.87941647
GO BP;RESPONSE TO ALCOHOL;GO:0097305;138;-0.18967193;-0.849974;0.8135861;0.8793737
GO BP;CEREBRAL CORTEX CELL MIGRATION;GO:0021795;27;-0.25990337;-0.8489816;0.6978022;0.8810331
GO BP;REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY;GO:2000810;18;-0.29700148;-0.8488116;0.6837294;0.88098717
GO BP;REGULATION OF EPIDERMIS DEVELOPMENT;GO:0045682;55;-0.22306544;-0.84879696;0.7159664;0.88060254
GO BP;REGULATION OF WATER LOSS VIA SKIN;GO:0033561;18;-0.2843761;-0.8486268;0.6767857;0.88053256
GO BP;METANEPHROS MORPHOGENESIS;GO:0003338;15;-0.3043803;-0.8486134;0.66786355;0.8801505
GO BP;REGULATION OF CALCIUM MEDIATED SIGNALING;GO:0050848;56;-0.2195195;-0.8482589;0.7440678;0.88045526
GO BP;RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS;GO:0046390;152;-0.18473656;-0.8480812;0.8266254;0.8803935
GO BP;BONE REMODELING;GO:0046849;54;-0.22297753;-0.8478991;0.7138047;0.8803778
GO BP;HINDBRAIN MORPHOGENESIS;GO:0021575;25;-0.26457295;-0.8466218;0.70934254;0.88260496
GO BP;REGULATION OF HEART RATE;GO:0002027;42;-0.23474607;-0.84590095;0.6857639;0.8837044
GO BP;PHAGOCYTOSIS;GO:0006909;159;-0.18321536;-0.8456413;0.81789637;0.88381386
GO BP;REGULATION OF CHEMOTAXIS;GO:0050920;103;-0.19755258;-0.84555995;0.7944535;0.88356537
GO BP;RESPONSE TO OXYGEN RADICAL;#N/A;18;-0.28136337;-0.8446486;0.69087523;0.88505447
GO BP;LOCOMOTORY BEHAVIOR;GO:0007626;94;-0.20173879;-0.8444664;0.7781403;0.88502365
GO BP;NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION;GO:0032692;16;-0.29695117;-0.8438795;0.69982237;0.885851
GO BP;POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT;GO:0048643;15;-0.3105746;-0.8434222;0.6818182;0.8863323
GO BP;PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS;GO:0006515;27;-0.26092952;-0.84332603;0.69174314;0.88611597
GO BP;RESPONSE TO CATECHOLAMINE;#N/A;46;-0.22781558;-0.84303904;0.7478849;0.8862731
GO BP;RNA STABILIZATION;GO:0043489;38;-0.2418222;-0.8429441;0.7160494;0.88605106
GO BP;CARBOHYDRATE BIOSYNTHETIC PROCESS;GO:0016051;138;-0.19008563;-0.84283143;0.8114105;0.885867
GO BP;NEUROTRANSMITTER RECEPTOR TRANSPORT;#N/A;29;-0.25961995;-0.8427453;0.72134036;0.8856387
GO BP;POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY;GO:2000273;17;-0.29005808;-0.8426852;0.6545454;0.8853685
GO BP;TETRAHYDROFOLATE METABOLIC PROCESS;GO:0046653;15;-0.2989216;-0.8422426;0.6793478;0.88588226
GO BP;NEGATIVE REGULATION OF PROTEIN ACETYLATION;GO:1901984;15;-0.3020346;-0.8416001;0.66484517;0.88673985
GO BP;SENSORY PERCEPTION OF LIGHT STIMULUS;GO:0050953;82;-0.2052572;-0.8414567;0.76744187;0.8866037
GO BP;2 OXOGLUTARATE METABOLIC PROCESS;GO:0006103;16;-0.2950846;-0.8412922;0.6897196;0.8865408
GO BP;ERAD PATHWAY;GO:0036503;88;-0.20123816;-0.8407811;0.7960199;0.88717103
GO BP;ENSHEATHMENT OF NEURONS;#N/A;92;-0.19947442;-0.8403373;0.80968857;0.8876331
GO BP;MITOCHONDRIAL FUSION;GO:0008053;20;-0.27947885;-0.83999485;0.68421054;0.8879268
GO BP;SYNAPSE ASSEMBLY;GO:0007416;66;-0.21168306;-0.8398166;0.7643208;0.88790643
GO BP;RUFFLE ORGANIZATION;GO:0031529;41;-0.23497297;-0.8397171;0.7160069;0.8877086
GO BP;NEURONAL STEM CELL POPULATION MAINTENANCE;GO:0097150;16;-0.29740715;-0.83965045;0.70535713;0.8874263
GO BP;GLUTAMINE METABOLIC PROCESS;GO:0006541;17;-0.29280597;-0.83944505;0.6849558;0.8874029
GO BP;REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY;GO:0043666;88;-0.19876815;-0.83941054;0.7910959;0.88705796
GO BP;VITAMIN BIOSYNTHETIC PROCESS;#N/A;15;-0.30483624;-0.8393865;0.66481483;0.8866958
GO BP;LAMELLIPODIUM ASSEMBLY;GO:0030032;41;-0.23466322;-0.83884066;0.7423729;0.88740045
GO BP;VESICLE ORGANIZATION;GO:0016050;261;-0.17259961;-0.8387191;0.8981763;0.887234
GO BP;REGULATION OF CYTOPLASMIC TRANSPORT;#N/A;22;-0.2654169;-0.83846265;0.6779661;0.8873405
GO BP;MULTI MULTICELLULAR ORGANISM PROCESS;#N/A;122;-0.18981785;-0.83824706;0.8288431;0.8873747
GO BP;RESPONSE TO GLUCAGON;GO:0033762;21;-0.27634856;-0.83779943;0.69611305;0.8878573
GO BP;SINGLE FERTILIZATION;GO:0007338;58;-0.21824655;-0.8367749;0.75438595;0.88951284
GO BP;OVULATION CYCLE;GO:0042698;37;-0.24211608;-0.83579975;0.7348353;0.89100194
GO BP;ENDODERM FORMATION;GO:0001706;35;-0.24457507;-0.83566105;0.7189097;0.8908527
GO BP;PROGRAMMED NECROTIC CELL DEATH;GO:0097300;33;-0.24523555;-0.8354665;0.73655915;0.8908492
GO BP;VESICLE BUDDING FROM MEMBRANE;GO:0006900;88;-0.20179032;-0.8350273;0.7715655;0.89135027
GO BP;NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION;GO:0046636;20;-0.27833232;-0.834439;0.7117117;0.8920806
GO BP;POSITIVE REGULATION OF LYMPHOCYTE MIGRATION;GO:2000403;19;-0.2796091;-0.834351;0.6959847;0.89184725
GO BP;DNA DEMETHYLATION;GO:0080111;18;-0.28077802;-0.8341762;0.69475657;0.89176923
GO BP;REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS;GO:0097006;61;-0.21344925;-0.8339827;0.7566225;0.89176315
GO BP;AROMATIC AMINO ACID FAMILY METABOLIC PROCESS;GO:0009072;26;-0.25643757;-0.8335246;0.69430053;0.89222723
GO BP;FOREBRAIN NEURON DEVELOPMENT;GO:0021884;15;-0.2987444;-0.833506;0.6985294;0.89186037
GO BP;GLUTATHIONE METABOLIC PROCESS;GO:0006749;35;-0.2397258;-0.83318603;0.73555166;0.89207536
GO BP;MALE MEIOSIS I;GO:0007141;16;-0.28851262;-0.83262557;0.65688074;0.8927828
GO BP;MODULATION BY VIRUS OF HOST MORPHOLOGY OR PHYSIOLOGY;#N/A;25;-0.25828564;-0.83171016;0.738574;0.8941482
GO BP;MYELOID LEUKOCYTE MIGRATION;#N/A;85;-0.19990882;-0.8315241;0.78369904;0.89408726
GO BP;PLATELET ACTIVATION;GO:0030168;88;-0.19757624;-0.83108515;0.7984252;0.89457214
GO BP;FEMALE PREGNANCY;GO:0007565;111;-0.1930527;-0.8305797;0.82107025;0.8951537
GO BP;POSITIVE REGULATION OF RNA SPLICING;GO:0033120;28;-0.25087;-0.8305055;0.72154117;0.8948854
GO BP;ORGANIC CATION TRANSPORT;GO:0015695;20;-0.27491564;-0.83029157;0.73142856;0.8948792
GO BP;REGULATION OF NEUROTRANSMITTER LEVELS;GO:0001505;181;-0.17854217;-0.8300139;0.8738462;0.8949967
GO BP;REGULATION OF CELLULAR AMIDE METABOLIC PROCESS;#N/A;336;-0.16601211;-0.82945555;0.93886465;0.8956696
GO BP;ENDOSOME ORGANIZATION;GO:0007032;71;-0.20229629;-0.82843834;0.8188034;0.89719236
GO BP;GOLGI TO ENDOSOME TRANSPORT;GO:0006895;16;-0.28983113;-0.828129;0.69202226;0.89738464
GO BP;RESPONSE TO NUTRIENT;GO:0007584;140;-0.18284966;-0.82773435;0.8596491;0.8977112
GO BP;CELLULAR RESPONSE TO RADIATION;GO:0071478;132;-0.18490906;-0.8275159;0.86567163;0.89772356
GO BP;REGULATION OF ERYTHROCYTE DIFFERENTIATION;GO:0045646;34;-0.24486856;-0.82742274;0.73380035;0.89747775
GO BP;CELL CYCLE CHECKPOINT;#N/A;196;-0.17361103;-0.82545173;0.88769233;0.9007576
GO BP;SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS;#N/A;49;-0.22263004;-0.8253949;0.74914676;0.90045685
GO BP;CALCIUM ION IMPORT;GO:0070509;35;-0.23427196;-0.8253478;0.738255;0.9001343
GO BP;BICARBONATE TRANSPORT;GO:0015701;23;-0.26649284;-0.8251337;0.75227684;0.9001036
GO BP;REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE;GO:0060688;28;-0.25041673;-0.8248727;0.7200704;0.90019196
GO BP;PROTEIN AUTOUBIQUITINATION;GO:0051865;61;-0.21088026;-0.8248403;0.78842974;0.8998406
GO BP;OOCYTE DIFFERENTIATION;GO:0009994;26;-0.2534449;-0.8241003;0.7285464;0.90083236
GO BP;ESTABLISHMENT OF RNA LOCALIZATION;#N/A;178;-0.17906062;-0.82404417;0.8766026;0.90053684
GO BP;EPHRIN RECEPTOR SIGNALING PATHWAY;GO:0048013;66;-0.20911801;-0.8239605;0.791019;0.90028244
GO BP;COFACTOR BIOSYNTHETIC PROCESS;#N/A;190;-0.1761615;-0.8236753;0.8897638;0.9004179
GO BP;REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION;GO:0032784;44;-0.22724836;-0.8235292;0.7447183;0.9002845
GO BP;REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING;GO:2000677;31;-0.24818225;-0.8226435;0.7358156;0.9015301
GO BP;CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE;GO:0071243;18;-0.2771137;-0.8222798;0.72400755;0.9018041
GO BP;SENSORY PERCEPTION;GO:0007600;215;-0.172745;-0.82174784;0.8971684;0.90236664
GO BP;ORGANOPHOSPHATE CATABOLIC PROCESS;GO:0046434;101;-0.19076899;-0.82139355;0.8319871;0.9025981
GO BP;NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS;#N/A;218;-0.17135224;-0.8210974;0.91284406;0.902704
GO BP;REGULATION OF SYNAPTIC VESICLE CYCLE;GO:0098693;59;-0.206935;-0.82043296;0.79796267;0.90346795
GO BP;GOLGI ORGANIZATION;GO:0007030;113;-0.18771446;-0.82013047;0.86644953;0.90360326
GO BP;POSITIVE REGULATION OF SYNAPSE ASSEMBLY;GO:0051965;20;-0.27561888;-0.8188655;0.7513812;0.9055073
GO BP;GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS;#N/A;50;-0.21499194;-0.81869334;0.78809106;0.90540904
GO BP;NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0045744;21;-0.27317974;-0.8185663;0.6991304;0.9052145
GO BP;POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE;GO:1900087;31;-0.24109694;-0.816827;0.7547496;0.9079652
GO BP;DNA DEALKYLATION;#N/A;24;-0.2464161;-0.8167182;0.7509363;0.90776396
GO BP;CELLULAR RESPONSE TO FATTY ACID;GO:0071398;30;-0.24618609;-0.8162071;0.77017546;0.9082371
GO BP;MITOTIC METAPHASE PLATE CONGRESSION;GO:0007080;42;-0.2207559;-0.8158652;0.7530435;0.9084554
GO BP;REGULATION OF LEUKOCYTE CHEMOTAXIS;GO:0002688;51;-0.21739821;-0.8142216;0.77759194;0.91095334
GO BP;PEROXISOMAL MEMBRANE TRANSPORT;#N/A;16;-0.28392124;-0.8138606;0.70944744;0.9112048
GO BP;REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT;#N/A;54;-0.21316384;-0.81386036;0.8024911;0.9107959
GO BP;LACTATION;GO:0007595;35;-0.2324377;-0.8137241;0.7559633;0.9106192
GO BP;NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION;GO:1904950;104;-0.19167168;-0.8136489;0.85504884;0.9103579
GO BP;MULTICELLULAR ORGANISMAL RESPONSE TO STRESS;GO:0033555;29;-0.24396749;-0.8130757;0.7714808;0.91096896
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE;GO:0061951;53;-0.21260211;-0.81099164;0.78511;0.91424096
GO BP;REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY;GO:0050999;29;-0.24500337;-0.81069624;0.7674825;0.91432905
GO BP;NECROTIC CELL DEATH;GO:0070265;39;-0.22771744;-0.8103535;0.74871796;0.91449654
GO BP;NEGATIVE REGULATION OF PEPTIDE SECRETION;#N/A;63;-0.20814323;-0.8101936;0.8169935;0.9143589
GO BP;REGULATION OF CELL CYCLE PHASE TRANSITION;GO:1901987;386;-0.16047852;-0.81017137;0.97127223;0.9139918
GO BP;BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS;GO:0001569;17;-0.27447888;-0.8086907;0.716094;0.916136
GO BP;ACETYL COA BIOSYNTHETIC PROCESS;GO:0006085;22;-0.25489363;-0.8085243;0.7709091;0.91602904
GO BP;REGULATION OF CHROMATIN BINDING;#N/A;19;-0.27002683;-0.8083193;0.7207031;0.91599995
GO BP;KIDNEY MORPHOGENESIS;GO:0060993;48;-0.21995178;-0.8074416;0.787307;0.91711336
GO BP;POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION;GO:1901989;81;-0.19647296;-0.80737936;0.83843535;0.91681147
GO BP;CILIARY BASAL BODY PLASMA MEMBRANE DOCKING;#N/A;94;-0.1926429;-0.80728894;0.84814215;0.91656405
GO BP;FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY;GO:0002431;65;-0.20239331;-0.8065351;0.8289902;0.91742206
GO BP;ORGANELLE FUSION;GO:0048284;99;-0.19066209;-0.8064009;0.85602504;0.91724813
GO BP;NEURAL NUCLEUS DEVELOPMENT;GO:0048857;36;-0.23244825;-0.80598116;0.7860963;0.91756916
GO BP;NEGATIVE REGULATION OF RNA CATABOLIC PROCESS;GO:1902369;48;-0.21770519;-0.80506873;0.7715736;0.91872257
GO BP;REGULATION OF CALCINEURIN MEDIATED SIGNALING;GO:0106056;25;-0.25870496;-0.80436563;0.7560074;0.9194701
GO BP;REGULATION OF ANION TRANSMEMBRANE TRANSPORT;#N/A;16;-0.28252286;-0.8032283;0.7614035;0.92096406
GO BP;NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS;#N/A;52;-0.20974815;-0.8032124;0.8090909;0.9205803
GO BP;PROTEIN CONTAINING COMPLEX REMODELING;#N/A;17;-0.2728365;-0.80316454;0.7380952;0.9202495
GO BP;PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL;GO:0070646;241;-0.16557145;-0.80275506;0.93721974;0.9205391
GO BP;ORGANELLE MEMBRANE FUSION;#N/A;79;-0.19563998;-0.8016748;0.8481848;0.9219015
GO BP;NEGATIVE REGULATION OF NEURON DIFFERENTIATION;GO:0045665;126;-0.18114394;-0.8011865;0.8867624;0.9222843
GO BP;FEMALE MEIOTIC NUCLEAR DIVISION;GO:0007143;24;-0.2458261;-0.80072266;0.76360226;0.92263806
GO BP;CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING;#N/A;408;-0.15738468;-0.80052507;0.9791667;0.92255527
GO BP;REGULATION OF PHOSPHOLIPID METABOLIC PROCESS;GO:1903725;60;-0.20459522;-0.8000662;0.8312611;0.9229162
GO BP;INORGANIC ANION TRANSPORT;GO:0015698;87;-0.19345915;-0.79982585;0.83666664;0.9228779
GO BP;POSITIVE REGULATION OF CILIUM ASSEMBLY;GO:0045724;20;-0.26662955;-0.79915357;0.75495493;0.9235674
GO BP;SEGMENTATION;GO:0035282;51;-0.21100326;-0.7987145;0.7996575;0.92386365
GO BP;BROWN FAT CELL DIFFERENTIATION;GO:0050873;24;-0.25207812;-0.79785186;0.77272725;0.92485934
GO BP;NEGATIVE REGULATION OF TRANSLATIONAL INITIATION;GO:0045947;18;-0.2714741;-0.79778516;0.7504762;0.9245618
GO BP;MRNA CLEAVAGE;GO:0006379;20;-0.262906;-0.7960901;0.76;0.92688817
GO BP;REGULATION OF LIPASE ACTIVITY;#N/A;49;-0.21494974;-0.79605764;0.81512606;0.926531
GO BP;POSITIVE REGULATION OF CYTOKINE SECRETION;GO:0050715;53;-0.20727983;-0.79592973;0.8265993;0.9263347
GO BP;RNA POLYADENYLATION;GO:0043631;43;-0.2186843;-0.7949501;0.7942177;0.9275332
GO BP;DNA DEPENDENT DNA REPLICATION;GO:0006261;136;-0.18024236;-0.7946045;0.89320385;0.92761135
GO BP;POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION;GO:0010575;16;-0.28026053;-0.79449415;0.7731239;0.92739034
GO BP;RNA INTERFERENCE;GO:0016246;16;-0.27640313;-0.7944559;0.74169743;0.9270464
GO BP;NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS;#N/A;65;-0.20036164;-0.7943613;0.83793104;0.92678326
GO BP;REGULATION OF PROTEIN DEPHOSPHORYLATION;GO:0035304;106;-0.18542537;-0.79414326;0.90332806;0.9266956
GO BP;FORMATION OF PRIMARY GERM LAYER;GO:0001704;73;-0.19653368;-0.7940989;0.84102565;0.926355
GO BP;POSITIVE REGULATION OF LIPASE ACTIVITY;#N/A;33;-0.2307171;-0.79386914;0.8140794;0.92632544
GO BP;RAC PROTEIN SIGNAL TRANSDUCTION;GO:0016601;27;-0.23901951;-0.7931885;0.7619863;0.9269412
GO BP;REGULATION OF SPROUTING ANGIOGENESIS;GO:1903670;44;-0.22241093;-0.79240257;0.7846154;0.92774034
GO BP;SCHWANN CELL DEVELOPMENT;GO:0014044;21;-0.25843892;-0.79071045;0.7556391;0.9299742
GO BP;PEROXISOMAL TRANSPORT;#N/A;61;-0.20154051;-0.7905091;0.8373288;0.9298961
GO BP;CARDIAC MUSCLE TISSUE MORPHOGENESIS;GO:0055008;36;-0.22629966;-0.7892709;0.7806216;0.931381
GO BP;NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION;GO:0045599;30;-0.23855072;-0.7888631;0.7960644;0.9316127
GO BP;RESPONSE TO COLD;GO:0009409;31;-0.23433866;-0.7888204;0.7825312;0.9312711
GO BP;MORPHOGENESIS OF A BRANCHING STRUCTURE;GO:0001763;106;-0.18417838;-0.78869295;0.9004975;0.9310645
GO BP;OOCYTE MATURATION;GO:0001556;17;-0.26924115;-0.7867659;0.74910396;0.93351775
GO BP;NATURAL KILLER CELL MEDIATED IMMUNITY;#N/A;21;-0.25576597;-0.78671557;0.78315413;0.93318397
GO BP;ACIDIC AMINO ACID TRANSPORT;#N/A;35;-0.22621006;-0.78646266;0.8011152;0.9331377
GO BP;MACROPHAGE CHEMOTAXIS;GO:0048246;19;-0.2598776;-0.78631043;0.7816514;0.93294823
GO BP;MESENCHYMAL CELL DIFFERENTIATION;GO:0048762;128;-0.17799081;-0.78616446;0.9083601;0.93276966
GO BP;CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION;GO:0021799;17;-0.2744116;-0.78606;0.770073;0.932518
GO BP;NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY;GO:1904030;24;-0.24682443;-0.7859581;0.7708333;0.9322822
GO BP;FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0008543;67;-0.19595595;-0.78569293;0.86882454;0.93227935
GO BP;PROTEIN DEMANNOSYLATION;#N/A;17;-0.26735878;-0.7842478;0.78236395;0.9339916
GO BP;POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY;GO:0090263;112;-0.17932087;-0.78403664;0.8998358;0.9338817
GO BP;REGULATION OF B CELL MEDIATED IMMUNITY;#N/A;26;-0.24028464;-0.78349537;0.7902098;0.93427444
GO BP;NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;GO:2000515;15;-0.27758598;-0.7828384;0.77196264;0.93483055
GO BP;POSITIVE REGULATION OF B CELL PROLIFERATION;GO:0030890;22;-0.2563203;-0.78266525;0.7643885;0.9346691
GO BP;NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS;GO:0009124;35;-0.22620974;-0.78215384;0.8241379;0.9350202
GO BP;BRAIN MORPHOGENESIS;GO:0048854;19;-0.25944322;-0.7812303;0.7706422;0.93590176
GO BP;NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS;GO:1903671;18;-0.25947818;-0.7811052;0.75768536;0.93570226
GO BP;MITOTIC CHROMOSOME CONDENSATION;GO:0007076;16;-0.27832147;-0.7810469;0.7662835;0.9353782
GO BP;AMINO ACID TRANSMEMBRANE TRANSPORT;GO:0003333;48;-0.20763382;-0.7803209;0.8318264;0.93599004
GO BP;CELL DEATH IN RESPONSE TO OXIDATIVE STRESS;GO:0036473;60;-0.19990936;-0.77953374;0.8569132;0.9367161
GO BP;REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS;GO:2000369;15;-0.27488303;-0.7784062;0.7427466;0.93792
GO BP;REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS;GO:0099072;43;-0.21413028;-0.7783322;0.85982907;0.93762755
GO BP;NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001237;70;-0.19698824;-0.7782461;0.8440208;0.93732595
GO BP;POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION;GO:0045648;24;-0.2473956;-0.77785146;0.7937385;0.93748266
GO BP;METAPHASE PLATE CONGRESSION;GO:0051310;54;-0.20140354;-0.7771481;0.8573883;0.9381096
GO BP;ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007193;20;-0.25658193;-0.77543145;0.7809695;0.94004333
GO BP;REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING;GO:0006349;15;-0.27598384;-0.7751535;0.7649186;0.9400229
GO BP;METAPHASE ANAPHASE TRANSITION OF CELL CYCLE;#N/A;52;-0.20117058;-0.77464557;0.8536155;0.9402998
GO BP;POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY;#N/A;39;-0.21823424;-0.77389175;0.8239437;0.94091153
GO BP;POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY;GO:0045747;32;-0.2266536;-0.77295125;0.8173759;0.941761
GO BP;POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION;GO:0035307;31;-0.23022431;-0.7728607;0.81475127;0.94147503
GO BP;NUCLEAR ENVELOPE REASSEMBLY;GO:0031468;17;-0.26472506;-0.771973;0.7892791;0.9422883
GO BP;RESPONSE TO X RAY;GO:0010165;29;-0.23222741;-0.77123314;0.81834865;0.94288915
GO BP;POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS;#N/A;31;-0.23096485;-0.7707787;0.83076924;0.9431101
GO BP;NEUROTRANSMITTER SECRETION;GO:0007269;85;-0.1843489;-0.7697435;0.8818493;0.94407874
GO BP;ENDOPLASMIC RETICULUM MANNOSE TRIMMING;#N/A;15;-0.27107725;-0.7684568;0.7816514;0.9453871
GO BP;GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT;GO:0043001;37;-0.21827164;-0.76841766;0.83161515;0.94503194
GO BP;IRON ION HOMEOSTASIS;GO:0055072;61;-0.19660895;-0.7680361;0.88729876;0.9451091
GO BP;RENAL TUBULE DEVELOPMENT;GO:0061326;51;-0.20711109;-0.7678284;0.85555553;0.9449817
GO BP;DEVELOPMENTAL PIGMENTATION;GO:0048066;29;-0.2309964;-0.7678242;0.8242531;0.9445795
GO BP;REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS;#N/A;80;-0.1882396;-0.767817;0.8877551;0.94418305
GO BP;POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;GO:1903428;25;-0.23808372;-0.76750666;0.8159292;0.94416994
GO BP;POSITIVE REGULATION OF B CELL ACTIVATION;GO:0050871;46;-0.20852135;-0.76697266;0.8629442;0.94451106
GO BP;CELL CYCLE G2 M PHASE TRANSITION;GO:0044839;241;-0.1590797;-0.7666345;0.9705015;0.9445399
GO BP;REGULATION OF KERATINOCYTE PROLIFERATION;GO:0010837;22;-0.24611706;-0.7658848;0.84;0.9451471
GO BP;SPERM EGG RECOGNITION;GO:0035036;20;-0.24834463;-0.7650316;0.7985348;0.9458257
GO BP;PROTEIN DEGLYCOSYLATION;GO:0006517;25;-0.2390946;-0.76479954;0.8078995;0.94570935
GO BP;NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION;GO:0032480;31;-0.22350237;-0.76415855;0.84375;0.9461237
GO BP;TERMINATION OF RNA POLYMERASE II TRANSCRIPTION;GO:0006369;33;-0.22297208;-0.7641262;0.8201439;0.9457532
GO BP;VESICLE LOCALIZATION;GO:0051648;165;-0.16653556;-0.7636932;0.9463722;0.9458937
GO BP;POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS;GO:2000573;56;-0.20061208;-0.76349604;0.8899836;0.9457877
GO BP;REGULATION OF RECEPTOR RECYCLING;GO:0001919;20;-0.25321606;-0.76339763;0.78798586;0.9454956
GO BP;POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS;GO:0002690;40;-0.21314615;-0.7625322;0.8680556;0.9461713
GO BP;NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION;GO:0032715;16;-0.26257503;-0.7610068;0.8235294;0.9476711
GO BP;NEGATIVE REGULATION OF PROTEIN MATURATION;#N/A;22;-0.24371333;-0.7599669;0.8256228;0.94855946
GO BP;CELLULAR IRON ION HOMEOSTASIS;GO:0006879;48;-0.20332338;-0.7594747;0.8423913;0.94874436
GO BP;DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION;GO:0006271;17;-0.26102942;-0.75905716;0.80106574;0.94884306
GO BP;MITOTIC G2 DNA DAMAGE CHECKPOINT;GO:0007095;18;-0.2561319;-0.758821;0.79602885;0.94873285
GO BP;REGULATION OF RNA SPLICING;GO:0043484;116;-0.17492408;-0.75881374;0.93585527;0.94833785
GO BP;POSITIVE REGULATION OF VIRAL PROCESS;GO:0048524;95;-0.17980057;-0.7587051;0.920339;0.948076
GO BP;POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY;#N/A;16;-0.26242366;-0.7582347;0.8164794;0.94825965
GO BP;RESPONSE TO FIBROBLAST GROWTH FACTOR;GO:0071774;85;-0.18239836;-0.75817627;0.92654425;0.9479267
GO BP;POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY;GO:0010518;27;-0.23299067;-0.7569164;0.83460075;0.94909394
GO BP;CYTOKINE SECRETION;GO:0050663;105;-0.17417663;-0.7565146;0.9361702;0.9491554
GO BP;COAGULATION;#N/A;194;-0.16144358;-0.7563501;0.98024315;0.94894695
GO BP;MONOSACCHARIDE BIOSYNTHETIC PROCESS;#N/A;72;-0.18825701;-0.75597733;0.89918697;0.948994
GO BP;MEIOTIC CHROMOSOME SEPARATION;GO:0051307;17;-0.26378208;-0.755356;0.81881535;0.94937414
GO BP;REGULATION OF NEURON PROJECTION REGENERATION;GO:0070570;20;-0.25236654;-0.75523084;0.797075;0.94911927
GO BP;PROTEIN POLYUBIQUITINATION;GO:0000209;260;-0.15405351;-0.7545434;0.98682284;0.9495446
GO BP;G1 DNA DAMAGE CHECKPOINT;#N/A;59;-0.1928196;-0.7527351;0.8718802;0.9513617
GO BP;MITOTIC CELL CYCLE CHECKPOINT;GO:0007093;149;-0.1656035;-0.75263184;0.96899223;0.9510773
GO BP;VITAMIN TRANSPORT;GO:0051180;26;-0.23297584;-0.75205046;0.8272059;0.95138377
GO BP;T CELL MEDIATED CYTOTOXICITY;GO:0001913;17;-0.2624939;-0.75119954;0.8201581;0.95198154
GO BP;REGULATION OF CELLULAR RESPONSE TO DRUG;GO:2001038;22;-0.2384389;-0.75048023;0.84036696;0.95244527
GO BP;PODOSOME ASSEMBLY;GO:0071800;16;-0.26448068;-0.7497939;0.8318426;0.9528432
GO BP;CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS;GO:0006921;27;-0.22456716;-0.74971783;0.8406305;0.952524
GO BP;ESTROGEN METABOLIC PROCESS;GO:0008210;16;-0.26417807;-0.74939924;0.8146067;0.9525117
GO BP;NEGATIVE REGULATION OF WNT SIGNALING PATHWAY;GO:0030178;151;-0.16409619;-0.74927527;0.96400625;0.952245
GO BP;REGULATION OF NEUROTRANSMITTER SECRETION;GO:0046928;52;-0.19718657;-0.74807817;0.8965517;0.9531922
GO BP;VENTRICULAR SYSTEM DEVELOPMENT;GO:0021591;19;-0.25004253;-0.7466667;0.8264015;0.9544394
GO BP;INTERLEUKIN 1 BETA PRODUCTION;GO:0032611;36;-0.2170378;-0.7456271;0.87808895;0.95517457
GO BP;HISTONE H2A MONOUBIQUITINATION;GO:0035518;17;-0.25991908;-0.74440885;0.83364487;0.95612913
GO BP;PROTEIN EXIT FROM ENDOPLASMIC RETICULUM;GO:0032527;39;-0.20701386;-0.74410546;0.8781302;0.9560907
GO BP;NUCLEOTIDE EXCISION REPAIR;GO:0006289;103;-0.17291334;-0.7426939;0.9453376;0.9572668
GO BP;NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY;GO:0043433;105;-0.1741885;-0.74231803;0.95309883;0.9572676
GO BP;STEM CELL DIVISION;GO:0017145;30;-0.21748926;-0.7418367;0.85842294;0.95736843
GO BP;NEGATIVE REGULATION OF BINDING;#N/A;103;-0.17150162;-0.74044794;0.93779904;0.9584853
GO BP;POSITIVE REGULATION OF PROTEIN MATURATION;GO:1903319;17;-0.2531704;-0.7387635;0.85009485;0.95988774
GO BP;MITOCHONDRIAL DEPOLARIZATION;GO:0051882;15;-0.26166362;-0.73851615;0.8414179;0.9597352
GO BP;REGULATION OF COFACTOR METABOLIC PROCESS;#N/A;27;-0.22614084;-0.7382717;0.8596491;0.95958626
GO BP;NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS;GO:1900077;23;-0.23664409;-0.73813635;0.85842294;0.95932543
GO BP;MECHANORECEPTOR DIFFERENTIATION;GO:0042490;38;-0.20401482;-0.73699814;0.88351256;0.96012545
GO BP;POSITIVE REGULATION OF LIPID KINASE ACTIVITY;GO:0090218;23;-0.23140536;-0.73642504;0.8596803;0.96030915
GO BP;HORMONE BIOSYNTHETIC PROCESS;GO:0042446;48;-0.19481705;-0.73610055;0.9072848;0.9602293
GO BP;REGULATION OF TELOMERASE ACTIVITY;GO:0051972;42;-0.20335668;-0.7358644;0.8747826;0.9600875
GO BP;MITOCHONDRIAL FISSION;GO:0000266;31;-0.214842;-0.73542255;0.8733459;0.9601372
GO BP;MITOCHONDRIAL GENOME MAINTENANCE;GO:0000002;20;-0.2408816;-0.7348651;0.835443;0.9603182
GO BP;POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING;GO:1900026;30;-0.21989778;-0.7346239;0.8599641;0.96017206
GO BP;ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY;#N/A;36;-0.20859772;-0.7335222;0.8862876;0.9609061
GO BP;NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT;GO:0010977;96;-0.17379309;-0.73285156;0.953719;0.96117616
GO BP;DIGESTIVE SYSTEM PROCESS;#N/A;40;-0.20682456;-0.7321175;0.9023973;0.9615303
GO BP;NEGATIVE REGULATION OF B CELL ACTIVATION;GO:0050869;19;-0.24358729;-0.7320882;0.82789856;0.96116143
GO BP;SYNAPTIC VESICLE ENDOCYTOSIS;GO:0048488;41;-0.19971278;-0.7312216;0.88495576;0.96162343
GO BP;SNARE COMPLEX ASSEMBLY;GO:0035493;16;-0.25394726;-0.7308409;0.82624114;0.96160984
GO BP;PROTEIN ADP RIBOSYLATION;GO:0006471;29;-0.22289921;-0.7292888;0.86725664;0.9627526
GO BP;CERAMIDE BIOSYNTHETIC PROCESS;GO:0046513;48;-0.19823608;-0.7288998;0.8991453;0.96273404
GO BP;REGULATION OF POSTSYNAPSE ORGANIZATION;GO:0099175;55;-0.19293897;-0.7285984;0.8983333;0.9626435
GO BP;PROTEIN LOCALIZATION TO NUCLEOLUS;GO:1902570;15;-0.2622188;-0.728406;0.8311927;0.9624153
GO BP;REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING;GO:1900024;43;-0.2000225;-0.727764;0.8831615;0.96262616
GO BP;REGULATION OF NEUROTRANSMITTER TRANSPORT;#N/A;67;-0.18027423;-0.7276361;0.9456869;0.9623435
GO BP;NEGATIVE REGULATION OF RESPONSE TO WOUNDING;#N/A;54;-0.19177441;-0.72735256;0.895189;0.9622144
GO BP;PEROXISOME ORGANIZATION;GO:0007031;70;-0.18182644;-0.7269038;0.925;0.9622183
GO BP;OLIGODENDROCYTE DIFFERENTIATION;GO:0048709;51;-0.19017974;-0.7268544;0.915683;0.9618707
GO BP;POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION;GO:0014911;25;-0.22666056;-0.72508156;0.8487085;0.9632011
GO BP;POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION;GO:0010800;20;-0.23736463;-0.7244845;0.8680927;0.96332854
GO BP;POSITIVE REGULATION OF TRANSLATION;GO:0045727;102;-0.16832727;-0.723804;0.9598662;0.96354204
GO BP;NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION;GO:0033137;19;-0.24083543;-0.7236314;0.8552381;0.963315
GO BP;FERTILIZATION;GO:0009566;79;-0.1746364;-0.7224204;0.928808;0.9640714
GO BP;POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY;GO:0002711;19;-0.24506155;-0.7221075;0.85251796;0.963957
GO BP;LONG TERM SYNAPTIC DEPRESSION;GO:0060292;16;-0.2550317;-0.721977;0.83778965;0.96368164
GO BP;POSTSYNAPTIC MEMBRANE ORGANIZATION;GO:0001941;17;-0.24746239;-0.7213741;0.845614;0.963841
GO BP;STRESS GRANULE ASSEMBLY;GO:0034063;19;-0.24153666;-0.7212282;0.8717949;0.9635802
GO BP;NEGATIVE REGULATION OF CYTOKINE SECRETION;GO:0050710;28;-0.21787393;-0.72099143;0.86491555;0.96338046
GO BP;REGULATION OF IMMUNOGLOBULIN PRODUCTION;GO:0002637;36;-0.20811528;-0.72033;0.88790035;0.9635531
GO BP;REGULATION OF BEHAVIOR;GO:0050795;21;-0.23246232;-0.719527;0.85714287;0.9638967
GO BP;TYPE B PANCREATIC CELL PROLIFERATION;GO:0044342;17;-0.25018588;-0.7183725;0.83425415;0.9645697
GO BP;NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS;GO:1903845;53;-0.1885204;-0.71661067;0.90909094;0.9657348
GO BP;REGULATION OF BONE REMODELING;GO:0046850;26;-0.22051224;-0.7158795;0.87298745;0.96596664
GO BP;LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT;GO:0060716;15;-0.25756878;-0.7158487;0.8589065;0.96559185
GO BP;RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE;GO:1990126;26;-0.21626516;-0.7149408;0.8723022;0.96598524
GO BP;RESPONSE TO COPPER ION;GO:0046688;23;-0.22439592;-0.71439916;0.8721137;0.9660623
GO BP;REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY;GO:2000479;15;-0.25334015;-0.7132507;0.8574007;0.9667038
GO BP;DNA DOUBLE STRAND BREAK PROCESSING;GO:0000729;22;-0.23346865;-0.71089566;0.85504586;0.96834034
GO BP;REGULATION OF MONONUCLEAR CELL MIGRATION;#N/A;24;-0.22524403;-0.710764;0.88224953;0.9680488
GO BP;REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR;GO:1902253;24;-0.22522792;-0.7106196;0.8780069;0.96776694
GO BP;PROTEIN TRIMERIZATION;GO:0070206;28;-0.2146452;-0.7087899;0.8955224;0.968928
GO BP;DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION;#N/A;48;-0.18902585;-0.7087571;0.9417808;0.9685472
GO BP;UBIQUINONE METABOLIC PROCESS;GO:0006743;16;-0.24364762;-0.70749724;0.8734694;0.9691856
GO BP;CYTOSOLIC TRANSPORT;GO:0016482;136;-0.15792674;-0.70713603;0.97987616;0.96909696
GO BP;CAMERA TYPE EYE MORPHOGENESIS;GO:0048593;66;-0.17849697;-0.70627314;0.9326765;0.96940243
GO BP;POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL;#N/A;108;-0.16327548;-0.7032821;0.980198;0.9714081
GO BP;NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION;#N/A;24;-0.22160083;-0.7028209;0.8839286;0.97136223
GO BP;NEURAL RETINA DEVELOPMENT;GO:0003407;31;-0.20810707;-0.701897;0.88949275;0.9716751
GO BP;DIGESTION;GO:0007586;51;-0.18581326;-0.70026934;0.93887943;0.9725471
GO BP;REGULATION OF RUFFLE ASSEMBLY;GO:1900027;24;-0.22333145;-0.69955605;0.88299817;0.97270536
GO BP;RETROGRADE TRANSPORT ENDOSOME TO GOLGI;GO:0042147;71;-0.17279522;-0.6972499;0.95726496;0.974129
GO BP;MESONEPHROS DEVELOPMENT;GO:0001823;53;-0.18107179;-0.6970775;0.9426087;0.9738648
GO BP;DRUG CATABOLIC PROCESS;GO:0042737;72;-0.17230332;-0.6961445;0.9532554;0.97416884
GO BP;NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION;GO:0035308;49;-0.18374433;-0.6960087;0.9522124;0.97386396
GO BP;REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY;GO:0060765;23;-0.22223778;-0.69586945;0.8667917;0.973588
GO BP;PHAGOSOME ACIDIFICATION;GO:0090383;24;-0.2198007;-0.69352007;0.8943396;0.97493404
GO BP;CELLULAR RESPONSE TO ALCOHOL;#N/A;52;-0.1827556;-0.69272757;0.9480519;0.97512233
GO BP;MYELOID CELL APOPTOTIC PROCESS;GO:0033028;19;-0.23154742;-0.6917342;0.8976661;0.9754635
GO BP;LENS FIBER CELL DIFFERENTIATION;GO:0070306;15;-0.2525629;-0.69144803;0.87142855;0.97526914
GO BP;INTERLEUKIN 1 PRODUCTION;GO:0032612;41;-0.19255851;-0.6901829;0.93939394;0.97582513
GO BP;REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY;#N/A;16;-0.24361986;-0.68939114;0.87895715;0.97599584
GO BP;MODULATION BY HOST OF VIRAL PROCESS;GO:0044788;19;-0.2319809;-0.6887317;0.90625;0.9760611
GO BP;NEGATIVE REGULATION OF MUSCLE HYPERTROPHY;#N/A;19;-0.22974513;-0.68815714;0.89279115;0.97604394
GO BP;NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY;GO:0032088;51;-0.18196632;-0.6878874;0.93939394;0.97584164
GO BP;DNA UNWINDING INVOLVED IN DNA REPLICATION;GO:0006268;15;-0.250994;-0.6878454;0.89311594;0.97546846
GO BP;L AMINO ACID TRANSPORT;GO:0015807;36;-0.19745812;-0.68707603;0.9178832;0.975599
GO BP;RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM;GO:1903514;16;-0.24036491;-0.68643063;0.8635548;0.975646
GO BP;NEGATIVE REGULATION OF ORGAN GROWTH;GO:0046621;21;-0.22375876;-0.6863182;0.8852459;0.9753179
GO BP;CATECHOLAMINE SECRETION;GO:0050432;19;-0.2262126;-0.68590564;0.9005628;0.9751941
GO BP;FEEDING BEHAVIOR;GO:0007631;29;-0.210004;-0.6847802;0.91240877;0.9755253
GO BP;TERMINATION OF RNA POLYMERASE I TRANSCRIPTION;GO:0006363;30;-0.20466189;-0.68355805;0.9270833;0.9759158
GO BP;CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION;#N/A;16;-0.24084032;-0.6810444;0.88747734;0.97716147
GO BP;NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE;GO:0032211;19;-0.22902411;-0.68071127;0.9007353;0.97698385
GO BP;ANDROGEN RECEPTOR SIGNALING PATHWAY;GO:0030521;51;-0.18026759;-0.68013287;0.9612142;0.97695684
GO BP;REGULATION OF PHOSPHOLIPASE ACTIVITY;#N/A;36;-0.19452584;-0.6801215;0.93613136;0.97656715
GO BP;CHROMATIN SILENCING AT RDNA;#N/A;28;-0.20641296;-0.6799397;0.91905564;0.9762717
GO BP;APOPTOTIC DNA FRAGMENTATION;GO:0006309;19;-0.22353049;-0.6792241;0.8815789;0.97630155
GO BP;POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM;GO:1905332;19;-0.2258399;-0.6783904;0.9010989;0.97641027
GO BP;CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE;GO:0036474;19;-0.2277212;-0.6759905;0.8936937;0.9775296
GO BP;BLASTOCYST GROWTH;GO:0001832;17;-0.23082927;-0.6758684;0.9032882;0.9772144
GO BP;POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY;GO:0051443;26;-0.21108271;-0.67578125;0.9031079;0.9768653
GO BP;CELL FATE SPECIFICATION;GO:0001708;34;-0.19233923;-0.67569035;0.9472727;0.9765195
GO BP;LAMELLIPODIUM ORGANIZATION;GO:0097581;56;-0.17446305;-0.6756589;0.9656357;0.9761388
GO BP;NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION;GO:0050805;35;-0.19354416;-0.67520165;0.9280702;0.97603667
GO BP;EMBRYONIC EYE MORPHOGENESIS;GO:0048048;16;-0.23556508;-0.66877335;0.9116118;0.9795329
GO BP;ESTABLISHMENT OF MITOCHONDRION LOCALIZATION;GO:0051654;22;-0.21138851;-0.6679507;0.92045456;0.979614
GO BP;ANDROGEN METABOLIC PROCESS;GO:0008209;16;-0.23021469;-0.6666676;0.9095841;0.97996897
GO BP;CELL FATE DETERMINATION;GO:0001709;17;-0.2262493;-0.6663888;0.88269234;0.97973996
GO BP;ACUTE INFLAMMATORY RESPONSE;GO:0002526;41;-0.18718992;-0.6663271;0.94938916;0.9793727
GO BP;NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION;GO:0010801;16;-0.2351971;-0.6644572;0.9003831;0.9800409
GO BP;REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM;GO:0070861;21;-0.21441633;-0.66386795;0.9193246;0.9799657
GO BP;SULFUR COMPOUND TRANSPORT;#N/A;33;-0.19278851;-0.66270083;0.94827586;0.98022926
GO BP;RECEPTOR CLUSTERING;GO:0043113;32;-0.19436513;-0.66003335;0.942959;0.98129857
GO BP;MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS;#N/A;22;-0.21326497;-0.65833694;0.9038817;0.98180854
GO BP;GLUCOSE 6 PHOSPHATE METABOLIC PROCESS;GO:0051156;20;-0.21530508;-0.6522482;0.90859234;0.9844595
GO BP;REGULATION OF VACUOLE ORGANIZATION;GO:0044088;42;-0.17778759;-0.6513283;0.9542962;0.9845273
GO BP;REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:1901796;158;-0.1417808;-0.6502975;0.9968553;0.98463696
GO BP;OXIDOREDUCTION COENZYME METABOLIC PROCESS;#N/A;39;-0.17973168;-0.64796996;0.96953404;0.9853642
GO BP;POSITIVE REGULATION OF LIPID TRANSPORT;GO:0032370;32;-0.19042332;-0.64686126;0.9503676;0.98548585
GO BP;REGULATION OF LAMELLIPODIUM ASSEMBLY;GO:0010591;21;-0.2076633;-0.64654094;0.93601465;0.98523146
GO BP;REGULATION OF CELLULAR RESPIRATION;GO:0043457;25;-0.20358902;-0.6460838;0.9491833;0.98504657
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS;#N/A;18;-0.21920116;-0.6456898;0.9422719;0.98481786
GO BP;GOLGI VESICLE BUDDING;GO:0048194;68;-0.16510926;-0.6446738;0.98126066;0.98489565
GO BP;NEGATIVE REGULATION OF WOUND HEALING;GO:0061045;45;-0.17555816;-0.64277905;0.95862067;0.98537946
GO BP;DOSAGE COMPENSATION;GO:0007549;18;-0.22043744;-0.641585;0.93135434;0.9855404
GO BP;PHAGOSOME MATURATION;GO:0090382;34;-0.18708095;-0.64153194;0.9554367;0.98517084
GO BP;POSITIVE REGULATION OF VIRAL GENOME REPLICATION;GO:0045070;31;-0.18951729;-0.64146715;0.9542373;0.98480356
GO BP;REGULATION OF RESPONSE TO INTERFERON GAMMA;GO:0060330;15;-0.230493;-0.64038724;0.90203327;0.9848919
GO BP;NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE;GO:0045824;26;-0.19901097;-0.6399776;0.93284935;0.9846943
GO BP;REGULATION OF TRANSLATIONAL INITIATION;GO:0006446;66;-0.16095568;-0.6387331;0.9779661;0.9848292
GO BP;DOPAMINE RECEPTOR SIGNALING PATHWAY;GO:0007212;20;-0.21002175;-0.6381535;0.94332725;0.98470134
GO BP;SYNAPTIC VESICLE PRIMING;GO:0016082;15;-0.23028268;-0.63784504;0.9328215;0.98442423
GO BP;REGULATION OF NUCLEASE ACTIVITY;#N/A;17;-0.21907575;-0.6370583;0.92395437;0.9843611
GO BP;PROTEIN HETEROTETRAMERIZATION;GO:0051290;33;-0.18746081;-0.63490385;0.9589286;0.98488164
GO BP;PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY;#N/A;16;-0.21812353;-0.633107;0.9237918;0.98520696
GO BP;PROTEIN KINASE A SIGNALING;GO:0010737;18;-0.21327068;-0.631559;0.9140351;0.9854475
GO BP;INTESTINAL ABSORPTION;GO:0050892;22;-0.20357306;-0.630898;0.93877554;0.985313
GO BP;PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS;GO:0042558;29;-0.18818909;-0.62879467;0.95035464;0.98574305
GO BP;B CELL RECEPTOR SIGNALING PATHWAY;GO:0050853;32;-0.18550925;-0.6265116;0.96350366;0.9862488
GO BP;SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT;GO:0070296;19;-0.21099448;-0.62552327;0.94609666;0.9862455
GO BP;CARBOHYDRATE PHOSPHORYLATION;GO:0046835;22;-0.20196602;-0.62386394;0.92706335;0.98649436
GO BP;EXPORT ACROSS PLASMA MEMBRANE;GO:0140115;23;-0.1984042;-0.62257075;0.9447323;0.98656404
GO BP;NEGATIVE REGULATION OF COAGULATION;GO:0050819;31;-0.18590352;-0.61953104;0.97431195;0.987243
GO BP;AMINO SUGAR METABOLIC PROCESS;#N/A;25;-0.1947636;-0.61903524;0.94485295;0.98703265
GO BP;SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS;GO:0016447;35;-0.17513245;-0.6171713;0.97020483;0.98726577
GO BP;REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902175;22;-0.19805901;-0.6153403;0.939781;0.98753697
GO BP;EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT;#N/A;21;-0.19765611;-0.6082814;0.9422383;0.9894876
GO BP;SERINE FAMILY AMINO ACID METABOLIC PROCESS;GO:0009069;31;-0.1801797;-0.60708445;0.9770723;0.9894754
GO BP;POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION;GO:1902745;21;-0.19812648;-0.6060614;0.95567375;0.98939323
GO BP;REGULATION OF FIBROBLAST MIGRATION;GO:0010762;19;-0.2034456;-0.6059291;0.9441624;0.9890306
GO BP;NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION;GO:2000104;18;-0.2074464;-0.59996164;0.9556377;0.99039817
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN;GO:0048002;139;-0.13277292;-0.59713703;1;0.9908016
GO BP;REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL;GO:0051279;37;-0.16810024;-0.5892032;0.9780776;0.9924392
GO BP;GLYCOGEN BIOSYNTHETIC PROCESS;GO:0005978;33;-0.17052831;-0.5881164;0.9810671;0.9922925
GO BP;SECONDARY METABOLIC PROCESS;GO:0019748;30;-0.17640547;-0.5875792;0.9896373;0.9920194
GO BP;HISTONE H2A ACETYLATION;GO:0043968;16;-0.20506719;-0.587191;0.9446367;0.9917304
GO BP;PSEUDOURIDINE SYNTHESIS;GO:0001522;17;-0.20304139;-0.5865754;0.9605735;0.9914933
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY;#N/A;15;-0.20888306;-0.5821399;0.9588015;0.99215144
GO BP;INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS;GO:0002437;24;-0.18293802;-0.57960296;0.9809886;0.9923566
GO BP;INTERMEDIATE FILAMENT BASED PROCESS;GO:0045103;35;-0.16892491;-0.57784206;0.9858906;0.9923496
GO BP;REGULATION OF GLUCONEOGENESIS;GO:0006111;33;-0.16739;-0.57590836;0.979206;0.992368
GO BP;NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902176;15;-0.20773372;-0.5746291;0.9708029;0.99224436
GO BP;ANTIBACTERIAL HUMORAL RESPONSE;GO:0019731;17;-0.19606268;-0.5664813;0.9692586;0.9934979
GO BP;RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION;#N/A;16;-0.1949928;-0.5550192;0.9662289;0.99510944
GO BP;COPII COATED VESICLE BUDDING;GO:0090114;60;-0.14339474;-0.55346143;0.9965217;0.994953
GO BP;TOXIN METABOLIC PROCESS;GO:0009404;15;-0.19741939;-0.55015075;0.9759259;0.9950808
GO BP;FOLIC ACID METABOLIC PROCESS;GO:0046655;16;-0.19588855;-0.5487652;0.98320895;0.9949094
GO BP;PROSTATE GLAND DEVELOPMENT;GO:0030850;32;-0.16000439;-0.543116;0.99445474;0.9953203
GO BP;INTERLEUKIN 1 SECRETION;#N/A;24;-0.16612643;-0.53116477;0.98059964;0.99643344
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION;GO:0030858;25;-0.1626202;-0.5256205;0.9910714;0.99664766
GO BP;FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS;GO:0006760;23;-0.16640413;-0.52330273;0.977193;0.9964776
GO BP;DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS;GO:0046386;19;-0.16616417;-0.5027408;0.98550725;0.9978633
GO BP;POSITIVE REGULATION OF TELOMERASE ACTIVITY;GO:0051973;32;-0.14903419;-0.49782816;0.99288255;0.99781793
GO BP;AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS;GO:0009074;20;-0.161342;-0.4896887;0.98899084;0.9979861
GO BP;PORE COMPLEX ASSEMBLY;GO:0046931;17;-0.16894747;-0.48473072;0.98848367;0.99790317
GO BP;PEPTIDE CROSS LINKING;GO:0018149;15;-0.16211586;-0.45701748;0.99633026;0.9986962
KEGG;LEUKOCYTE TRANSENDOTHELIAL MIGRATION;;69;-0.51176035;-2.0421097;0;0.007531414
KEGG;STEROID BIOSYNTHESIS;;16;-0.6312969;-1.7934824;0.015384615;0.104934976
KEGG;MELANOMA;;42;-0.4782168;-1.7519937;0.003590664;0.10756338
KEGG;FOCAL ADHESION;;137;-0.39052182;-1.7413452;0;0.09484818
KEGG;ACUTE MYELOID LEUKEMIA;;50;-0.46058708;-1.7361876;0;0.07895101
KEGG;SMALL CELL LUNG CANCER;;69;-0.42840704;-1.7294954;0;0.07015444
KEGG;APOPTOSIS;;59;-0.4440965;-1.7139217;0.003246753;0.06866804
KEGG;TIGHT JUNCTION;;98;-0.39562792;-1.6739576;0.008077544;0.089558914
KEGG;CHRONIC MYELOID LEUKEMIA;;62;-0.41784573;-1.6542908;0.00174216;0.09549392
KEGG;LYSINE DEGRADATION;;39;-0.46209207;-1.6472156;0.009363296;0.09125777
KEGG;PANCREATIC CANCER;;57;-0.41399208;-1.591482;0.003355705;0.13612725
KEGG;REGULATION OF ACTIN CYTOSKELETON;;148;-0.35163623;-1.5817729;0.001490313;0.13379097
KEGG;LEISHMANIA INFECTION;;39;-0.43763763;-1.5757715;0.019855596;0.12991585
KEGG;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC;;42;-0.42980975;-1.5554225;0.02617801;0.1416841
KEGG;HEMATOPOIETIC CELL LINEAGE;;32;-0.45631388;-1.5531459;0.013422819;0.13450709
KEGG;CYTOKINE CYTOKINE RECEPTOR INTERACTION;;74;-0.3709186;-1.5170809;0.011513158;0.17029983
KEGG;BLADDER CANCER;;35;-0.42638794;-1.4919468;0.038043477;0.19356164
KEGG;PENTOSE PHOSPHATE PATHWAY;;23;-0.4762358;-1.4689318;0.041894354;0.21649939
KEGG;ADIPOCYTOKINE SIGNALING PATHWAY;;49;-0.39653206;-1.4672997;0.031772576;0.20750146
KEGG;T CELL RECEPTOR SIGNALING PATHWAY;;70;-0.35917664;-1.4542584;0.027444255;0.21652442
KEGG;GLIOMA;;49;-0.38608107;-1.454065;0.036842104;0.2066108
KEGG;JAK STAT SIGNALING PATHWAY;;70;-0.3566655;-1.4408593;0.03548387;0.21778259
KEGG;DILATED CARDIOMYOPATHY;;47;-0.38240674;-1.4166815;0.054237287;0.24370433
KEGG;ERBB SIGNALING PATHWAY;;68;-0.35500935;-1.4129018;0.043771043;0.2392705
KEGG;PROSTATE CANCER;;75;-0.3459994;-1.4095004;0.026223777;0.2351656
KEGG;PATHWAYS IN CANCER;;227;-0.29139394;-1.3931416;0.00295421;0.25311992
KEGG;VEGF SIGNALING PATHWAY;;53;-0.364071;-1.3898937;0.06532663;0.24967359
KEGG;HYPERTROPHIC CARDIOMYOPATHY HCM;;47;-0.3739407;-1.3857894;0.05762712;0.24725877
KEGG;NON SMALL CELL LUNG CANCER;;46;-0.37850606;-1.3854573;0.04761905;0.23911774
KEGG;VIRAL MYOCARDITIS;;33;-0.39888418;-1.3742297;0.07636364;0.24798553
KEGG;INSULIN SIGNALING PATHWAY;;103;-0.31831613;-1.3714789;0.035772357;0.24431863
KEGG;B CELL RECEPTOR SIGNALING PATHWAY;;58;-0.34933636;-1.369087;0.061461795;0.24029914
KEGG;NOTCH SIGNALING PATHWAY;;36;-0.39363578;-1.3615569;0.1;0.24548934
KEGG;GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE;;15;-0.4921392;-1.3569725;0.129771;0.24573645
KEGG;MTOR SIGNALING PATHWAY;;40;-0.37278637;-1.3223418;0.09171076;0.29673862
KEGG;RENAL CELL CARCINOMA;;56;-0.3420903;-1.3086623;0.10891089;0.3131865
KEGG;LYSOSOME;;108;-0.29342312;-1.2642257;0.087025315;0.39073607
KEGG;ANTIGEN PROCESSING AND PRESENTATION;;34;-0.36384934;-1.2641696;0.16637169;0.38058066
KEGG;CHEMOKINE SIGNALING PATHWAY;;97;-0.29627526;-1.2578279;0.11336718;0.38380775
KEGG;GLYCOSAMINOGLYCAN DEGRADATION;;15;-0.44527003;-1.2506616;0.1969112;0.38949847
KEGG;CYSTEINE AND METHIONINE METABOLISM;;26;-0.38175735;-1.2464998;0.165692;0.38777578
KEGG;MAPK SIGNALING PATHWAY;;176;-0.26631698;-1.2363075;0.08952959;0.4004687
KEGG;TOLL LIKE RECEPTOR SIGNALING PATHWAY;;58;-0.3162837;-1.2270128;0.15870307;0.41149536
KEGG;BUTANOATE METABOLISM;;23;-0.39383984;-1.2015511;0.21592921;0.45532808
KEGG;CYTOSOLIC DNA SENSING PATHWAY;;31;-0.35180002;-1.191679;0.21880342;0.46813896
KEGG;ECM RECEPTOR INTERACTION;;49;-0.32219356;-1.1903472;0.20344828;0.46088734
KEGG;BASE EXCISION REPAIR;;32;-0.3539838;-1.1880875;0.2226087;0.45641735
KEGG;GLYCINE SERINE AND THREONINE METABOLISM;;21;-0.3873183;-1.1875346;0.22024867;0.4479738
KEGG;SELENOAMINO ACID METABOLISM;;20;-0.39018768;-1.1831319;0.2321755;0.44845566
KEGG;ABC TRANSPORTERS;;30;-0.3572145;-1.1707554;0.22841726;0.4670201
KEGG;CELL ADHESION MOLECULES CAMS;;51;-0.30729827;-1.1651492;0.21070234;0.46984607
KEGG;ENDOMETRIAL CANCER;;44;-0.30978665;-1.1345654;0.2777778;0.53240126
KEGG;ARACHIDONIC ACID METABOLISM;;28;-0.3370991;-1.1173751;0.2849365;0.566233
KEGG;COMPLEMENT AND COAGULATION CASCADES;;26;-0.34601042;-1.1155967;0.3094812;0.56055695
KEGG;AXON GUIDANCE;;84;-0.2635026;-1.0968436;0.2735043;0.5987452
KEGG;GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES;;15;-0.39146775;-1.096454;0.35424355;0.5889829
KEGG;WNT SIGNALING PATHWAY;;97;-0.2578867;-1.0822759;0.27483442;0.6136765
KEGG;TGF BETA SIGNALING PATHWAY;;56;-0.27926508;-1.066596;0.35241503;0.6443548
KEGG;METABOLISM OF XENOBIOTICS BY CYTOCHROME P450;;17;-0.37089518;-1.0574558;0.40574506;0.6576255
KEGG;PYRUVATE METABOLISM;;33;-0.31100726;-1.051682;0.397482;0.6613915
KEGG;O GLYCAN BIOSYNTHESIS;;15;-0.3676563;-1.0486879;0.4037037;0.65798986
KEGG;RIG I LIKE RECEPTOR SIGNALING PATHWAY;;44;-0.29242817;-1.048477;0.3962585;0.6478381
KEGG;FRUCTOSE AND MANNOSE METABOLISM;;30;-0.31331286;-1.039538;0.3871528;0.6601873
KEGG;TYPE II DIABETES MELLITUS;;28;-0.3196621;-1.0381233;0.40377358;0.6532104
KEGG;P53 SIGNALING PATHWAY;;59;-0.25891766;-1.0070869;0.43886098;0.7243502
KEGG;VASCULAR SMOOTH MUSCLE CONTRACTION;;63;-0.25432196;-1.0047153;0.43738976;0.71973634
KEGG;SYSTEMIC LUPUS ERYTHEMATOSUS;;67;-0.25095063;-1.0024484;0.4840336;0.71476805
KEGG;PATHOGENIC ESCHERICHIA COLI INFECTION;;42;-0.2766413;-1.000992;0.45762712;0.70793104
KEGG;NATURAL KILLER CELL MEDIATED CYTOTOXICITY;;56;-0.25942847;-0.9974544;0.4704861;0.70648897
KEGG;LONG TERM POTENTIATION;;42;-0.27615952;-0.9968746;0.48042706;0.69804144
KEGG;COLORECTAL CANCER;;51;-0.26767915;-0.9893895;0.47487003;0.7068329
KEGG;PEROXISOME;;70;-0.24059904;-0.9750977;0.5154639;0.7322775
KEGG;AMYOTROPHIC LATERAL SCLEROSIS ALS;;35;-0.27847567;-0.97340393;0.5123239;0.72608846
KEGG;FC GAMMA R MEDIATED PHAGOCYTOSIS;;73;-0.23963034;-0.9627206;0.5161871;0.74224
KEGG;ENDOCYTOSIS;;140;-0.21219738;-0.9413232;0.6069182;0.7840241
KEGG;HOMOLOGOUS RECOMBINATION;;26;-0.2924926;-0.9400392;0.5377856;0.77657664
KEGG;NEUROTROPHIN SIGNALING PATHWAY;;95;-0.2174364;-0.9303142;0.59247136;0.79133886
KEGG;OOCYTE MEIOSIS;;86;-0.21680064;-0.91301566;0.6229508;0.8246706
KEGG;GLYCEROLIPID METABOLISM;;37;-0.26198786;-0.90825325;0.5972927;0.82492083
KEGG;SPHINGOLIPID METABOLISM;;33;-0.2590891;-0.8987816;0.61702126;0.837217
KEGG;MISMATCH REPAIR;;22;-0.27835476;-0.87661105;0.64285713;0.87876207
KEGG;VASOPRESSIN REGULATED WATER REABSORPTION;;35;-0.24793708;-0.8726665;0.65363127;0.8769747
KEGG;UBIQUITIN MEDIATED PROTEOLYSIS;;122;-0.1972781;-0.8683335;0.7455717;0.87670046
KEGG;CELL CYCLE;;116;-0.19565849;-0.8514618;0.7830941;0.90478724
KEGG;ALDOSTERONE REGULATED SODIUM REABSORPTION;;28;-0.26253417;-0.8426299;0.6994434;0.91366935
KEGG;VIBRIO CHOLERAE INFECTION;;44;-0.22273614;-0.8075181;0.7918871;0.97461134
KEGG;CITRATE CYCLE TCA CYCLE;;29;-0.23916766;-0.80444694;0.75774133;0.9692458
KEGG;GLUTATHIONE METABOLISM;;38;-0.22620332;-0.79470235;0.8056042;0.97553223
KEGG;RNA POLYMERASE;;25;-0.2445722;-0.77490973;0.7798507;0.9974145
KEGG;THYROID CANCER;;23;-0.24450758;-0.7641839;0.8180147;1
KEGG;EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION;;54;-0.19833373;-0.75688845;0.8603839;1
KEGG;VALINE LEUCINE AND ISOLEUCINE DEGRADATION;;37;-0.21258914;-0.75613564;0.84680134;0.9929907
KEGG;INOSITOL PHOSPHATE METABOLISM;;47;-0.20405672;-0.74823624;0.8651877;0.992948
KEGG;DNA REPLICATION;;34;-0.21810885;-0.7373295;0.8938849;0.99628407
KEGG;GLYCOLYSIS GLUCONEOGENESIS;;41;-0.19964077;-0.72213304;0.8935018;1
KEGG;DRUG METABOLISM OTHER ENZYMES;;20;-0.23125774;-0.71421;0.8791209;1
KEGG;ONE CARBON POOL BY FOLATE;;15;-0.25192723;-0.7100288;0.84415585;0.9964701
KEGG;OLFACTORY TRANSDUCTION;;17;-0.23165151;-0.6802316;0.9192913;1
KEGG;PORPHYRIN AND CHLOROPHYLL METABOLISM;;21;-0.21759681;-0.6612545;0.8929889;1
KEGG;BIOSYNTHESIS OF UNSATURATED FATTY ACIDS;;18;-0.21600668;-0.6512286;0.9240506;1
KEGG;ADHERENS JUNCTION;;60;-0.1645726;-0.6380844;0.97565216;1
KEGG;TRYPTOPHAN METABOLISM;;20;-0.19423802;-0.58725077;0.9677419;1
KEGG;DRUG METABOLISM CYTOCHROME P450;;18;-0.17809336;-0.51928073;0.97894734;1
KEGG;AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM;;37;-0.14204864;-0.4957201;0.99822694;1
KEGG;GALACTOSE METABOLISM;;20;-0.16172422;-0.4899994;0.991119;1
KEGG;REGULATION OF AUTOPHAGY;;18;-0.15494265;-0.46326756;0.9947735;0.99823654
KEGG;RIBOSOME;;80;0.76115423;3.3238664;0;0
KEGG;OXIDATIVE PHOSPHORYLATION;;112;0.43576694;1.9923407;0;0.006585734
KEGG;PARKINSONS DISEASE;;107;0.43210694;1.9877541;0;0.005098816
KEGG;PROTEASOME;;36;0.5040236;1.837361;0;0.01974022
KEGG;PROTEIN EXPORT;;22;0.48015243;1.5695534;0.018604651;0.16565457
KEGG;NICOTINATE AND NICOTINAMIDE METABOLISM;;19;0.49607664;1.5656028;0.03524229;0.1422547
KEGG;ALZHEIMERS DISEASE;;130;0.32304284;1.5149873;0.008287293;0.17595868
KEGG;HUNTINGTONS DISEASE;;145;0.31369585;1.5069243;0.002724796;0.16325049
KEGG;PANTOTHENATE AND COA BIOSYNTHESIS;;15;0.46374714;1.3582543;0.11158799;0.37884644
KEGG;CARDIAC MUSCLE CONTRACTION;;44;0.35401064;1.3395058;0.08695652;0.38253027
KEGG;GNRH SIGNALING PATHWAY;;65;0.31671837;1.3115182;0.08095238;0.4114526
KEGG;SPLICEOSOME;;120;0.27910915;1.3110323;0.0359116;0.37823996
KEGG;AMINOACYL TRNA BIOSYNTHESIS;;39;0.3407657;1.2842904;0.10769231;0.41129407
KEGG;BASAL TRANSCRIPTION FACTORS;;28;0.35476556;1.2048416;0.2413793;0.59238905
KEGG;HEDGEHOG SIGNALING PATHWAY;;28;0.34382114;1.1907475;0.19585253;0.5923232
KEGG;PYRIMIDINE METABOLISM;;81;0.27292672;1.1844187;0.14182693;0.5739498
KEGG;MELANOGENESIS;;53;0.28504756;1.1453334;0.22110553;0.65585285
KEGG;RETINOL METABOLISM;;15;0.39225534;1.1366528;0.29662922;0.6448525
KEGG;NEUROACTIVE LIGAND RECEPTOR INTERACTION;;47;0.28462613;1.1283373;0.25995317;0.63465023
KEGG;NUCLEOTIDE EXCISION REPAIR;;41;0.29094273;1.0994741;0.3166287;0.6917118
KEGG;FC EPSILON RI SIGNALING PATHWAY;;51;0.27546915;1.0899069;0.30867347;0.6892263
KEGG;RNA DEGRADATION;;54;0.26642162;1.0883863;0.2975;0.66254514
KEGG;STARCH AND SUCROSE METABOLISM;;22;0.3116005;1.0109411;0.42093542;0.88120955
KEGG;BETA ALANINE METABOLISM;;18;0.33325383;1.0103196;0.45905173;0.84635377
KEGG;PURINE METABOLISM;;114;0.21548313;1.0053368;0.45918366;0.82937056
KEGG;STEROID HORMONE BIOSYNTHESIS;;16;0.32412276;0.96509963;0.49530515;0.92839134
KEGG;PHOSPHATIDYLINOSITOL SIGNALING SYSTEM;;59;0.2310191;0.93698615;0.57349396;0.9867339
KEGG;FATTY ACID METABOLISM;;31;0.26679307;0.9306419;0.5419355;0.97121644
KEGG;GAP JUNCTION;;58;0.23173107;0.9284293;0.5772947;0.94420636
KEGG;GLYCEROPHOSPHOLIPID METABOLISM;;59;0.22227728;0.91549;0.63221157;0.9523558
KEGG;DORSO VENTRAL AXIS FORMATION;;17;0.30130672;0.911407;0.5681342;0.9338126
KEGG;CALCIUM SIGNALING PATHWAY;;70;0.21785893;0.9091045;0.64483625;0.911396
KEGG;NOD LIKE RECEPTOR SIGNALING PATHWAY;;35;0.24674366;0.9046373;0.63785046;0.8966319
KEGG;N GLYCAN BIOSYNTHESIS;;41;0.22730698;0.86675984;0.7173913;0.96932226
KEGG;ALANINE ASPARTATE AND GLUTAMATE METABOLISM;;19;0.2764825;0.8602122;0.6689342;0.9581911
KEGG;PPAR SIGNALING PATHWAY;;47;0.21990274;0.8459361;0.7628635;0.96498895
KEGG;BASAL CELL CARCINOMA;;28;0.24592695;0.8415181;0.7152778;0.9480734
KEGG;GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS;;22;0.24894886;0.8016993;0.7804878;1
KEGG;ARGININE AND PROLINE METABOLISM;;39;0.20663296;0.78051686;0.8472222;1
KEGG;ETHER LIPID METABOLISM;;22;0.23659627;0.7725125;0.8163717;1
KEGG;LONG TERM DEPRESSION;;41;0.20361032;0.7720955;0.86098653;0.98097223
KEGG;PROGESTERONE MEDIATED OOCYTE MATURATION;;64;0.1849713;0.76914036;0.8894349;0.96140635
KEGG;TYROSINE METABOLISM;;19;0.24060887;0.7632461;0.8076923;0.94768333
KEGG;PRION DISEASES;;20;0.23940797;0.75787765;0.80215055;0.9334167
KEGG;SNARE INTERACTIONS IN VESICULAR TRANSPORT;;34;0.19461516;0.69251263;0.9310345;0.97868913
KEGG;PROPANOATE METABOLISM;;28;0.1923899;0.6745997;0.9216152;0.9698939
KEGG;HISTIDINE METABOLISM;;17;0.20538017;0.62647533;0.96567506;0.97318554